1
EDUCATION OF CANCER HEALING THE
VOLUME vii: heretics
PETER HAVASI (Adv. Herb., Natur., Nutr. Irid. Acu. Hom. Bsya, Aura, Itec) 2
IMPORTANT NOTICE This book was not edited in its whole. As the author does not come from an English speaking country, please excuse any grammatical or stylistic mistakes that might disturb you while reading. This book is not intended to prescribe or diagnose in any way. It is not meant to be a substitute for professional help. The intent is to offer historical uses of herbs and other potentially healing substances. Those who are sick should consult their doctor. Neither the author nor the publisher directly or indirectly dispense medical advice or prescribe the use of herbs, nutrients, or other substances as a form of treatment. The author and publisher assume no responsibility if you prescribe to/for yourself without your doctor’s approval. "Miseducation is more dangerous than uneducation." According to the American Medical Association, drugs approved by the FDA kill over 100,000 Americans in hospitals every year! According to a 174-page report by the U.S. National Poison Data System the number of people killed in 2009 across America by vitamins, minerals, amino acids or herbal supplements is exactly zero! The use of herbs and other natural remedies is a natural right. We assert that each individual human being owns his or her own body--and no government, person or corporate entity has the right to usurp that ownership. No mere statute or regulation can take away a human right.
Copyright All rights reserved. No part of this book may be reproduced, stored in a retrieval system, or transmitted by any means; including, but not limited to, digital, electronic or mechanical photocopying, printing, recording, or otherwise, without written permission from the author. Š 2012 Lulu Author. All rights reserved. ISBN 978-1-291-45368-3 3
"The best day of your life is the one on which you decide your life is your own. No apologies or excuses. No one to lean on, rely on, or blame. The gift is yours... it is an amazing journey... and you alone are responsible for the quality of it. This is the day your life really begins." Bob Moawad
A Chinese proverb says, "Better to light a candle than lament the darkness." Darkness still prevails in the world of cancer and other diseases. I attempt to keep the candle alight with EDUCATION. ~ Peter Havasi
4
Special Thanks: I would like to give SPECIAL THANKS to my editor, Priska Sekerovรก, who conceived and guided this book to fruition. Priska Sekerovรก, you're like a limited edition. You are just one of a kind. Just the one of them all, YOU ARE SPECIAL! Thank you for all.
Acknowledgment: I have much gratitude for the invaluable help, knowledge, advice, and inspiration to those who supported me throughout the difficult times. 5
Dedication This book is dedicated to my beloved mother, Eva Havasiovรก. This publication is also given to all present and future mothers around the globe because the best health conditions for strong health are the most precious gift from a mother to her child. After all, women are the most beautiful things on this planet; the center for health, longevity, love and beauty amongst mankind.
6
Contents DEDICATION .............................................................................................................................................. 6 FOREWORD ................................................................................................................................................ 9 PREFACE ................................................................................................................................................... 11 INTRODUCTION ...................................................................................................................................... 12 MOTIVATION: JUMPSTART YOUR HEALTH .................................................................................. 15 CHAPTER 1: OXYGEN IN CANCER TREATMENT ......................................................................... 20 (~ 1850 AD) LOUIS PASTEUR ...................................................................................................................... 21 (~ 1930 AD) OTTO H. WARBURG M.D. PHD............................................................................................... 24 (~ 1940 AD) JOHN HEINERMAN, PH.D. ........................................................................................................ 37 (~ 1940 AD) DR. ROBERT C. OLNEY ........................................................................................................... 42 (~ 1980 AD) WILLIAM CAMPBELL DOUGLASS, M.D. .................................................................................. 49 (~ 1980 AD) EDWARD ROSENOW, M.D. ...................................................................................................... 60 (~ 1990 AD) F. SWEET, M.D., ...................................................................................................................... 64 (~ 1980 AD) DR. JUDAH FOLKMAN, ............................................................................................................ 71 (~ 1990 AD) LOUIS IGNARRO, PHD.............................................................................................................. 78 CHAPTER 2: MICROBIOLOGY IN CANCER TREATMENT .......................................................... 90 (~ 1890 AD) WILLIAM RUSSELL ................................................................................................................. 91 (~ 1930 AD) ROYAL RAYMOND RIFE PHD.,................................................................................................. 94 (~ 1950 AD) ANTOINE PRIORÉ ................................................................................................................... 113 (~ 1940 AD) GASTON NAESSENS ............................................................................................................... 116 (~ 1940 AD) JOHN E. GREGORY, M.D. ...................................................................................................... 127 (~ 1940 AD) ROBERT E. LINCOLN M.D. .................................................................................................... 130 (~ 1960 AD) DR. VIRGINIA WUERTHELE CASP LIVINGSTON ..................................................................... 133 (~ 1980 AD) TULLIO SIMONCINI, M.D. ..................................................................................................... 142
7
CHAPTER 3: MICROBIOLOGY IN CANCER TREATMENT ........................................................ 144 (~ 1880 AD) WILLIAM B. COLEY, M.D. ..................................................................................................... 145 (~ 1920 AD) WILLIAM F. KOCH, M.D., PHD. ............................................................................................ 154 (~ 1940 AD) J.H. LAWRENCE, M.D............................................................................................................ 165 (~ 1950 AD) EVANGELOS DANOPOULOS, M.D. ......................................................................................... 166 (~ 1970 AD) STANISLAV R. BURZYNSKI, M.D. PHD. ............................................................................... 176 CHAPTER 4: EXTRACTS AND ANTI- SERUMS IN CANCER TREATMENT ............................ 194 (~ 1920 AD) DR. T. J. GLOVER .................................................................................................................. 195 (~ 1930 AD) DR. WALTER B. COFFEY....................................................................................................... 200 (~ 1940 AD) PHILLIP DROSNES AND LILLIAN LAZENBY ............................................................................ 205 (~ 1940 AD) STEVEN DUROVIC, M.D........................................................................................................ 208 (~ 1940 AD) ANDREW C. IVY, M.D. ......................................................................................................... 212 (~ 1950 AD) HENRY K. WACHTEL, M.D. ................................................................................................... 222 (~ 1950 AD) S. BEALE M.D., ..................................................................................................................... 225 (~ 1950 AD) LAWRENCE BURTON, PH.D................................................................................................... 227 (~ 1960 AD) WALTER BLUMER, M.D........................................................................................................ 235 (~ 1960 AD) MIRKO BELJANSKI, PHD....................................................................................................... 239 (~ 1970 AD) JOSEPH GOLD, M.D. ............................................................................................................. 244 EPILOGUE: REFORM YOUR HEALTH ........................................................................................... 255 NOTES ...................................................................................................................................................... 257 PETER HAVASI: BIOGRAPHY ........................................................................................................... 294 MAXIMIZE YOUR KNOWLEDGE WITH THE NEXT VOLUME! ................................................ 301 BECOME CERTIFIED IN "HAVASI LIFE BUILDING" ......ERROR! BOOKMARK NOT DEFINED.
8
Foreword ("The Adventures of Jonathan Gullible" Epilogue by Ken Schoolland)
"My philosophy is based on the principle of self- ownership. You own your life. To deny this is to imply that another person has a higher claim on your life than you do. No other person, or group of persons, owns your life nor do you own the lives of others. You exist in time: future, present, and past. This is manifest in life, liberty, and the product of your life and liberty. The exercise of choices over life and liberty is your prosperity. To lose your life is to lose your future. To lose your liberty is to lose your present. And to lose the product of your life and liberty is to lose the portion of your past that produced it. A product of your life and liberty is your property. Property is the fruit of your labour, the product of your time, energy, and talents. It is that part of nature that you turn to valuable use. And it is the property of others that is given to you by voluntary exchange and mutual consent. Two people who exchange property voluntarily are both better off or they wouldn’t do it. Only they may rightfully make that decision for themselves. At times some people use force or fraud to take from others without willful, voluntary consent. Normally, the initiation of force to take life is murder, to take liberty is slavery, and to take property is theft. It is the same whether these actions are done by one person acting alone, by the many acting against a few, or even by officials with fine hats and fancy titles. You have the right to protect your own life, liberty, and justly acquired property from the forceful aggression of others. So you may rightfully ask others to help protect you. But you do not have a right to initiate force against the life, liberty, or property of others.
9
Thus, you have no right to designate some person to initiate force against others on your behalf. You have a right to seek leaders for yourself, but would have no right to impose rulers on others. No matter how officials are selected, they are only human beings and they have no rights or claims that are higher than those of any other human beings. Regardless of the imaginative labels for their behaviour or the numbers of people encouraging them, officials have no right to murder, to enslave, or to steal. You cannot give them any rights that you do not have yourself. Since you own your life, you are responsible for your life. You do not rent your life from others who demand your obedience. Nor are you a slave to others who demand your sacrifice. You choose your own goals based on your own values. Success and failure are both the necessary incentives to learn and to grow. Your action on behalf of others, or their action on behalf of you, is only virtuous when it is derived from voluntary, mutual consent. For virtue can only exist when there is free choice. This is the basis of a truly free society. It is not only the most practical and humanitarian foundation for human action; it is also the most ethical. Problems that arise from the initiation of force by government have a solution. The solution is for people of the world to stop asking officials to initiate force on their behalf. Evil does not arise only from evil people, but also from good people who tolerate the initiation of force as a means to their own ends. In this manner, good people have empowered evil throughout history. Having confidence in a free society is to focus on the process of discovery in the marketplace of values rather than to focus on some imposed vision or goal. Using governmental force to impose a vision on others is intellectual sloth and typically results in unintended, perverse consequences. Achieving a free society requires courage to think, to talk, and to act – especially when it is easier to do nothing."
10
Preface Having witnessed how cancer systematically wiped out my own family members and friends, I became aware of the severity of the situation the modern society faces today. I disagree with the vision of ending this life somewhere in a cold hospital death bed, suffering from agonizing pain which lasts a small eternity. Dying without dignity is not the right way to end this beautiful life… I have no idea how others cope with this dreadful vision, but I decided to hit the "emergency button". I seriously started to think about what we can do to heal cancer and prevent it from spreading in modern day society. I have devoted my professional life together with my personal commitment to the exploration of the world’s natural healing systems because nature has no side-effects. The fruits of my CANCER HEALING CRUSADE are this masterwork. It is the most complex HISTORICAL REVIEW OF CANCER HEALING, based on the knowledge of the world’s ancient healing arts and successful pioneers that have stood the test of time. For the first time in the human history, you will see them all standing at one place, "running the show", and healing once again because this book collection carries a real lifesaving potential. It is also a safe alternative for you unless you are interested in cultivating and maintaining chronic diseases with chemical drugs and barbaric surgical operations as well as the physical, emotional, and financial breakdown that is caused by the current system of disease management. Some call it building up powerful health, but I call it LIFE BUILDING. YOU’VE JUST FOUND YOUR MAN ON THE WAY TO YOUR HEALTH! 11
Introduction "The Education of Cancer Healing" is the MOST comprehensive and COMPLETE study collection on the history of cancer healing on the market today. Totaling more than 2500 pages filled with invaluable information, this magnum opus holds answers to your questions regarding cancer and many other diseases. These books give you information which is in fact a HEALING DYNAMITE, covered by thousands of scientific and medical studies, independent professionals, and dozens of patient and witness testimonials. With this masterwork, I am giving you the BEST of my own research – the product of $300,000 and the result of more than 20,000 hours of exhaustive and careful research in the field of cancer. Where is cancer? It’s all around us! In fact, cancer cells develop spontaneously on a daily basis and they develop in YOUR body, too. Some findings even claim that a healthy individual develops about 350 cancerous cells a day. The number goes up to 100,000 cancerous cells and higher. Some do get cancer, some do not... How come that someone gets seriously ill but someone else doesn’t? How is that!? What makes the body develop these cancer cells further? My mission is to give you THE SUPER KNOWLEDGE – the foundation for super powers that are within you, so that you can heal yourself of cancer (and any other disease), and live your life to the fullest potential! I will be your guide on your way to POWERFUL HEALTH. This life is a blessing, so squeeze the best out of it! At the end of this study, I want YOU to be strong and confident enough to stare death right in the face… and spit in it. I truly wish you to grab hold of another 20, 30 or 40 years and live a wonderful life – as anyone really deserves!
12
Somebody told me once, "Peter, your topic makes me uncomfortable." Yes, I have to admit that this book is really going to be a tough reading… but hey! Only the tough ones survive, right?! HALLELUJAH! It’s my job to make you feel a bit uncomfortable! The concept of natural healing arts is identical with the concept of ancient martial arts: it is all about living OUTSIDE THE COMFORT ZONE because that’s the place where magic happens. Yes, we need to get uncomfortable to understand our dangers and realize the seriousness of the situation. In this volume I will show you how cancer was healed using natural techniques throughout human history. On these pages you will be revealed the lives of many forgotten mavericks that successfully healed people from cancer. With this volume, I bring you a step closer in answering: "How can be Cancer healed and prevented safely!?" You will be revealed things you have never seen, nor heard of before. This book opens up the world which has been hidden from you by the world’s industries for decades. You may not know anything about this hidden world, but the fact remains that cancer cells are here and our life-style feeds them. Not only that you yourself develop life-threatening and dehumanizing diseases, but also increase the risk of cancer for your own children as well as other future generations. You can run away from this fact, but you cannot really hide! Have you ever admitted the existence of this problem? What steps have you taken to win your health back...?
13
The good news is that cancer CAN be PREVENTED effectively. It CAN also be HEALED – with the right KNOWLEDGE and DISCIPLINE. To admit that you have a problem is the first step to solving it. Cancer is projected for EVERY second male and every third female by 2030. In other words: you cannot stop your body from developing cancerous cells, but you CAN DO a lot to expunge them out safely and efficiently by cultivating a STRONG DEFENSE SYSTEM and CREATING a POWERFUL BODY. If you care about your liberty and preserving it, you need to care about your health. If you want to be healthy, study "The Education of Cancer Healing" study collection today. READ IT, LOVE IT, LIVE IT! Realize the severity of the situation, and act. TODAY. Take the responsibility for your health NOW, before you allow your health and freedom to be taken away by the world’s leading health industries.
Welcome to The Education of Cancer Healing, Volume 7: HERETICS.
"Storms make trees take deeper roots." ~ Dolly Parton
14
Motivation:
Jumpstart Your Health
„Courage is not the absence of fear, but rather the judgment that something else is more important than fear." - Ambrose Redmoon
15
Havasi Life Building – Building a Powerful Body Healing cancer is about EDUCATION. It is about learning how to live in harmony with the laws of nature. Over the centuries, these laws have been explored and now are contained in many ARTS OF HEALING AND FIGHTING. The beauty of this combination lies in its connection: one art cannot live without the other. If you want to heal yourself of any disease, if you want to design a high quality life and have a successful family, it is absolutely important to study and practice the ways how to heal diseases as well as how to cultivate an unbeatable body, mind and spirit. This is the combination that makes healing miracles happen. At the end of the day, you will realize that true natural healing and life building is all about education, harmony, and a warrior’s spirit, together with a day-to-day kicking of your own butt. This I call Havasi Life Building, a new selforiented medical discipline which searches for PERFECTION in physical, emotional and spiritual aspects of YOUR health. The Shock Therapy – The Warrior’s Attitude: What I am going to show you in this book is not a bed of roses. What you are going to see is the history of cancer epidemics – a survival study that is hard to swallow! Cancer is not a fairy tale. Never was and never will be. Yes, this book kicks some serious ass and may even wipe the floor up with you. It will make you paralyzed, it may bring nightmares and it will make you wonder what planet you live on. The book you are holding in your hands is evil – but so is the world around you! I was just trying to reflect as much of the real world behind cancer as possible – even though there is probably much more to this topic than meets the eye. 16
Today, you may find this book evil and unconventional. Following the future volumes of "The Education of Cancer Healing", you will, however, realize that this book is an ESSENTIAL EVIL. It is the shock therapy which wakes a dead man up, opens his eyes, mobilizes his actions, and makes things happen. One day you will realize that this study collection has the potential of SAVING LIVES! Before you dive into the world of saving lives and natural healing, it is important to learn how people are killed today. Know your enemy, whoever or whatever it may be! THIS IS THE MOST IMPORTANT LESSON I TEACH! BE STRONG! After years of studies I realized that everything is all about "LEAVING THE COMFORT ZONE"! If you want to start changing things, you must find the strength to step outside of it because EVERY HEALING MIRACLE HAPPENS OUTSIDE THE COMFORT ZONE. I confess: my aim is to make you FEEL UNCOMFORTABLE! In order to wake you up, your world must be shaken vigorously. Pain – physical, emotional, or spiritual – can be a valuable asset for escalation of your actions. Throughout the millennia, your body, mind, and spirit have originally evolved in different ways of pleasure from the ones promoted by the today’s standard society. This master study will wake up the warrior inside you. BE STRONG! If this book makes you feel fear – use it! If you feel anger – use it! I want you to JUMPSTART your ACTIONS, and start CHANGING things today! I challenge you! Realize the seriousness of the situation today – before it’s too late! Start living, thinking, and acting as a warrior does on the battlefield. 17
Taking the Responsibility and Predicting Dangers One of the outcomes of studying the world of cancer healing is the cultivation of RESPONSIBILITY and PREDICTION/PREVENTION OF DANGERS. If you want to avoid dangers, predicting them is super important! Learning the history of events which happened gives you a sense of things which are very likely to take place in the future. Cultivating a strong sense of danger prediction and prevention is the vital aspect of Havasi Life Building. We can see that that people stopped sensing and taking the full responsibility for their lives and actions. If people are not able to take responsibility for their physical, emotional, and spiritual health, HOW CAN THEY TAKE CARE OF THE OTHERS? While the standard society seeks pleasure, a LIFE BUILDER builds up an UNBEATABLE BODY, MIND, AND SPIRIT as well as cultivates A CHARACTER OF A WARRIOR that is able to sense, predict and prevent dangers. This scenario can be applied to health and other aspects of your life, including cancer epidemics. Havasi Life Building teaches you how to walk the path of an ancient warrior – A TRUE MODEL – the missing key in modern society. THE STOP–START THEORY Healing yourself of cancer and building up powerful health is all about to STOP doing things that cause disease, and START doing things that heal your body, mind, and spirit! This is the most fundamental and simple theory. On the other hand, for many people it is also the most difficult task to achieve.
18
Ancient Chinese philosopher Lao-Tzu said, "A journey of a thousand miles begins with a single step." The first steps are always the most difficult ones to take. To succeed, you must put an enormous pressure upon your body, mind, and spirit while doing those first steps. Behind every success there is 100% devotion, followed by hard, hard work. I truly believe that every human being is equipped with a mind of unlimited boundaries. If there are boundaries – they are made by YOU! Whatever you want to achieve, I know that YOU WILL, you just HAVE TO be ready to fight for it! The biggest threat lies in the limitations you have set to your knowledge and mind. If you want to prevent from this disastrous road to hell, IT IS ABOUT TIME to make a change today! The Final Product At the end of the day, the concept remains unchanged. I want you to start BUILDING UP POWERFUL HEALTH TODAY. This concept is the absolute foundation for peace, love, and happiness. However, I have to point out that these heavenly assets don’t come for free! EVERYTHING YOU WANT, YOU CAN HAVE IT. BUT YOU MUST BE READY TO FIGHT FOR IT!
„A journey of a thousand miles begins with a single step." - Lao- Tzu
19
Chapter 1:
Oxygen in Cancer Treatment
"People say you can't live without love... I think oxygen is more important." 20
„Dr Otto Warburg won the nobel prize twice for stating that the cause of cancer is a normal cell denied 60% of its oxygen requirements"
(~ 1850 AD) Louis Pasteur Summary: Research into fermentation Recommended Literature: Louis Pasteur's Studies on Fermentation by Louis Pasteur (1876), Germ theory and its applications to medicine & on the antiseptic principle of the practice of surgery by Louis Pasteur (1996) Louis Pasteur (1822- 1895) was a French chemist and the first known zymologist, when in 1856 he connected yeast to fermentation. Pasteur originnally defined fermentation as "respiration without air". In 1907 he received the Nobel Prize in Chemistry for his research and discovery of "cellfree fermentation."
(The following information is excerpted from: Fermentation, www.angelfire.com) 1
Pasteur devoted himself to research on the process of fermentation when in 1856, Monsieur Bigo, (father of one of his pupils) who owned a large factory manufacturing alcohol from beet juice, came to him with a puzzling and interesting problem: most of the time the process of changing beet sugar into alcohol in his factory was going well, but in some of the vats, the juice wasn't turning into alcohol, it was going sour. The spoiled vats were losing Monseiur Bigo thousands of francs a day. Louis went to his factory to have a look. He sniffed at the vats of fermenting sugarbeet juice. Here the juice was turning into alcohol. But in Reference: Fermentation, www.angelfire.com
21
"It is surmounting difficulties that makes heroes." - Louis Pasteur "Never will the doctrine of spontaneous generation recover from the mortal blow struck by this simple experiment." - Louis Pasteur "I am on the edge of mysteries and the veil is getting thinner and thinner." - Louis Pasteur in letter (December 1851) "In the fields of observation chance favors only the prepared mind." - Louis Pasteur "Science knows no country, because knowledge belongs to humanity, and is the torch which illuminates the world. Science is the highest personification of the nation because that nation will remain the first which carries the furthest the works of thought and intelligence." - Louis Pasteur "I am utterly convinced that Science and Peace will triumph over Ignorance and War, that nations will eventually unite not to destroy but to edify, and that the future will belong to those who have done the most for the sake of suffering humanity." - Louis Pasteur "Let me tell you the secret that has led me to my goal. My strength lies solely in my tenacity." - Louis Pasteur "When I approach a child, he inspires in me two sentiments; tenderness for what he is, and respect for what he may become." - Louis Pasteur "Do not let yourself be tainted with a barren skepticism." - Louis Pasteur
some other vats, there was a slimy sour mess! Louis looked at it but could not figure out why so he decided to have a better look, properly, in his laboratory. He put some of the sour stuff into bottles, some of the good stuff and went off. He examined the fermenting juice under his microscope and saw thousands of yeast cells. Scientists had known that yeast cells were always present in fermenting liquors, but no one knew what effect they had. When Louis looked at the cells he noticed that they were alive. Suddenly he understood how fermentation took place. When the yeast cells grew and divided, they gave off alcohol and a clear gas called carbon dioxide. When he peered at a drop of liquid from the sour vats, he did not see any yeast cells. Instead, the liquid was swarming with millions of minute wriggling bacteria, which looked like tiny black rods. He realized what was happening. The bacteria had overrun the yeast cells and instead of producing alcohol and carbon dioxide, they were producing lactic acid, the acid that sours milk. He tested his theory by placing the growing bacteria in some soup made from yeast cells. He repeated his experiments several times until he was absolutely sure. The black rods were living bacteria and these tiny microbes were producing lactic acid, which spoiled alcohol and milk. Although he could not yet tell Reference: Fermentation, www.angelfire.com
22
"The idea of God is a form of the idea of the Infinite. As long as the mystery of the infinite weighs on human thought, temples will be erected for the worship of the Infinite, whether God is called Brahma, Allah, Jehovah, or Jesus; and on the pavement of these temples, men will be seen kneeling, prostrated, annihilated by the thought of the Infinite." - Louis Pasteur "The universe is asymmetric and I am persuaded that life, as it is known to us, is a direct result of the asymmetry of the universe or of its indirect consequences. The universe is asymmetric." - Louis Pasteur "Blessed is he who carries within himself a God, an ideal, and who obeys it: ideal of art, ideal of science, ideal of the gospel virtues, therein lie the springs of great thoughts and great actions; they all reflect light from the Infinite." - Louis Pasteur "Science brings men nearer to God." - Louis Pasteur "The Greeks have given us one of the most beautiful words of our language, the word "enthusiasm" — a God within." - Louis Pasteur
"A bottle of wine contains more philosophy than all the books in the world." - Louis Pasteur
Monseiur Bigo how to kill of the microbes in his vats, he was able to tell him how to ensure that good alcohol would be produced. If even one bacterium was found in the vats of juice, the whole vat had to be discarded. The fermenting industry was saved and Louis became a local hero.
Reference: Fermentation, www.angelfire.com
23
"When studying the fermentation of sugar to alcohol by yeast, Louis Pasteur concluded that the fermentation was catalyzed by a vital force, called "ferments," within the yeast cells. The "ferments" were thought to function only within living organisms. "Alcoholic fermentation is an act correlated with the life and organization of the yeast cells, not with the death or putrefaction of the cells,"[3] he wrote. Nevertheless, it was known that yeast extracts can ferment sugar even in the absence of living yeast cells. While studying this process in 1897, Eduard Buchner of Humboldt University of Berlin, Germany, found that sugar was fermented even when there were no living yeast cells in the mixture,[4] by a yeast secretion that he termed zymase.[5] In 1907 he received the Nobel Prize in Chemistry for his research and discovery of "cell- free fermentation." - Wikipedia.org, the free encyclopedia) 2
"Dr Otto Warburg won the Nobel prize twice for stating that the cause of cancer is a normal cell denied 60% of its oxygen requirements."
(~ 1930 AD) Otto H. Warburg M.D. PhD. Summary: Research into cellular respiration, the effect of oxygen on cancer, action of the respiratory enzyme. Warburg’s theory of cancer was monumental, and resulted in major advances in alternate cancer treatment later in the century. Otto Warburg (18831970), a German scientist who earned double doctorates in chemistry and medicine. The director of Max Planck Institute for Cell Physiology in Berlin-Dahlem; the foreign member of the Royal Society; a member of the Academies of Berlin, Halle, Copenhagen, Rome, and India. The Nobel Prize for Physiology.
Recommended Literature: Stoffwechsel der Tumoren (1926), Katalytische Wirkungen der lebendigen Substanz (1928), Schwermetalle als Wirkungsgruppen von Fermenten (1946), Wasserstoffübertragende Fermente (1948), Mechanism of Photosynthesis (1951), Entstehung der Krebszellen (1955), and Weiterentwicklung der zellphysiologischen Methoden (1962). (Reference: "Otto Warburg - Biography". Nobelprize.org.25 Feb 2013; Otto Warburg, NNDB tracking the entire world, http://www.nndb.com/) 6, 7
Otto Warburg was born on October 8, 1883, in Freiburg, Baden, Germany. He studied chemistry and obtained a degree in chemistry in 1906. Afterwards, Dr. Warburg decided to broaden his horizons in the field of medicine. He studied and gained the degree of a Doctor of Medicine in 1911. In 1918 he was appointed as a professor at the Kaiser Wilhelm Institute for Biology in Berlin-Dahlem. Since 1931 he Reference: Otto Warburg - Biography". Nobelprize.org. 25 Feb 2013; Otto Warburg, NNDB tracking the entire world, http://www.nndb.com/)
24
"major discoveries and fields of interest" are credited to Warburg. - According to Dictionary of Scientific Biography 7 "Cancer has only one prime cause. It is the replacement of normal oxygen respiration of the body's cells by an anaerobic [i.e., oxygen- deficient] cell respiration." - Dr. Otto Warburg M.D., PhD. "All normal cells have an absolute requirement for oxygen, but cancer cells can live without oxygen – a rule without exception." - Dr. Otto Warburg M.D., PhD. "Deprive a cell 35% of its oxygen for 48 hours and it may become cancerous." - Dr. Otto Warburg M.D., PhD. "Cancerous tissues are acidic, whereas healthy tissues are alkaline. Water splits into H+ and OH- ions, if there is an excess of H+, it is acidic; if there is an excess of OH- ions, then it is alkaline." - Dr. Otto Warburg M.D., PhD.
was the director of the Kaiser Wilhelm Institute for Cell Physiology. His early researches were involved in the field of polypeptides. Later, he focused on the process of oxidation. Oxidation and cancer were the topics which soon became one of the passions of Dr. Warburg’s life. The research on oxidation involved detailed studies on the chemical constituent of the oxygen transferring respiratory ferment, assimilation of carbon dioxide in plants, and the metabolism of tumors. Later, these researchers led Dr. Warburg to a discovery that flavins and nicotinamide were the active groups of hydrogen-transferring enzymes. This, together with the iron-oxygenase discovered earlier, gave a complete account of the oxidations and reductions in the living world. Dr. Warbug’s life as a researcher was broadranging and very rich. Among other research projects, he investigated photosynthesis, discovered ferredoxin (the electron carrier in green plants) and demonstrated how the energy of light becomes chemical energy. Dr. Warburg studied the process of biological dehydrogenations and the metabolism of sea urchin eggs; he isolated the first flavoproteins and showed that niacin is required for respiration.
Reference: Otto Warburg - Biography". Nobelprize.org. 25 Feb 2013; Otto Warburg, NNDB tracking the entire world, http://www.nndb.com/)
25
The physicist Manfred Von Ardenne recently discovered that cancer cells owing to their fermentation, are more acid - inside and on their surface than normal cells. "In 1965, just before Dr. Otto made the following speech the Ministry of Welfare of Japan announced that reduced water obtained from electrolysis can prevent abnormal fermentation of intestinal microbes. "When taken internally, the effects of reduced water are immediate. Ionized water inhibits excessive fermentation in the digestive tract by reducing indirectly metabolites such as hydrogen sulfide, ammonia, histamines, indoles, phenols and scatoles, resulting in a cleaner stool within days after reduced water is taken on a regular basis." In 1965, the Ministry of Welfare of Japan announced that reduced water obtained from electrolysis can prevent abnormal fermentation of intestinal microbes." - Dr. Hidemitsu Hayashi, M.D. Director, Water Institute of Japan AlkaViva, http://www.ionways.com 8 "The Women's Health Study found that those who consumed a diet which raised blood sugar levels more had a 135% higher risk of getting breast cancer in the 7-year period of the study." - www.NaturalNews.com 9 "An Italian study examined the habits of men aged 46 to 74 who had prostate cancer and compared their dietary choices to similar men who did not contract the disease. The study found that those men whose diets were more likely to increase blood sugar levels had a 57% higher risk of getting prostate cancer." - www.NaturalNews.com 9
In his research on cancer, one of Dr. Warburg’s projects showed the carcinogenic nature of food additives and smoking cigarettes. Other project demonstrated that cancer cells can be destroyed by radiation. He never believed that anaerobiosis was the primary cause of cancer. Dr. Warburg knew that ENVIRONMENTAL ASPECTS play a major role in the impact of the disease. Dr. Warburg’s own research on carcinogens made him terrifed of processed foods. Since that time, he avoided ALL PROCESSED FOODS around. Fully organic bread and butter were his requirements. Dr. Warburg knew that processed food and carcinogens have a strong impact on cancer. For his liberal thinking, he too was followed and his theories were disbelieved, suppressed and ridiculed by other scientists and medical doctors. Dr. Warburg’s research on cancer took place in Germany during the World War 2. As his father was Jewish, Dr. Warburg faced persecution by the Nazis. Once he was even ordered to stop his research completely – only because of his heritage. One of his Hungarian-Jewish lab technicians was escorted in the 1938. However, since German Chancellor Adolf Hitler had a deathly fear of cancer and Dr. Warburg was researching cancer, Hitler’s office intervened and Dr. Warburg was Reference: Otto Warburg - Biography". Nobelprize.org. 25 Feb 2013; Otto Warburg, NNDB tracking the entire world, http://www.nndb.com/)
26
"A large study carried out by Johns Hopkins Bloomberg School of Public Health and Yonsei University in Seoul, Korea tracked almost 1.3 million Korean men and women, aged between 30 and 95 years, for a period of 10 years. The study found that those with the highest fasting glucose levels were more likely to die from all types of cancer combined. For the men, the strongest link was found for pancreatic cancer, while significant links were also reported for oesophagus, liver and colorectal cancers. For the women, the strongest associations were for liver and cervical cancers. All in all, besides being more likely to die from cancer, those with highest fasting blood glucose levels also had higher risk of developing cancer. And obesity had a part to play, too. "This study provides more information on glucose intolerance, an emerging cause of cancer. It points to increased cancer risk as another adverse consequence of rising obesity around the world," concluded Sun Ha Jee, leader of the study. Another thing to note - the study participants were said to be substantially leaner than the typical population in Western countries, as mentioned by the study team." Source: www.NaturalNews.com 9
promptly reclassified as "less than one-quarter Jewish" and allowed to continue his work. It is very possible that Dr. Warburg would have been escorted, too... After decades of studying, Dr. Warburg officially announced in the 1960’s that cancer prevention and treatment should be built around respiratory enzymes, iron and B vitamins. One of his findings showed that even if there is plenty of oxygen in the body, cancer cells continue to use glycolysis. Remember that cancer is not all about oxygen deficiency. Dr. Warburg was talking about ENZYME DEFICIENCY. Glycolysis is a secondary system of producing energy, which normal cells use if they lack on oxygen. This theory had been DISMISSED for long by mainstream medicine, but it was brought back to the forefront by a 2007 research, which is now believed to hold great promise in the war on cancer. Dr. Warburg discovered the respiratory enzyme iron-oxygenase and identified its active group (iron). Soon, in 1931 Dr. Warburg was awarded with a Nobel Prize for discovering the nature and mode of action of the respiratory enzyme. Among other things, he demonstrated that cancerous cells can live and develop, even at the absence of oxygen. This Reference: Otto Warburg - Biography". Nobelprize.org. 25 Feb 2013; Otto Warburg, NNDB tracking the entire world, http://www.nndb.com/)
27
"A study carried out at Umea University Hospital in Sweden looked at almost 65,000 people in northern Sweden for a mean period of 8 years. The study found that women with the highest blood sugar levels had a higher risk of getting cancer before the end of the study period. This group of women also had higher risk of endometrial cancer, while those below 49 years of age had higher risk of breast cancer. In addition, both men and women who had the highest levels of blood sugar had higher risks of pancreatic cancer, urinary tract cancer, as well as malignant melanoma. These results led Par Stattin, MD, PhD, part of the study team, to state that keeping blood sugar levels within the normal range "may reduce cancer risk"." Source: www.NaturalNews.com 9 A study conducted by Harvard Medical School found that women who ate the most foods with high glycemic load – the glycemic index, or GI, of a food gives an idea of how quickly sugar (more specifically, glucose) levels in the blood rise after eating it – had almost three times the risk of getting colorectal cancer in the future, compared with women who ate lesser amounts of such foods. Typically, processed foods made from refined grains and refined sugar, including candy bars, cakes, cookies and other snacks, are high glycemic foods "We find a very straightforward and clear association between highglycemic foods and the risk of colorectal cancers," said lead researcher Simin Liu, MD, ScD. This study involved some 40,000 American women." Source: www.NaturalNews.com 9
discovery opened up new ways in the fields of cellular metabolism and cellular respiration for many other scientists for decades to come. In 1944, Dr. Warburg was offered a second Nobel Prize, but the Nazi government ordered to refuse it. This, however, doesn’t change the fact that he taught at least three Nobel Prizewinners: Hans Krebs, Axel Theorell and Otto Meyerhof. Dr. Warburg remains one of the world's greatest biochemists in the history of mankind.
"The Women's Health Study found that those who consumed a diet which raised blood sugar levels more had a 135% higher risk of getting breast cancer in the 7-year period of the study." Source: www.NaturalNews.com 9 "The Iowa Women's Health Study looked at some 23,000 postmenopausal women. It found that those who consumed a diet which raised blood sugar levels more had a 46% higher risk of getting endometrial cancer over a period of 15 years." Source: www.NaturalNews.com 9
"Another study in Italy carried out on women with endometrial cancer found that those who consumed a blood sugar-raising diet had a 110% higher risk of getting this disease." Source: www.NaturalNews.com 9 "In a study which followed almost 90,000 US women participating in the Nurse's Health Study for a period of 18 years, it was found that women with a high glycemic load intake had a 53% higher risk of getting pancreatic cancer. A similar increase in risk, 57%, was observed for fructose intake. Further, the study also found that women who were heavy and with low levels of physical activity experienced greatly enhanced risk. Women in this group with high glycemic load had 2.67 times the risk of their counterparts with low glycemic load intake!" Source: www.NaturalNews.com 9
Reference: Otto Warburg - Biography". Nobelprize.org.25 Feb 2013; Otto Warburg, NNDB tracking the entire world, http://www.nndb.com/)
28
Cause and Prevention of Disease (The following information is excerpted from an official speech by Dr. Otto Warburg's Address to Nobel Laureates, June 30, 1966 at Lindau, Lake Constance, Germany. O. Warburg won the Nobel Prize in Medicine in 1931 for his discovery of the oxygen transferring enzyme of cell respiration)
There are prime and secondary causes of diseases. For example, the prime cause of the plague is the plague bacillus, but secondary causes of the plague are filth, rats, and the fleas that transfer the plague bacillus from rats to man. By the prime cause of a disease, I mean one that is found in every case of the disease. Cancer, above all other diseases, has countless secondary causes. Almost anything can cause cancer. But, even for cancer, there is only one prime cause. The prime cause of cancer is the replacement of the respiration of oxygen ... in normal body cells by fermentation of sugar. All NORMAL BODY CELLS meet their energy needs by respiration of oxygen, whereas cancer cells meet their energy needs in great part by fermentation. All normal body cells are thus obligate aerobes, whereas all cancer cells are partial anaerobes. From the standpoint of the physics and chemistry of life this difference between normal and cancer cells is so great that one can scarcely picture a greater difference. Oxygen gas, the donor of energy in plants and animals, is dethroned in the cancer cells and replaced by the energy yielding reaction of the lowest living forms, namely the FERMENTATION OF SUGAR. In every case, during the cancer development, the oxygen respiration always falls, fermentation appears, and the highly differentiated cells are transformed into fermenting anaerobes, which have lost all their body functions and retain only the now useless property of growth and replication. Thus, when respiration disappears, life does not disappear, but the meaning of life disappears, and what remains are growing machines that destroy the body in which they grow. Reference: Excerpted from an official speech by Dr. Otto Warburg's Address to Nobel Laureates, June 30, 1966 at Lindau, Lake Constance, Germany
29
To PREVENT CANCER it is therefore proposed first to keep the speed of the blood stream so high that the venous blood still contains sufficient oxygen; second, to keep high the concentration of hemoglobin in the blood; third, to add always to the food, even of healthy people, the active groups of the respiratory enzymes; and to increase the doses of these groups, if a precancerous state has already developed. If at the same time exogenous carcinogens are excluded rigorously, then MUCH OF THE ENDOGENOUS CANCER MAY BE PREVENTED TODAY. These proposals are in no way utopian. On the contrary, they may be realized by everybody, everywhere, at any hour. Unlike the prevention of many other diseases, the prevention of cancer requires no government help, and not much money. Many experts agree that one could prevent about 80% of all cancers in man, if one could keep away the known carcinogens from the normal body cells. But how can the remaining 20%, the so- called spontaneous cancers, be prevented? It is indisputable that ALL CANCER COULD BE PREVENTED IF THE RESPIRATION OF BODY CELLS WERE KEPT INTACT. Nobody today can say that one does not know what the prime cause of cancer is. On the contrary, there is no disease whose prime cause is better known, so that today ignorance is no longer an excuse for avoiding measures for prevention. That the prevention of cancer will come there is no doubt. But how long prevention will be avoided depends on how long the prophets of agnosticism will succeed in inhibiting the application of scientific knowledge in the cancer field. In the meantime, millions of men and women must die of cancer unnecessarily."
Reference: Excerpted from an official speech by Dr. Otto Warburg's Address to Nobel Laureates, June 30, 1966 at Lindau, Lake Constance, Germany
30
OTTO WARBURG at Wiesenhof (August 1966) (Excerpted from a Follow- Up Lecture by Otto Warburg, Director, Max Planck- Institute for Cell Physiology, BerlinDahlem, English Edition by Dean Burk, National Cancer Institute, Bethesda, Maryland, USA)
If a lowered oxygen pressure during cell growth may cause cancer, or, more generally, if any inhibition of respiration during growth may cause cancer, then a next problem is to show why reduced respiration induces cancer. Since we already know that with a lowering of respiration fermentation results, we can re- express our question: Why does cancer result if oxygen- respiration is replaced by fermentation? The early history of life on our planet indicates that life existed on earth before the earth's atmosphere contained free oxygen gas. The living cells must therefore have been fermenting cells then, and, as fossils show, they were undifferentiated single cells. Only when free oxygen appeared in the atmosphere - some billion years ago did the higher development of life set in, to produce the plant and animal kingdoms from the fermenting, undifferentiated single cells. What the philosophers of life have called "Evolution crĂŠatrice" has been and is therefore the work of oxygen. The reverse process, the dedifferentiation of life, takes place today in greatest amount before our eyes in cancer development, which is another expression for dedifferentiation. To be sure, cancer development takes place even in the presence of free oxygen gas in the atmosphere, but this oxygen may not penetrate in sufficient quantity into the growing body cells, or the respiratory apo- enzymes of the growing body cells may not be saturated with the active groups. In any case, during the CANCER DEVELOPMENT the oxygen - respiration always falls, fermentation appears, and the highly differentiated cells are transformed to fermenting anaerobes, which have lost all their body functions and retain only the now useless property of growth. Thus, when respiration disappears, life does not disappear, but the meaning of life Reference: Excerpted from an official speech by Dr. Otto Warburg's Address to Nobel Laureates, June 30, 1966 at Lindau, Lake Constance, Germany
31
disappears, and what remains are growing machines that destroy the body in which they grow. But why oxygen differentiates and why lack of oxygen dedifferentiates? Nobody would dispute that the development of plants and animals and man from unicellular anaerobes is the most improbable process of all processes in the world... But according to the thermodynamics of Boltzmann, improbable processes require work to take place. It requires work to produce temperature differences in a uniformly temperatured gas; whereas the equalization of such temperature differences is a spontaneous process that does not require work. It is the oxygen - respiration that provides in life this work, and DEDIFFERENTIATION BEGINS at once when respiration is inhibited in any way. In the language of thermo- dynamics, differentiation represents a forced steady state, whereas dedifferentiation - that is, cancer - is the true equilibrium state. Or, illustrated by a picture: the differentiated body cell is like a ball on an inclined plane, which, would roll down except for the work of oxygen- respiration always preventing this. If oxygen respiration is inhibited, the ball rolls down the plane to the level of dedifferentiation. In Summary: Impairment of respiration is more frequent than impairment of fermentation because respiration is more complicated than fermentation. The impaired respiration can be easily replaced by fermentation, because both processes have a common catalyst, the nicotinamide. The consequence of the replacement of respiration by fermentation is mostly glycolysis, with death of the cells by lack of energy. Only if the energy of fermentation is equivalent to the lost energy of respiration, is the consequence anaerobiosis. Glycolysis means death by fermentation, anaerobiosis means life by fermentation. Cancer arises, because respiration, but not fermentation, can maintain and create the high differentiation of body cells. Reference: Excerpted from an official speech by Dr. Otto Warburg's Address to Nobel Laureates, June 30, 1966 at Lindau, Lake Constance, Germany
32
List of known health risks of refined sugar (The following information was excerpted from a book: Suicide By Sugar: A Startling Look at Our #1 National Addiction, Nancy Appleton Ph.D (Author), G. N. Jacobs (Author), www.nancyappleton.com) 10
- Sugar suppress the immune system - Sugar feeds cancer - Sugar upsets the mineral relationships in the body - Sugar causes hyperactivity - Sugar causes anxiety - Sugar causes difficulty concentrating in children - Sugar causes crankiness in children - Sugar produces a significant rise in triglycerides - Sugar contributes to the reduction in defense against bacterial infection - Sugar causes a loss of tissue elasticity and function - Sugar reduces high density lipoproteins - Sugar leads to chromium deficiency - Sugar leads to cancer of the ovaries - Sugar increases fasting levels of glucose - Sugar causes copper deficiency - Sugar interferes with absorption of calcium - Sugar weakens eyesight - Sugar raises the level of a dopamine neurotransmitter - Sugar raises the level of a serotonin, and norepinephrine Reference: Suicide By Sugar: A Startling Look at Our #1 National Addiction, Nancy Appleton Ph.D (Author), G. N. Jacobs (Author), www.nancyappleton.com
- Sugar raises the level of a norepinephrine - Sugar causes hypoglycemia - Sugar produces an acidic digestive tract - Sugar causes a rapid rise of adrenaline levels in children - Sugar malabsorption is frequent with functional bowel disease - Sugar causes premature aging - Sugar leads to alcoholism - Sugar causes tooth decay - Sugar contributes to obesity - Sugar increases the risk of Crohn's disease - Sugar causes changes frequently found in person with gastric or duodenal cancers - Sugar causes arthritis - Sugar causes asthma - Sugar greatly assists the uncontrolled growth of Yeast infections - Sugar causes gallstones - Sugar causes heart disease - Sugar causes appendicitis - Sugar causes multiple sclerosis - Sugar causes hemorrhoids - Sugar causes varicose veins - Sugar elevates glucose and insulin responses in oral contraceptive users 33
- Sugar leads to periodontal disease - Sugar contributes to osteoporosis - Sugar contributes to saliva acidity - Sugar decreases in insulin sensitivity - Sugar lowers the amount of Vitamin E (alpha- Tocopherol in the blood - Sugar decrease growth hormone - Sugar increases cholesterol - Sugar increases blood pressure - Sugar causes drowsiness and decreased activity in children - Sugar intake increases advanced glycation end products (AGEs) - Sugar interferes with the absorption of protein - Sugar causes food allergies - Sugar contributes to diabetes - Sugar causes toxemia during pregnancy - Sugar contributes to eczema in children - Sugar causes cardiovascular disease - Sugar impairs the structure of DNA - Sugar changes the structure of protein - Sugar makes our skin age by changing the structure of collagen - Sugar causes cataracts - Sugar causes emphysema - Sugar causes atherosclerosis - Sugar elevates of low density lipoproteins - Sugar impairs the physiological homeostasis of many body systems Reference: Suicide By Sugar: A Startling Look at Our #1 National Addiction, Nancy Appleton Ph.D (Author), G. N. Jacobs (Author), www.nancyappleton.com
- Sugar lowers the enzymes ability to function - Sugar intake is higher in people with Parkinson’s disease - Sugar causes a permanent altering the way the proteins act in the body - Sugar increases the size of the liver by making the liver cells divide - Sugar increases the amount of liver fat - Sugar increases kidney size and produces pathological changes in them Sugar damages the pancreas - Sugar increases the body's fluid retention - Sugar is enemy #1 of the bowel movement - Sugar causes myopia (nearsightedness) Sugar compromises the lining of the capillaries - Sugar makes the tendons more brittle - Sugar causes headaches, including migraine - Sugar plays a role in pancreatic cancer in women - Sugar causes learning disorders - Sugar increases in delta, alpha, and theta brain waves - Sugar causes depression - Sugar increases the risk of gastric cancer - Sugar causes dyspepsia (indigestion) - Sugar increases your risk of getting gout 34
- Sugar increases the levels of glucose in an oral glucose tolerance test over the ingestion of complex carbohydrates - Sugar increases the insulin responses in humans consuming high- sugar diets compared to low sugar diets - Sugar reduces learning capacity - Sugar causes less effective functioning of two blood proteins, albumin, lipoproteins, reducing the ability to handle fat and cholesterol - Sugar contributes to Alzheimer’s disease - Sugar causes platelet adhesiveness - Sugar causes hormonal imbalance; some hormones become underactive and others become overactive - Sugar leads to the formation of kidney stones - Sugar leads to the hypothalamus to become highly sensitive to a large variety of stimuli - Sugar leads to dizziness - Sugar causes free radicals and oxidative stress High sucrose diets of subjects with peripheral vascular disease significantly increases platelet adhesion - Sugar diet leads to biliary tract cancer - Sugar consumption of pregnant adolescents is associated with a twofold Reference: Suicide By Sugar: A Startling Look at Our #1 National Addiction, Nancy Appleton Ph.D (Author), G. N. Jacobs (Author), www.nancyappleton.com
increased risk for delivering a small- forgestational- age (SGA) infant - Sugar consumption leads to substantial decrease in gestation duration among adolescents - Sugar slows food's travel time through the gastrointestinal tract - Sugar increases the concentration of bile acids in stools and bacterial enzymes in the colon - Sugar increases estradiol in men - Sugar combines and destroys phosphatase, an enzyme, which makes the process of digestion more difficult - Sugar is a risk factor of gallbladder cancer - Sugar is an addictive substance - Sugar is intoxicating, similar to alcohol - Sugar exacerbates PMS - Sugar gives premature babies affect the amount of carbon dioxide they produce - Decrease in sugar intake increases emotional stability - Body changes sugar into 2 to 5 times more fat than it does starch. - Sugar promotes excessive food intake in obese subjects. - Sugar worsens the symptoms of children with attention deficit hyperactivity disorder - Sugar adversely affects urinary 35
electrolyte composition. - Sugar slows down the ability of the adrenal glands to function. - Sugar has the potential of inducing abnormal metabolic processes in a normal healthy individual and to promote chronic degenerative diseases. - I.Vs (intravenous feedings) of sugar water cut off oxygen to the brain. - High sucrose intake could be an important risk factor in lung cancer. - Sugar increases the risk of polio. - Sugar intake causes epileptic seizures. - Sugar may induce cell death. - Sugar increases the amount of food that you eat. - In juvenile rehabilitation camps, when children were put on a low sugar diet, there was a 44% drop in antisocial behavior. - Sugar leads to prostate cancer. - Sugar dehydrates newborns. - Sugar causes low birth weight babies. - Greater consumption of refined sugar is associated with schizophrenia - Sugar raises homocysteine levels in the blood stream. - Sweet food items increases the risk of breast cancer. - Sugar is a risk factor in cancer of the small intestine. Reference: Suicide By Sugar: A Startling Look at Our #1 National Addiction, Nancy Appleton Ph.D (Author), G. N. Jacobs (Author), www.nancyappleton.com
- Sugar causes laryngeal cancer. - Sugar induces salt and water retention. - Sugar contributes to mild memory loss. As sugar increases in the diet of 10 years old, there is a linear decrease in the intake of many essential nutrients. - Exposing a newborn to sugar results in a heightened preference for sucrose relative to water - Sugar causes constipation. - Sugar causes varicose veins. - Sugar causes brain decay in pre- diabetic and diabetic women. - Sugar increases the risk of stomach cancer. - Sugar causes metabolic syndrome. - Sugar ingestion by pregnant women increases neural tube defects in embryos. - Sugar causes asthma. - The higher the sugar consumption the more chances of getting irritable bowel syndrome. - Sugar affects central reward systems. - Sugar causes cancer of the rectum. - Sugar causes endometrial cancer. - Sugar causes renal (kidney) cell carcinoma. - Sugar causes liver tumors.
36
„The work of Dr. Heinerman was suppressed by the establishment."
(~ 1940 AD) John Heinerman, Ph.D.
John Heinerman, (1946 - ) is a medical anthropologist whose research has taken him to 33 countries, where he has worked with folk healers as well as top doctors and scientists.
Summary: Vitamin O Research, Liquid Oxygen therapy, Scientific Follow up on Oxygen Therapy Books: 67 books devoted to food therapy, folk medicine, and general nutrition. Totaling approximately 19 million copies worldwide, across 17 foreign languages. Author of around 691 journal reports and health magazine articles in some seven different languages, Flood Your Body with Oxygen by Ed McCabe
(Following information is excerpted from: Dr John Heinerman, Ph.D Article, Reach For Life, Oxyrich.net, 2000 Bio/Tech News Publishing, Ltd.)
John Heinerman, Ph.D has been the Director of the Medical Research Center, Salt Lake City, Utah for almost 20 years. For the last seven years he has closely supervised a number of human clinical trials with a variety of health products and has prepared and submitted comprehensive reports for numerous alternative medical publications / journals. Dr Heinerman utilizing the American equivalent of Oxyrich, has been involved in the study of liquid oxygen therapy for the past six years.
37
"Cancer has only one prime cause. It is the replacement of normal oxygen respiration of the body's cells by an anaerobic (i.e., oxygen- deficient) cell respiration." - Dr. Otto Warburg, Two- time Nobel Laureate, Winner of the Nobel Prize for Cancer Research "Oxidation is the source of life. Its lack causes impaired health or disease, its cessation, death." - Dr. F.M. Eugene Blass, PH.D, "Oxygen Therapy: Its Foundation Aim Results" "Lack of oxygen clearly plays a major role in causing cells to become cancerous." - Dr. Harry Goldblatt, Journal of Experimental Medicine "Cancer is a condition within the body where the oxidation has become so depleted that the body cells have degenerated beyond physiological control. Similarly, the true cause of allergy is lowered the oxidation process within the body, causing the affected individual to be sensitive to foreign substances entering the body. Only when the oxidation mechanism is restored to its original high state of efficiency can the sensitivity be eliminated." - Dr. Wendell Hendricks, Hendricks Research Foundation "Simply put, disease is due to a deficiency in the odixidation process of the body, leading to an accumulation of the toxins. These toxins would ordinarily be burned in normal metabolic functioning." - Dr. Albert Wahl
He is a leading authority on stabilized oxygen, having completed the only two valid medical research studies that have ever been conducted using stabilized oxygen therapy on different cohorts that were randomized and blinded. The first study's results showed that the product does increase and improve stamina and vitality in those suffering from shortages of either. The study found that these effects were more pertinent and long- lasting than merely boosting energy levels. The second study was a blood gas analysis to measure the increases in arterial blood oxygen of those using product or placebo. This study lasted for six months, was randomized and blinded, and involved a large cohort of volunteers. Both studies have been published – the first appeared in an alternative medical journal and the second was distributed and published by an accredited internet medical publication service. Dr Heinerman has agreed to provide research advice to Oxyman and to oversee Oxyman's research projects into the benefits of its stabilized oxygen products.
38
"Oxygen plays a pivotal role in the functioning of the immune system." - Dr. Parris M. Kidd, Ph.D., author of "Antioxidant Adaption" "In all serious disease states we find a concomitant low oxygen state...Low oxygen in the body tissues is a sure indicator for disease...Hypoxia, or lack of oxygen in the tissues, is the fundamental cause for all degenerative disease. Oxygen is the source of life to all cells." - Dr. Stephen Levine, Renowned Molecular Biologist and Geneticist Author, "Oxygen Deficiency: A Concomitant to All Degenerative Illness" "Starved of oxygen the body will become ill, and if this persists it will die, I doubt if there is an argument about that." - Dr. John Muntz, Nutruitional Scientist "Certainly, there is scientific proof that the oxygen concentration in the a atmosphere is being slowly reduced...In Japan we now see the regular use of 'oxygen booths' and portable oxygen cylinders because the people realize that the air is so contaminated they are not getting sufficient oxygen from it." - Dr. John Muntz, Nutruitional Scientist "Starved of oxygen the body will become ill, and if this persists it will die. I doubt if there is any argument about that." - Dr. John Muntz
Liquid "Stabilized Oxygen"... (Following information is excerpted from: Liquid "Stabilized Oxygen"... article – Editor’s Note Bio/Tech News, Inside Information on Important Innovations in BioScience and Technology)
Many scientists were stunned recently when it was revealed that air bubbles trapped in fossilized amber had been analyzed and found to contain oxygen levels of 38%. Yet today, it is well known that the average oxygen content of air is only 19% to 21%. In other words, since the early history of the earth, it appears there has been a whopping 50% drop in the average oxygen content of the air we breathe! This discovery was particularly startling to researchers because it suggests that the human body was originally designed to grow and operate at a 50% stronger concentration of oxygen than what's currently available. Worse yet, scientific analysis of the air in various parts of the world today reveals the frightening fact that the oxygen content of the air appears to be continuing to decline. In fact, in some of the larger (and therefore more polluted) cities, the oxygen levels of air have recently been measured at a distressing 12% to 15%. Scientists claim that anything under 7% oxygen in the air is too low to support human life, even for short periods.
39
"Insufficient oxygen means insufficient biological energy that can result in anything from mild fatigue to lifethreatening disease. The link between insufficient oxygen and disease has now been firmly established." - Dr. W. Spencer Way, from the Journal of the American Association of Physicians: In all serious disease states we find a concomitantconcomitant low oxygen state...Low oxygen in the body tissues is a sure indicator for isease...Hypoxia, or lack of oxygen in the tissues, is the fundamental cause for all degenerative disease. - Dr, Stephen Levine, Renowned Molecular Biologist, Author of "Oxygen Deficiency" "Cells undergoing partial oxygen starvation send out tiny panic signals which are collectively felt in the body as a continuous vage sensation of uneasiness, dread or disaster. This low level generalized warning tends to get tuned out as mere "background noise" by the individual experiencing it. Or, it is attributed to other sources of uneasiness...." People rarely suspect that the constant vague feelings of helplessness, fatigue....uneasiness are symptoms of cellular oxygen deprivation. - Townsend Letter for Doctors "One of the most overlooked benefits of extra oxygen in the tissues is their ability to detoxify more efficiently". - Dr. Kurt W. Donsbach, D.C., N.D., Educator, Scientist, Author, Lecturer, Consultant; author of "Super Health". "OxygenOxygen- Oxygen", and over 50 publications on the subject of heath and nutrition, Founder and Executive Director of Medicine at Hospital Santa Monica, Rosarita Beach, Baja California, the largest holistic hospital in the world;
This staggering decrease in the oxygen content of air has aroused a surge of concern among many respected cutting- edge researchers. They see a direct correlation between decreases in oxygen levels and seemingly concurrent increases in human illness and disease. This is particularly true among those who have followed the pioneering research of Nobel Prize- winning German biochemist Dr. Otto Warburg. Dr. Warburg, who was awarded the Nobel prize for his research into the cause of cancer, was convinced that cancer cells can only begin to proliferate in the human body when the cells become oxygen deficient. Furthermore, his research showed that cancer cells CANNOT proliferate at all when exposed to an oxygen- rich environment. Scientists are now concerned about the apparently declining oxygen content of the air because a growing body of research appears to conclusively back- up Warburg's conclusions. In fact, a number of world- class scientists, including renowned molecular biologist and geneticist Dr. Stephen Levine, have concluded from their own recent research that lack of oxygen in human cells and tissue is, indeed, the underlying ROOT CAUSE of not just not only of cancer but, quite possibly, of all chronic degenerative disease. It now appears that the dwindling oxygen content of air, combined with certain lifestyle factors that tend to rob Reference: Liquid "Stabilized Oxygen"... article – Editor’s Note Bio/Tech News, Inside Information on Important Innovations in Bio- Science and Technology
40
"Illness is the result of improper removal of toxins from the body. Oxygen is the vital factor which assists the body in removing toxins." - Ed McCabe, author, "Oxygen Therapies, A New Way of Approaching Disease" (1988). "A lack of oxygen (hypoxia) is the prime cause of 1.5 million heart attacks each year." - Dr. Richard Lippman, renowned researcher Dr. Lataste in 1992, conducted a study with a team of scientists on health at high altitdudes. The observed people who lived at high altitudes and found that there was a much higher incidence of drowsiness, apathy, delayed reaction time, and reduced motor capacity, as compared to those who lived in lower altitudes. - www.reach- for- life.com/ "It is very clear that stabilized oxygen has great promise beyond that ever envisioned by its inventors." – Gilbert Gordon, Professor and Chair Miami University
the human body of substantial amounts of oxygen, are in large part responsible for today's unprecedented worldwide upsurge in chronic degenerative diseases such as cancer, arthritis, heart disease, Alzheimer's disease, chronic fatigue syndrome, premature aging and many other serious ill- health conditions. Fortunately, this alarming situation has stimulated a tremendous new body of scientific and medical research which has resulted in what we believe to be one of the most important new health- giving, disease- preventing and life- extending breakthroughs of the entire 20th century. We can't emphasize enough how important it is for you to read the following report very carefully. It reveals one of the most exciting and dramatic new developments we've ever reported on – a healthboosting breakthrough that appears to be superior to anything we've ever come across in its ability to give your body a powerful natural defense against the ravages of illness, disease and even premature aging.
Reference: Liquid "Stabilized Oxygen"... article – Editor’s Note Bio/Tech News, Inside Information on Important Innovations in Bio- Science and Technology
41
Scientists like Dr. Way and many others now believe that the initial symptoms of oxygen deprivation – which in actuality constitutes simply means the gradual oxygen starvation of the body's seven trillion cells – are as follows: Overall bodily weakness, muscle aches, depression, dizziness, irritability, fatigue, memory loss, irrational behavior, chronic hostility, circulation problems, poor digestion, acid stomach, lowered immunity to colds, flu and infection; bronchial problems, tumors, and deposit buildups; bacterial, viral and parasitic infections. These symptoms often begin with a vague feeling of uneasiness. They progress, over time, to full blown illness and disease. - 2000 BIO/TECH NEWS Publishing, Ltd. Liquid "Stabilized Oxygen"...) Conclusions: Previous claims for test product's elemental oxygen content have been completely verified by blood gas analysis. The sophisticated technology employed made certain of this. And unsolicited remarks by a number of study subjects only reconfirmed this fact through oral anecdotes. "Vitamin O" does contain oxygen! - John Heinerman, Ph.D. Study: "Proving The Existence Of Elemental Oxygen In A Liquid Nutritional Product ("Vitamin O") Through Blood Gas Analyses Of Therapy/PlaceboSupplemented Hutterites"
„The work of Dr. Olney remains forgotten."
(~ 1940 AD) Dr. Robert C. Olney
(~ 1980 AD) W. C. Douglass (~ 1990 AD) Dr. Wright (~ 1990 AD) Dr. R. J. Rowen
ROBERT C. OLNEY, M.D. A.B., F.I.C.S., Member I.C.A.N., President A.B.I.S. is a member of the International College of Surgeons. President of the American Blood Irradiation Society
Jonathan V. Wright, M.D. has degrees from both Harvard University and the University of Michigan. He advanced nutritional medicine for nearly three decades.
Working Summary: Pioneer in Ultraviolet Blood Irradiation (UBI) or also known as Photoluminescence therapy, a remarkable adjunct to other cancer treatments Literature: Fluoride Deception Documentary, Olney, Robert C., M.D. and contributors: "Treatment of Viral Hepatitis with Ultraviolet Blood Irradiation," Am. J. of Surg., Sept. 1955; Miley, George, M.D.: "The Ultraviolet Irradiation of Auto- transfused Blood: Studies in Oxygen Absorption Valves," Am. J.M.SC. 197:873, 1939.; Olney, Robert C., M.D.: "Ultraviolet Blood Irradiation in Biliary Disease." American Journal of Surgery, August, 1946.; Olney, Robert C., M.D.: "Ultraviolet Blood Irradiation Treatment of Pelvic Cellulitis." American Journal of Surgery, Oct. 1947.; Olney, Robert C., M.D.: "Role of Ultraviolet Blood Irradiation Therapy, Not Technic, in Surgery." International College of Surgeons Journal, 1949.; Olney, R.C., M.D. Treatment of Viral Hepatitis with the Knott Technique of Blood Irradiation. American Journal of Surgery, 90(3), Sept 1955.
42
"There are dozens and dozens of articles in the so- called medical literature from the 1930s and mostly 1940s about outright cures of the dread viral diseases of the day with something called ultraviolet blood irradiation, and many of those articles were published by doctors working in hospitals at the time. And now you cannot find one hospital in the whole United States that has an ultraviolet blood irradiation machine, and you cannot find one hospital in the whole United States that gives high- dose intravenous Vitamin C. And there’s a third thing I’m going to be talking about, and that is the use of ozone intravenously, which was introduced in Germany in the 1920s and in German practice and in American practice, is known to reduce the odds, and none of these things eliminate the odds, but reduce the odds, dramatically, of dying from any of the serious viral diseases. - "Dr Jonathan Wright M.D.," http://www.whale.to/ 11, 12
In 1967, Robert Olney privately printed, short, undated pamphlet, sent to me by a friend, and entitled Blocked Oxidation, in- which he presented 5 cases of cancer, which were cured by a combination of techniques, including ultraviolet blood irradiation. He theorized, based on the work of previous researchers, that cancer was a result of blocked oxidation within the cells. Utilizing detoxification techniques, dietary changes, nutritional supplements, the Koch catalyst, and ultraviolet blood irradiation, he reported the reversal of generalized malignant melanoma, a breast cancer penetrating the chest wall and lung, highly metastatic colon cancer, thyroid cancer, and uterine cancer. - Ultraviolet Blood Irradiation Therapy (Photo- Oxidation) The Cure That Time Forgot by Robert Jay Rowen, MD, http://www.whale.to/ 13, 14
Dr. Olney Presentation on Blocked Oxidation (Following Information is excerpted from: Blocked Oxidation, By Robert C. Olney, M.D., Lincoln, Nebraska, www.whale.to)
This presentation deals with the prevention and treatment of "BLOCKED OXIDATION" which we consider the prime cause of malignant, viral, bacterial, and allergic diseases. With our present knowledge it should be possible to prevent and wipe out cancer and serious infectious diseases. We are in an era of destructive therapy, powerful poisonous insecticides, fluoride poisoning and "embalmed foods." This is an era of ignoring the principles of healthful living and then attempting to cure everything by taking an array of pills. We believe that the so- called "accepted" methods of treating cancer are no more successful today than they were 40 years ago. We are entering on an era of prevention and simple effective treatment of malignant, viral, bacterial, and allergic diseases. Blocking of,(15) or injury to the vital oxidation process (respiration) of the living cells by oxygen deficiency or various toxic substances we find to be the most important cause of malignant, viral, bacterial, and allergic diseases. Effective prevention and treatment of these diseases depends upon the restoration and maintenance of the NORMAL OXIDATION PROCESS. Knowing and eliminating the oxygen deficiency and these toxic substances is of prime importance, but once the blocking process or injury has become established effective means must be taken to reverse the process and restore normal oxidation. The condition will not return to normal simply by elimination of the cause. In malignant disease, (15, 16) when the oxidation process is blocked, energy is produced by fermentation and viruses grow profusely in this condition.
Reference: "Blocked Oxidation" by Robert C. Olney, M.D., Lincoln, Nebraska, www.whale.to, http://www.maebrussell.com
43
For many years Dr. William F. Koch (15) and Otto Warburg (16, 17) have claimed that blocking of, or impairment of oxidation in the enzymes and cells allows fermentation of sugar and that fermentation in these enzymes and cells is the PRIME CAUSE OF CANCER. Koch (15) has also proved that blocked oxidation in micro- organisms causes them to be pathogenic and parasitic, and that when this condition is corrected these organisms become non- pathogenic, non- parasitic, and non- virulent. In so many of these conditions patients have a low blood oxygen level as shown by blood oxygen studies. Some are only 50% to 60% of normal as shown in this paper. As part of this paper are the results of studies made in 1968 which confirm studies by Dr. George Miley.(20) Our clinical studies show that intravenous Ultraviolet effectively increases the blood oxygen to normal or near normal in most cases. Increasing blood oxygen is important, but when the oxidation process is blocked by certain amines it takes a powerful oxidation catalyst to bring about normal oxidation and eliminate the blocking substances. We now have an effective oxidation catalyst which does this. (15) In the treatment of these cases the following are very important: 1. Intravenous Ultraviolet rapidly increases the oxygen absorption of the patient bringing the blood oxygen up to normal. The powerful oxidation catalyst stimulates the use of this increased oxygen or the patient's oxygen at any level to restore the normal oxidation process (cell respiration). 2. The diet of these patients is extremely important, using foods grown with natural fertilizers and without poisonous fertilizers and insecticides, and eating much of it raw. Since so many of these patients are deficient in important trace minerals such as
Reference: "Blocked Oxidation" by Robert C. Olney, M.D., Lincoln, Nebraska, www.whale.to, http://www.maebrussell.com
44
magnesium and zinc it is important to see that these patients are supplied with sufficient trace minerals in chelated.form so that they are readily absorbed. 3. Since much of the toxic substances producing these diseases come from the colon we use colonic irrigations for thoroughly cleansing the colon of these substances. Since the normal pH (of fresh stool) of the colon must be properly maintained this is done with every means to promote the normal physiology of the colon. 4. All factors for the most healthful condition of each patient are carefully considered and treated. Pasteur was the first to discover the oxidation process or respiration in the cells and enzymes. Koch,(15) Warburg,(16) and others have firmly established the fact that oxygen deficiency and certain toxic substances block the oxidation process, and that in this condition energy is then produced by fermentation instead of oxidation. This is the pathological basis for malignant, viral, bacterial, and allergic diseases. The pathogenicity, (15) virilance and paracitism of micro- organisms is due to the same blocking of oxidation in these organisms. When normal oxidation is established in these organisms they lose their pathogenicity, virilance, and paracitism. Prevention of the devastating effects of these diseases is one of the principle goals of this work and study. Now that we know these causes of these diseases, it is imperative that we put forth every effort to prevent them. Treatment of all of these conditions in the earliest possible stages is also our goal, when these patients have not been subjected to destructive forces and treatments which are so generally used in the treatment of these diseases (‌).
Reference: "Blocked Oxidation" by Robert C. Olney, M.D., Lincoln, Nebraska, www.whale.to, http://www.maebrussell.com
45
Blood Oxygen Saturation after Intravenous Ultraviolet (Ultraviolet Blood Irradiation) (Following Information is excerpted from: Blocked Oxidation, By Robert C. Olney, M.D., Lincoln, Nebraska, www.whale.to)
Hypoxemia is a common and serious factor in so many diseases and surgical procedures. Correction of this and bringing the oxygen saturation of these patients to normal or near normal is vitally important in the treatment of these diseases and the success of serious surgical procedures. This report deals only with the blood oxygen saturation changes following intravenous ultraviolet therapy (UBI). (Ultraviolet Blood Irradiation is by use of the Knott Hemo- Irradiator. A definite amount of patient's blood, 1 1/2 cc per pound of body weight is withdrawn from a vein, citrated and returned immediately to patient after passing through the Knott- Hemo Irradiator and thus exposed to a certain band of ultraviolet light in an exact period of time, 10 cc in 20 seconds.) For this study twenty- three patients were selected at random regardless of the diagnosis in which there was clinical evidence of hypoxemia. Patients were selected in which there was no known condition which would interfere with or change the outcome of these studies. Before the first treatment of intravenous ultraviolet 5 cc of venous blood was removed and immediately taken to the American Optical Oximeter and the oxygen saturation was determined prior to the treatment. In this way the oxygen saturation was compared with the day previously, and the previous determinations, for the changes which could take place following the intravenous ultraviolet therapy. Normal oxygen saturation on the American Optical Oximeter is 100% for arterial and 72% for venous blood.
Reference: "Blocked Oxidation" by Robert C. Olney, M.D., Lincoln, Nebraska, www.whale.to, http://www.maebrussell.com
46
The following is a brief review of the cases in this study: - Mr. L.H. Middle- aged man with lymphatic leukemia. Venous oxygen 48% 24 hours after 1 UBI 65% - Mr. C.G. Metastatic carcinoma of the lung. Venous oxygen 54% 24 hours after 1 UBI 66.5% - Mrs. E.H. Hysterectomy for uterine fibroid. Venous oxygen 54.7% 24 hours after 1 UBI 75% - Miss D.W. Laboratory technician. Apparent good health, but heavy smoker. Venous oxygen 50% 24 hours after 1 UBI 64% 24 hours after 2nd UBI 81% - Mr. V.B. Acute severe respiratory infection. Venous oxygen 48% 24 hours after 1 UBI 65% 24 hours after 2nd UBI 81% - Mr. C.T. Severe diabetic with cerebral vascular accident. Venous oxygen 48.8% 24 hours after 1 UBI 84% - Mrs. B.S. Acute mastoiditis and upper respiratory infection. Venous oxygen 47% 24 hours after 1 UBI 71% - Mrs. H.M. Acute congestive heart failure. Venous oxygen 32% 24 hours after 1 UBI 56% 24 hours after 2nd UBI 70% - Mr. E.D. Asthma with acute myocarditis. Venous oxygen 48% 24 hours after 1 UBI 58% 24 hours after 2nd UBI 68% - Mr. A.V. Extensive malignancy of the ear and side of the head. Venous oxygen 52% 24 hours after 1 UBI 60% Reference: "Blocked Oxidation" by Robert C. Olney, M.D., Lincoln, Nebraska, www.whale.to, http://www.maebrussell.com
24 hours after 2nd UBI 66% - Mr. P.Z. Severe Diverticulosis of the colon, myocarditis and acute respiratory infection. Venous oxygen 53% 24 hours after 1 UBI 60% 24 hours after 2nd UBI 66% - Mr. C.C. Patient in critical condition with intestinal obstruction. Acute respiratory infection. Venous oxygen 50% 24 hours after 1 UBI 63% - Mr. R.D. Complete acute occlusion of the femoral artery at the femoral region with impending gangrene of the leg. Venous oxygen 38% 24 hours after 1 UBI 73% - Miss A.W. Operated on for cholecystectomy and appendectomy. Venous oxygen 42% 24 hours after 1 UBI 84% - Miss N.S. Coronary insufficiency. Respiratory infection. Venous oxygen 53% 24 hours after 1 UBI 60% 24 hours after 2nd UBI 68% - Mr. W.H. Acute cerebral vascular accident with severe acute otitis media and mastoiditis. Venous oxygen 40% 24 hours after 1 UBI 56% 24 hours after 2nd UBI 66% - Mr. A.C. Myocarditis, Acute respiratory infection. Carcinoma of the prostate. Venous oxygen 34% 24 hours after 1 UBI 48% 24 hours after 2nd UBI 60%
47
- Mr. R. Stricture of the lower esophagus with almost complete closure of the esophagus and marked dilation. Venous oxygen 32% 24 hours after 1 UBI 42% 24 hours after 2nd UBI 57% - Mr. B.S. Pericarditis, Cholecystitis and Pyelonephritis. Venous oxygen 47% 24 hours after 1 UBI 71% 24 hours after 2nd UBI 86%
- Mrs. F.B. Severe neurosis. Venous oxygen 29% 24 hours after 1 UBI 83% 24 hours after 2nd UBI 86% - Mrs. R.B. Thrombophlebitis and Cholecystitis. Venous oxygen 18% 24 hours after 1 UBI 62% - Mrs. P. General carcinomatosis of pelvis from CA of uterus and heavy cobalt treatments. Venous oxygen 43% 24 hours after 1 UBI 65% 24 hours after 2nd UBI 80
It is important to emphasize that in so many pathological conditions there is a very marked hypoxemia and that this is a very important factor in the diseased condition. Whether it is an etiological factor or a result is not important. It is important, however, that the blood oxygen saturation is returned to normal as rapidly as possible, in the treatment of these patients or in the performing of extensive surgical procedures, as a matter of giving these patients one of the most important factors in their defense mechanism and resistance. SUMMARY: Hypoxemia and blocked oxidation followed by fermentation of sugar in the enzymes and cells we consider to be the prime factor in malignant, viral, bacterial and allergic diseases. A program of prevention and treatment of this condition is presented which has proved in the past, and is proving at this time to be very effective, in correcting the pathological physiology which has taken place and returning normal oxidation to the enzymes and cells for the recovery of these patients.
Reference: "Blocked Oxidation" by Robert C. Olney, M.D., Lincoln, Nebraska, www.whale.to, http://www.maebrussell.com
48
„The work of Dr. Campbell remains forgotten."
(~ 1980 AD) William Campbell Douglass, M.D.
William Campbell Douglass, M.D., William Campbell Douglass II., M.D. has been called "the conscience of modern medicine." by some of the biggest names in the government and health establishments.
Working Summary: Advocate of Ultraviolet Blood Irradiation also known as Photoluminescence therapy, a remarkable adjunct to other cancer treatments Books: "Into the Light" by William Campbell Douglass, MD. (1993) (The following information is excerpted from a book by Vance Ferrell, "Alternative Cancer Remedies – Facts for Historians and Medical Researchers" Pilgrims Books, 1998 USA) 68
Dr. Douglass has publicized a little known method of treating cancer, called photoluminescence, which is inexpensive, painless, and only requires about half an hour per treatment. As the patient lies on a table, some of his blood is run into a quartz tube which is irradiated with ultraviolet light. Each treatment irradiates about 10% of his blood. This treatment has been used on cancer patients and, in Africa, on hundreds of AIDS patients. Because the process is simple and cannot be patented, organized medicine and the pharmaceutical industry are not interested in the procedure.
49
Ultraviolet Blood Irradiation Therapy The Cure That Time Forgot by Robert Jay Rowen, MD Study Abstract: "In the 1940s, a multitude of articles appeared in the American literature detailing a novel treatment for infection. This treatment had a cure rate of 98 to 100% in early and moderately advanced infections, and approximately 50% in terminally moribund patients. Healing was not limited to just bacterial infections, but also viral (acute polio), wounds, asthma, and arthritis. Recent German literature has demonstrated profound improvements in a number of biochemical and hematologic markers. There has never been reported any toxicity, side effects or injury except for occasional Herxheiner type reactions (…) In 1967, Robert Olney privately printed, short, undated pamphlet, sent to me by a friend, and entitled Blocked Oxidation, in- which he presented 5 cases of cancer, which were cured by a combination of techniques, including ultraviolet blood irradiation. He theorized, based on the work of previous researchers, that cancer was a result of blocked oxidation within the cells. Utilizing detoxification techniques, dietary changes, nutritional supplements, the Koch catalyst, and ultraviolet blood irradiation, he reported the reversal of generalized malignant melanoma, a breast cancer penetrating the chest wall and lung, highly metastatic colon cancer, thyroid cancer, and uterine cancer (…)." Study Reference: Robert Jay Rowen, MD, Omni Medical Center, Anchorage, USA, Foundation For Biosocial Research 24- 63
(Following information is excerpted from a book Into the Light written by William Campbell Douglass, 1993) 64
Dr. Douglass reveals medical truths, and deceptions, often at risk of being labeled heretical. He is consumed by a passion for living a long healthy life, and wants his readers to share that passion. He is antidogmatic and unwavering in his dedication to improve the quality of life of his readers. He has been called "the conscience of modern medicine," a "medical maverick," and his medical experiences are far reaching- from battling malaria in Central America – to fighting deadly epidemics at his own health clinic in Africa (…). This dedicated physician has repeatedly gone far beyond the call of duty in his work to spread the truth about integrating the best science- based medical therapies from all medical disciplines ("alternative medicine"). For a full year, he endured economic and physical hardship to work with physicians at the Pasteur Institute in St. Petersburg, Russia, where advanced research on photoluminescence was being conducted. Dr. Douglass comes from a distinguished family of physicians. He is the fourth generation Douglass to practice medicine. Dr. Douglass graduated from the University of Rochester, the University of Miami School of Medicine, and the Naval School of Aviation and Space Medicine.] 50
"Modern research on ultraviolet treatment for cancer is continuing. Edelson reported on a variation of the technique called extracorporeal photophoresis.1271 In this particular technique, a photosensitizing agent, 8methoxypsoralen (8- MOP), is given to patients two hours before blood is withdrawn and separated into cellular components. White blood cells were irradiated with UV- A and returned to the patient. This therapy has proven highly successful and actually has received FDA approval for its use in cutaneous T- cell lymphoma (CTCL). Gasparro explains the observed and presumed biochemical events underlying the response in this condition. Such response includes the induction of cytokines and interferons[52] (…). Finding of German Research: BIOPHYSICAI, AND CHEMICAL EFFECTS · Improvement of the electrophoretic movability of the red blood cells · Elevation of the electrical charge on the red blood cell · Lowering of the surface tension of the blood · Origin of free radicals · Elevation of the chemical illuminescence of blood(…)" "HEMATOLOGIC CHANGES · Increase in erythrocytes · Increase in hemoglobin · Increase in basophilic granulocytes · Lowering of thrombocytes · Increase in white blood cells · Increase in lymphocytes (…)" Study Reference: Robert Jay Rowen, MD, Omni Medical Center, Anchorage, USA, Foundation For Biosocial Research 24- 63
ULTRAVIOLET BLOOD IRRADIATION (UBI) THERAPY (Following information is excerpted from: Woodlands Healing Research Center, Ultraviolet Light Therapy, www.woodmed.com, 2012) 65
Ultraviolet blood irradiation (UBI) therapy is administered by a device called the Knott Hemo- irradiator. UBI therapy raises the resistance of the host and is therefore able to control many disease processes. A fundamental effect of UBI is to energize or enhance the biochemical and physiological defenses of the body by the introduction of ultraviolet energy into the blood stream. It is well known that ultraviolet radiation is used to purify water and treat sewage. So too it can purify and clean the blood of contaminations in the form of germs. This is intravenously applied by irradiating blood with a controlled amount of ultraviolet energy in the accepted therapeutic UV band. This produces a rapid detoxifying effect with subsidence of toxic symptoms. Venous oxygen is increased in patients with depressed blood oxygen values. Of special interest is that a rapid rise in resistance to viral and bacterial infection, acute or chronic, occurs. No harmful effects have been observed with UBI therapy in thousands of cases or viral infections, hepatitis, bacterial infections, hypoxemia, and many other illnesses, especially bloodrelated infections. The American Blood Irradiation Society published a favorable opinion of the use of UBI to control virus and viruslike disease. The opinion was based on thousands of clinical Reference: Ultraviolet Light Therapy, 2002. Woodlands Healing Research Center - All Rights Reserved. http://www.woodmed.com
51
"HEMOSTATIC CHANGES · Lowering of fibrin · Normalization of fibrinolysis · Trend towards normalization of fibrin- split products · Lowering of platelet aggregation BLOOD PARAMETER CHANGES · Lowering of full- blood viscosity · Lowering of plasma viscosity · Reduction of elevated red blood cell aggregation tendencies METABOLIC CHANGESIMPROVEMENT IN OXYGEN UTILIZATION · Increase in arterial pO2 · Increase in venous pO2 · Increase in arterial venous oxygen difference (increased oxygen release) · Increase in peroxide count · Fall in oxidation state of blood (increase in reduction state) · Increase in acid- buffering capacity and rise in blood pH · Reduction in blood pyruvate content · Reduction in blood lactate content · Improvement in glucose tolerance · Reduction in cholesterol count, transaminases, and creatine levels HEMODYNAMIC CHANGES · Elevation of poststenotic arterial pressure · Increase in volume of circulation IMPROVEMENT IN IMMUNE DEFENSES · Increase in phagocytosis capability · Increase in bacteriocidal capacity of blood · Modulation of the immune status"" Study Reference: Robert Jay Rowen, MD, Omni Medical Center, Anchorage, USA, Foundation For Biosocial Research 24- 63
cases treated with this therapy, many of which were reported in published papers and presented before official medical groups. Much additional clinical data has been reported. Indications: According to the Foundation For Blood Irradiation, Inc, UBI has been found useful in treating: Viral Infections - Poliomyelitis, polio- encephalitis, myelitis - Hepatitis: infectious, serum - Influenza - Common upper respiratory disease - Herpes simplex, Herpes zoster - Mononucleosis, Mumps, Measles Bacterial Infections - Pneumonia - Septicemia (staphyloccocus, streptococcus, pneumococcus) - Wound Infections, lymphatic infections (lymphangitis) - Peritonitis - Typhoid Fever - Recurrent skin infections (furunculosis, carbunulosis) Inflammatory Conditions - Acute thrombophlebitis, fibrositis, bursitis, nephritis, iritis, uveitis, cholecystitis, pancreatitis - Rheumatoid arthritis Reference: Ultraviolet Light Therapy, 2002. Woodlands Healing Research Center - All Rights Reserved. http://www.woodmed.com
52
Conclusion: "This simple, inexpensive, and nonspecific technique was clearly shown years ago to be a totally safe and extremely effective method of treating and curing infections; promoting oxygenation; vasodilatation; improving asthma; enhancing body physiology, circulation, and treating a variety of specific diseases. Its use in hospitals and offices could significantly reduce mortality, morbidity, and human suffering. Much more research needs to be done in determining all of the potential uses of ultraviolet blood irradiation therapy and also its correlation with other oxidative therapies. Discussion: In the 1800s, arguments raged between Pasteur and his rival, Bechamp, over the true cause of infectious disease. Pasteur claimed the cause was the organism alone, while Bechamp claimed the disease rose from organisms already within the body, which had pleomorphic capability (the ability to change). It is rumored that Pasteur, on his deathbed, admitted that Bechamp was correct. Forgotten in the debate was Bernard who argued it was the terrain or fertility of the body which permitted disease or allowed bacterial infection to take root. Perhaps UV blood irradiation can be explained best in the general effect of the treatment on the physiology and terrain of the body. For example, it is known that the phagocytic respiratory burst, in response to infection, consumes up to 100 times the oxygen that white cells require in the resting state. The improvement in oxidation, rise in red blood cells, and increase in red cell 2,3 DGP[331 may provide a significant boost to the body." Study Reference: Robert Jay Rowen, MD, Omni Medical Center, Anchorage, USA, Foundation For Biosocial Research 24- 63
Circulation Conditions - Varicose and diabetic ulcers - Peripheral vascular disease - Gangrene - Vascular headaches
Others - Non- healing Wounds and Fractures - Pemphigus - Emphysema - Adjunctive cancer treatment (Germany)
Preliminary reports indicate that UBI may be useful in treating HIV. Work is currently under way to evaluate the effects of UBI on eliminating HIV from blood and blood products. Should this be successful, this would have major implications in ensuring the safety of blood in blood banks. The efficacy of this method is attested to by the REMARKABLE and consistent recovery of patients with a wide variety of diseases. In addition, it can be stated that UBI has never caused a disease of any sort, nor has it ever damaged a patient in its use. Over 60 scientific and clinical papers on ultraviolet blood irradiation have been reported in medical journals and before medical groups (see end). Rationale and Method of Treatment The Knott technique of blood irradiation (approved by the American Blood Irradiation Society) achieves the following physiologic objectives: - Increases the blood oxygen level - Increase phagocytosis - Relieves toxemia,
- Decreases edema (swelling) - Controls nausea and vomiting.
The treatment consists of withdrawing blood from the patient and by use of the Knott hemo- irradiator, exposing it to radiant energy between the wave lengths of 2,399 and 3,900 angstrom units as it passes through the irradiation unit at a predetermined rate. The blood is returned to the patient through the needle used for the initial venipuncture (IV). The entire system is "closed" meaning the patient’s blood never leaves the tubing or the bottle and is simply returned back into the vein after passing through the UV device. Treatment requires 15- 60 minutes depending on the amount of blood treated and how fast the blood flows (‌). Reference: Ultraviolet Light Therapy, 2002. Woodlands Healing Research Center - All Rights Reserved. http://www.woodmed.com
53
The Healing Power of Light, Photoluminescence: UV Light Irradiation in the Laboratory by E.W: McDonagh, D.O. (Following information is excerpted from: The Light Party, 1997, http://lightparty.com) 66
In his 318- page book entitled Into the Light, William C. Douglass, M.D., outlines the tremendous powers of light. He delves into the many varied functions, properties and unique abilities of the color spectrum. Each color has its wavelength that accounts for its activity. The medical use of ultraviolet (UV) in particular is demonstrated by published scientific studies, and patient case histories to have great curative ability in a wide range of disease entities. Conventional medicine treats patients after the establishment of disease. Early detection and prevention is ignored. Usually irreversible structural change follows functional change that has been in progress for months or years. When "modern medicine" states "nothing abnormal found" but the patient has obvious complaints, the sufferer must wait until he can exhibit sufficient, unmistakable morbidity to be eligible for treatment. At this point the system cranks up to do battle with a vast array of expensive drugs, specialist physicians, surgeries, and hospitalization time. Advanced degenerative diseases are rarely reversed or cured, but controlled so long as the patient continues under the care of his or her physician. UV LIGHT: Ultraviolet light as a medical treatment has been used since the beginning of the century. The technique is merely using UV light to stimulate the immune system and various enzyme systems. It is a tested and PROVEN THERAPY that has accomplished incredibly MIRACULOUS CURES with absolutely no side effects, and yet until recently it has been suppressed and ignored by American medicine. UV light has been used in disinfection for many years, and it is still used for that purpose. It requires little sophisticated equipment, no complicated drugs, and it cures by stimulating the body's own immune response and various enzyme systems.
Reference: Ultraviolet Light Therapy, 2002. Woodlands Healing Research Center - All Rights Reserved. http://www.woodmed.com
54
A small quantity of blood is treated with UV light (photoluminescence) and amazing things happen upon re- injection into the bloodstream. The body's defenses are rapidly organized to destroy all invading organisms whether viral, bacterial or fungal. The author cites two cases, husband and wife, who both had the flu. One treatment completely reversed the system in both patients within two hours. In the case of serious infections, marked reduction in toxic symptoms is observed in 12 to 48 hours. MECHANISMS: Less UV exposure is required to kill bacteria in the human body than is necessary in the laboratory. When a small part of the infected bloodstream is exposed to UV light for less time than is required to kill bacteria in the laboratory, the pathogenic bacteria in the body are usually completely destroyed. In fact, many organisms are destroyed by an amount of irradiation that merely stimulates normal body cells. Blood cells are huge compared to bacteria and are stimulated, while the same UV dosage kills the bacteria. "UV light therapy (photoluminescence) has the remarkable ability to allow the ill body to make rapid readjustments back to normal biological self regulation." Also, certain significant amounts of two photo- sensitive amino acids - - phenylalanine and tyrosine - - that are absent in most body cells. These amino acids absorb additional UV energy that kills the bacteria. There is also reason to believe that by destroying the bacteria in the treated sample of blood, an "autogenous vaccine" is produced that aids in rapid destruction of bloodstream bacteria. The first article on the benefit of phototherapy was published in June 1934 by Hancock and Knott. By June 1942, 6,520 patients had been treated with UV therapy. The treatment was successful nearly every time. There was complete absence of any harmful effect. Other effects of UV irradiation of the blood include increased effficiency of oxygen exchange, dilation of coronary arteries, rapid reversal of paralytic ileus (paralyzed gut
Reference: Ultraviolet Light Therapy, 2002. Woodlands Healing Research Center - All Rights Reserved. http://www.woodmed.com
55
following surgery), prevention and reversal of thrombophlebitis, restoration of normal autonomic nervous system balance, and dramatic relief in 80 percent of asthma patients. Ultraviolet irradiation typically causes the body to eliminate uric acid more rapidly, suggesting usefulness as a treatment for gout, gouty arthritis, bursitis and other inflammatory conditions of muscles and joints. Researchers also have found that blood sugar is temporarily diminished in diabetic patients by UV irradiation. This is probably due to an increase in insulin sensitivity. The pineal gland, located at the epithalamus of the brain, secretes the vital hormone melatonin. It is the body's chief photoreceptor - - a receiver of photons from the eyes, and thus protects the body from light deficiency. Calcification of the pineal glad occurs in a large percentage of people over 60 years of age. It is not a natural part of the aging process because it doesn't happen in everyone, but it is very common. "If a method could be devised," says the author, "to decalcify the pineal gland, I believe wondrous health benefits would ensue." Some of the benefits of Chelation therapy using EDTA and/or UV therapy may be due to decalcification of the pineal gland. It has been our experience that all organ function and glandular function improves as a result of EDTA Chelation therapy, but I never considered its beneficial effect on the pineal gland before, I just assumed it should be enhanced as are all other tissues. TOXIN NEUTRALIZATION: Botulism, a deadly form of food poisoning, causes extreme toxicity and carries a high mortality rate. Photoluminescence is very effective within 24 to 72 hours after treatment. Miley, writing in Archives of Physical Therapy, Volume 25, June 1944, reports a case of a patient near death from classic botulism neurotoxin. He was unable to swallow, or see. The patient was treated with photoluminescence and within 48 hours was able both to swallow and see, and was completely clear mentally. As Miley said, "There is, to my knowledge, no record in medical science or of any other therapy that can produce such an effect on a patient in the last stages of botulism." Reference: Ultraviolet Light Therapy, 2002. Woodlands Healing Research Center - All Rights Reserved. http://www.woodmed.com/
56
Patients with advanced pneumonia, acute gangrenous appendicitis, multiple pelvic abscesses, and peritonitis have made hard to believe reversal of the problems in 24 to 72 hours. THE RUSSIANS: Necessity is the mother of invention. It would seem to me that the Creator has mixed some good into every catastrophe. Most of us, however, can't find it; maybe we get sidetracked because of the tragedy. Russia, with its long history of communist suppression and severe financial constraint could not encourage the organized development of high- tech medical hospitals, drugs, and hardware to reverse serious illness in their populace. Physicians and researchers turned to more natural, more effective, less expensive methods. They have developed photoluminescence to a very effective degree and have published much on the subject for 20 years. In the field of surgery alone, doctors of the former USSR have used UV therapy in over 100,000 patients. Surgeons Kutushev and Chalenko in St. Petersburg reported that UV therapy cut by 50 percent the number of complications and the necessity of using antibiotics in severe trauma cases. In the past ten years, these two surgeons have successfully treated over 3,000 patients with severe trauma using UV blood irradiation. Cases ranged from crushed kidneys to extensive bleeding into chest or abdominal cavities. Extensive third degree burns also respond to photoluminescence. Bacterial endocarditis, an infection of the heats valves, one of the most dreaded infections seen in medical practice, carries a high mortality rate. Dr. Krishtof and associates treated 250 cases that all had undergone prolonged therapy with antibiotics and cortisone with little effect. The patients were given two to three treatments per day. UV light therapy was so successful that 43 of the patients were able to avoid surgical repair of their heart valves - - a remarkable achievement. Those who had surgical repair fared better posts- op than would be expected from such serious surgery, and their hospital stay was significantly shortened.
Reference: Ultraviolet Light Therapy, 2002. Woodlands Healing Research Center - All Rights Reserved. http://www.woodmed.com
57
The Russians have successfully treated 128 comatose patients who have been poisoned by organophosphate or had psychotropic drug intoxication. Twenty- two patients with cancer of the colon and rectum were treated with UV photoluminescence four times daily beginning with the first post- op day. A report from the Krasnoyarsk Cancer Center found: 1. Narcotics often were not necessary, or they could be discontinued on the second day. 2. There were no cases of adynamic ileus, the paralysis of the intestines so often seen following abdominal surgery. 3. Post- op infections were seen in only 10 percent of the patients compared with 30 percent in those patients not receiving light therapy. A group of St. Petersburg physicians studied the effect of photoluminescence on 145 patients with severe blockage of the coronary arteries, who had suffered a previous heats attack. The doctors chose only patients who had not responded well to conventional drug therapy. Significant improvement was registered in 137 of the 145 patients treated, as compared to control patients who did not receive UV light therapy. Pain was quickly relieved and analgesics were often discontinued. The dosage of heart medications, such as beta- blocking agents, was reduced in most patients and the attacks of angina were less frequent than the controls. The authors attributed the good results to dilation of the coronary arteries, and improvements of oxygen uptake in tissues. I believe the combination of photoluminescence and intravenous EDTA therapy given simultaneously would produce even more outstanding results. A. Levin and his associates studied the effect of UV blood irradiation on blockage of the arteries of the legs, a common problem in diabetics and heavy smokers. They reported positive results in eight of 11 cases with significant relief of pain, less dependence on pain killers, better sleep, better appetites and quick healing of ulcerations caused by poor circulation. Dutkevich and associates reported that 10.3 percent of surgical cases in their series developed some degree of thrombophlebitis or thrombosis following surgery if not treated with UV Reference: Ultraviolet Light Therapy, 2002. Woodlands Healing Research Center - All Rights Reserved. http://www.woodmed.com
58
light therapy. Not a single case developed these venous complications if they had been treated with UV light therapy prior to or after surgery. The Wistar Institute made public a report in 1993 that Chronic Fatigue Syndrome, which is believed to affect 10 million Americans, is caused by HTLV- II, a viral organism that causes hairy cell leukemia. Remember, there is no cure for any virus and no cure for any form of leukemia. What will America's doctors do if 10 million young middle class citizens suffering Chronic Fatigue Syndrome come down with hairy cell leukemia? On the front page of USA Today, August 22, 1997, there is an article by Steve Steinberg entitled, "U.S. Wary of Germ that Resists Drugs." A deadly microbe that has developed resistance to the last of the antibiotics readily capable of killing it has turned up in a Michigan man, health officials warned. His case marks the first time the microbe, known as Vancomycin- resistant Staphylococcus aureus, has shown up in the United States. Our reliance on the present treatment modalities is obsolete. Many more pathogens will be immune to antibiotics in the future. SUMMARY: UV light therapy (photoluminescence) has the REMARKABLE ABILITY to allow the ill body to make rapid readjustments back to normal biological self- regulation. The self- regulatory abilities of the body are really responsible for the many healings of medical science. No drug can cure an illness - - unless the body's own mechanisms are functioning correctly. UV light irradiation of the patient's blood can SAVE untold billions of dollars by reduced need for our medical system of hospitalization, drug usage and surgical procedures. For this reason, it will be fiercely suppressed in this country. Any treatment that threatens the status quo, no matter if it is ineffective and outrageously expensive is always opposed by the old guard.
Reference: Ultraviolet Light Therapy, 2002. Woodlands Healing Research Center - All Rights Reserved. http://www.woodmed.com
59
(~ 1980 AD) Edward Rosenow, M.D. Working Summary: advocate of the remarkable ability of hydrogen peroxide to oxygenate the body
Edward Rosenow, III, M.D., (1909- 2002) was a physician at the Mayo Clinic; achieved numerous awards and honors, including the Mayo Fellows Hall of Fame of Outstanding Teachers, president of the Mayo staff, president of the American College of Chest Physicians, Distinguished Mayo Clinician Award and many other.
Recommended Literature: The Cancer Cure That Worked: Fifty Years of Suppression by Barry Lynes with John Crane, Flood Your Body with Oxygen by Ed McCabe (2004), The Oxygen Prescription: The Miracle of Oxidative Therapies by Nathaniel Altman, The Oxygen Revolution: Hyperbaric Oxygen Therapy: The Groundbreaking New Treatment for Stroke, Alzheimer's, Parkinson's, Arthritis, Autism, Learning Disabilities and More by Paul Harch (2010), O2xygen Therapies: A New Way of Approaching Disease by Ed McCabe and Betsy Bullard (Jun 1988)
(The following information is excerpted from: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell, Pilgrims Books, 1998 USA) 68
Dr. Rosenow, a physician at the Mayo Clinic for over 40 years, discovered that HYDROGEN PEROXIDE was a safe, effective, antimicrobial, antiviral agent. Without his discovery, we might not know of this remedy today (although the substance had been used to treat infections back in the 1920s).
Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell, Pilgrims Books, 1998 USA 68
60
Hydrogen Radiation
Peroxide
and
"It has been shown that there is a direct relationship between the oxygen content in tumor cells during radiation therapy and the effectiveness of the treatment. (10) Higher levels of oxygen produce better results. Hyperbaric oxygen chambers have been used to achieve better tumor oxygenation during radiation therapy. (2, 3) However, biological and physiological problems associated with the administration of oxygen at increased pressures plus the expense of the hyperbaric chambers themselves make this method of oxygenation somewhat impractical. With the above difficulties in mind, a group of physicians decided to try using intra- arterial hydrogen peroxide as a source of oxygen along with radiation therapy in the treatment of 190 g individuals with advanced cancer. (1) The main criterion for the selection of cases for this study was that their tumors were either so very advanced or metastatic that they were considered poor candidates for any form of conventional therapy. Fewer than 10 percent of the subjects were expected to survive more than one year. The individuals in this study showed the following overall survival for the five years of the study: year one = 77 percent; year two = 62 percent; year three = 46 percent; year four = 36 percent; and year five =28 percent (…)." Reference: - Alternatives in cancer therapy: the complete guide to nontraditional treatments" by Ross, R.Ph. Pelton, Lee Overholser 67
Unfortunately, Rosenow died, in 1966, before his discovery could be published. But he had explained it to a priest, named Wilhelm, who was a chemistry teacher. Wilhelm determined to promote hydrogen peroxide. Throughout the 1970s, he tried to get pharmaceutical companies to do research on it, but the substance was a common, inexpensive item which could not be patented—and thus had no commercial value to them. Then, in the winter of 1982, he met Walter (Wally) Grotz. Following an earlier auto accident, Wally had developed a severe, crippling, and very painful arthritis. He despaired of life. Then his wife encouraged him to take a warm Caribbean cruise, in the hope that it might help. On the ship, he met Wilhelm, who urged him to take HYDROGEN PEROXIDE for his arthritis. Although he only took small amounts, within a few months his arthritis was gone. Immediately, Grotz set to work; he must convince the world that hydrogen peroxide was the GREAT ANSWER to mankind’s problems. What is hydrogen peroxide? It is a very simple compound, with the chemical formula H2O2. All it consists of is a molecule of water, plus an added atom of oxygen. It is found throughout nature, in plants and animals. Every cell in your body makes it. Reference: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell, Pilgrims Books, 1998 USA 68
61
"(…) Patients with cancers of the head and neck, cervix, and bladder seemed to respond much better than would be expected under standard therapeutic treatment. The authors of this study point out that their preliminary results suggest that the use of intra- arterial hydrogen peroxide can improve the effectiveness of standard radiation therapy for some types of malignancies (…). "From the 2,500 or more references on hydrogen peroxide we have collected and reviewed, we have come to appreciate this physiological product as an extremely important molecule in metabolism. Hydrogen peroxide is produced by all cells of the body for many different physiological reasons. The granulocytes produce H2O2 as a first line of defense against bacteria, yeast, virus, parasites, and most fungi. It is involved in any metabolic pathway which utilizes the many different types of oxidase enzymes. Our studies demonstrate a positive metabolic effect to intravenous infusion of H2O2. Its ability to oxidize almost any physiological substance, in addition to producing increased tissue and cellular oxygen tensions, has proven it to have therapeutic value. (5) Hydrogen peroxide is one of those substances that cries out for needed changes in FDA policy. Because it is a cheap, un- patentable chemical, no company is willing to invest the time and money needed to gain FDA approval. H2O2 therapy is not illegal in the U.S., but it remains unapproved by the AMA and the FDA(…)." Reference: "Alternatives in cancer therapy: the complete guide to nontraditional treatments" by Ross, R.Ph. Pelton, Lee Overholser 67
Every plant cell makes it also. When ozone in the sky mixes with moisture in the air, it forms hydrogen peroxide, which comes down in rain or snow. It is in fresh fruits and vegetables. Plants take it in with the rainwater they absorb; they also make it via photosynthesis. It is rich in mother’s milk—and especially so in colostrum (the first milk secreted after birth). All this, of course, relates closely to Otto Warburg’s discovery that, when cells become DEFICIENT IN OXYGEN, they tend to become cancerous. By releasing more oxygen into the body, hydrogen peroxide promotes healthy, oxygen based metabolism. It not only stimulates the immune system, but a single injection almost doubles the metabolic rate. Its extra oxygen atom provides it with sterilizing power. As noted elsewhere in this book, in the 1950s Dr. Harman discovered the relationship of free radicals to aging and disease. But it has since been noted that not all free- radical reactions are bad. One of these is the manner in which oxygen helps enzymes remove toxins. Another is the way it attacks invading bacteria. It is now known that hydrogen peroxide does not increase the bad kind of free radicals in the body. Instead, it stimulates natural killer (NK) cells, which attack cancer cells when they try to spread throughout the body. Dr.T.L.Dormandy, president of the Free Reference: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell, Pilgrims Books, 1998 USA 68
62
"There is a growing number of physicians who are administering hydrogen peroxide infusions in the United States. However, there are also many cases where doctors have been confronted by medical boards and have been forced to spend considerable time and money defending themselves. Some have had their licenses revoked. "Hydrogen peroxide is one of the most widely researched and documented of all the alternative cancer therapies, with over five thousand studies published on its therapeutic effects. Yet it is still not approved by the FDA for use in treating cancer, arthritis, or other diseases." Alternatives in cancer therapy: the complete guide to non- traditional treatments" by Ross, R.Ph. Pelton, Lee Overholser 67 "The generation of H2O2 in cellular processes seems to be purposeful, and H2O2 cannot be dismissed as a mere undesirable by- product . . The capacity for generation of H2O2 is not found to be widespread in a variety of organisms and in the organelles of the cells." - T.H. Oliver and B.C. Cantab, Lancet, 1:432- 33, 1920.
Radical Research Association of Europe, has stated that current levels of hydrogen peroxide, taken orally, cannot damage any organ. He also says that the hydrogen peroxide is taken up though the mucous membranes of the mouth, throat, and stomach within one or two minutes after being swallowed. Intravenous injections of hydrogen peroxide release pure oxygen into the body. This saturates the cells and aids in treating cancer as well as other diseases. Hyperbaric oxygen chambers are another means of increasing the body’s supply of oxygen. But they are very expensive to use, even for half an hour. Yet another method is the use of ozone. Ozone is O3, and also has antiviral properties. Ozone functions in the same manner as hydrogen peroxide; however, clinics which have used both have found that hydrogen peroxide seems to be a more efficient method of administering oxygen than ozone. (But keep in mind that the clinics use intravenous hydrogen peroxide injections, something many people at home do not have available to them). So hydrogen peroxide is a good, inexpensive source of extra oxygen; but no pharmaceutical company will touch it, since it cannot be patented and is so inexpensive. Yet, without their involvement, the government will not approve its use as an official remedy (…). In summary: There are few side effects with hydrogen peroxide therapy. In rare cases, a problem involving inflammation of veins at the site of injection will occur. Hydrogen peroxide should not be taken orally, as it causes nausea and vomiting; and rectal administration can lead to inflammation of the lower intestinal tract. Other side effects observed include temporary faintness, fatigue, headaches, and chest pain. Most peroxide problems stem from the use of either an inappropriate administration route, administration above patient tolerance, the mixing of oxidative chemicals with other substances, or using oxidative chemicals in too great a concentration.
Reference: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell, Pilgrims Books, 1998 USA 68
63
„Ed McCabe is a health journalist who reported success of oxygen therapy. Sentenced to 3 years in prison on the pre- text of tax evasion 1999 (and served 2 years)..Dr. Blass was murdered outside his house, same year and month as Dr Koch. The FDA won’t spend a dime on ozone research, but they spent over $1 million intimidating, harassing, and persecuting Dr. Wright alone"
(~ 1990 AD) F. Sweet, M.D., (~ 1990 AD) Dr. F.M. Eugene Blass, Dr Jonathan Wright, M.D., Ed McCabe Working Summary: advocate of the ozone therapy Books: Flood Your Body with Oxygen by Ed McCabe (2004), The Oxygen Prescription: The Miracle of Oxidative Therapies by Nathaniel Altman (2007) (The following information is excerpted from: Alternative Cancer Remedies – Facts for Historians and Medical
Researchers by Vance Ferrell, Pilgrims Books, 1998 USA) 68
About one- fifth of the air you breathe is oxygen in its two- atom form (O2). Ozone (O3) contains three oxygen atoms and is a less stable form. Because of the added oxygen molecule, it more quickly enters into reactions in the body to oxidize other chemicals. During this process, the extra oxygen molecule breaks away, leaving a normal O2 molecule. This increases the oxygen content of the blood or tissues. For this reason, ozone therapy involves both oxygenation therapy and oxidation therapy. Careful laboratory research by Dr. F. Sweet and his associates has shone that human lung, breast, and uterine cancer cells are inhibited by ozone (F. Sweet, M. Ka, and S. Lee, "Ozone Selectively Inhibits Growth of Cancer Cells," Science, 2009 (72) 931, 1990). Yet ozone therapy, as an alternative remedy for cancer, is still in its formative stages. We should not place reliance on it yet. Jonathan Wright, M.D., of Kent, Washington, finds ozone very effective against a number of diseases, when combined with dietary changes and high doses of intravenous ascorbate (a form of vitamin C). He says that vitamin C must be given with any oxidative therapy, in order to prevent uncontrolled oxidation which is detrimental to the body.
64
It should be noted that ozone therapy is not used in the treatment of cancer, as much as it is used for other diseased conditions (such as inflammatory infections, arterial circulatory problems, allergic diseases, arthritis, hepatitis, herpes infections, joint problems, fungal infections, leg ulcers, infected or poorly healing wounds, and burns. Professional help is needed when ozone is taken internally. Keep in mind that adverse effects associated with intravenous ozone have been reported to include phlebitis (inflammation of a vein), circulatory depression, chest pain, shortness of breath, fainting, coughing, flushing, cardiac arrhythmias, and gas embolus (bubbles). Rectal administration can lead to inflammation of the lower intestinal tract. Although easily tolerated in other tissues, in high concentrations ozone causes inflammation of the lung tissue. Obviously, there are other alternative cancer remedies which are less problematic.
Reference: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell, Pilgrims Books, 1998 USA 68
65
History of Ozone (The following information is excerpted from: The Story of Ozone by Dr. Saul Pressman, DCh, LTOH, http://www.o3center.org/)478
Ozone was first discovered and named by German scientist C.F. Schonbein in 1840. The first ozone generators were developed by Werner von Siemens in Germany in 1857. The first report of ozone being used to purify blood in test tubes was by the German Dr. C. Lender in 1870. The first American therapeutic use of ozone was by Dr. John H. Kellogg in ozone steam saunas at his Battle Creek, Michigan sanitarium from 1880, as he wrote in his book, "Diphtheria: Its Nature, Causes, Prevention and Treatment". We have revived this powerful therapy 100 years later with our company, Plasmafire Intl. In October 1893, the world's first water treatment plant using ozone was installed in Ousbaden, Holland, and today there are over 3000 municipalities around the world that use ozone to clean their water and sewage, including all the great cities. In 1885, the Florida Medical Association published "Ozone" by Dr. Charles J. Kenworthy, MD, detailing the use of ozone for therapeutic purposes. In September 1896, the electrical genius Nikola Tesla patented his first ozone generator, and in 1900 he formed the Tesla Ozone Co. Tesla sold ozone machines and ozonated olive oil to doctors for medical use. (100 years later we are doing the same things with our company, Plasmafire Intl, with the adaptation and perfection of another unpatented electrostatic Tesla design built up until the 1920s. We have seen several of these 80 year old generators and they still work perfectly. With this in mind, we offer the world's only Lifetime Warranty on an ozone generator). In 1898, the Institute for Oxygen Therapy Healing was started in Berlin by Thauerkauf and Luth. They experimented with injecting ozone. Ozone was bonded to magnesium in a catalytic process to produce Homozon by Dr. Eugene Blass in 1898. Beginning in 1898, Dr. Benedict Lust, a German doctor practicing in New York, established the practice of Naturopathy, based on ozone therapy.
Reference: The Story of Ozone by Dr. Saul Pressman, DCh, LTOH, http://www.o3ceanter.org/
66
Also in 1898, homeopathic Dr. S.R. Beckwith, of New York, published his booklet describing the use of his invention, the Thermo- Ozone Generator, in the treatment of a wide variety of diseases. In 1902, J.H. Clarke's "A Dictionary of Practical Materia Medica", London, describes the successful use of ozonated water ("Oxygenium") in treating anemia, cancer, diabetes, influenza, morphine poisoning, canker sores, strychnine poisoning and whooping cough. In 1902, Dr. Charles Linder, MD, of Spokane, Washington was written up in an article in a local paper that stated that he injected ozone as part of his standard medical practice. In 1904, "The Medical Uses of Hydrozone (ozonated water) and Glycozone (ozonated olive oil)" by Charles Marchand, a New York chemist appeared in its 19th edition. The book is in the Library of Congress with the US Surgeon General's stamp of approval on it. This active use of therapeutic ozone predates the establishment of the FDA in 1906 and therefore qualifies ozone therapy to be grandfathered into acceptance. In 1911, "A Working Manual of High Frequency Currents" was published by Dr. Noble Eberhart, MD, the head of the Dept. of Physiologic Therapeutics at Loyola University, Chicago. In Chapter 9, he details the use of ozone to treat tuberculosis, anemia, chlorosis, tinnitus, whooping cough, asthma, bronchitis, hay fever, insomnia, pneumonia, diabetes, gout and syphilis. In 1912, Dr. H.C. Bennett published "Electro- Therapeutic Guide". He described the use of Ozol, ozone breathed after running through eucalyptus, pine or thyme oils. In 1913, the Eastern Association for Oxygen Therapy was formed by Dr. Eugene Blass and some German associates. During World War I, (1914- 1918) ozone was used to treat wounds, trench foot, gangrene and the effects of poison gas. Dr. Albert Wolff of Berlin also used ozone for colon cancer, cervical cancer and decubitus ulcers in 1915.
Reference: The Story of Ozone by Dr. Saul Pressman, DCh, LTOH, http://www.o3ceanter.org/
67
In 1920, Dr. Charles Neiswanger, MD, President of the Chicago Hospital College of Medicine published "Electro Therapeutical Practice". Chapter 32 was entitle "Ozone as a Therapeutic Agent". In the 1920s, Nikola Tesla allowed licensed production of an ozone air purifier in Canada, based on his cold plasma design. In 1926, Dr. Otto Warburg of the Kaiser Institute in Berlin announced that he had found that the cause of cancer is a lack of oxygen at the cellular level. For his discovery, he was awarded the Nobel Prize for Medicine in 1931 and again in 1944, the only person ever to receive two Nobel Prizes for medicine. He was also nominated for a third. In 1929, a book called "Ozone and Its Therapeutic Action" was published in the US listing 114 diseases and how to treat them with ozone. Its 40 authors were the heads of all the leading American hospitals. In 1930, the Swiss dentist Dr. E. A. Fisch was using ozone in dentistry, and wrote many papers on it. He also introduced it to the Austrian surgeon Dr. Erwin Payr in 1932. [In 1933, the American Medical Association, headed up by Morris Fishbein, set out to eliminate all medical treatments that were competitive to drug therapy. The suppression of ozone therapy in the US began then, and continues to this day, except in ten US states, where doctors are protected by state laws. At the behest of the AMA, the FDA began seizing generators in the 1940s.] In 1935, M. Sourdeau published a paper on "Ozone in Therapy" in France. Dr. Aubourg and Dr. Lacoste were French physicians using ozone insufflation 1934- 1938. Aubourg wrote "Medical Ozone: Production, Dosage and Methods of Clinical Application" in 1938. He gave ozone rectally, vaginally, injected into wounds and by breathing. In 8000 applications, there were no harmful side effects. Dr. Hans Wolff wrote the book "Medical Ozone" in the 1940s. In 1942, "Gordon Detoxification and Hydro Surgery: Theory and Practice" was published covering the medical uses of ozone as colon cleanser.
Reference: The Story of Ozone by Dr. Saul Pressman, DCh, LTOH, http://www.o3ceanter.org/
68
During World War II, Dr. Robert Mayer learned of ozone therapy from German prisoners of war at Ellis Island, and used ozone in his practice for the next 45 years. In 1944, Dr. Otto Warburg earned his second Nobel Prize in Medicine for his discovery of the basic cause of cancer in damaged cell respiration. In 1948, Dr. William Turska of Oregon began using an ozone machine of his own design (Aethozone). In 1951, Dr. Turska wrote the article "Oxidation", still appropriate today. In 1952, the National Cancer Institute verified Dr. Otto Warburg's findings regarding lack of oxygen being the cause of cancer. From 1953, German Dr. Hans Wolff began training many doctors in ozone therapy. In 1954, Frank Totney published "Oxygen : Master of Cancer". In 1956, Dr. Otto Warburg published "On the Origin of Cancer Cells" in Science, 24 February 1956, Vol. 123, Num. 3191. In 1957, Dr. J. Hansler patented an ozone generator which has formed the basis of the expansion in German ozone therapy over the last 40 years. Today, over 8000 German doctors use ozone therapy daily. In 1961, the Encyclopedia of Chemical Technology stated: "During the 80 year history of the large scale usage of ozone, there has never been a human death attributed to it". In 1961, Dr. Hans Wolff introduced the techniques of major and minor autohemotherapy. In 1966, Dr. Otto Warburg, now director of the Max Planck Institute for Cell Physiology, delivered a lecture on "The Prime Cause and Prevention of Cancer" to a meeting of Nobel laureates at Lake Constance, Germany. In 1971, Dr. Hans Wolff and Prof. Dr. Siegfried Rilling founded The German Medical Society for Ozone Therapy. In 1972, The International Association for Oxygen Therapy was founded by Dr. George Freibott as the successor to the Eastern Association for Oxygen Therapy of 1913. In 1977, Dr. Renate Viebahn provided an overview of ozone's biological action. In 1979, Dr. George Freibott successfully treated a Haitian AIDS patient suffering Kaposi's sarcoma with ozone. Reference: The Story of Ozone by Dr. Saul Pressman, DCh, LTOH, http://www.o3ceanter.org/
69
In 1980, Dr. Horst Kief also reported success with ozone therapy for AIDS patients. In 1980, F. Sweet, et al, publish "Ozone Selectively Inhibits Human Cancer Cell Growth" in the peer- reviewed journal, Science, Vol. 209. In 1982, the German medical textbook "Medical Ozone" is published by Dr. E. Fischer Medical Publications in Heidelberg. In 1983, the first International Ozone Association medical ozone conference was held, in Washington, D.C., USA. The abstracts were published in the book "Medical Applications of Ozone", compiled and edited by Julius Laraus. In 1985, Dr. Renate Viebahn published "The Biochemical Process Underlying Ozone Therapy". Dr. Siegfried Rilling published "Basic Clinical Applications of Ozone Therapy". In 1987, Dr. Siegfried Rilling and Dr. Renate Viebahn collaborated on the publication of "The Use of Ozone in Medicine", now the standard medical text on ozone application. In 1990, the Cubans reported success in treating glaucoma, conjunctivitis and retinitis pigmentosa with ozone. In 1992, the Russians reported the successful use of ozone in a brine bath to treat burns. In June 1994, Plasmafire Intl sponsored an ozone symposium in Vancouver, with 160 attendees, and as a direct result, ozone therapy is recognized as an accepted modality by the Naturopathic Association of BC, with over 40 naturopaths treating patients with ozone therapy currently. Today, after 125 years of usage, ozone therapy is recognized in Germany, Italy, France, Russia, Romania, Poland, Czech Republic, Hungary, Yugoslavia, Bulgaria, Israel, Japan, Singapore, Brazil, Cuba, Mexico, 4 Canadian provinces and 14 US states (Alaska, Washington, California, Colorado, Nevada, New Mexico, Texas, Oklahoma, Georgia, New York, North Carolina, Ohio, Minnesota).
Reference: The Story of Ozone by Dr. Saul Pressman, DCh, LTOH, http://www.o3ceanter.org/
70
„ Dr. Folkman is the pioneer of the field of angiogenesis research."
(~ 1980 AD) Dr. Judah Folkman, (~ 2000 AD) William Li, M.D.
Dr. Judah M. Folkman, M.D. (1933- 2008) was the founder and pioneer of the field of angiogenesis research and recognized as one of the leading scientific figures of our time. He was a remarkable surgeon, scientist, teacher, and visionary.
Nutshell: Research into Angiogenesis Books: Dr. Folkman's War: Angiogenesis and the Struggle to Defeat Cancer by Robert Cooke and C. Everett Koop (2001); Angiogenesis: An Integrative Approach from Science to Medicine by Judah Folkman, William D. Figg (2008); Tumor Angiogenesis BY Francis S. Markland, Stephen Swenson, Radu Minea, 2010 (The following information is excerpted from: Judah Folkman, M.D. Foundations for Cancer Therapy, American Academy of Achievement, www.achievement.org) 479
Dr. Judah Folkman was first inspired to become a surgeon at the age of seven, when he accompanied his rabbi father visiting sick members of his congregation in the hospital. Born in Cleveland, Ohio, he graduated from Ohio State University and won admission to Harvard Medical School. While still a medical student at Harvard, Folkman developed one of the first pacemakers. He completed his surgical residency at Massachusetts General Hospital, where he became chief resident and continued his work with pacemakers.
Reference: American Academy of Achievement, 2010, www.achievement.org
71
"Most research is failure. You go years and years and years, and then every once in a while there is a tremendous finding, and you realize for the first time in your life that you know something that hour or that day that nobody else in history has ever known, and you can understand something of how nature works." - Dr. Folkman Folkman’s remarkable results in the laboratory set off worldwide speculation that he would be the man to cure cancer, but he was uneasy with the accolades because cancer is such a complex disease. "We never use the word ‘cure’ because it is far away," Folkman said in one of his last interviews. "It may be that patients will have little tiny cancers that lie dormant for a long time." - Dr. J. Folkman 481 "Dr Judah Folkman was frequently described as a highly compassionate physician who served his patients not only by performing surgery and offering them comfort and reassurance, but also by working tirelessly in the laboratory to find new approaches to the treatment of disease. His dedication to understanding the role of angiogenesis, the formation of new blood vessels, in human disease has given rise to new treatments for several diseases, including inflammatory diseases, visionthreatening diseases of the eye and, as will be emphasized in this Perspective, cancer." Zetter BR., Nature Reviews Cancer (2008), Harvard Medical School, Boston, Massachusetts 02115, USA.480
At the same time he observed hundreds of juvenile cancer patients, and began to wonder if there was a way to STOP the spread of cancer by blocking the growth of the capillaries that supply the tumors with blood. Folkman began to focus on ANGIOGENESIS, the little understood process by which the body develops new blood vessels. After completing his residency, Dr. Folkman was commissioned as a lieutenant in the United States Navy, serving from 1960 through 1962. During his service, he created an implantable device for timed drug- release, and donated it patent- free to the World Population Council. It is now known as Norplant. While working at the National Naval Medical Center in Bethesda, Maryland, he continued his exploration of angiogenesis and cancer, conducting a study of mouse melanoma cells. He saw that in some instances, the tumors failed to establish new blood vessels, and STOPPED GROWING. He began a long and frustrating search for the system that regulates the growth of blood vessels in men and animals, more convinced than ever that this was the key to controlling cancer. At age 34, Judah Folkman became chief of surgery at Boston's Children's Hospital. For many years, he also directed the Hospital's Surgical Research Laboratories, now known as the Vascular Biology Reference: American Academy of Achievement, 2010, www.achievement.org
72
"Surgery has the disadvantage that the training takes so long and is so physically demanding. It's like training for the Olympics practically. There's often little time for any kind of research or scholarly work, and surgeons often do not have any ability to have the very long period of scientific training that basic scientists have. And so surgeons often are ridiculed because they are thought not to be able to do research. Yet many great, interesting, and important advances have come from surgeons." - Dr. Folkman "Clinical medicine has tremendous feedback, so the people who work in it are willing to work night and day. Patients just call you up all the time and say you saved my son's life and all that. Research is the opposite. It's just years of frustration. You have to live with experiments that don't work and grants that don't get funded. You have nothing to show for it. You've got critics all over, and scientists are sometimes mean to each other; they criticize the ideas in the name of scientific skepticism. It's not an easy life. You know that line, ‘I've been rich, and I've been poor, and rich is better’? Well, it's easier to be a physician than to be a researcher. I've been both, and physician is easier.... [I] always thought of it in an amused way, because I knew something that no one else knew, and I had been at the operating table." - Dr. Folkman
Center. In 1968, he was named Julia Dyckman Andrus Professor of Pediatric Surgery at Harvard Medical School, where he was also professor of cell biology. In 1971 he published his views on angiogenesis and cancer in The New England Journal of Medicine. Despite his fine reputation as a surgeon and researcher, Folkman's hypothesis met with indifference and ridicule. For 20 years, despite the criticism of his colleagues, he pursued the relationship of tumors and blood vessel growth. In 1994, Dr. Folkman tested a compound named ANGIOSTATIN on laboratory mice with lung cancer. Half were given only saline solution, while the other half was treated with angiostatin. In the control group, which received only saline, the cancer continued unchecked; in the mice who had received angiostatin, the tumors had vanished. Folkman's hypothesis was vindicated, and a new era in cancer research had finally begun. This initial success soon led to the development of even more potent compounds, such as endostatin, avastin and vasculostatin, which SUCCESSFULLY halted the growth of tumors in laboratory mice. Skeptics charged that Folkman's test results could not be duplicated in other labs, but in 1999 the National Cancer Institute successfully repeated his experiments with endostatin, and the compound is now being studied not only for cancer treatment, but for the prevention of stroke and heart disease. They also show promise for more accurate diagnosis of human cancers. In addition to his work on angiogenesis, Dr. Folkman pioneered the use of interferon in cancer therapy, healing hemangiomas, growths that often threaten the life of infants. Interferon is now applied to the treatment of numerous cancers and of hepatitis. When Dr. Judah Folkman died of a heart attack in 2008, he was already a legend in the world of cancer research. His achievements were celebrated in the 2001 book Dr. Folkman's War by Robert Cooke. Within two years of his death, more than 50 angiogenesis inhibitors were in clinical trials (‌).
Reference: American Academy of Achievement, 2010, www.achievement.org
73
Anti- cancer foods (The following information was excerpted from: Anti- cancer foods by Giselle Brand, http://conceptnutrition.com.au/ 2008) 482, 483- 516
Thanks to major scientific breakthroughs in cancer research, the Achilles’ heel of cancer’s mechanism for promoting inflammation has been identified. This pro- inflammatory factor is Nuclear Factor- kappa B. According to Professor Albert Baldwin, most cancer prevention is aimed at inhibiting NF- kappaB. As such, the whole pharmaceutical industry is looking for a drug to inhibit or block the inflammatory action of this key substance and prevent the spread of tumors. Another phenomenon that is important for tumorgrowth/mortality is "angiogenesis". In Greek, "angio" means vessels and "genesis" is birth. Blocking angiogenesis enables us to undercut cancer’s spread. Did you know that molecules known to act against NFkappa B are freely available in common foods? Many of these molecules also block angiogenesis. Let’s have a look at a list of common foods that make up the anti- cancer diet: 1. Green Tea – contains polyphenols called "catechins" or epigallocatechin gallate (EGCG), EGCG blocks
Reference: American Academy of Achievement, 2010, www.achievement.org
74
Obesity and Angiogenesis "Obesity is a disease now linked to angiogenesis. Adipose tissue is highly vascularized, and angiogenesis promotes fat expansion by supplying fat cells with oxygen and nutrients. Fat tissue itself contains many promoters of angiogenesis, including angiogenic stem cells. Laboratory studies have shown that inhibiting angiogenesis in obese mice decreases their weight to normal levels. Obesity increases the risk of various cancers. Obese individuals have increased levels of proangiogenic factors that may contribute to tumor growth (…). We all know eating well is important for health. Now we know that how we eat can impact on angiogenesis. Many foods contain naturally occurring inhibitors of angiogenesis. When these foods are consumed and absorbed into the bloodstream, the inhibitors act to boost the body’s existing system that suppresses undesirable angiogenesis that can promote or accompany disease." References: Trayhurn P, Wang B, Wood IS. Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity? Br J Nutr. 2008 Aug;100(2):227- 35. Brandon EL, Gu JW, Cantwell L, et. al. Obesity promotes melanoma tumor growth: role of leptin. Cancer Biol Ther. 2009 Oct;8(19):1871- 9. Rupnick MA, Panigrahy D, Zhang CY, et. al. Adipose tissue mass can be regulated through the vasculature. Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10730- 5. The above Information was excerpted from: Diet, Lifestyle & Angiogenesis, The Angiogenesis Foundation 517
2.
3. 4. 5. 6.
7.
8. 9.
receptors on a cells surface that issue command for the creation of new blood vessels. Red Wine – "resveratrol" (this is not an endorsement to drink, quantities of >100ml per day seem to lose their protective effect, Professor Riboli of the famous EPIC study thinks this study was poorly designed and conclusions dubious) Garlic – "dialyl sulphide" Cabbage, Kale, Brussels Sprouts – cruciferous vegetables contain "indol- 3- carbinol" Rosemary – "carnosol" Raspberries, Strawberries, Walnuts, Hazel Nuts and Pecans – contain polyphenol called "ellagic acid". Ellagic acid has been demonstrated to act against 2 most common mechanisms of stimulation of blood vessels: VEGF and PDGF. Mushrooms – shiitake, maitake, kawaratake, enokitake contain "lentinan" and other polysaccharides Broccoli – "sulphoraphane" Turmeric – "curcumin", a yellow powder used in Indian curries. Also, one of the most potent naturally occurring anti- inflammatory agents. In the laboratory it has been shown to inhibit angiogenesis and promote cancer cells death or cell "apoptosis". Indians have less than 20% of colon, breast, lung and
Reference: American Academy of Achievement, 2010, www.achievement.org
75
Exercise and Angiogenesis "Exercise builds muscle, and to do this, it stimulates growth factors to increase in the bloodstream, and these growth factors not only provides an expanded blood supply to support enlargement of the muscle itself, but the factors also attract angiogenic stem cells that normally reside in the bone marrow to enter the circulation and home in on growing muscle. These stem cells build both muscle and the blood vessels required to supply it. Exercise also increases angiogenesis in the lung and brain. Regular exercise is important for health." References: Bonsignore MR, Morici G, Riccioni R, et. al. Hemopoietic and angiogenetic progenitors in healthy athletes: different responses to endurance and maximal exercise. J Appl Physiol. 2010 Jul;109(1):607. Möbius- Winkler S, Hilberg T, Menzel K, et. al. Time- dependent mobilization of circulating progenitor cells during strenuous exercise in healthy individuals. Appl Physiol. 2009 Dec;107(6):1943- 50. Tang K, Xia FC, Wagner PD, Breen EC. Exercise- induced VEGF transcriptional activation in brain, lung and skeletal muscle. Respir Physiol Neurobiol. 2010 Jan 31;170(1):16- 22. The above Information was excerpted from: Diet, Lifestyle & Angiogenesis, The Angiogenesis Foundation 517
kidney cancers compared to Westerners of the same age. This is true despite high exposure to environmental toxins on a worse scale than in the West. Could their diet have something to do with the favourable statistics? 10. Tomatoes – "lycopene" 11. Soy Beans – "genistein", "daidzein" and "glyciteine". Researchers wrote that "soy and green tea may be used as potentially effective dietary regimen for inhibiting progression of oestrogendependent breast cancer". Soy phyto- oestrogens act along similar lines as common breast cancer drug Tamoxifen. 12. Ginger – "6 - gingerol" 13. Cherries – "glucaric acid" which can facilitate elimination of xenoestrogens from environmental chemicals 14. Blueberries, Cranberries, Cinnamon, Dark Chocolate – "anthocyanidins" and "proanthocyanidins" 15. Parsley And Celery – "apigenine" 16. Rosemary, Thyme, Oregano, Basil And Mint – essential oils of the terpene family 17. Seaweed – "fucoidan" and "fucoxanthin" 18. Salmon, Tuna, Trout, Meckarel, Cod, Sardine – omega- 3s Reference: American Academy of Achievement, 2010, www.achievement.org
76
Stress and Angiogenesis "Stress activates the ‘fight or flight’ response in the body. Many stress hormones are released, among them are catecholamines and neuropeptides. Both of these molecules influence cancer cell growth and tumor angiogenesis. Norepinephrine and epinephrine are potent stimulators of tumor vascularization, acting directly on the endothelial cells comprising blood vessels. They also cause cancer cells to release angiogenic factors that grow blood vessels to feed tumors. Relaxation decreases catecholamines and neuropeptides in the bloodstream. Decrease your stress levels. Get enough sleep." References: Park SY, Kang JH, Jeong KJ, Lee J, Han JW, Choi WS, Kim YK, Kang JK, Park CG, Lee HY. Norepinephrine induces VEGF expression and angiogenesis by a hypoxia- inducible factor- 1alpha protein- dependent mechanism. Int J Cancer. 2010 Aug 16. Tilan J, Kitlinska J. Sympathetic Neurotransmitters and Tumor Angiogenesis- Link between Stress and Cancer Progression.. J Oncol. 2010;2010:539706. The above Information was excerpted from: Diet, Lifestyle & Angiogenesis, The Angiogenesis Foundation 517
19. Orange, Mandarin, Lemon, Grapefruit – antiinflammatory ‘flavinoids’ 20. Pomegranate – antioxidant 21. Yoghurt – ‘probiotics’ 22. Vitamin D 23. Selenium In conclusion, we can make food our medicine and actively choose foods that defend our bodies against invasion of cancer by: 1. detoxifying carcinogens 2. boosting immune system and increasing natural killer (NK) cell production 3. blocking angiogenesis 4. blocking inflammation 5. promoting cancer cell "apoptosis" or cancer cell suicide
Reference: American Academy of Achievement, 2010, www.achievement.org
77
Cigarettes and angiogenesis "Cigarette smoking causes cancer and serious lung damage. The many carcinogens found in cigarette smoke stimulate angiogenesis and increase the growth rate of lung cancers. Smoking increases the production by lung cancer cells and inflammatory cells of the angiogenic protein called vascular endothelial growth factor (VEGF). Studies by veterinarians have also shown that secondary smoke found on the fur of cats, increases the risk of oral cancers when cats lick their fur. Don’t smoke. If you do, quit to improve your health. Avoid secondary smoke." References: Egleton RD, Brown KC, Dasgupta P. Angiogenic activity of nicotinic acetylcholine receptors: implications in tobacco- related vascular diseases. Pharmacol Ther. 2009 Feb;121(2):205- 23. Cooke JP, Bitterman H. Nicotine and angiogenesis: a new paradigm for tobacco- related diseases. Ann Med. 2004;36(1):33- 40. The following Information was excerpted from: Diet, Lifestyle & Angiogenesis, The Angiogenesis Foundation 517
„Louis Ignarro is a winner of Nobel Prize."
(~ 1990 AD) Louis Ignarro, PhD.
Louis Ignarro PhD. (1941 ) Italian, American pharmacologist. Winner of the 1998 Nobel Prize in Medicine.
Nuttshell: Discovery of Nitric Oxide, "the atom" of cardiovascular health, Nitric Oxide Therapy Books: No More Heart Disease - How Nitric Oxide Can Prevent- - Even Reverse- - Heart Disease And Stroke by Louis Ignarro (2006), Health Is Wealth: 10 Power Nutrients That Increase Your Odds of Living to 100 by Louis Ignarro (2009) (The following information is excerpted from:
Dr. Louis Ignarro, American Entertainment International Speakers Bureau, http://www.aeispeakers.com) 69
Louis Ignarro is a Distinguished Professor of Pharmacology at the UCLA School of Medicine and winner of the 1998 Nobel Prize in Medicine for his groundbreaking discovery of the importance of Nitric Oxide in cardiovascular health. In addition to the Nobel Prize, Dr. Louis Ignarro has also received numerous other special awards for his research, including the Basic Research Prize of the American Heart Association, the CIBA award for Hypertension Research and the Roussel Uclaf Prize for Cell Communication and Signaling. He has been elected to the National Academy of Sciences and the American Reference: No More Heart Disease - How Nitric Oxide Can Prevent- - Even Reverse- - Heart Disease And Stroke by Louis Ignarro (2006)
78
"The discovery of Nitric Oxide by Lou Ignarro, and the role that it plays in reducing the risk of cardiovascular disease, is as important as the discovery of penicillin and insulin." - David Heber, M.D., Ph.D., Director, UCLA Center for Human Nutrition "By feeding experiments with animals and human beings consuming nearly a quarter million dollars in labor and materials over a period of seven years I finally determined that the true cause of arteriosclerosis is simple: Stale Food. " - Robert S. Ford "This world is like a beautiful rose garden and a person has an opportunity to pass through it once ‌ so smell as many flowers as you can" - Dr. Sonnenblic "It's important to realize that Larginine is not a magic potion in and of itself either. Some studies have found its effectiveness alone is on par with a placebo. But several studies have concluded that L- arginine in combination with other herbs is a remarkably effective treatment for mild to moderate Erectile Dysfunction." - Doctor Joseph Mercola MD "The effectiveness of L- Arginine for HBP relates to its ability to directly produce nitric oxide a vasodilator produced in the arteries." - Brunini et al "L- Arginine supplementation may address some cardiovascular risks associated with decreased nitric oxide synthesis." - Fried et al
Academy of Arts and Sciences and has published over 500 scholarly articles in his career. For nearly 30 years Dr. Louis Ignarro's research has focused on the role of Nitric Oxide in the cardiovascular system. Among the most significant contributions from Dr. Ignarro's wealth of research is the discovery that Nitric Oxide is produced in the blood vessels and controls the flow of blood by signaling the vessels to expand and contract. A shortage of Nitric Oxide production, caused by poor diet and lack of physical activity, leads to the onset and increasing severity of cardiovascular disease, including heart attack, stroke, and high cholesterol. In addition, Dr. Louis Ignarro's experiments in 1990 led to the discovery that Nitric Oxide is the neurotransmitter responsible for penile erection. The discovery made it possible to develop and market Viagra, the first oral medication for the effective treatment of erectile dysfunction. As a result of his role in this blockbuster drug, Dr. Louis Ignarro is sometimes known as "the Father of Viagra". In addition to continuing to lead an active team of researchers in his lab at UCLA, Dr. Ignarro now focuses on communicating the benefits of enhanced Nitric Oxide production to the general public. His goal is to wipe out heart disease using the scientific knowledge he has Reference: No More Heart Disease - How Nitric Oxide Can Prevent- - Even Reverse- - Heart Disease And Stroke by Louis Ignarro (2006)
79
"Both L- Arginine and forearm exercises increased the body’s vasodilatation by about 400% each and when added together by about 450%." - Hambrecht et al "L- Arginine produced a four fold increase in blood vessel dilation." - Hambrecht et al "After twelveweeks of supplementation, body weight gain in the rats receiving the high fat diet was 40 percent lower among those that received arginine compared with the control group. For rats on the low fat diet, weight gain was 60 percent lower in the arginine group compared with those that received alanine. White fat pad weight increased by 98 percent in animals that received alanine; while in animals that received L- arginine the increase averaged only 35 percent. Arginine supplementation was also associated with lower serum leptin, glucose, triglycerides, urea, glutamine, and branched chain amino acids, as well as improved glucose tolerance." - Guoyao Wu et al, Texas A&M, Note arginine appears to be an excellent weight loss supplement. "Large artery elasticity index (LAEI) ... was significantly greater in patients treated with L- arginine than in the placebo group ... Systemic vascular resistance was significantly lower in patients treated with L- arginine ... This improvement was associated with a decrease in systolic blood pressure, peripheral vascular resistance as well as a decrease in aldosterone levels." Journal of Cardiovascular Pharmacology June 7, 2010
created, because his work proves that almost all cardiovascular disease is preventable. Louis Ignarro was born in Brooklyn, New York in 1941, the son of uneducated Italian immigrants. He received a B.Sc. in Chemistry and Pharmacy from Columbia University in 1962, a Ph.D. in Pharmacology from the University of Minnesota in 1966, and postdoctoral training in the Laboratory of Chemical Pharmacology at the NIH in 1966- 1968. Dr. Louis Ignarro's life and story are particularly unique, because as he stated while testifying before Congress in 2000, only in America could the son of a carpenter receive the Nobel Prize in medicine. His story truly personifies the American Dream.
Reference: No More Heart Disease - How Nitric Oxide Can Prevent- - Even Reverse- - Heart Disease And Stroke by Louis Ignarro (2006)
80
Arginine and cancer. "Arginine is a dibasic, cationic, semiessential amino acid with numerous roles in cellular metabolism. It serves as an intermediate in the urea cycle and as a precursor for protein, polyamine, creatine and nitric oxide (NO) biosynthesis. Arginine is conditionally essential since it becomes necessary under periods of growth and after recovery after injury. Arginine also promotes wound healing and functions as a secretagogue stimulating the release of growth hormone, insulin- like growth factor 1, insulin, and prolactin. Furthermore, arginine has several immunomodulatory effects such as stimulating T- and natural killer cell activity and influencing pro- inflammatory cytokine levels. The discover that l- arginine is the sole precursor for the multifunctional messenger molecule nitric oxide (NO) led to investigation into the role of arginine in numerous physiologic and pathophysiologic phenomena including cancer. Although NO was first identified in endothelial cells, it is now recognized to be generated by a variety of cell types, including several tumor cell lines and solid human tumors. Unfortunately, the precise role of NO in cancer is poorly understood but it may influence tumor initiation, promotion, and progression, tumorcell adhesion, apoptosis angiogenesis, differentiation, chemosensitivity, radiosensitivity, and tumorinduced immunosuppression. The biological effects of NO are complex and dependent upon numerous regulatory factors. Further research is necessary to enhance our understanding of the complex mechanisms that regulate NO's role in tumor biology. A better understanding of the role of arginine- derived NO in cancer may lead to novel antineoplastic and chemopreventative strategies." Lind DS., Department of Surgery, University of Florida College of Medicine, Surgical Services, North Florida South Georgia VA Health Care System, Gainesville 74
Arginine in the Treatment of Cancerous Tumors (The following information is excerpted from: "Arginine in the Treatment of Cancerous Tumors" by Karen Railey, ChetDay.com, P.O. Box 755
Cancer is a systemic disease that causes severe wasting, metabolic disturbances, and often induces anorexia. More than 40% of cancer patients die from malnutrition and not from the cancer ("For the Technically Oriented Reader," Quillin, Patrick, pg.1). All cells in the body have the ability to become cancerous and many do so on a daily basis. The immune system, IF FUNCTIONING PROPERLY, is able to destroy these cells or reprogram them back into normally functioning cells. Cancer can manifest itself as tumorous growths and the disease is able to proliferate in the body when the immune defense has become inadequate and unable to deal with the various stresses put on it. When the cell’s metabolism is affected and the normal cycle of cell regeneration and death is interrupted, changes occur in the DNA and cells become mutated. The mutated cells begin to multiply uncontrollably, dividing when they are not needed and forming a mass of excess tissue, which can develop its own network of blood vessels. This mass will draw nourishment away from the body’s blood supply to feed itself, and if left unchecked can develop into a cancerous tumor. Cells from malignant tumors can invade nearby tissues and organs causing damage and can also break away from the tumor and enter the bloodstream causing the
Reference: Arginine in the Treatment of Cancerous Tumors" by Karen Railey, ChetDay.com,
81
Exercise interventions on healthrelated quality of life for cancer survivors. BACKGROUND: Cancer survivors experience numerous disease and treatment- related adverse outcomes and poorer health- related quality of life (HRQoL). Exercise interventions are hypothesized to alleviate these adverse outcomes. HRQoL and its domains are important measures for cancer survivorship. OBJECTIVES: To evaluate the effectiveness of exercise on overall HRQoL and HRQoL domains among adult post- treatment cancer survivors (…). AUTHORS' CONCLUSIONS: "This systematic review indicates that exercise may have beneficial effects on HRQoL and certain HRQoL domains including cancer- specific concerns (e.g. breast cancer), body image/selfesteem, emotional well- being, sexuality, sleep disturbance, social functioning, anxiety, fatigue, and pain at varying follow- up periods. The positive results must be interpreted cautiously due to the heterogeneity of exercise programs tested and measures used to assess HRQoL and HRQoL domains, and the risk of bias in many trials. Further research is required to investigate how to sustain positive effects of exercise over time and to determine essential attributes of exercise (mode, intensity, frequency, duration, timing) by cancer type and cancer treatment for optimal effects on HRQoL and its domains." Mishra SI, Scherer RW, Geigle PM, Berlanstein DR, Topaloglu O, Gotay CC, Snyder C. University of New Mexico, Albuquerque, NM, USA.75
cancer to spread and tumors to grow in other areas of the body. The spread of cancer is called metastasis. Though there are many different types of cancer, there are five basic categories: Carcinomas – the most common cancers, which are those that originate in the tissues which cover a surface or line internal organs. Carcinomas include lung, breast, prostate, skin, and intestinal cancers. Sarcomas – cancers which originate in the connective and muscle tissue, attacking bones, muscles, cartilage, or the lymph system. These are considered to be the rarest and also the most deadly types of cancer. Myelomas – these tumors are also rare and originate in the plasma cells, which are found in bone marrow. Lymphoma – these are cancers of the lymph system. The two most prevalent types in the U.S. are Hodgkin’s disease and non- Hodgkin’s lymphoma. Leukemias – this type of cancer originates in the tissues of the bone marrow, spleen, and the lymph nodes. Leukemia manifests itself as an overproduction of white blood cells and is not a cancer that forms solid tumors. Risk factors for cancer include overexposure to toxins such as pollution, chemicals and drugs, improper diet and lifestyle, malnutrition, and/or emotional and physical trauma. These factors contribute directly to diminished immune function, thus increasing cancer risk. Considering the relationship between cancer and impaired immune function, the need to support, build, and stimulate the immune system of those with the disease is obvious. The amino acid L- ARGININE HAS BEEN PROVEN to be helpful in enabling the immune system to be more proficient in fighting cancer in the body and has shown promise in the treatment of cancer.
82 Reference: Arginine in the Treatment of Cancerous Tumors" by Karen Railey, ChetDay.com,
What is Arginine? Arginine is a complex amino acid and is considered to be conditionally essential. It does not fall perfectly into the essential or non- essential categories, due to the fact that arginine can be synthesized in the body at adequate levels for maintenance in normal adults. The body needs higher levels of arginine when it is under conditions of stress, illness, malnutrition or injury. When these conditions are present arginine is essential. There are also some rare genetic disorders in which the synthesis of arginine is impaired; in these conditions supplemental arginine is necessary. It is interesting that even in those not deficient in arginine; beneficial effects were realized by supplementation. In the human body arginine is most concentrated in skin and connective tissue. Arginine has many benefits: Aids in liver detoxification Detoxifies ammonia Increases sperm count in males Aids in kidney disorders and trauma Maximizes protein synthesis Helps lower cholesterol Stimulates blood flow Stimulates cerebral circulation Promotes optimum growth Helps to reduce body fat and increase lean muscle mass Assists the body in collagen production
Reference: Arginine in the Treatment of Cancerous Tumors" by Karen Railey, ChetDay.com,
83
Assists in the release of growth hormones Enhances immune system function Causes retardation of tumor growth The actions of L- arginine which are related to its use in cancer treatment are: Inhibits cellular replication of tumors Assists in the release of growth hormones Enhances immune response Improves rate of wound healing (in cases of surgical intervention)
Arginine retards the growth of tumors and cancer by enhancing immune function. The thymus gland is the "director" of the immune system and plays a key role in determining the effectiveness of the immune response to cancer. When the body is under attack from cancer, protein loss causes the thymus to shrink, drastically reducing the strength of the body’s immune response. Supplements of free- form arginine, acting as the precursor of growth hormone, have shown the ability to increase the size and health of the thymus gland. The immune response becomes more vigorous as the thymus gland produces more of its enzyme, thymosin, which in turn stimulates the spleen and lymph nodes to manufacture higher levels of T lymphocytes (T- cells). The T- cells are not only increased in number, but also become more active and effective. T- cells aid in the destruction of pathogens, including cancerous cells, either by digesting the invading agents or by sending out toxic compounds to destroy them. A correlation has been seen between the excess of an enzyme, ornithine decarboxylase, and increased tumor growth. Arginine supplementation has been shown to decrease the activity of ornithine decarboxylase and aid in slowing tumor development in this manner also (The Healing Nutrients Within, Braverman, Eric, and pg. 222). It is also believed that the by- products of normal arginine metabolism produce anti- tumor activity resulting in lowering polyamines, which are elevated in many cancer patients. Food Sources: Foods high in arginine include carob, chocolate, coconut, dairy products, gelatin, fish, poultry, meat, oats, peanuts, soybeans, walnuts, brown rice, wheat, wheat germ, sesame and sunflower seeds, popcorn, and raisins.
Reference: Arginine in the Treatment of Cancerous Tumors" by Karen Railey, ChetDay.com,
84
L- Arginine and Cardiovascular Health (The following information was excerpted from: "Arginine Helps Counter Atherosclerosis", Life Enhancement, © Copyright 2013 Life Enhancement Products, Inc. All Rights Reserved. http://www.life- enhancement.com/) 7073
There is a large body of scientific evidence that LArginine supplementation has potentially positive benefits in patients with cardiovascular disease. L- Arginine is the precursor for the synthesis of Nitric Oxide by the three enzymes called Nitric Oxide Synthase (NOS). Endothelial NOS (eNOS) is the form of the enzyme that produces Nitric Oxide in the lining of the arteries (the endothelium) where it is VITAL for vascular health and prevention of cardiovascular diseases. The Champion among Amino Acids Holds the Key: Nitric Oxide Got arginine? Of course you do - we all have a substantial amount of this "champion" amino acid in our bodies, performing life- sustaining functions of such stunning variety that, in that regard, it could lay claim to the title of "spice of life." Which brings sex to mind and it is no coincidence that, without arginine, sex would be, well, kind of limp. Arginine (technically, L- arginine) plays important roles in physiological functions of the cardiovascular, immune, central nervous, and neuroendocrine systems. Its benefits arise primarily through its ability to stimulate the
Reference: "Arginine Helps Counter Atherosclerosis", Life Enhancement, © Copyright 2013 Life Enhancement Products, Inc. All Rights Reserved.
85
Dietary supplementation with Larginine in patients with breast cancer (> 4 cm) receiving multimodality treatment: report of a feasibility study. J. Brittenden, S. D. Heys, I. Miller, T. K. Sarkar, A. W. Hutcheon, G. Needham, F. Gilbert, M. McKean, A. K. Ah- See, and O. Eremin; Department of Surgery, University of Aberdeen, UK. "LArginine has been shown, in human breast cancers, to increase protein synthesis and the number of cells in the growth phase of the cell cycle. LArginine, therefore, may potentiate the response of breast cancers to cell cycle- specific cytotoxic agents. This phase II pilot study assessed the clinical, radiological and pathological responses in 44 patients with breast cancers > 4 cm in diameter (46 tumours: T2, n = 6; T3, n = 22; T4, n = 19), who received oral L- arginine 30 g day- 1 for 3 days prior to each cycle of CHOP chemotherapy, followed after 4- 6 cycles by radiotherapy. Following this treatment, 95% of patients had a clinical response: complete response in 30% and partial response in 65%. Imaging, ultrasound and mammography revealed response rates of 91% and 76% respectively. Surgery was performed in 43 patients. Histological examination revealed that in 18% of cases there was no residual evidence of tumour. Furthermore, if residual tumour was identified, the degree of destruction was graded as 'severe' in 36% and 'moderate' in 30% of cases. Further studies are now required to evaluate the potential beneficial use of nutritional pharmacology in combination with existing treatment regimens." J. Brittenden, S. D. Heys, I. Miller, et al., Br J Cancer. 1994 May; 69(5): 918–921 76- 94
production - through entirely different mechanisms - of two of the body's most important compounds: growth hormone and nitric oxide. These are two very different compounds. Growth hormone is a large, complex polypeptide molecule about 700 times heavier than tiny, simple nitric oxide, which consists of just two atoms - its formula is NO. ARGININE PRODUCES NITRIC OXIDE Not surprisingly, growth hormone and nitric oxide play very different roles in human physiology, but at least one thing they have in common is a tendency to counteract atherosclerosis, the buildup of fatty plaque in our arteries (with ultimately dire consequences). Here nitric oxide takes center stage, and it is arginine's role as the direct chemical precursor of NO that makes it of such great interest to medical scientists. The discoveries of some of NO's vital roles in human physiology, in fact, were rewarded with the Nobel Prize in medicine - to the astonishment of scientists everywhere, who could scarcely believe that this poisonous industrial gas (and notorious air pollutant) could play any role in the human body except to injure it. Science is full of surprises. NITRIC OXIDE IS THE KEY Far from injuring us, NO - when it is made inside the body from arginine - helps regulate our blood pressure, among other functions. It is synthesized, with the help of an enzyme called nitric oxide synthase, in the vascular
86 Reference: "Arginine Helps Counter Atherosclerosis", Life Enhancement, Š Copyright 2013 Life Enhancement Products, Inc. All Rights Reserved.
RADIATION AND ARGININE L- arginine mitigates radiationinduced early changes in cardiac dysfunction: the role of inflammatory pathways. "Our earlier studies demonstrated the ability of L- arginine (L- Arg) to reverse radiation- induced immune dysfunction. The aim of the present study was to investigate cardiac dysfunction up to 24 h after 2 Gy of total- body irradiation (TBI) and its mitigation by L- Arg. The current studies also explore the association of radiation- induced inflammation and electrocardiographic (ECG) abnormalities. TBI- induced cardiac iNOS and kinin B1 R, changes in the ECG profile like bradycardia, increased RR interval, ST elevation and increased QRS duration at 4 h and 24 h after TBI. TBI with 2 Gy induced inflammatory responses in spleen and cardiac tissue. L- Arg administered 2 h after TBI (TBI+L- Arg) mitigated the entire inflammatory response and ECG profile toward normalcy. L- Arg administered just before TBI (L- Arg +TBI) could not reverse the abovementioned changes. Radiation- induced inflammatory responses at +4 h and +24 h after TBI in spleen and cardiac tissue correlated with the changes in ECG profile at the corresponding time. The results suggest the ability of L- Arg administered at the correct therapeutic window to mitigate radiation- induced cardiac dysfunction at 4 and 24 h after TBI." Shukla J, Khan NM, Thakur VS, Poduval TB., Immunology and Hyperthermia Section, Radiation Biology and Health Sciences Division, Bhabha Atomic Research Centre, Trombay, Mumbai- 400,085, India 95
endothelium - that is, in the layer of smooth cells (called epithelial cells) that line the inside walls of blood vessels. There it exerts its vasodilating effect, i.e., it triggers the cellular responses that dilate the vessels when needed, so as to lower blood pressure (and, when appropriate, to facilitate erections). In the central nervous system, NO is essential for motion- related learning processes that take place in the cerebellum. There is also evidence that it enhances cognitive functions throughout the brain and that it may be necessary for long- term potentiation, the mechanism involved in longterm memory. It plays a vital role in kidney function, and it is believed to have immune- system- enhancing properties. When its production is increased due to supplementation with arginine, it is responsible for an improvement in insulin sensitivity in diabetics. CAN SUPPLEMENTAL ARGININE HELP? There's more, but let us return to the blood vessels and the atherosclerosis that so commonly afflicts them. In both animal and human studies, it has been found that two characteristics of this disease are: (1) an impairment of the endothelium- dependent dilatation of the artery by NO, and (2) an enhanced tendency of monocytes (a type of white blood cell) to adhere to the epithelial cells. Both of these factors are believed to be due in part to a reduction in the availability of NO. Such a reduction could be due to any number of causes, one of which is an arginine deficiency. If the latter is
87 Reference: "Arginine Helps Counter Atherosclerosis", Life Enhancement, Š Copyright 2013 Life Enhancement Products, Inc. All Rights Reserved.
Sitting time and mortality from all causes, cardiovascular disease, and cancer. "PURPOSE:Although moderate- tovigorous physical activity is related to premature mortality, the relationship between sedentary behaviors and mortality has not been fully explored and may represent a different paradigm than that associated with lack of exercise. We prospectively examined sitting time and mortality in a representative sample of 17,013 Canadians 18- 90 yr of age (â&#x20AC;Ś). RESULTS: There were 1832 deaths (759 of cardiovascular disease (CVD) and 547 of cancer) during 204,732 person- yr of follow- up. After adjustment for potential confounders, there was a progressively higher risk of mortality across higher levels of sitting time from all causes (hazard ratios (HR): 1.00, 1.00, 1.11, 1.36, 1.54; P for trend <0.0001) and CVD (HR:1.00, 1.01, 1.22, 1.47, 1.54; P for trend <0.0001) but not cancer. Similar results were obtained when stratified by sex, age, smoking status, and body mass index. Ageadjusted all- cause mortality rates per 10,000 person- yr of follow- up were 87, 86, 105, 130, and 161 (P for trend <0.0001) in physically inactive participants and 75, 69, 76, 98, 105 (P for trend = 0.008) in active participants across sitting time categories. CONCLUSIONS: These data demonstrate a doseresponse association between sitting time and mortality from all causes and CVD, independent of leisure time physical activity. In addition to the promotion of moderate- to- vigorous physical activity and a healthy weight, physicians should discourage sitting for extended periods." Katzmarzyk PT at al. Pennington Biomedical Research Center, Baton Rouge, USA. 96
true - and even if it’s not - an obvious potential countermeasure would be to supplement with arginine to try to make up for the deficit in NO. ARGININE PRODUCES SIGNIFICANT IMPROVEMENT The result of this experiment was a 2.6- fold greater increase in arterial dilatation caused by arginine (4.7% increase in diameter) than by placebo (1.8%). That increase in diameter may not sound like much, but it is equivalent to a substantial 9.6% increase in the cross- sectional area of the artery, meaning improved blood flow. In the same study, using methods too complicated to describe here, the researchers measured the effect of the arginine on the adhesion of monocytes to the patients' epithelial cells. There was a 16% reduction compared with placebo - another favorable result. In another study, conducted at the Collegium Medicum in Cracow, Poland, researchers evaluated 14 male patients aged 39- 66 years (average 54) who had suffered from peripheral arterial obliterative disease and showed atherosclerotic lesions.71 The patients were hospitalized and received 3- hour intravenous infusions daily for 14 consecutive days: first a saline placebo for 7 days, then 12.6 grams of arginine for 7 days. The results were clinically significant improvements in terms of a treadmill test for leg pain and maximum walking distance, as well as for a variety of tests for blood circulation and composition.
88
Role of arginine and its methylated derivatives in cancer biology and treatment "Although data in the literature are pointing to the anti proliferative effect of both Arg depletion and supplementation, Arg proved to be essential for tumour cell growth. This observation raises the question, whether decreasing the concentration of Arg in nutrients and consequently in blood serum or the administration of D- arginine may lead to retardation of tumour growth in humans, too. Arg, because of its strong basic guanidine group, plays an important role in molecular interactions in biological systems, such as interaction between Arg and formaldehyde, both of which are normal components of cells and biological fluids. As a result, hydroxymethyl derivatives of Arg are formed. These compounds may be the source of formaldehyde generation. Arg may be considered a formaldehyde capturer, carrier and generator molecule. These functions may also play role in the biological activity of Arg and its methylated and hydroxymethylated derivatives. An interesting therapeutic possibility worthy of further investigation may be the administration of methylated and hydroxymethylated Arg in order to induce tumour cell death or to prevent tumour cell proliferation. " Bela Szende, Erno Tyihák and Lajos Trézl, Hungarian Academy of Sciences, Budapest, University of Technology and Economics, Budapest, Hungary 97
PEOPLE WITH RISK FACTORS COULD BENEFIT In a review article on the subject of arginine in Reference: "Arginine Helps Counter Atherosclerosis", coronary atherosclerosis by Life a Enhancement team of cardiologists from Life Enhancement, © Copyright 2013 Products, Inc. All Rights Reserved. Athens and London, many similar studies demonstrating the beneficial effects of supplemental arginine in heart disease are discussed, and the authors reach the following conclusion: 72 "Clinical and experimental studies show that L- arginine administration may have an impact in vascular atherosclerosis. There is evidence to suggest that at the site of stenosis [a constriction], the mechanism of nitric oxide production is intact, and therefore stimulation of this pathway might provide therapeutic benefit in angina patients. Stimulation of endogenous [made by the body] nitric oxide production could inhibit atherogenesis or induce regression of pre- existing lesions. Patients with risk factors for atherosclerosis could benefit from L- arginine administration."
89 Reference: "Arginine Helps Counter Atherosclerosis", Life Enhancement, © Copyright 2013 Life Enhancement Products, Inc. All Rights Reserved.
Physical exercise and reduced risk of breast cancer in young women. "Epidemiologic evidence strongly suggests that cumulative exposure to ovarian hormones is a determinant of breast cancer risk. Because physical activity can modify menstrual cycle patterns and alter the production of ovarian hormones, it may reduce breast cancer risk; yet few epidemiologic studies have assessed this relationship. PURPOSE: The major objective of this study was to determine whether young women (aged 40 and younger) who regularly participated in physical exercise activities during their reproductive years had a reduced risk of breast cancer (…). CONCLUSIONS: Most previously identified risk factors for breast cancer are reproductive and menstrual events that cannot be readily altered. The protective effect of exercise on breast cancer risk in the women whom we studied suggests that physical activity offers one modifiable lifestyle characteristic that may substantially reduce a woman's lifetime risk of breast cancer. IMPLICATIONS: Whether the protective effects of exercise on breast cancer risk are due to alterations in ovarian function and whether they extend into women's menopausal years need to be established. Our results suggest that implementation of regular physical exercise programs as a critical component of a healthy lifestyle should be a high priority for adolescent and adult women." Bernstein L et al.,
Department of Preventive Medicine, University of Southern California School of Medicine, Los Angeles 98
Chapter 2:
Microbiology in Cancer Treatment
"Never memorise something that you can look up." - Albert Einstein 90
„Russell sacrificed his life in the name of science."
(~ 1890 AD) William Russell Nuttshell: Parasites of Cancer Research Books: The Cancer Microbe – The hidden killer in Cancer, AIDS and other Immune Diseases by Alan Cantwell Jr., M.D. William Russell (18521940) was a Scottish biologist, who described ‘the parasite of cancer‘ in 1800. The microbe was found inside and outside the cells and ranged in the size from barely visible – up to the size of red blood cells and larger. Russell’s ‚Parasites‘ were also found in tuberculousis, syphilis and skin ulcers.
(The following information is excerpted from: The Russell Body - The Forgotten Clue to the Bacterial Cause of Cancer. By (C) Cantwell AR Jr, M.D., 2003, Jeff Rense, rense.com, All Rights Reserved) 99
On December 3, 1890 William Russell, a pathologist in the School of Medicine at the Royal Infirmary in Edinburgh, gave an address to the Pathological Society of London in which he outlined his histopathologic findings of "A CHARACTERISTIC ORGANISM OF CANCER" that he observed microscopically in fuchsine- stained tissue sections from all forms of cancer that he examined, as well as in certain cases of tuberculosis, syphilis and skin infection. The parasite was seen within the tissue cells (intracellular) and outside the cells (extracellular). The size of Russell's parasite ranged from barely visible, up to "half again as large as a red blood corpuscle." The Reference: Russell Body - The Forgotten Clue to the Bacterial Cause of Cancer. By (C) Cantwell AR Jr, M.D., 2003, Jeff Rense, rense.com, All Rights Reserved
91
The Russell body and the origin of cancer In 1981 King and Eisenberg’s article on "Russell’s fuchsin body: ‘The characteristic organism of cancer’ " appeared in the American Journal of Dermatopathology. They reconfirmed that "Russell bodies have now been shown to be immunoglobulins." They remarked that Russell was not the first to describe them; and that similar bodies were reported by Cornil and Alvarez in rhinoscleroma five years earlier in a French journal in 1885. Declaring it ironic that these "bodies should bear the name of a man who so thoroughly misunderstood them", the authors ended by stating: "Hence, when the term Russell body is used today, one should be aware that the eponym is as inaccurate as was Russell’s perception of their significance." Unlike King and Eisenberg, I believe Russell was right on the mark. There is a parasite in cancer. It has been studied and reported by various scientists throughout the world for many decades, and a wealth of scientific information on the cancer microbe is available in medical libraries. For those with Internet capability, the words "cancer microbe" typed into Google.com will give instant access to a treasure trove of information on the subject. There is no secret to cancer. In my view, the cause is staring us right in the face in the form of the Russell body. William Russell understood very well in the nineteenth century what medical science in the twenty- first century has yet to discover. (The Russell Body The Forgotten Clue to the Bacterial Cause of Cancer. By (C) Cantwell AR Jr, M.D., 2003, Jeff Rense, rense.com, All Rights Reserved) 99
largest round forms were easily seen microscopically. The large size of some of these bodies suggested a fungal or yeast- like parasite. Russell provisionally classified the parasite as a possible "blastomycete" (a type of fungus); and called the forms "fuchsine bodies" because of their bluish- red staining qualities. Microbiology was still in its infancy in Russell's era, and it was generally thought that each microbe could only give rise to a single disease. Thus, the idea of a cancer germ (especially one that could also be identified in TB and syphilis) was received cautiously. Nine years later in 1899, in yet another report on "THE PARASITE OF CANCER" appearing in The Lancet (April 29), Russell admitted that finding cancer parasites in diseases other than cancer was indeed a "stumbling block." By this time a considerable number of scientists concluded that Russell bodies were merely the result of cellular degeneration of one kind or another. Furthermore, no consistent microbe was cultured from tumors; and the inoculation of these microbes into animals produced conflicting and often negative results. Russell was trained as a pathologist, not as a microbiologist, and he avoided getting into the bacteriologic controversies regarding various microbes grown from cancer. He simply concluded, "It seems almost needless to add that there remains abundant work to be done in this important and attractive field." After three years' work at the New York State Pathological Laboratory of the University of Buffalo, Harvey Gaylord confirmed Russell's research in a 36 page report titled "The protozoon of cancer", published in May, 1901, in the American Journal of the Medical Sciences. Gaylord found the small forms and the large sacs characteristic of Russell bodies in every cancer he examined. Some large spherical bodies were four times the diameter of a leukocyte (white blood cell). Red blood cells measure about 7 micron in diameter and leukocytes are 2 to 3 times larger than red blood cells. Thus, some of the bodies that Gaylord observed attained the amazing size of around 50 micron in diameter. Reference: Russell Body - The Forgotten Clue to the Bacterial Cause of Cancer. By (C) Cantwell AR Jr, M.D., 2003, Jeff Rense, rense.com, All Rights Reserved
92
In addition, he found evidence of internal segmentation within the larger bodies "after the manner recognized in malarial parasites." The tiniest forms appeared the size of ordinary staphylococci. Russell's 1899 paper ended his writings of a cancer parasite, but his discovery quickly became known to pathologists as Russell bodies. These bodies continue to fascinate researchers and physicians (like myself) up to the present time. When Russell died at the age of 89 in 1940, the British Medical Journal published a large obituary noting that he was universally respected and embued with the dignity and highest ideals of his profession, and that he had served at one time as President of the Royal College of Physicians. NO MENTION was made of his "parasites" or his "bodies", except to remark that "in his earlier years Russell devoted much time to the study of the cancer Photo #7: Pleomorphic growth forms (L- forms) of tuberculosis mycobacteria photographed with an electron cell." His published books on Clinical microscope. Note the darker staining tiny coccal forms Methods and widely read texts on circulation (similar in size to ordinary staphylococci) and the larger clear balloon- sized "ghost" forms similar in size and shape and gastro- intestinal diseases were cited, but to Russell bodies found in tissue. These forms are all NOT A WORD about his discovery in characteristic of "cell wall- deficient bacteria" and totally unlike the well- known "typical" acid- fast rod forms of cancer. Mycobacterium tuberculosis. Reproduced from L- forms of Mycobacteria and Chronic Nephritis (1970), by Dr. C. Xalabarder P., page 51. Article: The Russell Body - The Forgotten Clue to the Bacterial Cause of Cancer. By Cantwell AR Jr, JOIMR 2003;1(6):1 (C) 2003, by Alan Cantwell, Jr. M.D.) 99 Reference: Russell Body - The Forgotten Clue to the Bacterial Cause of Cancer. By (C) Cantwell AR Jr, M.D., 2003, Jeff Rense, rense.com, All Rights Reserved
93
For his revolutionary discoveries, he was slated by the establishmen, denounced as a quack and a charlatan. He is one of the most brilliant scientists in the history."
(~ 1930 AD) Royal Raymond Rife PhD.,
Dr. A. Abrams, Dr James Couche, Dr. Kendall
Royal Raymond Rife PhD. (1888 – 1971) Neraska Ohio, Pathologist and Bacteriologist. Dr. Rife received 14 major awards and honors and was given an honorary Doctorate by the University of Heidelberg for his work. Honored by forty- four of the nation's most respected medical authorities with a banquet billed as ‚The End To All Diseases‘ Rife also worked with the top scientists and doctors of his day. They included: E.C. Rosenow, Sr. (Chief of Bacteriology, Mayo Clinic),
Nuttshell: Developer of the "Rife microscope." Books: Dr. Rife and the Death of the Cancer Industry by Gary Wade. The Cancer Cure That Worked by Barry Lynes, Lost Science by Gerry Vassilatos, The Healing of Cancer by Barry Lynes. (The following information is excerpted from: Royal Raymond Rife by Jeff Rense, rense.com) 100
66 years of his life, Dr. Rife have spent designing and building medical instruments. It is a fair statement that Dr. Rife practically developed bioelectric medicine himself. After studying at Johns Hopkins, Dr. Rife developed technology which is still commonly used today in the fields of optics, electronics, radiochemistry, biochemistry, ballistics, and aviation. Because
94
"Here are a few technical details to placate the skeptics... Dr. Rife have painstakingly identified the individual spectroscopic signature of each microbe, using a slit spectroscope attachment. Then, Dr. Rife slowly rotated block quartz prisms to focus light of a single wavelength upon the microorganism Dr. Rife was examining. This wavelength was selected because it resonated with the spectroscopic signature frequency of the microbe based on the nowestablished fact that every molecule oscillates at its own distinct frequency. The atoms that come together to form a molecule are held together in that molecular configuration with a covalent energy bond which both emits and absorbs its own specific electromagnetic frequency. No two species of molecule have the same electromagnetic oscillations or energetic signature. Resonance amplifies light in the same way two ocean waves intensify each other when they merge together. The result of using a resonant wavelength is that micro- organisms which are invisible in white light suddenly become visible in a brilliant flash of light when they are exposed to the color frequency that resonates with their own distinct spectroscopic signature (Nuclear Magnetic Resona nce utilizes the same principle in the electromagnetic spectrum). Using this concept Dr. Rife was thus able to see these otherwise invisible organisms and watch them actively invading tissues cultures." - Royal Raymond Rife by Jeff Rense, rense.com) 100
Arthur Kendall (Director, Northwestern Medical School), Dr. George Dock (internat. renowned), Alvin Foord (famous pathologist), Rufus Klein- Schmidt (President of USC), R.T. Hamer (Paradise Valley Sanitarium), Dr. Milbank Johnson (Director of AMA), Whalen Morrison (Chief Surgeon), George Fischer (Hospital, N.Y.), Edward Kopps (Metabolic Clinic) Karl Meyer (Hooper Foundation, S.F.), M. Zite (Chicago University), and many others.
Dr. Rife was selfeducated in so many different fields, he intuitively looked for the answers of his questions in areas beyond the rigid scientific structure of his day. Dr. Rife mastered so many different disciplines that he literally had, at his intellectual disposal, the skills and knowledge of an entire team of scientists and technicians from a number of different scientific fields. So, whenever new technology was needed to perform a new task, Dr. Rife simply invented and then built it himself. His inventions include a heterodyning ultraviolet microscope, a micro- dissector, micromanipulator and other. By 1920, he finished building the world's first VIRUS MICROSCOPE.
Reference: Royal Raymond Rife by Jeff Rense, rense.com
95
â&#x20AC;&#x17E;His discovery enabled Dr. Rife to view organisms that no one else could see with ordinary microscopes. One was Virginia Livingston. She eventually moved from New Jersey to Rife's Point Loma (San Diego) neighborhood and became a frequent visitor to my lab. Virginia Livingston is now often given the credit for identifying the organism which causes human cancer, beginning with research papers she began publishing in 1948. In reality, Dr. Rife had identified the human cancer virus first... in 1920. Soon after then, Dr. Rife made over 20,000 unsuccessful attempts to transform normal cells into tumor cells. Dr. Rife finally succeeded when he irradiated the cancer virus, passed it through a cell- catching ultrafine porcelain filter, and injected it into lab animals. Not content to prove this virus would cause one tumor, Dr. Rife then created 400 tumors in succession from the same culture. He documented everything with film, photographs, and meticulous records. Dr. Rife named the cancer virus 'Cryptocides primordiales.' Virginia Livingston, in her papers, renamed it Progenitor Cryptocides. Royal Rife was never even mentioned in her papers. In fact, Dr. Rife seldom got credit for his monumental discoveries. He was a quiet, unassuming scientist, dedicated to expanding his discoveries rather than to ambition, fame, and glory. Dr. Rifeâ&#x20AC;&#x2DC;s distaste for medical politics (which he could afford to ignore thanks to generous trusts set up by private benefactors) left Dr. Rife at a disadvantage later, when powerful forces attacked him. Coupled with the influence of the pharmaceutical industry in purging him papers from medical journals, it is hardly surprising that few heave heard of him, Royal Rife, today." Reference: Royal Raymond Rife by Jeff Rense, rense.com) 100
By 1933, Dr. Rife perfected that technology and had constructed the incredibly complex Universal Microscope, which has nearly 6,000 different parts and is capable of magnifying objects 60,000 times their normal size. With this incredible microscope, Dr. Rife became the first human being to actually see a LIVE VIRUS, and until quite recently, the Universal Microscope was the only one which was able view live viruses. Modern electron microscopes instantly KILL everything beneath them, viewing only the mummified remains and debris. The significance of his microscope is that with Dr. Rife device you could see is the bustling activity of living viruses as they change form to accommodate changes in environment, replicate rapidly in response to carcinogens, and transform normal cells into tumor cells. Dr. Rife ignored the debate, preferring to concentrate on refining his method of destroying these tiny killer viruses. Dr. Rife used the same principle to KILL THEM, which made them visible: RESONANCE. (Photo: Rife Microscope. By Jeff Rense)
Reference: Royal Raymond Rife by Jeff Rense, rense.com
96
By increasing the intensity of a frequency which resonated naturally with these microbes, Rife increased their natural oscillations until they distorted and disintegrated from structural stresses. He called this frequency 'the mortal oscillatory rate,' or 'MOR', and it did no harm whatsoever to the surrounding tissues. This principle can be illustrated by using an intense musical note to shatter a wine glass: the molecules of the glass are already oscillating at some harmonic (multiple) of that musical note; they are in resonance with it. Because everything else has a different resonant frequency, nothing but the glass is destroyed. There are literally hundreds of trillions of different resonant frequencies, and every species and molecule has its very own. It took Dr. Rife many years, working 48 hours at a time, until he discovered the frequencies which specifically destroyed herpes, polio, spinal meningitis, tetanus, influenza, and an immense number of other dangerous disease organisms. In 1934, the University of Southern California appointed a Special Medical Research Committee to bring terminal cancer patients from Pasadena County Hospital to Rife's San Diego Laboratory and clinic for treatment. The team included doctors and pathologists assigned to examine the patients - if still alive - in 90 days. After the 90 days of treatment, the Committee concluded that 86.5% of the patients had been COMPLETELY CURED. The treatment was then adjusted and the remaining 13.5% of the patients also responded within the next four weeks. The total recovery rate using Dr. Rifeâ&#x20AC;&#x2DC;s technology was 100%. On November 20, 1931, forty- four of the nation's most respected medical authorities honored him with a banquet billed as THE END TO ALL DISEASES at the Pasadena estate of Dr. Milbank Johnson. But by 1939, almost all of these distinguished doctors and scientists were denying that they had ever met Dr. Rife. What happened to make so many brilliant men have complete memory lapses? It seems that news of his positive results with terminal patients close to miracles had reached other ears. At first, a token attempt was made to buy out Dr. Rife's device. Morris Fishbein, who had acquired Reference: Royal Raymond Rife by Jeff Rense, rense.com
97
the entire stock of the monopoly, the American Medical Association by 1934, sent an attorney to Dr. Rife with 'an offer you can't refuse.'... Dr. Rife refused. We many never know the exact terms of this offer, but we do know the terms of the offer Fishbein made to Harry Hoxsey for control of his herbal cancer remedy. Since then it came to a gradual pilfering of components, photographs, film, and written records from Rife’s lab. The culprit was never caught. Then, while Dr. Rife struggled to reproduce his missing data (in a day when photocopies and computers were not available), someone vandalized his precious virus microscopes. Pieces of the 5,682 piece Universal microscope were stolen. Earlier, an arson fire had destroyed the multi- million dollar Burnett Lab in New Jersey, just as the scientists there were preparing to announce confirmation of his work. But the final blow came later, when police illegally confiscated the remainder of Dr. Rife’s 50 years of research. Then in 1939, agents of a family which controlled the drug industry assisted Philip Hoyland in a frivolous lawsuit against his own partners in the Beam Ray Corporation. This was the only company manufacturing Dr. Rife‘s frequency instruments. Hoyland lost, but his assisted legal assault had the desired effect: the company was bankrupted by legal expenses. And during the Great Depression, this meant that commercial production of Rife’s frequency instruments ceased completely. Doctors, who tried to defend Rife, lost their foundations grants and hospital privileges. On the other hand, big money was spent ensuring that doctors who had seen the Rife’s therapy would forget what they saw. Almost no price was too much to suppress it. Remember that, today, treatment of a single cancer patient averages over $300,000. Thus, Arthur Kendall, the Director of the Northwestern School of Medicine who worked with Dr. Rife on the cancer virus, accepted almost a quarter of a million dollars to suddenly 'retire' in Mexico. That was an exorbitant amount of money in the Depression. Dr. George Dock, another prominent figure who collaborated with Dr. Rife, was silenced Reference: Royal Raymond Rife by Jeff Rense, rense.com
98
with an enormous grant, along with the highest honors the AMA could bestow. To finish the job, the medical journals, support almost entirely by drug company revenues and controlled by the AMA, refused to publish any paper by anyone on my therapy. Therefore, an entire generation of medical students graduated into practice without ever once hearing of Rife’s success, the ‘Rife's breakthroughs in medicine’. The magnitude of such an insane crime eclipses every mass murder in history. Cancer picks us off quietly...but by 1960 the casualties from this tiny virus exceeded the carnage of all the wars America ever fought. In 1989, it was estimated that 40% of us will experience cancer at some time in our lives. In Rife’s lifetime, he had witnessed the progress of civilization from horse- andbuggy travel to jet planes. In that same time, he saw the epidemic of cancer increase from 1 in 24 Americans in 1905 to 1 in 3 in 1971 when his journey ended. The inevitable conclusion reached by Rife was that his life- long labor and discoveries had not only been ignored but probably would be buried with him. At that point, Dr. Rife ceased to produce much of anything and spent the last third of his life seeking oblivion in alcohol. It dulled the pain and his acute awareness of half a century of wasted effort - ignored - while the unnecessary suffering of millions continued so that a vested few might profit. And profit they did, and profit they do... In 1971, Dr. Rife‘s journey ended from a combination of valium and alcohol at the age of 83.
Reference: Royal Raymond Rife by Jeff Rense, rense.com
99
HISTORY OF THE DEVELOPMENT OF A SUCCESSFUL TREATMENT FOR CANCER AND OTHER VIRUS, BACTERIA AND FUNGI By Royal Raymond Rife (The following information is excerpted from: History Of The Development Of A Successful Treatment For Cancer And Other Virus, Bacteria And Fungi By Royal Raymond Rife. Copyright Š Rifevideos.com. All rights reserved, http://www.rifevideos.com) 101
Before my discovery of the cause of cancer and other diseases, I had sought to find such evidence with standard research microscopes. I observed all types of malignant tissue to find some trace of the cause. I felt that the start of malignancy would be originated by some type of micro- organism. It became obvious that in order to find the cause, better means of observation had to be developed. Thus five microscopes were designed and built in the laboratory with a range of 5,000 to 50,000 X. Working in magnifications of 17,000 X and higher revealed new cells and microorganisms requiring much skill and patience to focus and photograph. After the isolation of the filtered virus and other pathogenic organisms, the idea was conceived, that it would be possible to create an electronic frequency that was in the correct coordination or RESONANCE of the chemical constituents of a given organism or virus, and to devitalize with said frequency, the organism or virus in question. The initial frequency instrument of this nature was first used and developed in the laboratory in 1920. Due to the great advancement in the field of electronics, these frequency instruments have steadily improved to the present day. The isolation of cancer virus and other micro- organisms was an accomplishment with which I felt a great deal of pride. Finally in 1931, I discovered the transformation of cancer virus and the successful treatment for cancer and other diseases by actual observation of the universal microscope while applying the frequency instrument. Thus, this data is presented for evaluation. With the frequency instrument, no tissue is destroyed, no pain is felt, no noise is audible, and no Reference: History Of The Development Of A Successful Treatment For Cancer And Other Virus, Bacteria And Fungi By Royal Raymond Rife. Rifevideos.com.
100
sensation is noticed. A tube lights up and 3 minutes later the treatment is completed. The virus or bacteria is destroyed and the body then recovers itself naturally from the toxic effect of the virus and or bacteria. Several disease forms may be treated simultaneously. METHODS OF CULTURE AND TECHNIQUES OF ISOLATION OF THE VIRUS OF CANCER The methods and principles that were used in this procedure were as herein related. An un- ulcerated breast mass that was checked for malignancy by their laboratory and ourselves came to our laboratory from the Paradise Valley Sanatorium of National City, California. The experiments of 1931 and 1932 were conducted in our Point Loma Laboratory, then known as the Rife Research Laboratory. Ten millimeter blocks of this tumor (in 1932) were placed in "K" media and incubated at 37.5 degrees C with no results. After many long procedures and attempts to grow the cancer virus had failed, the discovery of the GROWTH METHOD of cancer virus was found. A test tube containing a sample from the un- ulcerated breast mass was sealed and placed in an argon gas filled loop with 15 mm vacuum and activated with 5000 volts. This produced a decided change of ionized cloudiness in the media. (This media was of tyrode solution and desiccated slime (sic) intestine). This test tube was then checked for cancer virus, but at this point none were visible. Then the test tube was subjected to a 2inch water vacuum and incubated for 24 hours. Upon examination the solution in the test tube was teeming with cancer virus, which were the most highly motile and the smallest in size of any of the viruses previously isolated. These BX or cancer viruses refracted a purplish red color with the monochromatic beam. We have not thoroughly determined the phenomenon that takes place with this technique of culturization, but we believe that this method brings the organism from the ultraviolet band into the visibility of refraction. (This method does not alter the virulence Reference: History Of The Development Of A Successful Treatment For Cancer And Other Virus, Bacteria And Fungi By Royal Raymond Rife. Rifevideos.com.
101
of the virus in any way). This virus is bi- polar (and will attract to both the positive and negative poles), but requiring both the + & - parts to produce a reaction in the tissues of the experimental animals. Our method used in this procedure was as follows: Albino rats were generally used. The animal chosen for this experimental work is carried no less than 12 day through quarantine. The animal is shaved at the point of inoculation and placed under a partial anaesthesia. The needle for inoculation is filled with triple sterilized petroleum jelly and the inoculum and passed no less than 20 mm under the epidermis to the point of inoculation. In 3 to 4 days almost invariably there is an open lesion which appears in the thyroid area. This recedes at the end of that time and the growth of the tumor starts at the seat of inoculation which is a mammary gland. These tumors develop very rapidly owing to the metabolic rate of the albino rat. In many cases these tumors have grown to weight exceeding that of the animal. Upon surgical removal of this mass and upon microscopical examination- - - a true malignancy is shown. That proved that the virus was pathological. These experiments were carried through no less than one hundred times with the same methods and careful technique with the same end results. We sincerely believe that this leaves no doubt as to the fact (that the BX organism initially isolated from the unulcerated human tumor and recovered from the tumor produced by that BX virus and that BX virus again recovered) that BX is the primary cause of cancer. We have in our own classification called this virus of cancer - BX. We do not expect any laboratory to be able to produce BX on account of the technique involved and the lack of adequate optical equipment. This BX or any other virus cannot be seen with the CONVENTIONAL MICROSCOPE and illuminating systems as we have explained often before. That these tiny live living entities (known as BX virus) cannot be stained with any of the conventional acid or aniline dye stains as they are much smaller in dimension than the Reference: History Of The Development Of A Successful Treatment For Cancer And Other Virus, Bacteria And Fungi By Royal Raymond Rife. Rifevideos.com.
102
molecular particles of said stain and can be seen only by a frequency of light which coordinates with their chemical constituents. All viruses require their own individual frequency of the mono- chromatic beam to make them visible to the human eye. We have come to the conclusion that the illuminant in the fields of high powered microscopy is a more important factor than the high power in magnification of the microscope because without this source of illumination these particles called virus ARE INVISIBLE with any amount of magnification. We have used Koch's postulates in our methods of recovery which are that the organism inoculated into the host must again be recovered in its true form from the host and thus, as stated before this has been repeated hundreds of times proving to our own satisfaction that BX or cancer virus is the cause of malignancy. This BX virus can be readily changed into different forms of its life cycle by the media upon which it is grown (â&#x20AC;Ś).
Reference: History Of The Development Of A Successful Treatment For Cancer And Other Virus, Bacteria And Fungi By Royal Raymond Rife. Rifevideos.com.
103
The Possible Genetic Cause of the Great Majority of Cancer Cases that are Microbe Induced Reference: Dr. Rife And The Death Of The Cancer Industry. By Max Planck. Taken from: DR. RIFE AND THE DEATH OF THE CANCER INDUSTRY. Rife Research Europe, Copyright, Peter Walker, http://www.rife.de/) 102
I will now share with you some observations about cancer cells and a classic experiment in which they are compared to normal cells, which suggests a simple answer to how cells infected with the BX cancer virus become cancerous. It has long been noted that cancer cells act and appear somewhat like UNDIFFERENTIATED embryonic cells. Furthermore, cancer cells apparently have mostly an ANAEROBIC (without oxygen) metabolism. Note that the only time in the normal life cycle of mammalian cells in which they are of an undifferentiated embryonic nature and also have an apparent appreciable anaerobic metabolism is the period between the time the female egg, the ovum, has been fertilized in the fallopian tube and just before a viable placenta has developed in the uterus. Geneticists and embryologists have shown that the entire development of the fetus from just- fertilized ovum to the fully developed fetus is governed completely by sequentially read and expressed genetic information. There is an exceedingly complex genetic interchange and feedback control system in operation. Some of this genetic code is used only for a short period of time and is then sealed away Reference: Dr. Rife And The Death Of The Cancer Industry. By Max Planck., Rife Research Europe, Copyright, Peter Walker, http://www.rife.de/
104
Tuberculosis in rod form by Royal Rife
The BX Cancer Virus at about 17000X
Royal Rife Cross- section of Single tetanus Spore Dissected with Dr. Rife's Micromanipulator 25,000x on 35 mm film - Enlarged 227,000x Source: Rife Research Laboratory
not to be read or opened up again in the individuals existence, except during chromosome copying prior to cell division. Cancer cells act as though they have had some set of embryonic gene sequences REACTIVATED. However, in the now mature differentiated mammalian cells from which this cancer cell has been derived, the control system that normally would have deactivated this embryonic gene sequence(s) is itself long since deactivated. The cancer cell is in a run away catch 22 situation. It has been found that many genes occur in sequenced sets in which none of the genes in the sequence can be read and expressed unless the first gene in the sequence has been opened to be read. Just in front of that first gene there is a DNA code sequence which has to have a promoter protein bound to it so that the DNA code sequence reading enzyme can temporarily attach to this promoter protein and then begin reading/translating the DNA code of the gene sequences into messenger RNA for protein synthesis by ribosomes. For this promoter protein to attach to its DNA coupling sequence at the beginning of the gene sequence, this sequence must be in the normal B- DNA right handed double helix. If the coupling site code sequence or the DNA code sequence immediately in front of it has a Reference: Dr. Rife And The Death Of The Cancer Industry. By Max Planck., Rife Research Europe, Copyright, Peter Walker, http://www.rife.de/
105
A Placebo Study Of Audio Frequency Therapy In The Treatment Of Arthritis by Geoff Baker (B. App. Sci) ABSTRACT: "The effectiveness of Audio Frequency Therapy in relieving arthritic symptoms in 49 randomly selected volunteers suffering from chronic Rheumatoid and Osteoarthritis was investigated in a three month placebo study conducted at the Tuggerah Lakes Community Centre on the Central Coast of New South Wales (10th May 1993 to 14th August 1993). The study was initiated by a private company, BWBGELTECH PTY LTD seeking assistance from an arthritis support organisation, interested doctors, and a commercial laboratory. Placebo study conditions were strictly adhered to, with no volunteer being aware of whether he or she was receiving treatment. Three treatments per week of three hours duration were administered using thirty- four Audio Frequency Therapy Units (AFTU's - ARTG No. AUST L 48725) produced by BWBGELTECH. These pocket sized computerised devices allowed carefully selected menus of frequency programs to be applied to each chosen volunteer (â&#x20AC;Ś)." Reference: A PLACEBO STUDY OF AUDIO FREQUENCY THERAPY IN THE TREATMENT OF ARTHRITIS by Geoff Baker (B. App. Sci) Director of Research & Development BWBGELTECH PTY LTD / now: Electromed (Aust.) P/L, Copyright, Peter Walker, http://www.rife.de/) 103
blocking protein attached or is in the form of the left handed Z- DNA double helix (see Figure 2), the promoter protein can not bind/couple with its DNA code sequence and therefore the entire sequence of genes will not be read and expressed. The Z- DNA double helix form is a very compact form of the double helix. It has no major grove structure like the B- DNA double helix which allows a promoter protein to physically match up with a specific DNA code sequence which will manifest itself in the unique molecular structure of the surface of the major grove for that unique DNA code sequence. The Z- DNA double helix structure gives very little information about what the DNA code sequence is in its core. For a left handed ZDNA double helix associated with a specific DNA code sequence to convert itself into a right handed B- DNA double helix, so that the promoter protein can attach, the concentrations of various ions in the cell nucleus must be in certain specific ranges for that specific Z- DNA sequence. The specific concentrations and ratios of ions in the nucleus is determined by the actions of ion gates and pumps in the cell outer membrane. These ion gates and pumps are controlled by messenger proteins and compounds from both inside and outside the cell membrane. What this means is that the cell genetic expression can be greatly influenced and controlled by Reference: Dr. Rife And The Death Of The Cancer Industry. By Max Planck., Rife Research Europe, Copyright, Peter Walker, http://www.rife.de/
106
"All participants were regularly monitored by self- evaluation of pain on visual analogue scales which complied with a standard hospital protocol for monitoring pain in arthritis patients. Also pre and post study HLB testing was provided by Australian Biologics Testing Services (Sydney) for seven randomly selected volunteers from the treated and placebo groups. Similarly, independent post- study appraisal of each volunteer's condition by their referring General Practitioner was requested. On completion of the study, the mean value of percentage reduction in overall pain (Figures 1 and 2) of the treated group was 34 percent (n = 28 ) compared with 13 percent reduction in the untreated group (n = 21). The mean 13 percent reduction of pain in the untreated volunteers was generally attributable to the emotional benefits received by being involved in the study. This improvement was not evidenced in the blood test results. The mean value of percentage decrease in inflammatory oxidative processes in the extremities of volunteers (ROTS masses, HLB test) which relates to the severity of the arthritic state was 26 percent in treated volunteers ( n = 8 ) compared with one percent increase in untreated volunteers (n = 7), fig 3. i.e. high oxidative states equate to increased severity of the arthritic condition (â&#x20AC;Ś)." Reference: A PLACEBO STUDY OF AUDIO FREQUENCY THERAPY IN THE TREATMENT OF ARTHRITIS by Geoff Baker (B. App. Sci) Director of Research & Development BWBGELTECH PTY LTD / now: Electromed (Aust.) P/L, Copyright, Peter Walker, http://www.rife.de/) 103
the genetic expression of other cells and cell sets (organs). And of course during embryonic development this external cell influence is in dominant control of the whole cell system of membrane ion gates and pumps. Now that some of the basic genetic control process has been stated, several questions need to be asked. Can one or more microbe proteins or chemical compounds be generated and released inside a mammalian cell by a parasitic microbe? Can these proteins or compounds act as a messenger to open up or close down cell membrane ion gates or pumps? Can this opening or dosing of ion gates and or pumps cause a gene sequence which is normally only open during early embryonic development to open up again and thereby cause the cell to go cancerous? I believe the answer to all these questions is yes. Of course there are many other possibilities i.e. some of these protein fragments may act as promoter proteins or combine with and remove blocker proteins, thereby allowing a promoter protein to attach to a DNA sequence and thereby initiate DNA transcription. Dr. Robert 0. Becker, M.D. has written a book The Body Electric in which he goes into great detail about tissue regeneration processes and their electrical and ionic connection to genetic expression. I will now use information distilled from Becker's book which Reference: Dr. Rife And The Death Of The Cancer Industry. By Max Planck., Rife Research Europe, Copyright, Peter Walker, http://www.rife.de/
107
"The net mean reduction in pain of the treated volunteers when compared with the untreated group was 21 percent which is in good agreement with the net mean 26 percent reduction in oxidative processes in the treated versus untreated groups. The significant improvement in treated volunteers signs and symptoms was confirmed in written testimonies requested from each participant at the conclusion of the study. Those who experienced no improvement with treatment during the short term of the Study were generally late stage chronic arthritics whose pain was primarily related to an advanced state of degeneration of their joints (generally joint replacements were pending) or they were suffering from pain due to unrelated illnesses. Further long term treatment may bring improvement in these individuals when combined with other forms of regenerative therapy." The results of the trial suggest Audio Frequency Therapy offers an effective non- drug based alternative in the treatment of chronic Osteo and Rheumatoid Arthritis with minimal short term side effects. Reference: A PLACEBO STUDY OF AUDIO FREQUENCY THERAPY IN THE TREATMENT OF ARTHRITIS by Geoff Baker (B. App. Sci) Director of Research & Development BWBGELTECH PTY LTD / now: Electromed (Aust.) P/L, Copyright, Peter Walker, http://www.rife.de/) 103
supports my above suppositions. In 1948 Dr. Meryl S. Rose performed a mile stone experiment on salamanders. Rose transplanted frog kidney cancer tumor tissue onto a salamander's hind limb. These frog tumors were virus induced. The results of his experiment, however are the same even if the tumor is carcinogen induced, which was done later. The transplanted tumors would grow and spread, leading to the salamander's death, if no intervention was taken. However, if Rose amputated the limb below or through the middle of the tumor, the salamander would regrow the limb and in the process the tumor(s) would disappear, even if the tumor had already spread to other body locations. Tissue biopsies of the wound region during regeneration showed that both salamander cells as well as cancerous frog kidney cells dedifferentiated into embryonic cell forms during the blastema formation process as the wound healed. Even more amazing, as the blastema propagated forward, regenerating the limb, both embryonic frog and embryonic salamander cells of the blastema multiplied (devided). They differentiated into the cell types needed to form the new limb tissue, i.e. muscle cells, cartilage cells, capillary cells, etc. In later years researchers such as Becker demonstrated that it was the near unique ability of the salamander's nervous system to drastically change the ionic environment around blastema cells, along with hormone secretions from nerve dendrites, which allowed blastema cells to dedifferentiate into embryonic cells and then to red differentiate into the new cell types of the regenerating limb. Becker and other researchers were able to get rats to regrow most of, or all of an amputated limb. They implanted a negative current source that produced a negative electric potential distribution inside the limb directly behind the amputation site. This closely mimicked what a salamander would have at that site if it were scaled up to the rats size. To understand what is happening here, you need to know that in a rat just as in a salamander the myelin sheath cells coating the motor nerve fibers carry an electron current through collagen fibers which are N- type semi- conductors. This current Reference: Dr. Rife And The Death Of The Cancer Industry. By Max Planck., Rife Research Europe, Copyright, Peter Walker, http://www.rife.de/
108
is deposited mostly into the body's electrolytic solution surrounding the cells near where the nerve fiber ends. The myelin sheath cells coating the sensor nerve fibers carry an electron current on their collagen fibers away from where the sensor nerve fiber ends. The motor nerve fibers are essentially all in the body interior and the sensor nerve fibers are essentially all on the body surface. As an amputation wound heals over with skin, surface sensor nerve fibers cover over what is normally a motor nerve fiber region. In a short period of time the cells under the new forming skin layer can be converted into dedifferentiated embryonic cells under the influence or control of the external cell membrane ionic environment at the wound site as determined by the electric current potential of the combined sensor and motor nerve sheaths activity in the wound area (blastema formation zone). I cannot here go into all of the wonderful detail of Becker's book. However, I hope I have given the reader at least an understanding of how cancer can possibly come about by a simple change in the ion environment in the cell nucleus. If you are interested in tissue regeneration or are aserious biologist. I cannot recommend Becker's book enough. Particularly the last chapter, Postcript: Political Science. This chapter with great clarity and skill clearly shows why we as a nation need to dismantle all centralized cesspools of corruption as exemplified by the National Institutes of Health. The NIH needs to be replaced by regional institutes which are government funded, but ran and controlled by democratically elected administrators elected by the research community. Before ending this appendix, a warning and an explanation of why X- ray radiation should NEVER be used to treat cancer. Rife was able to isolate the BX cancer virus from cancer tumor tissue samples. He then exposed these viruses to 24 hours of ultra violet light exposure. This virus obtained in this manner was 100% effective in inducing cancer in lab animals. His form of the BX cancer virus was exceedingly virulent. Other researchers who apparently isolated the same BX cancer virus, or a form of Reference: Dr. Rife And The Death Of The Cancer Industry. By Max Planck., Rife Research Europe, Copyright, Peter Walker, http://www.rife.de/
109
it, and inoculated test animals by similar methods only had approximately 25% cancer induction rates. A possible simple answer for the discrepancy is that the ultraviolet light from the argon discharge caused some of the adjacent thimine DNA base codes to dimerize (chemically bond together). When the DNA reader enzyme which translates the DNA base code into messenger RNA for protein synthesis comes across a dimerized thimine base code pair, it stops RNA synthesis. The reader enzyme then breaks into two fragments. One fragment stays at the dimerization site to mark it and the other fragment initiates a complex set of enzyme reactions to remove the dimerized pair and replace them with a new undimerized pair. During this repair process the messenger RNA generated fragment is released. If this messenger RNA fragment contains the genetic RNA base code sequence for ribosome attachment, it will be read by the ribosomes and a protein fragment will be generated and released. In particular, if the RNA fragment is fed into a cluster of ribosomes (polyribosomes) which are located on or associated with the intercellular matrix web intersections, we can expect many copies of the coded protein fragment to be generated and released Furthermore, since the RNA fragment does not contain the normal stop synthesis code and message RNA end sequence base code, the RNA fragment is not likely to be immediately dismantled after polyribosome reading and protein synthesis like regular messenger RNA is. This fragment is likely to be read over again and again. Now. if the generated protein fragment happens to be an activator or suppressor of a cell membrane ion channel or ion pump you have the potential beginnings of a cancer producing situation as discussed above. This protein fragment(s) might also act as a promoter protein that enables the DNA reader enzyme to attach to and read a gene sequence. Or this protein fragment may combine with a blocker protein on a repressor gene at the front of a DNA gene sequence and remove it, thereby allowing a promoter protein to combine with a DNA sequence and Reference: Dr. Rife And The Death Of The Cancer Industry. By Max Planck., Rife Research Europe, Copyright, Peter Walker, http://www.rife.de/
110
then facilitating attachment of the DNA reader enzyme (RNA polymerase). All of this is not the normal "plan" of the normal cell metabolism. An excellent example of this sort of defective protein production and its cancerous consequences is the genetic disease xeroderma pigmentosum. In it the individual has an inherited defect in their ability to repair the aforementioned DNA base code dimerization damage. They are hypersensitive to sun light exposure and develop pre- cancerous and cancerous skin conditions. They usually die of skin cancer before their twentieth birthday. Now what does this have to do with massive cellular tissue damage suffered by cancer patients while under going standard allopathic medical X- ray treatment for cancer? As stated in Appendix B. Rife's normal treatment for cancer patients was three minutes of exposure once every three days to his frequency instrument. This frequency instrument, when treating cancer, probably produced repeating packets of 11,780,000 or 23.560,000 light pulses per second. These light pulses in turn produced ultra low intensity ultra sound in the patient's body of a frequency of 11.780.000 or 23.560.000 cycles per second, which is the approximate mechanical structural resonance frequency of the BX cancer viruses. The Bx viruses disintegrated. In the normal carcinoma cancer cell, there are thousands of BX cancer viruses. When these BX cancer viruses all disintegrate together at the same time, they release their gnome, digestive enzymes, ribosomes, assorted proteins, enzymes, etc. into the cell. The cancer cell is overwhelmed, dies, and promptly disintegrates. When using Rife's cancer treatment method on a cancer patient that has undergone extensive allopathic medical X- ray damage, there is the high possibility of an encounter with a new kind of cancer cell which Rife's treatment method won't work on. Allopathic medical X- ray treatment causes significant ultraviolet light, ionization, and free radical production both in tumor tissue and adjacent normal tissue. With this ultraviolet light, ionization and free radical production, there is the associated dimerization of adjacent DNA base code Reference: Dr. Rife And The Death Of The Cancer Industry. By Max Planck., Rife Research Europe, Copyright, Peter Walker, http://www.rife.de/
111
molecular pairs. Both cancer cells and adjacent non cancer cells suffer significant cell membrane integrity damage from the X- ray radiation. All of this culminates in the possibility of a heavily radiation damaged BX cancer virus penetrating the cell membrane of a non cancerous cell and instigating production of cancer causing protein fragments as discussed above. But its own gnome so badly damaged that it cannot propagate itself. If this were to occur, then a cancer cell could be created which was not infested with the BX cancer virus and therefore not treatable by Rife's frequency instrument or ultra sound of 11.789,000 or 23.560.000 cycles per second. Of course the X- ray radiation alone could generate a cancer cell that the original Rife's treatment method would not cure. Well we have skimmed over a lot of technical data in this appendix. However, I hope the reader now has a conceptual frame work in which to begin questioning the current allopathic medicine approach to cancer causes, treatments, and cures. Only by honest researchers going back and looking at the suppressed results of past honest cancer researchers can we hope to find honest valid answers about cancer causes and cures.
Reference: Dr. Rife And The Death Of The Cancer Industry. By Max Planck., Rife Research Europe, Copyright, Peter Walker, http://www.rife.de/
112
„A vicious campaign was set- up to destroy the work of Priore."
(~ 1950 AD) Antoine Prioré (~ 1950 AD) Christopher Bird (~ 1950 AD) Dr Pautrizel
Working Summary: bioelectric medicine in cancer research Books: Dossier Prioré. The mystery of "L'affaire Prioré" remains unsolved by Jean- Michel Graille Antoine Prioré (1912 - 1983) was born in Trieste, Italy. Prioré was a radar technician for the Italian Navy.
(The following information is excerpted from: The Story of Antoine Prioré, Rife Research Europe, Copyright, Peter Walker, http://www.rife.de/) 104
Over a period of 25 years, between 1950 and 1975, he is said to have CURED ALL INCURABLE CANCERS in animals, from mice to dogs with a unique electrotherapy device he invented. He hoped to do no less than to revolutionize the treatment of cancer. Many tests on man were successful, with the decrease and sometimes with the disappearance of the tumor although the adjustments were very delicate and some modifications led to a worsening of the cancer. The majority of these treatments, conducted in collaboration with the Faculty of Medicine, hospitals in Bordeaux and sometimes with the Academy of Sciences, consisted of a POWERFUL RADIATION OF ELECTROMAGNETIC WAVES. In all his life, Prioré tried to increase the power of his appliances in order to improve their efficiency. Reference: The Story of Antoine Priore, Rife Research Europe,, Copyright, Peter Walker, http://www.rife.de
113
Photo: Priore and Dr Pautrizel under the apparatus (very partial View of "The Machine" with size of two floors..) "Several experiments have been carried out by Antoine Prioré. Some of these are summarized below: 1. A cancerous tissue was grafted to laboratory rats. Twenty- four control rats died within 22- 30 days. In those rats which had been exposed to radiation to the magnetic field from Priore’s machine, the cancerous tissue was either completely absorbed, or, if the treatment was begun after cancer had started to spread, had regressed to the point of total cure (…)" (The above information is excerpted from: The Story of Antoine Priore, Rife Research Europe,, Copyright, Peter Walker, http://www.rife.de/) 104
Supported by the most renowned scientists, he got some enormous state and industrial financial assistance (more than twenty million franc, approx. 3 million dollars) to finalize a machine permitting to validate his results in an unquestionable way. Unfortunately, he used this amount for the construction of a last apparatus with technologically limited possibilities. An apparatus with such a power that it would be able to cure any incurable human tumor or illness (…). A twenty- man commission composed of well known men of science, medicine, law and other professionals have begun and are continuing investigations into the claims made for this mystery machine. They have been able to report experimental findings, but have not been able to provide an explanation of the workings of the Prioré equipment. Funding was provided by the French Government to construct a third and more powerful machine which cost 3.5 million dollars. It was called the M- 600 and functioned for about one week until a huge tube in it exploded. Due to the inflation rampant in the early 70’s, the replacement cost would have exceeded one million dollars which was felt to be too high to continue the project (…).
Reference: The Story of Antoine Priore, Rife Research Europe,, Copyright, Peter Walker, http://www.rife.de
114
"(…) There were no observed bad side effects and there was no recurrence of the cancer. 2. A different and highly malignant strain of cancerous tissue, leukaemia, which can cause death in as little as two weeks, was grafted onto laboratory rats. Again, exposure to the radiation in the magnetic field resulted in the complete inhibition of growth of the cancerous grafts, or, if the disease had started to develop before the treatment was begun, to its total regression. 3. Mice were inoculation with a microscopic blood parasitic (Trypanosoma equiperdum) which causes sleeping sickness and death in short time. The course of the experiment could be followed closely by analyzing blood samples taken daily. All control animals died by the fifth day. Mice exposed daily to the radiation and magnetic field survived (38 out of 46 animals) with complete disappearance of the parasites from their systems.They also developed a specific immunity to further infection. Animals exposed some days before inoculation appeared to have developed an immunity. 4. Rabbits, which develop a chronic illness when inoculated with trypanosomes from which they usually die after several weeks, were tested with the radiation in a magnetic field with the same positive results as described above." (Source: The Story of Antoine Priore, Rife Research Europe,, Copyright, Peter Walker, http://www.rife.de/) 104
The story of this remarkable work began in 1944 when Antoine Prioré noticed some oranges which had been left in a room next to some electrical equipment. These oranges remained in a fresh state while others not near the electrical equipment became rotten and putrid. This anomaly intrigued young Prioré to explore magnetic and electromagnetic effects on various plants. One of his earlier experiments was the exposure of lentil seeds to a magnetic field of 225 gauss at electromagnetic frequencies of 80, 32, 3 and 10 Hertz. This caused the lentils to grow 12- 15 centimeters in length as compared to only a 5 centimeter growth for controls not subjected to the same treatment. The effect proved similar for asparagus, tulips, and other plants. Hens’ eggs were then exposed to the same energies which brought about hatching in 19 days as opposed to the normal 21 days. Later research using CANCEROUS TISSUE yielded partial or total remissions when exposed to these energies. Similar reports of tumor regressions were obtained by Kenneth McLean with the use of a 3000 gauss or greater magnetic field. Later tests made by Biraben and Delmon using a field strength of 4500 gauss on T- 8 tumors had not the slightest trace of remission. This showed that there was obviously something besides a magnetic field at work. Tests made with the Prioré machine on cancer tissues ALWAYS caused total remission in all tissues exposed to the peach blossom violet color which the machine emitted. The machines of Antoine Prioré were dismantled shortly after his death in the early 80’s. Rumors say that research on his equipment is continuing in South Africa.
Reference: The Story of Antoine Priore, Rife Research Europe,, Copyright, Peter Walker, http://www.rife.de
115
„The price of his ground breaking research was suppression, prosection, and threatening with life imprisonment "
(~ 1940 AD) Gaston Naessens
Gaston Naessens (1924 ) Quebec Biomedical Physicist Cellular Ecology Hall of Fame. "Galileo of the Microscope." Founder of "International Academy of Somatidian Orthobiology," His somatid theory of the origins of cancer is the result of over 40 years of research in bacteriology and biology
Nuttshell: Inventor of "Somatoscope". Father of somatid theory of the origins of cancer Books: The Life and Trials of Gaston Naessens: The Galileo of the Microscope by Christopher Bird, Politics in Healing: The Suppression and Manipulation of American Medicine by Daniel Haley (The following information is excerpted from: Gaston Naessens and 714X written by Gavin Phillips. www.cancerinform.org/, According to the author, the information was derived from Daniel Haley's book, "Politics in Healing" 2000. All quotes have a bracketed page number by them.) 105
Gaston Naessens was born 1924 in a comfortably off family in Northern France. Just prior to World War II Gaston was studying physics, chemistry and biology at the University of Lille. When the war started he was evacuated to the South of France where his studies continued. He received a degree in biological engineering from the Union Nationale Scientifique Francaise but never bothered to obtain an official diploma from the de Gaulle government after the war.
116
"Naessens stated: "I've been able to establish a life cycle of forms in the blood that add up to no less than a brand new understanding of the basis of life. What we're talking about is an entirely new biology, one out of which has fortunately sprung practical applications of benefit to sick people, even before all of its many theoretical aspects have been sorted out" Famed American AIDS researcher Dr. Robert Gallo said, "pleomorphism is insanity." (p101) But what is insanity is that one of sciences supposed icons is ignorant (or doesn’t want to admit it) of what Naessens has known for 50 some years.When microbiologist Walter Clifford took researchers into his laboratory and showed them "…From their own blood, things they had never before seen…" it did not change their opinions. "Many of them unblinkingly told me that, because what they had seen was not approved by any professional society or governmental agency, they simply would not believe it – that is, believe their own eyes."" - Politics in
Healing: The Suppression and Manipulation of American Medicine, Daniel Haley, 2000 "Galileo was vilified and imprisoned some 400 years ago for saying the earth revolved around the sun and scientists refused to look through his telescope. Here we are in the 21st century and scientists are refusing to investigate or look through Naessens microscope because it will completely change the accepted concepts of microbiology. It doesn’t matter what age we are in, human nature and ego never changes." - Gavin Phillips, Gaston Naessens and 714X, www.cancerinform.org/
During his scientific studies, the thing that really bothered Naessens was the limited power of light microscopes. He decided to make a better one. Through complex manipulation of light Naessens was able to make a microscope that enabled him to see organisms as small as 150 angstroms (1 angstrom is 100 millionth of a centimeter). This allowed Gaston to see the TINY MICROORGANISMS in our blood while still alive; as opposed to dead as is the case with electron microscopes. The difference is of colossal importance in observing what the tiniest form of life is doing and its purpose. Naessens built his microscope in 1949 and called it the "Somatoscope". With this unprecedented magnification at his fingertips Naessens started studying human blood. He immediately noticed that the blood of sick people was vastly different to that of healthy people. After thousands of hours glued to his microscope he found three organisms unknown to microbiologists that he named "Somatids". There are three basic forms of Somatids that Naessens says are essential to life because they produce a particle responsible for cell division. Healthy bodies keep the Somatid number in check but in unhealthy bodies the Somatids change form pleomorphically, evolving from one shape to another and can reach as many as sixteen. This is another fact of enormous importance because most of today’s microbiologists think that pleomorphism is fantasy. Their conclusions are based on their observations using electron microscopes and they are unable to see this whole other world. Famed American AIDS researcher Dr. Robert Gallo said, "pleomorphism is insanity." (p101) But what is insanity is that one of sciences supposed icons is ignorant (or doesn’t want to admit it) of what Naessens has known for 50 some years. When microbiologist Walter Clifford took researchers into his laboratory and showed them "…From their own blood, things they had never before seen…" it did not change their opinions. "Many of them unblinkingly told me that, because what
Reference: Gaston Naessens and 714X written by Gavin Phillips. www.cancerinform.org/
117
they had seen was not approved by any professional society or governmental agency, they simply would not believe it – that is, BELIEVE THEIR OWN EYES."( p267) Galileo was vilified and imprisoned some 400 years ago for saying the earth revolved around the sun and scientists refused to look through his telescope. Here we are in the 21st century and scientists are REFUSING to investigate or look through Naessens microscope because it will completely change the accepted concepts of microbiology. It doesn’t matter what age we are in, human nature and ego never changes. Naessens approach to treating cancer is COMPLETELY DIFFERENT to orthodox methodology that is trying to kill all cancer cells. Naessens totally nontoxic treatment is designed to reestablish the body’s natural immune system that is virtually PARALYZED in cancer victims. Naessens tested his treatment on cats with cancer and he was successful. For humans, Naessens’ latest patented treatment, called 714X, is injected into a lymph node in the groin for 21 days. Naessens early successes in treating cancer was not approved by medical authorities and he was fined whilst in Paris for practicing medicine without a license. He moved to Corsica but was soon on the move again in 1965 when a French policeman, whose wife he’d helped in Paris, warned him that an upcoming investigation was imminent. Naessens immediately moved to Quebec. In 1971 he met David Stewart, a rich philanthropist who was determined to find a cancer cure. Stewart was intrigued by Naessens theories and decided to fund him. In 1972 Stewart asked the McMaster University Medical School in Hamilton, Ontario to study Naessens findings. Initially Dr. Daniel Perey conducted the research and was extremely enthusiastic about it. In a 1972 letter about Naessens discoveries Perey writes "The Scope and insight which Mr. Naessens has brought to this area of research potentially stand to benefit mankind and may be a source of pride for Canada." In a September 1972 report to David Stewart, Dr. Perey wrote, "that he had Reference: Gaston Naessens and 714X written by Gavin Phillips. www.cancerinform.org/
118
been struck almost ‘dumb’ by the somatid cycle and its tremendous pleomorphism…" (p249) After Perey’s positive report on Naessens he was removed from the project and other researchers placed in charge. They ultimately sent Stewart a very negative report. In 1974 Dr. Raymond Brown from the Memorial Sloan Kettering cancer center in New York wrote about what he had seen whilst visiting Naessens. "What I have seen is a microscope that reveals with spectacular clarity the motion and multiplicity of pleomorphic organisms in the blood which are intimately associated with disease states. The implications…are STAGGERING…It is imperative that what its inventor, a dedicated biological scientist, is doing be totally reviewed. I am convinced that he is an authentic GENIUS and that his ACHIEVEMENTS cut across and illumine some of the most pertinent areas of medical science." "Dr. Brown returned to Rock Forest with an oncologist and a microscopist from Sloan Kettering. The three eventually drafted and signed a second and longer memorandum that reiterated the first."(p250) Apparently Sloan- Kettering * was initially very interested in this news, but when they found out that the American Cancer Society had BLACKLISTED Naessens; they did NOT pursue it any further. Little wonder, the ACS was probably SloanKettering’s biggest monetary supporter during the 1970’s. David Stewart was confounded by the near total lack of interest in academic institutions for Naessens work. His quote about scientists should be remembered by anybody who still wonders how effective cancer treatments are suppressed. Stewart said, "I can say categorically that most scientific researchers with whom I have had to deal are highly opinionated, arrogant, condescending, and have built- in, insurmountable prejudices. While showing not the slightest desire to learn Naessens’
Reference: Gaston Naessens and 714X written by Gavin Phillips. www.cancerinform.org/
119
techniques, they are nevertheless not loathe to brush aside his findings without having any knowledge whatsoever about them" (p252) Stewart UNEXPECTEDLY died in 1984 of a viral infection. [Author’s comment: Steward was not the first who died ‘unexpectedly’. It is possible that Steward, like many other mavericks was murdered.] Without Stewart’s support the medical authorities raided Naessens laboratory in December 1984, seizing patient files and vials of 714X. It wasn’t until 1989 that the Quebec Medical Corporation arrested Naessens and charged him for being an accessory to murder. The charge was based on the fact that Mme. Langlais had come to Naessens with very advanced breast cancer. She had refused any conventional treatment but her cancer was too advanced and she died. The medical authorities had managed to persuade her husband to press charges. Support for Naessens was organized by Ralph Ireland. Dozens of demonstrators gathered outside the courthouse with banners showing their support for him. Chris Bird sat in court every day and documented the proceedings in his book, "Galileo of the Microscope." Numerous cancer patients testified that Naessens had saved their lives after orthodox medicine had given up on them. Roland Caty had adenosarcoma of the prostate and was told by his doctor that he should have all his sexual organs removed. He refused and was told he’d be dead in three months. He learned how to inject himself with 714X and told the press "And here I am testifying to you, eleven years after I got well."(p254) Marcel Caron testified in Naessens defense. He’d been diagnosed with cancerous polyps of the intestines in 1981 and surgery was recommended. He refused because his brother had died after surgery for the same condition about eleven years before. After taking 714X for 21 days he was cancer free. That was in 1982. Caron told the jury, "I am not here to defend alternative medicine against traditional medicine but to say that I and all other people should be granted the right to choose the treatment we see fit." (p259) Amen to that. The first Reference: Gaston Naessens and 714X written by Gavin Phillips. www.cancerinform.org/
120
person testimony’s continued. Naessens lawyer Conrad Chapdelaine, said in part in his closing argument, "There’s something totally incomprehensible going on here. INCOMPREHENSIBLY INHUMANE! Thousands and thousands of terminal cases have been told things are ‘hopeless.’ Gaston Naessens can, and has, provided that salvation. And now he’s not in his laboratory but in a courtroom. It’s hard to fathom how our society can brook such INTOLERANCE! I ask you for acquittal on all counts." (p260/61) The following day the jury returned NOT- GUILTY VERDICTS ON ALL COUNTS. Naessens was vindicated. Naessens treatment gained much publicity from newspaper coverage of his victory and later the publication of Chris Bird’s book. 714X was LEGALIZED under Canada’s Emergency Drug Release Act. In 1995 Naessens and his wife created the "International Academy of Somatidian Orthobiology," a private research institute where Naessens theory and treatment are taught to others. In 1998 Naessens developed a new condenser for scientists to be able to put on their microscopes. It enables them to see what Naessens can see without having to go to the enormous expense of building his microscope. In 1999, CBS’s 48 Hours aired an 8- minute section about Naessens showing a teenage boy and young girl healed of cancer using 714X. The publicity gained Naessens many new patients. Dr. Jan Merta’s quote succinctly sums up Naessens achievements when she says, "Because Gaston Naessens has offered- and offers- good health for a tiny fraction of the cost which people are forced to pay for bad health, HE IS SIMPLY NOT WANTED…As a single individual, Gaston Naessens has achieved more than dozens of institutes full of Ph.D.’s that have been supported, year after year, by billions of dollars." (p267)
Reference: Gaston Naessens and 714X written by Gavin Phillips. www.cancerinform.org/
121
THEMODERN UNIVERSAL MICROSCOPE (Following information is excerpted from: The Amazing Wonders of Gaston Naessens, by Steven R. Elswick. Editor, Extraordinary Science, 1994, Nexus Magazine, http://www.nexusmagazine.com/, http://www.whale.to) 106
What Rife accomplished optically in the 1930s with his Universal Microscope, Gaston Naessens accomplished with a combination of optics and electronics in the 1940s in his Somatoscope. Born on 16 March 1924 in Roubaix, France, Gaston displayed a predisposition to be an inventor when at the age of five he built a little moving autolike toy from a Meccano set and powered it with an alarm clock spring. Later, he built a homemade motorcycle and a mini- airplane! While attending the University of Lille, Gaston nearly had his education disrupted by the German invasion. Fortunately, Gaston and his fellow students escaped to Nice where they carried on their education in exile. He was awarded a diploma from the Union Nationale Scientifique Francaise—a quasi- official institution under whose auspices the education of the displaced students continued. He did not bother seeking an equivalency degree from the de Gaulle government when the French rule was restored. At the young age of twenty- one, frustrated by the limitations of conventional microscopes, Gaston set out to build a superior microscope. Technical assistance was provided by German craftsmen from Wetzlar, Germany, who checked out many of Gaston's original ideas on optics. Privately, Gaston devised the electrical manipulation of the light source. Once the technical aspects were resolved, Gaston had the body of his microscope constructed by Barbier- Bemard et Turenne, technical specialists and defence contractors near Paris. THEORY OF OPERATION The Somatoscope mixes light from two orthogonal light sources—a mercury lamp and a halogen lamp. The light from both sources enters a glass tube at 90° from each other. As the light waves beat against each other, a strong carrier wave of light emerges and Reference: The Amazing Wonders of Gaston Naessens, by Steven R. Elswick. Editor, Extraordinary Science
122
travels down the light tube. (It should be noted that two electromagnetic fields superimposed upon each at 90° is a classic scalar formation!) As the light travels down the tube, it passes through a monochromatic filter which forms it into a monochromatic ray. The ray is then passed through a large coil that surrounds the tube. The coil's magnetic field divides the ray into numerous parallel rays that are then passed through a Kerr cell which increases the frequency of the rays before being injected onto the specimen. Two light sources, the first an incandescent one with a wavelength of about 3600 angstrom, the second an ultraviolet one with a wavelength of about 2200 angstrom beat against each other to produce a third wavelength of which passes through a monochromatic filter to produce a monochromatic ray. This ray is exposed to magnetic fields - the Zeeman effect- that divides tt to produce numerous parallel rays that in turn pass through a Kerr- cell that increases the frequency. It is this light source, invisible to the naked eye that strikes the specimen slides. The Image is reconstituted by the microscope. Credit: Guide Resources. The light, which contains the carrier and a mixture of selected signals in the UV range, stimulates the biological material in the Somatoscope to the point that the specimens give off their own light. (Rife referred to this as luminescence.) This is the key to the ultra- high resolution that has been achieved by Gaston Naessens. Conventional microscopes pass light through the specimen which theoretically limits the resolution of optical microscopes to the wavelength of light. The finest optical microscopes have achieved magnification levels of 2,500 diameters. At levels above this, the resolution is limited by the wavelength of light and further magnification merely creates a blur! Higher resolutions have been achieved by microscopes which do not use lenses, but rather apertures which are smaller than the wavelength of light. One such microscope engineered in Cornell University has achieved a resolution of 400 angstroms—a far cry from the 150 angstroms achieved by Naessens' Somatoscope. The Reference: The Amazing Wonders of Gaston Naessens, by Steven R. Elswick. Editor, Extraordinary Science
123
Somatoscope does not attempt to illuminate the specimen by passing light through two small objects. Instead, the illumination source is actually stimulating the specimen to the point it generates its own light. The light itself expands as it moves outward and because the specimen itself is generating the light, the physiÂcal restrictions encountered by regular optical microscopes do not apply. By converting the specimen into a light source, Gaston Naessens has converted the magnification problem from one of resolution to that of light detection! At magnification levels above 5,000 diameters, light levels drop off the point that film is necesÂsary, but the resolution is there. To further research along the lines he has pioneered, Gaston has developed junior models of his Somatoscope for field use. These field units allow researchers to obtain illumination and stimulation of the specimens of the larger unit. The field units are capable of magnifying 6,000- 7,000 diameters, although routine work will usually be at 3,5004,000 diameters. The lower light levels of the higher magnification require that a lower level of magnification be accepted for field use in order to maintain portability in the smaller units. One such unit will be in use in Colorado Springs at Clifford and Associates. The Somatoscope has enabled researchers to discover the importance of color and its relationship to the material being observed. The wavelengths of light generated are related to the size of the object and the health of the cell. For instance, the red blood cells vary from yellow/green to orange (540 nm to 580 nm) and white blood cells are rich in blue/violet (490 nm to 510 nm). Exposure to toxic materials, even in minute amounts, causes significant shifts in color. Even 'safe' amounts of toxic materials like mercury and the aluminum in toothpaste cause significant degradation to red blood cells as I was able to witness from specimens on a videotape produced from the Somatoscope.
Reference: The Amazing Wonders of Gaston Naessens, by Steven R. Elswick. Editor, Extraordinary Science
124
THE SOMATID CYCLE In a long lost chapter of history in science, a violent controversy took place in France between the illustrious Louis Pasteur and Antoine Bechamp, a noted professor of physics, toxicology, medical chemistry, and biochemistry. Bechamp's work led him to discover 'microzymas' (tiny ferments) which were characterised by a host of small bodies in his fermenting solutions. After years of study, Bechamp came to the conclusion that these microzymas were more basic to life than cells. Even with his crude equipment, he was able to observe that the microzymas underwent dramatic transformations during their life cycle. This caused Bechamp to champion the idea that the cause for disease lay within the body. Pasteur's germ theory held that the cause came from without Pasteur's outspokenness helped the germ theory win out and dominate medical philosophy for the past century. Now, a hundred years later, Gaston Naessens has discovered an Reference: The Amazing Wonders of Gaston Naessens, by Steven R. Elswick. Editor, Extraordinary Science
125
ultramicroscopic, subcellular, living and reproducing microscopic form which he christened a 'somatid' (tiny body). This new particle could be cultured outside the bodies of the host. Naessens also observed that the particle had a pleomorphic (form- changing) life cycle, and had a sixteen- stage life cycle. Only the first three stages of the somatid life cycle ARE NORMAL. Naessens discovered that when the IMMUNE SYSTEM is WEAKENED or disrupted, the somatids go through the other thirteen stages. The weakening of the immune system could be brought about by a number of reasons such exposure to CHEMICAL POLLUTION, IONISING RADIATION, ELECTRIC FIELDS, POOR NUTRITION, ACCIDENTS, SHOCK, DEPRESSION, AND MANY MORE. Incredibly, Naessens' research has resulted in the association of degenerative diseases (rheumatoid arthritis, multiple sclerosis, lupus, cancer and AIDS) with the development of forms in the sixteen- stage pathological cycle. The ability to associate the disease with specific stages has enabled Naessens to 'prediagnose' conditions in advance of when they would clinically appear. This discovery puts Gaston Naessens at odds with the orthodox medical philosophy today which has embraced Pasteur's germ theory wholeheartedly. Naessens' work is repeatable. The ability to culture somatids is a bellwether to the rewriting of microbiology!
Reference: The Amazing Wonders of Gaston Naessens, by Steven R. Elswick. Editor, Extraordinary Science
126
„Dr Gregory was a well- respected, medical doctor."
John E. Gregory, M.D. was a medical doctor. Several researchers believed that a bacteria caused cancer. Gregory thought it was a virus. Based on the concept that it was a bacteria, Livingston later developed a vaccine—which worked.
(~ 1940 AD) John E. Gregory, M.D. Working Summary: research in cancer, viruses and bacteria. Development of the ultimate antibiotic, Antivin Books: The Pathogenesis of Cancer by Dr. Gregory (1955) (The following information is excerpted from: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell, Pilgrims Books, 1998 USA) 68
Dr. Gregory was another believer in the virus theory of cancer. From 1945, onward, he carried on research in this field, as he stated later in his 1955 book, The Pathogenesis of Cancer: "[My study] is the result of exhaustive and careful research work, all of which has been repeated by competent men in their fields. The research outlined here has cost the author over $250,000. It is the result of more than 20,000 hours of research in the field of cancer. In the past ten years, forty weeks have been spent at research clinics and at scientific meetings which pertained to this subject." With such a background of study, one would imagine that Gregory might have something to say on the subject of causative agents in cancer. Like Royal Rife, Gregory used a high- power microscope to help Reference: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell 1998
127
"[It is] an infectious disease in which the infecting organism is a cancer virus, which sensitizes cells to grow invasively and metastasize, when stimulated by chemicals, irritants, or excess hormones. An overwhelming infection may produce the disease." - Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell, Pilgrims Books, 1998 USA) 68 "An oncovirus is a virus that can cause cancer. This term originated from studies of acutely- transforming retroviruses in the 1950–60s, often called oncornaviruses to denote their RNA virus origin. It now refers to any virus with a DNA or RNA genome causing cancer and is synonymous with "tumor virus" or "cancer virus". The vast majority of human and animal viruses do not cause cancer, probably because of long- standing coevolution between the virus and its host. Worldwide, the WHO International Agency for Research on Cancer estimated that in 2002 17.8% of human cancers were caused by infection, with 11.9% being caused by one of seven different viruses." - Parkin, Donald Maxwell (2006). "The global health burden of infection- associated cancers in the year 2002". International Journal of Cancer 118 (12): 3030–44. doi:10.1002/ijc.21731. PMID 16404738. http://en.wikipedia.org/wiki/Oncovir us#cite_note- Parkin06- 0
Timeline of Discovery Cancer Viruses
him in his work. Early versions of the electron microscope had already been invented, and he used magnifications as high as 50,000. His conclusion was that CANCER IS AN INFECTIOUS DISEASE, caused by a virus. " Part of Gregory’s theory was that the cancer virus produces an enzyme which he named chymotrypsin. After injecting a malignant melanoma culture into laboratory animals, he withdrew some of the virus from the malignancy which developed in the animal. The virus withdrawn was the same as the virus injected, thus supposedly fulfilling Koch’s criteria. Gregory said he did that 50 times. Assuming then that the cancer was virus caused, Gregory looked to ANTIBIOTICS as the treatment of choice, realizing that virus strains eventually become immune to antibiotics. So Gregory felt that a wide variety of antibiotics would have to be used. (Keep in mind that this was in the 1940s and 1950s. Back then, it was thought that antibiotics could overcome viruses. We now know they cannot do this. Perhaps Gregory’s "cancer viruses" were actually bacteria.) The Treatment: As Gregory continued his work, he was able to help over one hundred advanced cases of cancer. He named his ultimate antibiotic, ANTIVIN. Did Gregory really eliminate cancer with his Reference: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell 1998
Human
"1964: Anthony Epstein, Bert Achong and Yvonne Barr identify the first human cancer virus from Burkitt lymphoma cells. A herpesvirus, this virus is formally known as human herpesvirus 4 but more commonly called Epstein- Barr Virus or EBV. Achong, a Trinidadian of Ghanaian ancestry, is frequently forgotten for this work but was central to the electron microscopy that allowed detection.[108] mid- 1960s: Baruch Blumberg first physically isolated and characterized Hepatitis B while at NIH and later Fox Chase Laboratory, receiving the 1976 Nobel Prize in Medicine or Physiology.[109] Although this agent was the clear cause of hepatitis and might contribute to liver cancer hepatocellular carcinoma, this link was not firmly established until epidemiologic studies were performed in the 1980s by R. Palmer Beasley and others.[110] 1980: Human T- lymphotropic virus 1 (HTLV I), the first human retrovirus was discovered by Bernard Poiesz and Robert Gallo[111][112] at NIH and Mistuaki Yoshida and coworkers in Japan.[113] 1984–86: Harald zur Hausen, together with Lutz Gissman, discovered first HPV16 and then HPV18 responsible for approximately 70% of cervical cancers. For discovery that human papillomaviruses (HPV) cause human cancer, zur Hausen won a 2008 Nobel Prize.[114]"
128 Source: Oncovirus Article, From Wikipedia, the free encyclopedia 122
antibiotic? Perhaps. But it should be kept in mind that Gregory also did something that many others in his time were not doing: He required his patients to CHANGE a number of things in their lifestyle. They had to eat lots of fruit and fresh vegetables, and totally stop the use of meat and fat. Those changes alone would help a number of people with cancer. In later years, Gregory’s methods died with him. No medical group came to his defense or support. Estimated percent of new cancers attributable to the virus worldwide in 2002 122 carcinoma (liver Hepatitis viruses, Hepatocellular cancer). [123][124] including hepatitis B C Human T- lym- Tropical spastic paraparesis and adult T- cell leukemia [125] photropic virus Cancers of cervix,[126] anus,[126] Human papillomaviruses penis,[126] vulva/vagina,[127] and some cancers of the head and neck.[127] Kaposi’s sarcoma, multicentric Kaposi’s Castleman's disease and primary sarcomaeffusion lymphoma herpesvirus (HHV- 8) Merkel cell carcinoma Merkel cell polyomavirus Burkitt’s lymphoma, Hodgkin’s Epstein–Barr lymphoma, posttransplantation virus (EBV) lymphoproliferative disease and Nasopharyngeal carcinoma.[128] Reference: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell 1998
129
"1987: Hepatitis C virus, or HCV, discovered by panning a cDNA library made from diseased tissues for foreign antigens recognized with patient sera. This work was performed by Michael Houghton at Chiron, a biotechnology company, and D.W. Bradley at CDC. [115] Controversy erupted when Chiron claimed all rights to the discovery although the work had been performed under contract with the CDC using Bradley's materials and ideas. Eventually, this was amicably settled. HCV was subsequently shown to be a major contributor to liver cancer (hepatocellular carcinoma) worldwide. 1994: Patrick S. Moore and Yuan Chang (a husband and wife team [116] then at Columbia University) working together with Frank Lee and Ethel Cesarman [117] isolated Kaposi sarcoma- associated herpesvirus (KSHV or HHV8) using representational difference analysis. This search was prompted from work by V. Beral, T. Peterman and H. Jaffe who showed from accumulating evidence from the epidemic of Kaposi sarcoma associated with AIDS, that this cancer must have another infectious cause besides HIV itself.[118] This agent was predicted to be a new virus. Subsequent studies revealed that KSHV is indeed the "KS agent" and is responsible for the epidemiologic patterns of KS and related cancers.[119] 2008: Chang and Moore, now at the University of Pittsburgh Cancer Institute, developed a new method to identify cancer viruses based on computer subtraction of human sequences from a tumor transcriptome, called digital transcriptome subtraction (DTS).[120] DTS was used to isolate DNA fragments of Merkel cell polyomavirus from a Merkel cell carcinoma and it is now believed that this virus causes 70–80% of these cancers.[121] This is the first polyomavirus to be well- established as the cause for a human cancer." - Oncovirus Article, From Wikipedia, the free encyclopedia 122
„Dr. Lincoln was the first who was ridding cancer with vaccines."
Dr. Robert E. Lincoln was a medical doctor and the father of Staphage Lysate Vaccine. His method seemed to be useful and he had much patients. (f.e. he cured Senator Charles Tobey's son).
(~ 1940 AD) Robert E. Lincoln M.D. Working Summary: originator of Staphage Lysate Vaccine. Dr. Robert E. Lincoln used parasitic virus bacteriophages to attach and destroy specific bacteria, ridding cancers Books: New Cures for Old Ailments by Robert E. Lincoln (1952) (The following information is excerpted from: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell, Pilgrims Books, 1998 USA)
Dr. Lincoln entered medical practice in 1926, at the same time that he was engaged in physics research at Harvard. He invented a mechanical heart pump. Lincoln was obviously a careful, thoughtful researcher. Most of the discoverers of alternative methods of treating cancer were brilliant, innovative, and highly trained. In the 1940s, in the midst of an influenza epidemic, Dr. Lincoln made what he thought were important discoveries concerning the bacterial origin of certain diseases— which he later extended to CANCER. He thought he had also found a possible cure for some forms of these diseases in bacteriophages. These are viruses which parasitically attack and destroy specific bacteria. Lincoln eventually began treating patients with injections of these viruses, and claimed to see some remarkable Reference: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell 1998
130
"The vaccine, Staphage Lysate, has been in use for over fifty years. Typically, it was attacked and surpressed by Establishment Medicine and the American Cancer Society. The claims by its originator, Robert E. Lincoln, MD., have been supported by scientific studies in the past decade. "The vaccine stimulates the production of natural body Interferon, which has no side effects and is far less expensive than the toxic commercially available Interferon. Laboratory studies indicate that Staphage Lysate should be considered as a means of stopping the spread and growth of breast cancer" - A. Mathur, et al., Journal of Investigative Surgery, 1988." "(…) Significantly higher antibody levels in the test groups were observed when compared with the control animals, peak antibody titers being 21 days following antigenic challenge. Furthermore, staphage lysate administered without an accompanying antigen evoked a heightened serum immunoglobulin level in mice for a period of more than 14 days after injection. IgG1, IgG2a and IgG2b were significantly elevated as a direct result of this treatment. This increased output of immunoglobulin synthesis and heightened hemagglutinin titers demonstrate that staphage lysate is not only an immunomodulator of cellmediated immunity, as previously reported, but also an effective immunoadjuvant of the humoral antibody response capability in the host. Staphage lysate: an immunomodulator of the primary immune response in mice." - Esber HJ, Ganfield D, Rosenkrantz H. Staphage lysate, 1985 Oct;10(2):7782, PMID:4066283
results—including the REMISSION of cancer. It is intriguing how many different methods have been devised to control or eliminate cancer! This is particularly REMARKABLE, when so many techniques rely on a single factor while ignoring the discoveries which others have used successfully. Indeed, rarely are changes in diet or living habits required. After isolating two particularly virulent staph viruses in 1946, Lincoln found that each virus lived only in a single type of host bacterium. So he tried an experiment: At regular 48- hour intervals, he would inject solutions containing a certain virus (bacteriophage) into cancer tissue. It would seek out a specific host cell and destroy it. He decided that he could do this best by placing the virus in the nasal passage, which he called "nature’s own bacteriophage chambers." Using this technique, he was able to obtain 95% apparent cures of sinus infections(…). When it was discovered that Lincoln was successfully treating cancer, he was besieged with hundreds of cancer patients, which he treated for a charge of one to five dollars each. Wealthy benefactors established a Lincoln Foundation to underwrite the costs of his work. Lincoln carried on his work in the small town of Medford, outside Boston. Rather quickly he ran into OPPOSITION from the Journal of the AMA. Soon afterward, other journals would not publish reports about his work. In 1949, he requested conferences with the Massachusetts Medical Society, but the meetings were repeatedly postponed. Without investigating the matter, the Society announced that the treatment was useless. As for the AMA headquarters, it told Lincoln in August 1949 that the matter was a "local one," and it should be handled by the medical society in his state. A breakthrough of sorts came when Lincoln successfully eliminated cancer in the son of Charles W. Tobey, a U.S. Senator from New Hampshire. Tobey was extremely angry that Lincoln’s work was being ignored, and he said so on the floor of the U.S. Senate. This aroused the Massachusett Medical Society, and they sent a team of surgeons and radiologists to Medford, where they talked to some patients sitting on the back porch Reference: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell 1998
131
of Lincoln’s house. Returning to Boston, they claimed to have seen no signs of improvement in the patients while conceding that there were some "cases of marked symptomatic improvement," which they attributed to "the tremendous force of faith and hope." Lincoln replied publicly that such a report showed a "high degree of stupidity." That comment, of course, did little to calm the storm. The Society demanded his resignation; and when he refused to do so, they expelled him on April 8, 1952. Then the dean of the Boston University Medical School, whose laboratories always prepared the Lincoln antibiotics, wrote him that the supplies had been cut off. The director of the laboratory had been forbidden to send him anymore. This stoppage continued for 14 days, and it appeared that many people would die. But urgent telegrams from members of Congress got the supplies started again, until a separate laboratory could be set up to provide them. But, when the cultures were turned over to the Lincoln Foundation laboratory, the original culture strains were MISSING. Fortunately, Dr. Lincoln had some of the original strains stored in other places. Otherwise production would have been completely sabotaged. Throughout the controversy, no bacteriologists were included in the investigation committees, ONLY surgeons and radiologists. In January 1954, Dr. Lincoln died. He was in his 60s. Many believed that the primary problem with his bacteriophages was that they provided an inexpensive method of TREATING CANCER, as well as many other chronic conditions. Prior to Lincoln’s death, Senator Tobey wrote to over a hundred medical schools, requesting them to send representatives to the Lincoln Clinic, to investigate and study the therapy. In reply, he was told that the Massachusett’s Medical Society was conducting the research, and it would be unethical for them to become involved. Then Tobey turned to the Veterans Administration, to carry out such an investigation. They responded that the National Research Council advised against doing this. Reference: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell 1998
132
"The greatest physician of the twentieth century was censored and suppressed by the medical establishment."
(~ 1960 AD) Dr. Virginia Wuerthele Casp Livingston (~ 1960 AD) Dr. Alan Cantwell (~ 1900 AD) Dr. James Ewing (~ 1910 AD) Peyton Rous Working Summary: relationship between bacteria and cancer. She was given the credit for identifying the organism which causes human cancer Books: Cancer: A New Breakthrough by Livingston (1972), Conquest of Cancer: Vaccines and Diet by Livingston (1983), The Microbiology of Cancer: Compendium by Livingston (1977) Food Alive by Livingston (1977), Cancer: A New Breakthrough, The Cancer Industry- - - Ralph Moss PhD (1996), The Cancer Microbe by Dr Alan Cantwell MD (1990), Four Women Against Cancer by Cantwell A. (2005), Intracellular acid- fast organisms isolated from malignant tissues By Diller IC, Diller WF. (1965), Aids and the Doctors of Death by Alan Cantwell Jr., M.D., Queer Blood – The Secret Aids Genocide Plot by Alan Cantwell Jr,M.D., The Cancer Microbe – The Hidden Killer in Cancer.
Dr. Virginia WuertheleCaspLivingston- Wheeler (1906–1990) was an American physician and cancer researcher. For more than 40 years she championed the revolutionary idea, that bacteria caused cancer.
(The following information is excerpted from: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell, Pilgrims Books, 1998 USA, )
(…)In 1907, James Ewing, M.D., medical director of Memorial Hospital in New York City, listed 38 different kinds of protozoa, molds, bacilli, and
133
"There is no doubt in my mind that Virginia Livingston was the greatest physician of the twentieth century, even though she was never widely known..." - Alan Cantwell "That may have been one of the earliest positions on a microorganismcausation of cancer. Back then, "germs" could refer either to bacteria or viruses. The closer distinctions we use today, were not commonplace then. Most physicians are wrong in their understanding of most diseases, most of the time." - Cantwell's law, Dr Alan Cantwell, M.D. In 1905, one well- known health writer spoke of "cancerous germs": "Those who use flesh foods little know what they are eating. Often if they could see the animals when living and know the quality of the meat they eat, they would turn from it with loathing. People are continually eating flesh that is filled with tuberculous and cancerous germs. Tuberculosis, cancer, and other fatal disease are thus communicated." - Ellen G. White, Ministry of Healing 130 "The big question everyone seems to avoid is: Can vaccines cause cancer? There is certainly evidence connecting contaminated vaccines to AIDS. And HIV is a cancer- causing virus. Robert Gallo, the co- discoverer of HIV in 1984, has clearly stated AIDS is an epidemic of cancer. Animal and avian viruses can contaminate vaccines and have all been studied as cancercausing agents. And cancer and vaccine research would be much more difficult without the use of cell lines, some of which are derived from cancer." - Dr Alan Cantwell, M.D.
spirochetes, which were possible causes of cancer. Some even thought that parasites might be the cause. Yet historical facts are not quite so neatly contained. Throughout most of the 20th century, as in the centuries before, many experienced physicians and researchers believed that cancer was caused by a "GERM" of some kind. As we found earlier in this historical review, in the first part of the century William Coley searched for a "mixed bacterial toxin" which could destroy cancer germs. An intriguing claim had been advanced in 1910, when Peyton Rous, a medical researcher at the Rockefeller Institute said he had found an infectious agent in fowl—which would pass through the smallest filter known. Rous was laughed to scorn by his contemporaries, but the development of virology (the study of sub- microscopic organisms) caused scientists to re- examine Rous’ monograph. In 1966, at the age of 89, Rous was given the NOBEL PRIZE for his 1910 research. But later official interest waned in viruses as a cause of cancer. But both viruses and bacteria have continued on as special topics of interest and study among cancer researchers and specialists. In the latter part of this century, Dr. Virginia Wuerthele- Casp- LivingstonWheeler (Dr. Livingston, for short) has been at the center of the controversy over a bacterial origin of cancer. Reference: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell 1998
134
"Until it is settled beyond the shadow of a doubt that cancer is not due to a microorganism, we believe that every effort should be made to stimulate to the utmost cancer research along these lines rather than to attempt to hinder or to discredit it." - The Cancer Industry by Ralph W. Moss, Ph.D. 131 "Livingston now formulated a remarkably fluid and dynamic view of the microscopic world, a view perhaps too radical for her more conventional colleagues: Instead of a bacillus being a bacillus, ad infinitum, it can and does change into numerous other forms dictated by its need to survive or stimulated to greater productivity by an unusually favorable environment." - The Cancer Industry by Ralph W. Moss, Ph.D. 131 "My studies had led me to the conclusion that cancer is an immune deficiency disease based on infection by a definite etiological agent, the Progenitor cryptocides. On the basis of treating an immune deficiency in man, we began to accept cancer patients." - Virginia Livingston, A New Breakthrough, 1972 132 "Commenting on Livingston’s findings, Acevedo wrote: "The impact of these findings in the fields of oncology, bacteriology, epidemiology, genetics and molecular biology is so great that a detailed description will be beyond the scope of this communication . . It is apparent that his phenomenon exposes the need for a new approach to the analysis as well as to our current concepts of cancer." — Hernan F. Acevedo, Cancer 41:1217- 29, 1978 68
It would require a lengthy paragraph to list all the medical hospitals, universities, and research departments that she has been affiliated with. By the early 1980s, she was working in San Diego at the Livingston- Wheeler Medical Clinic. It was in 1946 that she first discovered that, INJECTING GERMS, which caused scleroderma, from a person to a guinea pig, caused cancer in the guinea pig—and cancer was extremely rare among guinea pigs. At this juncture, her research caused Livingston to adopt the theory we have noted several times earlier—that a microorganism can change in its size and shape. By the early 1950s, her ideas were gaining favor with many scientists, and she received grants from a number of foundations to carry on her research. She did much basic work at this time. It was decided that the organism in question was part of the Actinomycetales order, a family of germs (ibid.). The famed researcher, Robert Koch (1843- 1910) had laid down four postulates which must be met in order to establish the microbial origin of any disease.
Reference: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell 1998
135
"Abscisic acid is a plant dormancy hormone and vitamin A analog found in plants; it has profound anti- cancer activity. Abscisic acid is a carotenoid factor and is especially found in green leafy vegetables. Here is a list of foods containing abscisic acid. It comes from Livingston’s book, Food Alive: Fruits: Mangoes, Grapes, Avocados, Pears, Oranges, with the white underpeel and pulps, Apples, whole with the seeds, Strawberries Fruit Blossoms and Leaves as Tea, Peach Flowers, Strawberry Leaves, Cherry Flowers, Apple Blossoms Vegetables: Pea shoots, Lima Beans, Potatoes, Peas, Dwarf, Yams, Sweet Potatoes, Asparagus, Tomatoes, Onions, Spinach, Root Vegetables: All root vegetables, especially Carrots, Seeds and Nuts: Seeds and Nuts of all Kinds Leafy vegetables: Mature Greens" - Food Alive: a Diet for Cancer and Chronic Diseases, LivingstonWheeler, Livingston, Wheeler Medical Clinic Publications (1977), Excerpted from: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell 68
"Sixteen years after her death she is now largely forgotten but still condemned by such powerful organizations as the American Cancer Societyand blacklisted on Quackwatch- a self- proclaimed "nonprofit corporation dedicated to combating health- related frauds, myths, fads, and fallacies." - Virginia Livingston, MD, Cancer Quack Or Medical Genius? By Alan Cantwell, MD Los Angeles, CA © 2006 All Rights Reserved, rense.com 133
Livingston and her associates said they had succeeded in achieving each one: 1. The organism must be present in every case of the disease which is examined. 2. The organism can be cultivated outside the host animal in an artificial medium. 3. Inoculation of this culture into a susceptible animal will produce the disease in it. 4. The germ can be obtained from the inoculated animal and cultivated once again. By this time, in addition to her other work, Livingston was caring for 20- 30 cancer patients daily at the Presbyterian Hospital in Newark. She obtained blood from them and injected it into guinea pigs. Probably one of Livingstonâ&#x20AC;&#x2122;s most important discoveries concerned ABSCISIC ACID. This is a natural substance present in many foods. She found that it neutralized the HCG. This means that it should have anti- cancer effects in the body. Abscisic acid is very difficult and expensive to purify, so you are not likely to be able to afford it in tablet or capsule form. But it is very common in many healthful foods. Abscisic acid is chemically similar to vitamin A, and is probably another vitamin. It is plentiful in plant foods. Animal experiments showed it to be a POWERFUL anti- cancer agent. She discussed it in her 1977 book, Food Alive. After her retirement, Dr. Reference: Alternative Cancer Remedies â&#x20AC;&#x201C; Facts for Historians and Medical Researchers by Vance Ferrell 1998
136
Bacteria and cancer: cause, coincidence or cure? A review "Research has found that certain bacteria are associated with human cancers. Their role, however, is still unclear. Convincing evidence links some species to carcinogenesis while others appear promising in the diagnosis, prevention or treatment of cancers. The complex relationship between bacteria and humans is demonstrated by Helicobacter pylori and Salmonella typhi infections. Research has shown that H. pylori can cause gastric cancer or MALT lymphoma in some individuals. In contrast, exposure to H. pylori appears to reduce the risk of esophageal cancer in others. Salmonella typhi infection has been associated with the development of gallbladder cancer; however S. typhi is a promising carrier of therapeutic agents for melanoma, colon and bladder cancers. Thus bacterial species and their roles in particular cancers appear to differ among different individuals. Many species, however, share an important characteristic: highly sitespecific colonization. This critical factor may lead to the development of non- invasive diagnostic tests, innovative treatments and cancer vaccines." - DL Mager, The Forsyth Institute, 140 The Fenway, Boston, MA, USA 128
Livingstonâ&#x20AC;&#x2122;s work continued to be carried on by other physicians. Using the Livingston vaccine, they noted shrinkage or DISAPPEARANCE of tumors, as well as COMPLETE REMISSIONS in patients with lymphocytic leukemia and malignant lymphoma (Townsend Letter for Doctors, May 1987). Neil Nathan, M.D., carried on her work at the Livingston Foundation in San Diego, California, for a time. He said the success of the treatment depends on whether or not the cancer has metastasized or they have received chemotherapy, radiation, or surgery. If they have, there is only a 40- 50% success rate; but if not, there is 70- 95% SUCCESS RATE. But in terminal patients, with wide metastasis, the rate drops to 20%. Unfortunately, in February 1990, the California Department of Health Services issued an order to the Livingston Foundation Medical Center Clinic, in San Diego, to STOP administering and prescribing the autogenous vaccine. By that time, it was the only place which still offered the Livingston therapy. That same year, Dr. Livingston died. Since then, the clinic has remained open. Patients are treated with vaccines based on PC cultures, together with the diet and other aspects of the program. But the autogenous vaccine is no longer given.
Photo: Intracellular variablysized coccoid forms in breast cancer. Acid- fast stain; Magnification x1000, in oil
Photo: Intracellular bacteria in prostate cancer. Acid- fast stain; magnification x1000, in oil.
137
Photo: Lymph node showing Hodgkin's lymphoma. Arrows point to variablysized round coccoid forms and larger Russell bodies. Gram stain; magnification x1000, in oil.
BACTERIA AS A CAUSE OF CANCER (The following information is excerpted from: Virginia Livingston, MD Cancer Quack Or Medical Genius? By Alan Cantwell, MD. Dr. Alan Cantwell is a retired dermatologist and the author of THE CANCER MICROBE 153 and FOUR WOMEN AGAINST CANCER, 154 both available from Aries Rising Press, USA, rense.com) 134 - 152
The recognition of disease- producing bacteria allowed medical science to emerge from the dark ages into the era of modern medicine. In the late nineteenth century when diseases like tuberculosis (TB), syphilis, and leprosy were proven to be caused by bacteria, some doctors also suspected human cancer might have a similar cause. The idea that bacteria cause cancer is considered PREPOSTEROUS by most physicians. However, despite the antagonistic view of the American Cancer Society and medical science, there is ample evidence in the published peer- reviewed literature that strongly suggests that 'CANCER MICROBES' cause cancer. According to reports by Livingston and various other researchers, cancer is caused by PLEOMORPHIC, cell wall deficient bacteria. The various forms of the organism range in size from submicroscopic virus- like forms, up to the size of bacteria, yeasts, and fungi. In culture and in tissue the bacterial forms are variably 'acid- fast' (having a staining quality like TB bacteria). These bacteria are ubiquitous and exist in the blood and tissues of all human beings (yet another 'heresy'). In the absence of a protective immune response, these cell wall deficient bacteria may become pathogenic and foster the development of cancer, autoimmune disease, AIDS, and certain other chronic diseases of unknown etiology. Needless to say, all this research fell on deaf ears because bacteria were totally ruled out as the cause of all cancers in the early years of the twentieth century. Thus, bacteria observed in cancer were simply dismissed as elements of cellular degeneration, or as invaders of tissue weakened by cancer, or as 'contaminants' of laboratory origin (â&#x20AC;Ś).
Reference: Virginia Livingston, MD Cancer Quack Or Medical Genius? By Alan Cantwell, MD.
138
THE CANCER MICROBE AND BACTERIAL PLEOMORPHISM Microbiologists have long resisted the idea of bacterial pleomorphism, and do not recognize or accept the various growth forms and the bacterial 'life cycle' proposed by various cancer microbe workers. Most bacteriologists do not accept the idea of a bacterium changing from cocas to a rod, or to a fungus. Depending on the environment, the microbe in its cell wall- deficient phase may attain large size, even larger that a red blood cell. Other forms are submicroscopic and virus- sized. Electronic microscopic studies and photographs of filtered (bacteria- free) cultures of the cancer microbe show virus- size elements of the cancer microbe that can revert into bacterialsized microbes. The cancer microbe has adapted to life in man and animals by existing in a mycoplasma- like or cell wall deficient state. In tissue sections of cancer stained for bacteria with the special acid- fast stain, the microbe can be seen as a variably acid- fast (blue, red, or purple- stained) round coccus or as barely visible granules. At magnifications of one thousand times (in oil), these forms can be observed within and also outside of the cells. Careful study and observation of the tiny round coccoid forms in cancer tissue indicate they can enlarge progressively up to the size of so- called Russell bodies, which are well- known to pathologists. Russell bodies can attain the size of red blood cells, and even larger. William Russell was a well- respected Scottish pathologist who in 1890 first reported the finding of 'cancer parasites' in the tissue of all the cancers he studied. However, MODERN PATHOLOGISTS deny that Russell's bodies are microbial in origin.
Reference: Virginia Livingston, MD Cancer Quack Or Medical Genius? By Alan Cantwell, MD.
139
OVERLOOKING HIDDEN BACTERIA IN CANCER Once bacteria were eliminated as a cause of cancer a century ago, it became dogma and impossible to change medical opinion. In this current era of medical science, one would think it impossible for infectious disease experts and pathologists to not recognize bacteria in cancer. However, bacteria can still pop up in diseases in which they were initially overlooked. When a new and deadly lung disease broke out among legionnaires in Philadelphia in July 1976, two hundred twenty- two people became ill and thirty- four died. The cause of the killer lung disease remained a medical mystery for over five months until Joe McDade at the Leprosy Branch of the CDC detected unusual bacteria in guinea pigs experimentally infected with lung tissue from the dead legionnaires. Further modification of bacterial culture methods finally allowed the isolation of the causative and previously overlooked bacteria, now known as Legionella pneumophila. Yet another example of dogma- defying research is provided by recent studies proving that bacteria (Helicobacter pylori) are a common cause of stomach ulcers, which can sometimes lead to stomach cancer and lymphoma. For a century, physicians refused to believe bacteria caused ulcers because they thought bacteria could not live in the acid environment of the stomach. In 2005 the Nobel Prize in Medicine was awarded to two Australian researchers for their 1982 discovery. These stomach bacteria could only be detected by use of special tissue stains. The CDC now claims that H. pylori causes more than 90% of duodenal ulcers and 80% of gastric ulcers. Approximately two- thirds of the world's population is infected with these microbes. In the past four years there have been medical reports of newly discovered bacteria in serious lymph node disease; in Hodgkin's lymphoma; in cancer of the mouth; and in prostate cancer, to name only a few. All these studies PROVE bacteria can pop up in diseases where they are least expected. Such a caveat is appropriate for doctors who think they know everything about cancer and who pooh- pooh all aspects of cancer microbe research. Reference: Virginia Livingston, MD Cancer Quack Or Medical Genius? By Alan Cantwell, MD.
140
A CENTURY OF CANCER MICROBE RESEARCH Livingston never claimed that she was the discoverer of the microbe of cancer. In her writings she always gave credit to various scientists, some dating back to the nineteenth century, who attempted to prove that bacteria cause cancer. Some of these remarkable researchers include the long- forgotten cancer microbe studies of Scottish obstetrician James Young, Chicago physician John Nuzum, Montana surgeon James Scott, the infamous psychiatrist and cancer researcher Wilhelm Reich, microscopist Raymond Royal Rife, and others too numerous to mention. This cancer microbe research has been explored in my books The Cancer Microbe: The Hidden Killer in Cancer, AIDS, and Other Immune Diseases [1990] and in Four Women Against Cancer: Bacteria, Cancer, and the Origin of Life [2005]- the story of Livingston, Alexander- Jackson, Diller and Seibert- four outstanding women scientists who attempted to bring the cancer microbe to the attention of a disinterested medical establishment. I was privileged to have met all these remarkable women, who greatly influenced my own cancer research. Why is research exploring bacteria in cancer so strongly opposed? Perhaps it poses a threat to the MONEY INTERESTS involved in the established and orthodox treatment for cancer. Various forms of cancer treatment include surgery, radiation and chemotherapy. These therapies might have to be reevaluated if it were proven that cancer was an infectious disease.
Reference: Virginia Livingston, MD Cancer Quack Or Medical Genius? By Alan Cantwell, MD.
141
"An outlawed cancer maverick."
(~ 1980 AD) Tullio Simoncini, M.D. (~ 1980 AD) Gerald Green, (~ 1990 AD) Dr. Hulda Clark
Tullio Simoncini, M.D. (*1953 - ) is a surgeon pecialising in oncology, diabetology and metabolic disorders.
Working Summary: relationship between fungus and cancer. Books: Cancer is a Fungus: A Revolution in Tumor Therapy (2007),Breaking Through The Untouchable Diseases by Gerald Green (2008), The Cure for All Diseases: With Many Case Histories by Hulda Clark (1995) (The following information was excerpted from: www.cancercontrolsociety.com)
Tullio Simoncini, M.D. received his Degree in 1976 from La Sapienza University, Rome Italy, majoring in Surgery. He followed this with specialized studies in Diabetes and Metabolic Illnesses at the Sacro Cuore University, also in Rome, in 1983. In 1996 Dr. Simoncini received his Ph.D. in Philosophy from La Sapienza University. From 2000 to 2004 he devoted his focus to Oncology, also at La Sapienza University. Throughout his medical career, Dr. Simoncini pursued his personal theories regarding cancer. His first terminal patient, who went into remission in 1981, is still alive and well today.
142
Bicarbonate increases tumor pH and inhibits spontaneous metastases. The external pH of solid tumors is acidic as a consequence of increased metabolism of glucose and poor perfusion. Acid pH has been shown to stimulate tumor cell invasion and metastasis in vitro and in cells before tail vein injection in vivo. The present study investigates whether inhibition of this tumor acidity will reduce the incidence of in vivo metastases. Here, we show that oral NaHCO(3) selectively increased the pH of tumors and reduced the formation of spontaneous metastases in mouse models of metastatic breast cancer. This treatment regimen was shown to significantly increase the extracellular pH, but not the intracellular pH, of tumors by (31)P magnetic resonance spectroscopy and the export of acid from growing tumors by fluorescence microscopy of tumors grown in window chambers. NaHCO(3) therapy also reduced the rate of lymph node involvement, yet did not affect the levels of circulating tumor cells, suggesting that reduced organ metastases were not due to increased intravasation. In contrast, NaHCO(3) therapy significantly reduced the formation of hepatic metastases following intrasplenic injection, suggesting that it did inhibit extravasation and colonization. In tail vein injections of alternative cancer models, bicarbonate had mixed results, inhibiting the formation of metastases from PC3M prostate cancer cells, but not those of B16 melanoma. Although the mechanism of this therapy is not known with certainty, low pH was shown to increase the release of active cathepsin B, an important matrix remodeling protease. - Robey IF et al, University of Arizona, Tucson, Arizona, USA. 518
Dr. Simoncini believes cancer is caused by a fungus, namely Candida Albicans. He has been developing techniques aimed at eradicating the fungus utilizing SODIUM BICARBONATE. Because of his unorthodox approach, Dr. Simoncini has been disbarred from the Italian Medical Order, and at the same time he has endured a massive, concerted attack by the Italian media, promoted by the Italian Medical Establishment. Despite these obstacles, Dr. Simoncini has managed to advance his theories at medical conferences in Italy and abroad. Among the venues where he has presented are the International Oncology Convention, Treviso, Italy (2000); Convention on Holistic Medicine in Oncology, Udine, Italy (2006); International Anti-Aging Convention, Paris, France (2008) and the Convention on Natural Medicine, Phoenix, Arizona (2008).
143
Fungal infections in cancer patients: an international autopsy survey. In an attempt to estimate the frequency of fungal infections among cancer patients, a survey of autopsy examinations was conducted in multiple institutions in Europe, Japan and Canada. Fungal infections were identified most often in leukemic patients and transplant recipients (25% each). Fifty-eight percent of fungal infections were caused by Candida spp. and 30% by Aspergillus spp. There was considerable variability in the frequency of fungal infections in different countries. Nevertheless, this study clearly demonstrates that fungal infections represent a common complication in cancer patients, especially in patients with leukemia. - Bodey G, M.D. Anderson Cancer Center, Houston, Texas 77030 519
Chapter 3:
Microbiology in Cancer Treatment
"Never memorise something that you can look up." - Albert Einstein 144
„The work of Dr. Coley remains forgotten."
(~ 1880 AD) William B. Coley, M.D.
Dr. B. Coley (1862 – 1936) was a U.S. bone surgeon and cancer researcher, pioneer of cancer immunotherapy. He developed a treatment based on provoking a fever based immune response to bacteria.
Working Summary: Father of immunotherapy, Books: "The Toxins of William B. Coley and the Treatment of Bone and Soft- Tissue Sarcomas by McCarthy, EF (2006)" (The following information is excerpted from: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell, Pilgrims Books, 1998 USA)
Dr. Coley, a New York City physician, was a graduate of Harvard Medical School and a surgeon at Memorial Hospital. Noting that operations killed not the cancer but the patient, he decided to methodically search the bone cancer medical records of New York Hospital for the previous 15 years. To his amazement, he found one case in which a man’s cancer totally disappeared! After being given up for lost, he walked out of the hospital COMPLETELY CURED. Coley discovered that, on his deathbed, the man had suffered two attacks of erysipelas (streptococcus pyogenes), a severe and sometimes life threatening skin infection, accompanied by severe fever and chills. Reference: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell 1998
145
"The concept of using fever to treat tumors has been around for ages. Three hundred years before Archimedes' statement, "Give me a lever long enough and a place to stand, and I will move the world," Parmenides, the famous Greek physician said, "Give me the power to induce fever and I will cure all diseases." www.correlatingcancer.com/ Correlating the many complexities of Cancer, All Rights Reserved "Five year survival rates based on data collected by Helen Nauts in the 1970’s showed: 65% for patients with inoperable breast cancer; 69% for patients with inoperable ovarian cancer; and 90% for those with bone cancer. Research conducted at Memorial Sloane Kettering Cancer Centre in 1976 showed that patients with advanced non- Hodgkinson’s lymphoma experienced a 93% remission rate versus 29% for the chemotherapy alone group. "It could just be that the results achieved by Coley are the best results we will ever achieve in the treatment of cancer." - Dr Charles Starnes, Ph.D. an immunologist 157 "Why some of us die from cancer? As quoted in An Alternative Medicine Definitive Guide to Cancer 155 , Dr. Douglas Brodie says: "Each one of us produces several hundred thousand cancer cells every day of our lives. Whether we develop clinical cancer or not depends upon the ability of our immune systems to destroy these cancer cells. That's because cancer thrives in the presence of a deficient immune system." Cancer & Vitamin C, http://www.cforyourself.com/ 158
The physicians called it "spontaneous remission" (a cure with no apparent cause), and quickly forgot it. Searching the streets of New York, Coley found the man who, seven years earlier, was dying of cancer. He was still in complete remission! Coley decided to repeat it, by giving another patient a bacterial infection that might kill him. He did it several times, without effect. But then, from the famous German "microbe hunter," Robert Koch, Coley got a particularly virulent culture of strep germs. When he administered this culture, the patient’s temperature shot skyward, and developed a severe case of erysipelas. All feared for his life; but, within a few days, he recovered—and the cancer was gone. Only scars remained of the tumors on his tonsils and neck. The next patient had his bone cancer entirely eliminated. In 1883, Coley published his first paper on this event, which occurred at Memorial Hospital, in full view of Dr. Bull and other surgeons and pathologists. In later years, he published dozens of other papers. But each infection was an ordeal for the patient and for the staff (the strep germs were highly infectious). But radium mining interests (Douglas- Phelps- Dodge) gained control of the hospital, and Coley fell into disrepute. Radium was costly ($15,000 a gram back then), and Coley’s treatment was relatively inexpensive. Reference: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell 1998
146
"It was discovered at MSK in 1893 and the results...over a 1000 people were treated with it. It is basically a high fever treatment. Some guy rung a radio show I was on, he had a sarcoma that was operated on, it spread, and his doctor sent him to Dr Coley. He was 13 at the time and 95 now. This is 82 years. Sarcoma is an incurable disease. A blow away treatment. In advanced terminal breast cancer they got complete remissions in 50% of the cases using this treatment. That is not saying what you would get if you used it in conjunction with surgery, you may get a 100%.……..it is criminal. I have known about this and lived with it for 20 years. You know what? THEY know about it at Sloane Kettering. They even put Coleys picture in their publicity material, as a pioneer of immunology, but they would never use the treatment themselves. They want to develop DRUGS that can be spun off like Tumour Necrosis Factor, like these other immunologically based drug treatments, highly toxic, destructive of the immune system, incredibly expensive. …this is really an effective treatment and it an OUTRAGEOUS crime of the century that we at MSK were able to cure cancer a 100 years ago that they can't cure today. This is a fraud being perpetrated on the public..." - Ralph Moss 131, 157 "This (Coley’s Toxins) is really an effective treatment and it an OUTRAGEOUS crime of the century that we at MSK were able to cure a 100 years ago that they can’t cure today." - Ralph Moss 131
But Coley kept giving his dangerous treatment for many years thereafter. What had actually happened? Coley had happened upon an alternative cancer treatment used today in certain locations: fever therapy. It is a variation of natureâ&#x20AC;&#x2122;s method of healing: fever. (In 1866, William Busch, M.D., a Prussian physician, had also observed a remission of cancer following an attack of erysipelas.) Today, fever therapy (also known as hyperthermia) continues to be given with fair success. But it must be given under the direct supervision of an experienced expert! This fact must not be overlooked! The patientâ&#x20AC;&#x2122;s body is heated to 106oF. (sometimes only to 104oF.) While he is under anesthesia. His head and heart are kept cool. It is now known that, at that high temperature, cancer cells cannot live. It is not necessary to give a person a dangerous disease in order to produce a favorable fever. But Coley did not know that. Upon his death in 1936, his daughter, Helen Coley Nauts, advanced his method so it would not die. She gathered over a thousand cases of cancer remission which he had achieved during his practice, but the cancer organizations refused to consider the findings. (For more on safer methods of hyperthermia, see pages 111- 113; cf. 53- 55, 103- 104, and 152.) Coley believed that cancer was caused by a virus; and, in 1929, he presented evidence supporting it. He was one of the first to come forward with this theory. In later years, additional evidence would surface, pointing to a microorganism of some kind as the cause. Some believed the virus or germ could only gain a toehold in a body Picture 1: A macrophage attacking a cancer cell (two objects in center) weakened by improper eating and other factors. Reference: Alternative Cancer Remedies â&#x20AC;&#x201C; Facts for Historians and Medical Researchers by Vance Ferrell 1998
147
Picture 2: A T- cell (small sphere) attacks a cancer cell
Fever and cancer in perspective (The following information is excerpted from: Fever and cancer in perspective Uwe Hobohm, F. Hoffmann â&#x20AC;&#x201C; La roche Ltd. Pharma Research, Basel, Switzerland, Cancer Immunol Immunother, Copyright Springer â&#x20AC;&#x201C; Verlag 2001 163, References 164- 204
Throughout Coley's career there were at least 13 different vaccine preparations in use, with different methods of production and therapeutic efficiency. ColeyNauts. again after careful retrospective analysis of Coley's publications, found that three preparations were considerably more potent than the rest. These three preparations had the highest rate of curation (survival longer than 10 years) and were the most powerful in inducing febrile reactions. Effectiveness was also correlated with mode and duration of application of the vaccine. Although Coley. In his numerous publications, seldom gave full details of site, dosage, frequency, or duration of vaccine application, the optimal therapy regimen, with hindsight, seemed to be intratumoral, intramuscular or intraperitoneal high- dosage injections over long periods of time. Coley- Nauts end- result studies showed that 80% of inoperable soft tissue sarcoma patients survived 5- 88 years if injections were given daily, or at least 2- 3 times a week, irrespective of regression, for at least 6 months, with each injection raising the body temperature considerably for 12- 24 h. Given that most of these cases were inoperable late148
"Dr. Laurie H. Glimcher, the Stephen and Suzanne Weiss Dean of Weill Cornell Medical College and provost for medical affairs of Cornell University, is a winner of the 2012 William B. Coley Award for Distinguished Research in Basic Immunology from the Cancer Research Institute for her outstanding achievements in immunology and cancer research. "I am honored and humbled to receive this prestigious immunology research award from the Cancer Research Institute," says Dr. Glimcher, the Stephen and Suzanne Weiss Dean of Weill Cornell Medical College, who is also a member of the Cancer Research Institute's Scientific Advisory Council. "Research discoveries identified about T cells hold tremendous promise for enhancing our knowledge of the fundamental immune responses involved in malignant diseases. Together, our steadfast progress can catapult cancer care to the next level of discovery to develop innovative therapies that improve the lives of cancer patients."" - Cancer Research Institute Honors Dr. Laurie H. Glimcher, Dean of Weill Cornell Medical College Receives the 2012 William B. Coley Award for Distinguished Research in Basic Immunology, Weill Cornell Medical College 156
stage cancers, an 80% rate of curation is extraordinary. Caulkins. A contemporary physician achieved the same 80% survival rate with a similar 6- to 12- month vaccination regimen. Coley himself stated: "I feel that many of the past failures might have resulted otherwise had larger doses and more frequent injections been given" [173] . However, Coley did not sufficiently recognize the correlation between survival rate and induced fever temperature [193]. After the tragedy of thalidomide in 1963, very stringent regulations regarding clinical trials of new drugs were installed by the FDA. Although Coley's toxins were 70 years old. the Kefauver Act decided it was a new drug requiring special permission. Therefore, a novel formulation of bacterial toxins was developed, which is called mixed bacterial vaccine (MBV) and has less adverse side effects [182]. In recent years. Coley's toxin and MBV have been tested again in a few clinical trials in an attempt to scrutinize the drug by applying higher scientific standards compared to Coley's time (see Table 1). In all those studies, no selection for patients with cancers of mesodermal origin was performed. In most studies using MBV. A few injections were given over short periods of time, paying no attention to the correlation between length of treatment and severity of fever induced, on the one hand, and effectiveness, on the Reference: Fever and cancer in perspective Uwe Hobohm, F. Hoffmann – La roche Ltd. Pharma Research, Basel, Switzerland
149
"Cancerous cells are not inherently more susceptible to the effects of heat.[159] When compared in in vitro studies, normal cells and cancer cells show the same responses to heat. However, the vascular disorganization of a solid tumor results in an unfavorable microenvironment inside tumors. Consequently, the tumor cells are already stressed by low oxygen, higher than normal acid concentrations, and insufficient nutrients, and are thus significantly less able to tolerate the added stress of heat than a healthy cell in normal tissue.[159]" Carolyn Freeman; Halperin, Edward C.; Brady, Luther W.; David E. Wazer (2008). Wikipedia.org 159, 160 "A retrospective study compared the 10- year survival rates of patients treated by Coley’s toxins and modern chemotherapy/radiation therapies (of the late 1990s) using data from the Surveillance Epidemiology End Result cancer registry. This study found that despite the billions of dollars spent to develop modern cancer treatments, patients receiving modern conventional therapies did not fare better than patients receiving the treatment initiated by Coley over 100 years ago. Coley died without ever really knowing the mechanism behind his vaccine. He knew the fever was critical though. In 1969, a retrospective study of patients with inoperable soft tissue sarcomas treated with Coley’s vaccine found a superior five year survival in patients whose fevers averaged 38–40°C, compared with those having little or no fever (38°C) during treatment (60% vs. 20%). " Can a fever cure cancer? http://correlatingcancer.com 161, 162,
other, which is apparent from Coley's experiments. Most of the patients in Table 1 were late- stage cancers, most of them treated previously by chemotherapy and radiation without success. Since these prior treatments might reduce the efficacy of Coley's toxin due to their immune- compromising effects, and since late- stage cancers are particularly difficult challenges, the few responses and even cures reported might be. in fact, a surprisingly favorable outcome. Richardson et al. [196] tried to match 128 Coley cases with 1.675 controls from the Surveillance Epidemiology End Result (SEER) population- based cancer registry. Groups were matched on age, sex, ethnicity, and stage and radiation treatment status. The results are summarized in (Table 2). The authors state: "Given the tremendous advances in surgical techniques and medicine in general, any cohort of modern patients should be expected to fare better than patients treated 50 or more years ago. Yet no such statistical advantage for the modern group was observed in this study." Concurrence of fever and spontaneous remission Cautious physicians, in their bedside practice, sometimes recognized beneficial fever effects. In 1950. Shear reported that brief remissions in children with untreated leukemia were observed in about 10% of the patients. Three quarters of those remissions were preceded by an episode of acute infection. In a remarkably lucid statement, he wrote: "Are pathogenic and non- pathogenic microorganisms one of Nature's controls of microscopic foci of malignant tissue, and. in making progress in the control of infectious diseases, are we not removing one of Nature's controls of cancer?" [195]. Literature surveys on spontaneous remissions and regressions, including the reviews of Everson and Cole [177]. Boyd [168]. Stephenson et. al. [200]. Challis and Stam [171]. Reference: Fever and cancer in perspective Uwe Hobohm, F. Hoffmann â&#x20AC;&#x201C; La roche Ltd. Pharma Research, Basel, Switzerland
150
and Maurer and Kolmel [190]. covered more than 700 case studies of spontaneous regression, and all authors underlined the coincidence of spontaneous regression and feverish infection, which occurred in at least a quarter of cases [190. 200]. One might speculate that the sex- specific incidence of bladder cancer, which is four times lower in women than in men. could possibly be caused by the more frequent bladder infections in women due to a shorter urethra. Furthermore. Kolmel et al. [185]. who compared the history of severe infections in 603 melanoma patients with that in 627 population controls, found inverse correlations between melanoma risk and number of recorded infections, and between melanoma risk and fever height, leading to a combined reduction of melanoma risk of about 40% for people with a history of three or more infections with fever above 38.5 °C. The observation that cancer patients very often report long- lasting periods without any disease may also provide some insight [164. 176]. An immunological hypothesis The effects of the Busch- Coley treatment and the frequent concurrence of spontaneous remissions with fever might both be explained by the following hypothetical cascade of events: fever generates inflammatory factors with co- stimulatory activity, which activate resting dendritic cells (DC), leading to the activation of anergic T- cells. maybe accompanied by a second process, where a possible physical damage of cancer cells leads to a sudden supply of cancer antigens to DC. It has been known for a long time that in many cancer cases a T- cell response occurs, but cancer- cell- specific T- cells usually remain in a state of energy, most likely because of the absence of danger signals that accompany tissue destruction and inflammation upon (e.g.) infection, i.e., T- cells remain anergic due to a lack of costimulatory signals [194]. Potent co- stimulatory signals (e.g.. B7. IL- 12) are expressed by Reference: Fever and cancer in perspective Uwe Hobohm, F. Hoffmann â&#x20AC;&#x201C; La roche Ltd. Pharma Research, Basel, Switzerland
151
antigen- presenting cells (APC), in particular DC. Resting DC can be activated by a number of stimuli, including: lipop- olysaccarides (LPS), contact allergens, bacterial and viral products, products from necrotic cells. TNF- alpha. IL- lbeta, PGE2, unmethylated CpG tracts in DNA and signalling molecules like CD40. A feverish bacterial infection may have a three- fold beneficial effect. First, many infectious agents release endotoxins, like LPS. and induce inflammatory cytokines, stimulating DC. Second, both thymocyte proliferation and generation of allo- specific CTL are increased with temperature in vitro [181]. Third, cancer cells may be less heat- resistant than normal cells [202] and. consequently, fever may cause an increase in tumor- cell death and the production of tumor- cell debris. This latter effect may also be produced by hyperthermia [139. 202]. DC can be activated by antigen- carrying dying cells [165]. Where death may be mediated both by apoptotic [172] and necrotic [180] pathways. Activation of DC might lead to subsequent activation of cytotoxic T- lymphocytes (CTL). Perhaps in some cases leading to a full- blown attack against antigen- carrying cancer cells. The antigenicity of tumor antigens depends on whether the antigens are highly tumor- specific or whether they are shared by other body tissues. Almost exactly 100 years after Coley's seminal experiments. Srivastava and co- workers found a hint as to why sarcoma might be particular. They determined that membrane- bound heat- shock proteins complexed to tumor peptides as powerful antigens on sarcoma cells [203]. Soon afterwards. Multhoff et al. showed that physical (non- lethal) heat shock results in an increased cell- surface expression of Hsp70 heat- shock protein on sarcoma and lymphoma cell lines [192]. It would be interesting to know whether this behavior extends to other cancers of mesodermal origin. Certain carcinoma cell lines exhibit this unusual Hsp70 cell- surface expression even under normal physiological conditions [167]. Although the carcinoma stress- independent membrane expression of Hsp70 corresponds with an increased Reference: Fever and cancer in perspective Uwe Hobohm, F. Hoffmann â&#x20AC;&#x201C; La roche Ltd. Pharma Research, Basel, Switzerland
152
sensitivity to lysis by natural killer (NK) T- cells in vitro [167]. The situation in vivo may be different. As Pardoll pointed out. immunological kinetics may be crucial: full- blown T- cell activation by DC may require the presence of co- stimulatory signals at the time offirst antigen recognition [194]. Perhaps leading to the alleged higher efficiency of fever therapy with sarcoma compared to carcinoma. Conclusion A huge body of scientific literature indicates that the immune system can sometimes be a very POWERFUL WEAPON AGAINST CANCER. As yet, there is no modern clinical study with cancer patients treated by MBV aimed at optimizing patient selection and treatment protocol, namely, selecting for patients with cancers of mesodermal origin and treatment for long periods of time, beginning at a very early stage of the disease. Treatment might be combined with strategies to block inhibitory pathways of T- cell activation temporarily, e.g., blockade of CTLA- 4 [187] by an anti- CTLA- 4 antibody [189] or blocking FASL- FAS interactions [197]. Immune strategies targeting unique tumor- specific antigens should be individualized rather than generic. And fever induction is. by necessity, a means of inducing an individualized response. Today, we can induce and control fever much better than 100 years ago. We have a much better understanding at the molecular level, and we have a plethora of additional immune- stimulators available, which might be combined into a synergistic therapy regimen. It is time to scrutinize fever therapy again.
Reference: Fever and cancer in perspective Uwe Hobohm, F. Hoffmann â&#x20AC;&#x201C; La roche Ltd. Pharma Research, Basel, Switzerland
153
"A cancer maverick was heavily suppressed, prosecuted and murdered."
(~ 1920 AD) William F. Koch, M.D., PhD.
William Frederich Koch, M.D., PhD. 306 (1885- 1967) was a U. S. medical doctor pharmaceutical entrepreneur and a brilliant researcher,
Working Summary: improved on Coleyâ&#x20AC;&#x2122;s fever Treatment. Pioneering in oxygen therapies, several synthetic antitoxins: Homeopathic Formulations and 5 Mineral Catalyst Formula supported by juicing and fasting later followed by a vegan diet. Recommended Literature: Cancer and Allied Diseases, (1933), Daniel Haley's book, "Politics in Healing." (2000), Survival Factor in Neoplastic and Viral Diseases by William Koch (1958), (The following information is excerpted from: Alternative Cancer Remedies â&#x20AC;&#x201C; Facts for Historians and Medical Researchers by Vance Ferrell, Pilgrims Books, 1998 USA) 68
In 1931, Otto Warburg received the Nobel Prize, in physiology and medicine for some of his work, which related to his discovery that cancer CELLS cannot survive in the presence of oxygen. But a decade earlier, a remarkable man of the highest intellect had anticipated Warburgâ&#x20AC;&#x2122;s discovery. In this report, his theories of cancer and methods for treating it are closely interwoven. Dr. Koch had an M.D., Ph.D., was a teacher at a medical college and a careful researcher. He it was who, before the age of 30, discovered that the removal of the parathyroids would produce death. Physicians were
154
Photo: The chemicals in breast cancer tumours "British researchers have found traces of chemicals called parabens in tissue taken from women with breast cancer. While there is no evidence they cause cancer, the scientists have called for the use of parabens to be reviewed. The cosmetics industry insists the chemicals, which are used as preservatives and are approved for use by regulators, are safe. Dr Philippa Darbre and colleagues at the University of Reading carried out tests on samples of 20 different human breast tumours. Writing in the Journal of Applied Toxicology, they say they found traces of parabens in every sample. Their tests suggested the chemicals had seeped into the tissue after being applied to the skin. "This is the first study to show their accumulation in human tissues," said Dr Darbre. "It demonstrates that if people are exposed to these chemicals, then the chemicals will accumulate in their bodies." - Concern over deodorant chemicals, BBC News 2004 205
routinely removing thyroids and wondering why so many of their patients died from tetany (the parathyroids regulate calcium metabolism). About the year 1915, while teaching at the University of Detroit, Koch noted that there was a marked coagulation of blood and tissues in cancer tissue. He reasoned that, since this normally was a protective mechanism because of toxic problems, injury, or irritation, could it be that there might be TOXINS IN THE CANCER TISSUE which could be removed? With this in mind, Koch set about devising a means of eliminating those toxins. Actually, Koch had a good basis of thinking. It is now known that CANCER frequently is a garbage dump for poisons and waste products produced by wrong eating, overeating, stress, environmental chemicals, etc. Koch’s first treatment method was to initiate a fevered condition in the body which burn off the toxins. From 1888 to 1936, William Coley, M.D., did this also, using strep germs; but Koch’s fever therapy method was more consistent—and without the aid of a dangerous infection. Koch’s fever treatments were affected by means of tissue thrombin, a ferment which brings on a fever when heat burns off the toxic elements in the system. Then in 1920, following eight successful recoveries, Koch announced that he had a cure for Reference: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell 1998
155
Significance of the detection of esters of p- hydroxybenzoic acid (parabens) in human breast tumours. "This issue of Journal of Applied Toxicology publishes the paper Concentrations of Parabens in Human Breast Tumours by Darbre et al. (2004), which reports that esters of phydroxybenzoic acid (parabens) can be detected in samples of tissue from human breast tumours. Breast tumour samples were supplied from 20 patients, in collaboration with the Edinburgh Breast Unit Research Group, and analysed by high- pressure liquid chromatography and tandem mass spectrometry. The parabens are used as antimicrobial preservatives in underarm deodorants and antiperspirants and in a wide range of other consumer products. The parabens also have inherent oestrogenic and other hormone related activity (increased progesterone receptor gene expression). As oestrogen is a major aetiological factor in the growth and development of the majority of human breast cancers, it has been previously suggested by Darbre that parabens and other chemicals in underarm cosmetics may contribute to the rising incidence of breast cancer. The significance of the finding of parabens in tumour samples is discussed here in terms of 1). Darbre et al's study design, 2). what can be inferred from this type of data (and what can not, such as the cause of these tumours), 3). the toxicology of these compounds and 4). the limitations of the existing toxicology database and the need to consider data that is appropriate to human exposures. - Harvey PW, Everett DJ., J Appl Toxicol. 2004Copyright 2004 John Wiley & Sons, Ltd.
cancer. Immediately, the surgeons in charge of the Wayne County Medical Society instituted a war against him. By that decade, surgery was still the most profitable treatment for cancer. It was not until the late 1940s that the cost of cancer drugs was raised enough, to make them equally profitable. From then on, chemotherapy ranked with surgery and radiation as the approved medical treatments for cancer. Another aspect of Koch’s brilliant thinking revolved around sugar metabolism. Fifteen years before Warburg discovered the same principle (and received a Nobel Prize the following year for doing so); Koch had stumbled upon the fact that SUGAR OXIDATION was a key factor in cancer formation. According to his thinking, if the SUGARS COULD BE OXIDIZED, the cancer would be reduced. What was needed was more oxygen to the site of the tumor. Although Koch already had one treatment for cancer (fever therapy), he set to work devising another—one which would not require the fever. He searched for more active catalysts to stimulate the body’s capacity to oxidize toxins. —The result was Glyoxylide. This is the name he gave a liquid formula which he developed. Koch was an extremely capable and original thinker. His bold idea was that Glyoxylide would cause toxins in the cancer cells (and elsewhere Reference: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell 1998
156
(…) "Recent laboratory studies have demonstrated that hyperthermia can inactivate cells, cause tumor regression, cause normal 1- 1 tissue damage, potentiate the effects of radiation therapy, and enhance the action of many anticancer drugs." - Daniel S Kapp, PhD, MD, George M Hahn, PhD, and Robert W Carlson, MD, © 2000, BC Decker Inc. 207 – 210 References 211 - 291 "At the Third National Cancer Conference in Detroit that year one of the main speeches was delivered by Dr. Wendell Meredith Stanley, who had been awarded the Nobel Prize in 1946 for crystallizing the tobacco mosaic virus. Dr. Stanley bluntly told an audience composed of the world's most active cancer investigators that they should mend their ways, abandon the notion of an impenetrable species barrier, and seriously consider the possibility that viruses are involved in human cancer. 'Basic biologic phenomena generally do not differ strikingly as one goes from one species to another,' Doctor Stanley reminded the cancer specialists. 'I regard the fact, now proved beyond contention, that viruses can cause cancer in animals to be directly pertinent to the human cancer problem.' A few months later Duran- Reynals, the gentle man of soft voice and iron determination, fell prey to a strange cancer that first paralyzed him, then killed him."
- What the ACS Knew in 1955 About Infections and Cancer, The American Cancer Society has suppressed research on infection and lung cancer for over 70 years. www.smokershistory.com/ 292
in the body) to be changed into antitoxins—by oxydizing them. This was to be done by adding molecules which changed their composition. Another part of Koch’s theory was that cancer was caused by a germ or virus; and that originally it was harmless, but only became deadly when poisoned by the toxins in the system. This concept closely relates to the discoveries of Royal Rife in the 1930s, a young man who, subsidized by the Mr. Timpkin (owner of Timpkin Roller Bearing Company), invented a superpowerful microscope (the Rife microscope) and, then, with it, he discovered that germs change from one type to another, depending on conditions in the body. One stage is a FUNGUS; the last is CANCER. That was in the days before the development of the electron microscope, but there has been silence in regard to any efforts made, using the electron microscope to duplicate Rife’s germ transformations which occur in toxic bodies. (See Pleomorphism, later in this book.) Koch’s theories were never investigated by the medical authorities. He was treated as a charlatan and fake. Although Glyoxylide was said to be nothing more than distilled water, no examination was ever made to determine exactly what it was.
Reference: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell 1998
157
"One particular case was Wesley Roebuck, who had surgery in 1926 for cancer of the stomach. The disease returned so he went to Koch and received a shot of Glyoxylide. The cancer cleared up and he testified at Koch’s trial over 14 years later and cancer free. In the first trial, two newspapers closely followed the proceedings, the "Detroit Times" and the "Detroit Free Press." Headlines taken form court testimony read, (p72) Three Cancer Cures Put in Record at the Koch Trial…Hospital Executive gives Case Histories as Defense Witness…Doctor Testifies Koch Formula Aided 16 Cases…Cancer Doctor Says Koch Cure Replaced XRays." - Dr Koch and Glyoxylide/ Malonide, cancerinform.org based on Daniel Haley's book, "Politics In Healing. 105, 293
"Chemotherapy and second Cancers Some second cancers result from the risk factors responsible for the original disease. Some are caused by radiation or chemotherapy treatments that damage normal cells or suppress the patient's immune system. Chemotherapy generally increases the likelihood of leukemia. Radiation raises the risk of developing breast cancer or other solid tumors. Scientists do not fully understand why chemotherapy causes some cancer survivors to develop new malignancies." - Cancer Prevention, by Marian Johnson, Fred Hutchinson Cancer Research Center, Seattle, 294
Dr. Kochâ&#x20AC;&#x2122;s Treatment: The Koch treatment was more rounded than that of some others. He did not rely merely on Glyoxylide, but also required a rigid diet which excluded all foods which were toxic or contained oxygen inhibitors. Included in this list were meats, beans, lentils, coffee, alcohol, and tomatoes. Only distilled water was to be drunk, and daily enemas were required. Koch maintained that both the diet changes and the Glyoxylide were needed to eliminate the cancer. Individuals taking the Koch treatment needed no hospitalization. The person would receive one injection of Glyoxylide and no more for about six weeks or until decreased oxidation was observed. As with all worthwhile natural alternate remedies for cancer while on the program, pain would subside and tend to disappear. This tends to be a hallmark of genuine cancer remedies. In 1933, Koch published his book, Cancer and Allied Diseases, in which he explained the thinking behind his treatments. He maintained that CANCER resulted from years of toxic conditions in the body. When the cancer growth begins, these toxic conditions lessen somewhat, since some are being stored in the cancerous tissue, somewhat as you might place garbage in a garbage can, so the house can remain clean and neat. Surgery, by removing the surrounding Reference: Alternative Cancer Remedies â&#x20AC;&#x201C; Facts for Historians and Medical Researchers by Vance Ferrell 1998
158
"With the increased survival of cancer patients, more than 10 percent of all invasive cancers are second or later primary cancers, making this an important area of concern for patients and their physicians. The large numbers of cancers available from the SEER populationbased tumor registries and the long 30year followup period provide an ideal resource with unique opportunities to study second cancers and add to our understanding of the causes of human cancer. One important area of research has been the late complications of cancer therapy, including second cancers induced by radiotherapy or chemotherapeutic and hormonal agents. In addition, investigators have used SEER data to explore hypotheses on the environmental, genetic, and other causes of increased second cancer risk. Highlights include the following: - Young women treated with radiotherapy for Hodgkinâ&#x20AC;&#x2122;s disease (HD) experienced a threefold increased risk of breast cancer, which rose with higher radiation doses to the breast. HD patients treated with radiotherapy had a sixfold risk of lung cancer, with risk related to dose of radiation received. - Breast cancer patients initially treated with tamoxifen have a twofold increased risk of uterine corpus cancer, with particularly high risks seen for rare tumors of the mixed mullerian type. Platinum- based chemotherapy for ovarian cancer increased the risk of leukemia three- to fourfold, and risk rose with increasing cumulative doses to reach eightfold. - Men with testicular cancer continue to be at significantly increased risk of second malignancies for more than 20 years after treatment." Second Cancers, Surveillance Epidemiology and End Results, National Cancer Institute, http://seer.cancer.gov/ 295- 301
container, damages the house and does nothing to reduce the influx of toxins. Koch said that CANCER was a response of protection against dangerous toxins; it tried to bottle them up in tumors. He also maintained that, when the toxins were eliminated, the cancer would automatically shrink and disappear; and all its essential elements would be reabsorbed by the body. In contrast, Koch declared that cutting out pieces of the body, to rid it of a cancerous condition, accomplished nothing positive but instead it caused great injury, weakened the body, and laid the groundwork for even more trouble later on. Surgery and biopsy, Koch said, only spread cancer faster. Yet, he added, it was the surgeons who were given the authority to decide which remedies could be approved! Dr. Koch‘s Support: Several top physicians, throughout the world, saw the value of the Koch treatment and began using it—until threats stopped them. This included Allen, of Tulane University; Bryan, of Vanderbilt University; Maisin, of Belgium; Godfrey, in Toronto; and Kannel, of Ft. Wayne, Indiana. One of these, Forbes Godfrey, who for 26 years was the Canadian Minister of Health and Education, said, "Radium has a dangerous effect on the human system. In a couple of years people who have used it usually die suddenly because it affects the
"(…) Chemotherapy drugs are the most toxic substances ever put deliberately into the human body. They are known poisons, they are designed poisons. In a number of surveys most chemotherapists have said they would not take chemotherapy themselves or recommend it for their families." - Mike Howell, The Man Who Questions Chemotherapy, 1998 http://www.positivehealth.com 302 "It is considered that the mechanical irritation acts as an inducer in the canceration process of tongue cancer. The purpose of this study was to clarify the effect of mechanical irritation on the development and progression of tongue cancer. These results suggest that the mechanical irritation acts accelatively in canceration and progression of tongue cancer and causes DNA damage." - Sato T., Faculty of Dentistry, Tokyo Medical and Dental University 303 Source: Whale.to 304 "One death from poisoning, and one from being run down by an automobile, both victims being physicians of distinction and prominent in the advocacy of Dr. Koch treatment. Mail has been opened... Dr. Koch himself was the target of at least 13 unsuccessful attempts on his life' - Riley H. Crabb.)" - M. Layne, The Koch Remedy for Cancer Source: Whale.to 304 "Following the Koch trial, a number of physical attacks were made upon me...I was robbed and beaten in my office and on the street...Similar attentions were paid other physicians who agreed with Dr. Koch.' - Anonymous MD, Whale.to 304
Reference: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell 1998
159
heart." J.W. Kannel later testified about how, over a period of 14 years, he had successfully treated 72 cases with the Koch preparation. Many were hopelessly advanced to begin with. About a third was still alive. He noted that, before adopting the Koch treatment, he had operated on at least 50 cases of cancer, had followed surgery with X- ray or radium, — and yet the longest survival time had been only two and a half years. Kannel mentioned that, on a visit to Mayo Clinic, he saw a surgeon remove five cancerous breasts in one day. When asked about success rate, the surgeon admitted that surgery and radiation accomplished NOTHING, but that he did not know what else to do. The Suppression of Dr. Koch In 19401941 in Brazil, Koch SUCCESSFULLY treated leprosy, tuberculosis, and mental conditions. Then an agent for a large pharmaceutical firm (which reaped immense profits from repeated injections into the insane) shook his fist in Koch’s face and said he would not be interfering much longer in Brazil. In April 1942, Koch was arrested in Florida for "false labeling" of his product. The district attorney Reference: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell 1998
160
Edward J. McCabe: "Health journalist who reported success of oxygen therapy. Sentenced to 3 years in prison on the pretext of tax evasion 1999 (and served 2 years)." - Whale.to 304 "One death from poisoning, and one from being run down by an automobile, both victims being physicinas of distinction and prominent in the advocacy of the Koch treatment." - M. Layne "Dr. F.M. Eugene Blass: Developer of "Homozon™" (the original oxygen therapy product) - murdered outside his house, same year and month as Dr Koch." - Whale.to 304 "Dr Basil Earle Wainright: Physicist inventor of polyatomic apheuresis oxygen therapy. Imprisoned for 4 years. Claims he survived six assassination attempts whilst in prison." - Whale.to 304 "Dr George A. Freibott, IV. President of the American Naturopathic Association, consultant for International Association for Oxygen Therapy, US Government approved and internationally accepted expert witness on oxygen/oxidation therapies. Survived numerous assassination attempts and several anonymous phone calls threatening him with his life." - Whale.to 304 "Dr James Boyce: Turned 254 people HIV+ to HIV- using ozone therapy: Charged with using unproven methods and sentenced to 5 years in prison. Had his medical license revoked." - Whale.to 304
"Ken Thiefault sold ozone generators: Sentenced to 7 years in prison for making medical claims for ozone generators. His wife was sentenced to three years." - Whale.to 304
demanded an immense bail of $10,000. When asked why, since only murder cases required such a bail, the DA admitted that he had received orders from Detroit to do this so Koch would not return to Brazil and finish his research there. Both in 1942 and 1946, the FDA fought Koch in two bitter trials, claiming that the remedies were indistinguishable from distilled water. A temporary injunction was made to stop his work until a thorough investigation could be made. Of course, the investigation was remarkably slow in getting started. In 1950, the injunction was made permanent. Koch had been stopped. At this juncture, Koch gave his formulas and methods to the Christian Medical Research League of Detroit, and then moved permanently to Brazil. But the preparation was incompetently processed, was no longer effective, and was soon abandoned. Meanwhile, another cancer investigation was set up, this time in Ontario, Canada. One witness, J.W. Kannel of Fort Wayne, Indiana, told of treating 72 patients in 14 years with Glyoxylide, due to their own pleadings for help. He said they were too hopeless for any other kind of treatment. Of that number, 21 were still alive and four others had died of other causes. Kannel said it was the first cancer treatment he had ever found which provided any hope. In spite of such testimony, no formal report of this hearing was ever made. Reference: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell 1998
161
"One doctor...J.W. Kannel, saved a young girl...She had hopeless cancer of the spleen...One shot of Glyoxylide, and she became well (in 1943; still alive in 1983)...For (this), Kannel was barred from all hospitals in Fort Wayne...The FDA had (Glyoxylide inventor, Dr. William Frederick) Koch arrested and thrown into an incredibly filthy jail cell in Florida in 1942." - Barry Lynes's book, The Healing of Cancer: The Cures the Cover- Ups 305 and the Solution Now! the Wayne County Medical Society to appoint a committee to test his treatment in five terminal cancer cases. The committee chose five "stretcher" cases, all at death's door. Koch treated them and in three weeks they were all up and about, cheerful and gaining strength. The committee immediately ordered them all home and "forbade them any more care from Koch." (p 55). The committee’s final report was "no results." (…) Koch wrote about one of the patients’ recoveries in his 1955 book, "Survival Factor." "Mrs. Edith Fritts had cancer of the uterus proven by laporotomy as extending throughout the abdomen and perforating the stomach so as to cause severe bleeding. She lived fifteen years in good health after the treatment and died from an accident. The coroner’s autopsy showed no cancer was present…" Koch had given Edith one shot of Glyoxylide. "(p55.) (…) Incredibly, during 30 some years of Koch’s therapy being used in the U.S., the Wayne County Medical Society’s "trial" is the only official test ever carried out despite repeated requests from Koch. - cancerinform.org Daniel Haley's book, "Politics In Healing." 293, 307
Principles of the Koch Introduced in 1918 by Dr William F. Koch (Following information is excerpted from: http://www.rexresearch.com,Copyright 1941 By Koch Laboratories, Inc..) 307
PATHOGENESIS: Primary, general, and residual focal infections take place and persist only where there is deficiency in the tissue oxidation catalysis. Germ poisons absorbed from infection foci may circulate in the blood and adsorb into tissues and produce their specific effects only when the oxidation catalysis of blood and tissues is deficient. Germ poisons are negative oxidation catalysts. They secure "anaerobic" environment necessary to the life of germ chemistry and unfavorable to the progress of tissue oxidation chemistry, by (a) totally quenching it and producing tissue necrosis, by (b) absorbing the energy of cell oxidations and under specific conditions transferring it to the chemical process of some functional unit in the cell, thus forcing uncontrolled, continuous allergic activity of that functional unit. (The specific condition that determines this energy transfer and acceptance action is the similarity in emission range of fluorescence of the toxin to the energy absorption range of the functional unit;) by (c) quenching the oxidation of ethylene or quinone groups of fluorescent substances in foods or tars or certain germ poisons so they remain to disturb function, producing allergic action of the reproductive elements, or of the contractile, secreting, or conductile elements of the cell, thus producing cancer, asthma, hay fever, contractures, or fixed ideas, etc., respectively. The atomic groups concerned in all germ poisonings and allergenic action are the unsaturated valencies between carbon atoms, between carbon and oxygen, and between carbon and nitrogen, which confer photochemic properties. They are destructible by vigorous oxidation brought about through appropriate oxidation catalysis. The severity of any allergic change follows certain definite conditions. Thus the degree of malignancy is proportionate to, (1) the degree of oxidation deficiency present (2) Reference: Principles of the Koch Introduced in 1918 by Dr William F. Koch, Koch Laboratories, Inc, Copyright 1941
162
the amount of toxin circulating, (3) the closeness of the source of toxin to the malignant cells, as when the neoplasm takes origin in the infection focus itself, (4) the degree of injury to the circulation within the focus of infection and within the neoplasm, as when caused by scar or the effects of traumatism, and finally (5) the degree of malignant expression in the forefathers, especially where each successive generation tends to develop cancer earlier and earlier in life. (Thus the pre-growth toxic period tends to become shorter and shorter with each successive generation until the growth develops and kills before the reproductive age arrives.) THERAPY: The destruction of toxic action through oxidation is the natural protective process. The catalysts concerned are those that mediate oxidation of sugars and fats for energy production for normal functional purposes. These bodies are Glyoxylide, O=C=C=O. Malonide, O=C=C=C=O. Ketene, H2C=C=O. Lactene, H2C=C=C=O. and 1:4, Benzoquinone. They activate oxygen and they also activate ethylene and quinone groups of toxic molecules to take up oxygen, thus destroying the free valency that produces their toxic photochemic action. This is the ultimate in all immunity chemistry and even where obscure chemotherapeuticâ&#x20AC;&#x2122;s have been found helpful this principle will he found operative fundamentally. For instance, the sulpho compounds in common use are very toxic to the tissues, each must first be oxidized to para amino quinone, which is next oxidized to 1 :4, benzoquinone and then to two molecules of the suboxide of carbon, "Malonide" or three molecules of Glyoxylide before it serves as a protective oxidation catalyst. When the tissue oxidations are too feeble to accomplish this oxidation, harm instead of benefit is received. There can be no question as to the preference of the harmless directly active agents, over the original toxic sulphonamide molecules.
Reference: Principles of the Koch Introduced in 1918 by Dr William F. Koch, Koch Laboratories, Inc, Copyright 1941
163
Glyoxylide is basic to every disease known to man in our experience and is not contraindicated in meningitis or any other condition but can be used with the expectation of doing good and not injuring the patient in any way whatever. RECOVERY PROCESS: When the pathogenic toxin is removed by this type of oxidation, its intermediaries have catalytic curative action also and so the "cause is turned into the cure," as I have insisted since 1918. The GERMS depending upon it must die and all secondary toxins are burned; TISSUES still living resume normal function; INJURED CELLS are removed and replaced by normal tissue elements, and not by scar. Hence, normal function is restored. Scars that had been protecting focal infections are now obsolete and are absorbed and replaced by normal tissue elements more or less thoroughly. Focal infection as well as acute germ invasion is routed out and the allergies and degenerative diseases depending upon the old focal poisoning give way to normalcy, even with tissue reconstruction and return of function. This return to normalcy is a cyclic procedure, the periodicity of which is grossly similar to the periodicity of the genesis of the disease. The periods are made up of positive and negative phases, the shortest unit of which is three hours. This period is multiplied into twelve, twenty- four, thirty- six hour cycles, etc., these are further multiplied into three and a half, seven, ten and a half. and fourteen- day cycles, these into three- week, six- week, nine- week, and twelve- week cycles, and these into six- month, nine- month, twelvemonth, and greater cycles. Especially important are the twelfth, twenty- fourth, thirtysixth, sixtieth and seventy- second week periods. Recovery is generally secured on one or two doses, but if the dose is to be repeated this is done during a negative phase only and at one of the divisional periods, such as the third, sixth, ninth, twelfth, twenty- fourth, thirty- sixth, fifty- first, sixtieth, or seventysecond week. It is never repeated while recovery is in progress. Reference: Principles of the Koch Introduced in 1918 by Dr William F. Koch, Koch Laboratories, Inc, Copyright 1941
164
„One of the oldest medical practices in our history is revealed!"
(~ 1940 AD) J.H. Lawrence, M.D.
"If you believe in me, you will never thirst (…). Rivers of living water shall flow from your bellies." - Jesus (in John 7:38) "Let the venom be the antidote" - Sufi Poet Rumi
Working Summary: Lawrence was one of the first of several to use purified urine factors in the treatment of cancer. Books: The Water of Life by Armstrong, J.W., 1971, The Miracles of Urine Therapy, by Bartnett, Dr B, 1988, Your Own Perfect Medicine Christy, M, 1994, Urine the Holy Water, by Tietze, H.W., 1996., The Miracle of Urine Therapy' by Dr Beatrice Bartnett, 'Your Own Perfect Medicine' by Martha Christy. "UROPATHY, The Most Powerful Holistic Therapy" by Martin Lara, "The Golden Fountain: The Complete Guide to Urine Therapy," by Coen van der Kroon's, Urine Therapy: Nature's Elixir for Good Health by Flora Peschek- Böhmer Ph.D. (et al.) Golden Fountain: The Complete Guide to Urine Therapy by Coen van der Kroon, Liquid Gold: The Lore and Logic of Using Urine to GrowPlants, Carol Steinfeld by Carol Steinfeld 2004, Shivambu Geeta - English by Dr. G K Thakkar 2007 (The following information is excerpted from: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell, Pilgrims Books, 1998 USA)
Dr. Lawrence was a British scientist who carried on medical research during World War II. In the course of his work, he discovered that there was a factor in urine which seemed to have antitumor activity in animals. His work has since been continued and refined by other scientists elsewhere in the world.
165
"Everything we do, everything we are, rests on our personal power. If we have enough of it, one word is enough to change the course of our lives. If we don't, the most magnificent piece of wisdom can be revealed to us and that revelation won't make a damn bit of difference." - Don Juan "I had over 30 cases of Bright's disease and other afflictions of the bladder and kidneys to advise upon, and in no instance did it take longer than from 4 to 14 days of urine fasts to restore normality, and a satisfying state of general health." - J.W. Armstrong (A Treatise on Urine Therapy p. 57) "Armstrong began urine therapy after a long and agonizing journey in which doctor after doctor proved unable to cure him of his TB symptoms. On the contrary, his condition only worsened. He decided to try urine therapy for two reasons. First of all, a quotation from the Bible stimulated his curiosity: "Drink water from your own cistern, flowing water from your own well." (The Book of Proverbs 5:15) Secondly, he had childhood memories of his mother smearing urine on his face which was swollen from a bee sting, and of his grandfather treating animals with urine. Recently, a lot of books have been published on urine therapy, especially in Germany, and some of those books have been written by regular doctors." - The simple use of ones own urine" Copyright HPSONLINE.COM, Helping People Survive, 1996- 2010, All Rights Reserved. 313
„One of the oldest medical practices remains forgotten."
Evangelos D. Danopoulos, M.D., was a Greek physician, Dr. Evangelos D. Danopoulos, reported discovering that urine had anticancer properties, opening a window into one of the oldest medical practices in our history.
(~ 1950 AD) Evangelos Danopoulos, M.D. Working Summary: The pioneer in cancer treatment with urea This was the second of three purified urine factor methods of treating cancer (The following information is excerpted from: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell, Pilgrims Books, 1998 USA)
For thousands of years, natives have used URINE to treat disease. In the early 1950s, Dr. Danopoulos, a Greek physician, found that it had anti- cancer properties. Trying to isolate the specific factor which was the active agent, he found it was UREA. Urea is the end product of protein metabolism and is the primary substance excreted in urine. Of course, all the urine research carried on by Danopoulos and others used purified, sterilized extracts; they did not use raw urine. Urea is not urine. Danopoulos injected 2- 3 ml of a 50- percent urea solution directly into the mass of a fast- growing tumor, which showed good results. But he found that he did better by injecting the urea very close to the tumor.
166
University of Illinois Medical Center researchers found that urea injections disrupt this water matrix, and interferes with the processes needed for continued uncontrolled cellular growth (Clinical Oncology, 3:319- 320, 1977). They disrupted it with a 40% urea solution, injected directly into the tumor mass and into the area surrounding it. - Vance Ferrell, Alternative Cancer Remedies – Facts for Historians and Medical Researchers Pilgrims Books, 1998 USA 68
"Urine is the main component of the amniotic fluid that bathes the human fetus. Normally the baby 'breathes' this urine- filled amniotic fluid into its lungs. If the urinary tract is blocked, the fetus does not produce the fluid, and, without it, the lungs do not develop." - G. Kolata, "Surgery on Fetuses Reveals They Heal Without Scars", The New York Times, Medical Section, 16 August 1988 "One of the most important functions of the kidney is to excrete material and substances for which the body has no immediate need..." - A. H. Free, and H. M. Free, Urinalysis in Clinical and Laboratory Practice, CRC Press, Inc., USA, 1975, pp. 13- 17 "Urokinase, an enzyme present in urine, prevents the formation of blood clots in the blood vessels, and is even capable of dissolving clots already formed. When such blood clots obstruct the flow of blood in the blood vessels of the heart a heart attack may be precipitated. Dr. Mezel of the Edgewater Hospital of Chicago, IL USA, injects urokinase into the bodies of victims of heart attacks thus aborting the attack and saving the life of the patient."
The urea must be injected into and close to the tumor itself. A research study in India reported as much as 75% REDUCTION in inoperable cancer of the uterine cervix by means of injections of 40% urea solution directly into the tumor, along with a localized application of a 50% urea ointment (G.M. Gandhi,et. al, "Urea in the Management of Advanced Malignancies," Journal of Surgical Oncology, 9:139- 46, 1977). In the case of liver cancer, urea is best taken orally. It reaches the liver directly from the intestines via the portal vein in a high enough concentration to be of significant value. The outer surface of tumor cells have a special type of chemical which enables them to more easily enlarge and bond with other cells. The result is a structured water matrix surrounding cancer cells, which enables them to crowd together and excrete and absorb chemicals in abnormal ways. The normal injection dosage varies from 10% to 50% urea, depending on the type of tissue. These injections can produce a burning sensation (because urea is an acid), but injections of a local anesthetic can prevent this.
167
"Many studies show that urine helps prevent and cure cancer. "Bringing Cancer Cells into Line" was a report at the 1966 "Federation of American Society for Experimental Biology", which showed how Uric acid, Directin, H- 11, and 3- methylglyoxal in urine negatively affects cancer." - Tantra Bensko, 2009, unlikelystories.org 313 According to Science Digest, in July 1958, "urine dilates arteries similarly to nitroglycerin, bringing blood to the heart, thus relieving angina." - Tantra Bensko, 2009, unlikelystories.org 313 "Doctors Alexander Glazer and Stocker, from University of California have showed that bilirubin in urine reduces damage from cancer, the effects of growing older, coronary disease, as well as anti- inflammatory ("Express" (U.S.A.) 1.3.87.) Retine and antineoplastens in urine are also helpful against cancer." Tantra Bensko, 2009, unlikelystories.org 313 Uric acid, another ingredient of urine, is normally thought of as an undesirable waste product of the body that causes gout. But even uric acid has recently been found to have tremendous health- promotion and medical implications." Medical researchers at the University of California at Berkeley reported in 1982 that they have discovered that: "Uric acid could be a defense against cancer and ageing.It also destroys body- damaging chemicals, called free radicals, that are present in food, water and air and are considered to be a cause of cancer and breakdowns in immune function. Uric acid could be one of the things that enables human beings to live so much longer than other mammals." - O. Davies, "Youthful Uric Acid", Omni magazine, October 1982. By Martha M. Christy, Your Own Perfect Medicine, Extracted from Nexus Magazine, 1996 313
URINE & UREA Therapy By Walter Last (Following information is excerpted from: www.health- sciencespirit.com 338 Further Book References on Urine Therapy 316- 337)
Scientific Evidence The most amazing aspect of urine therapy is its effectiveness in such a wide range of different diseases. There are several reasons for this. For one, urine contains ANTIBODIES AND IMMUNE STIMULATING FACTORS against all viruses, harmful bacteria or fungi that we may harbor in our body. The researchers stated that even minute amounts of antibodies, sometimes so low that they cannot be detected with conventional methods, are effective in preventing and treating diseases. There are reports investigating and describing the curative effects of urine therapy on a wide range of infectious, fungal and viral infections, such as hepatitis, poliomyelitis and AIDS. Urine is especially effective against allergies, autoimmune diseases and other disorders of the immune system. To switch off an allergic reaction one must put a few drops of urine under the tongue, collected during the reaction, or the urine may be homeopathically diluted and some of it kept in the mouth for a few minutes. When drinking urine routinely, allergic reactions may not occur at all, thus doing away with the need to identify which substance one has been reacting to.
Reference: URINE & UREA Therapy By Walter Last, www.health- science- spirit.com
168
"An article, titled "Autouro- therapy", published in the New York State Journal of Medicine (vol. 80, no. 7, June 1980), written by Dr John R. Herman, Clinical Professor of Urology at Albert Einstein College of Medicine in New York City, points out the general misconceptions regarding urine and its medical use: - "Autouropathy (urine therapy) did flourish in many parts of the world and it continues to flourish today, There is, unknown to most of us, a wide usage of uropathy and a great volume of knowledge available showing the multitudinous advantages of this modality." - " Urine is only a derivative of the blood, If the blood should not be considered 'unclean', then the urine also should not be so considered. Normally excreted, urine is a fluid of tremendous variations of composition." - "â&#x20AC;Ś Actually, the listed constituents of human urine can be carefully checked and no items not found in human diet are found in it. Percentages differ, of course, but urinary constituents are valuable to human metabolism." - O. Davies, "Youthful Uric Acid", Omni magazine, October 1982. By Martha M. Christy, Your Own Perfect Medicine, Extracted from Nexus Magazine, 1996 315 "Lars Hanson and Eng Tan proved that urine successfully provides antibodies needed for the things they studied: cholera, Salmonella typhus, diphtheria, tetanus toxoid, and polio. Who knows what else would have shown up if they had tested even more diseases. This study was done in 1965 at the Rockefeller Institute." - Tantra Bensko, 2009, unlikelystories.org 314
Curing Cancer 'Child's Play'! Cancer, too, RESPONDS very well to urine therapy. Very effective appears to be the urine fast employed by Armstrong. His first cancer patient was a nurse who had herself cared for over fifty cancer patients. She knew that any cancer pain is mild as compared to that experienced from the regrowth commonly occurring after medical intervention. Usually VISIBLE TUMOURS such as with breast cancer DISAPPEARED within three weeks, but sometimes even in one week. Armstrong called curing cancer 'child's play' except if patients had already received chemotherapy or radiotherapy. I also know personally of several cases of cancer cures exclusively or mainly due to urine therapy; sometimes the addition of urine therapy to a natural cancer program appeared to be responsible for the successful outcome. Most of the scientific cancer reports concentrate on urine extracts of anti- cancer agents. One such extract is called H- 11, another HUD, others Retine, DHEA hormone or Antineoplaston.
Reference: URINE & UREA Therapy By Walter Last, www.health- science- spirit.com
169
"Modern research and clinical studies have proven that the thousands of critical body chemicals and nutrients that end up in your individual urine reflect your individual body functions, and, when re- utilised, act as natural vaccines, antibacterial, antiviral, anti- cancer agents, hormone balancers, allergy relievers, etc. (Talk about the perfect preventive care treatment!) Many doctors have discovered and shown that it's extremely important to use our own natural urine in healing because extracts or synthetic drug forms of urine don't contain all of these individualised elements that address our personal, individual health needs. Another reason that many doctors have emphasised the use of the natural form of urine is that it does not produce side- effects whereas synthetic drugs and therapies all produce sideeffects, many of which are extremely dangerous (â&#x20AC;Ś). On the other hand, in almost 100 years of laboratory and clinical studies on the use of natural urine and simple urea in medicine, extraordinary results have been obtained, but no toxic or dangerous side- effects to the user have ever been observed or reported by either researchers or patients using the therapy. As we've learned, urea, which is the principal solid ingredient of urine, has been synthesised and medically used with excellent results and with no side- effects. But again, research has shown that whole urine can cure many disorders that urea cannot, because urine contains thousands of therapeutic agents such as important natural antibodies, enzymes and regulating hormones that urea alone does not contain. Urine therapy not only has dozens of successful research trials supporting it, but also thousands of success stories from people all over the world. As many people today have discovered, conventional medicine held no answers for either their chronic or acute illnesses and health disorders- but urine therapy did." - O. Davies, "Youthful Uric Acid", Omni magazine, October 1982. By Martha M. Christy, Your Own Perfect Medicine, Extracted from Nexus Magazine, 1996 315
While good results were reported with all of these, it is very expensive to treat patients in this way and the treatment would be even more effective and much cheaper if all of these cancer- fighting ingredients of urine were used together by ingesting whole urine. Surprisingly, uric acid is not just the villain causing gout; it is also a proven anticancer agent and rejuvenating factor. However, the crown of the cancer- fighting urine ingredients may actually belong to UREA, the most common chemical in urine. Benefits of Urea: Only recently has it been discovered that the concentration of urea in the blood has a key role in regulating at least 7 major pathways. Urea levels are low with cancer and many other diseases. The frequency of cancer and especially of multiple tumors and metastases increases greatly if urea levels are low. Urea is not just a waste product or the end state of the protein metabolism as commonly assumed. Biochemical research has shown that urea, both from internal sources or externally supplied, is used by the body as a raw material to synthesise amino acids and proteins. This is especially important for patients with kidney failure. These deteriorate quickly on a diet containing normal amounts of protein, but do much better if the diet is extremely low in protein, below 20g per day. Another research report states that patients with kidney failure on very low protein intake show progressive clinical improvement when receiving added urea, which then becomes the main source of nitrogen for protein synthesis. Urea may thus be the main reason why urine therapy and especially urine fasts are so successful with kidney failure I believe that it is the best and sometimes the only successful therapy. One of my patients with kidney failure continued to deteriorate on a fast of fresh vegetable juices, but was cured when fasting on urine for 2 weeks.
Reference: URINE & UREA Therapy By Walter Last, www.health- science- spirit.com
170
Another helpful factor is the role of urea as the best natural diuretic and far better than synthetic ones. This is not only important for those with deem or fluid retention because of kidney or heart weakness but especially with fluid pressure on the brain or spinal cord or in the eye with glaucoma. With this, additional urea is important with brain tumors, stroke, meningitis and other inflammations of the brain and spinal cord. One report cites the case of a massive brain tumor reappearing 3 months after surgical removal of another brain tumor. The patient received 256ml of 30% urea. After 2 hours the TUMOUR HAD COMPLETELY DISAPPEARED. When applied externally, urea has a very beneficial effect on wound healing, including infected wounds, burns and ulcerating tumors. The urea crystals may be directly packed into the wound or a strong or saturated solution may be applied. In this way, urea removes the foul odor often associated with an ulcerating tumor or other dead or putrefying tissue. Other Beneficial Ingredients: Another important reason for the effectiveness of urine is its content of countless hormones, enzymes, vitamins, trace minerals and other valuable biochemical. Some companies make a fortune by extracting some of these substances from collected urine on a large scale. The fact is that urine is not a waste product full of harmful substances as is commonly believed, but instead a treasure- trove of just the right bio- chemicals that we need for our condition. The main function of the kidneys is to regulate the concentration of all these countless bio- chemicals in our blood. Any unwanted surplus is as harmful as any deficiency. However, any hormone or enzyme removed as surplus at one time may be in short supply a few hours later. Furthermore, with advancing age, our hormone and enzyme production DECLINES to sub- optimal levels while the kidneys become less and less efficient in retaining needed ingredients. Reference: URINE & UREA Therapy By Walter Last, www.health- science- spirit.com
171
Therefore, it greatly helps, especially with chronic degenerative diseases and advancing age to recycle these valuable hormones and enzymes. Urine Rejuvenates: Urine ingestion is frequently praised as possibly the best rejuvenation therapy known to us. It certainly rejuvenates the hair and the skin. The youthful appearance of many Buddhist monks is ascribed to their routine urine ingestion. It seems that historically all cultures have used urine for medicinal purposes. It is praised in ancient Egyptian papyri, was used in ancient Rome, in China, India, America as well as European countries. The Journal of the American Medical Association states that in 'PRIMITIVE MEDICINE' there is scarcely a disease that has not been treated with the external or internal use of urine. A 5000- year old Sanskrit text describes in a religious context in 107 verses the virtues of urine. In one verse Lord Shiva, the great destroyer and re- generator, says that he who drinks urine sweetened with honey is cleared of any ailment within 6 months. He attains brilliant brainpower and his voice becomes melodious. One well- known urine ingredient is MELATONIN, the hormone of the pineal gland. It regulates our body rhythms linked to the dark- light cycle. It is produced in the night and mostly expelled with the morning urine. However it is now highly valued as protecting us from CANCER AND AGEING. Melatonin sales in California are said to top aspirin sales. But why pay much money for just one beneficial ingredient when there are thousands for free? Problems may arise from ingesting large amounts of urine if one takes medicinal or recreational drugs as these drugs may be recycled and cause an overdose. The same may happen if one ingests other toxic substances. However, harmful substances are not necessarily reabsorbed and may just cause diarrhea instead. Reference: URINE & UREA Therapy By Walter Last, www.health- science- spirit.com
172
How to Use Urine: There are various ways to use urine but generally it is advisable to start with small amounts. This is not only to get accustomed to the taste of it, but also to slow down any healing reactions. These occur commonly with methods that genuinely improve our health. Reactions may manifest as diarrhea, vomiting, nausea, skin problems or a temporary flareup of old health problems prior to their final elimination. Start with a few drops or a teaspoonful. These may be swallowed immediately and you may wash it down with some water or juice or eat a piece of fruit. However, with allergies and immune disorders it is more effective to leave the diluted urine under the tongue for a few minutes. An allergic reaction can best be stopped or neutralized by collecting the urine when the symptoms are worst, however in practice you try to use it as soon as you notice the first symptoms. Some researchers suggest that the proper dose can be found by slowly putting single drops under the tongue until the taste and temperature of a drop can no longer be distinguished. This is then the neutralizing dose. Each subsequent day you may double the previous dose or the number of times you take them per day until you reach your target amount or the dose that you are comfortable with. Homoeopathic Urine: A final possibility is to use urine in homoeopathic form. The simplest way to prepare it is as follows: To one teaspoon of non- chlorinated water add one drop of fresh urine. Shake it vigorously in a small bottle about 50 times with a sharp downward stroke. One drop of this mixture is then added to another teaspoon of water, shaken again and then the whole procedure repeated a third time. Place 3 drops under the tongue several times daily. When it is used up, wait a few days and then prepare a new homoeopathic remedy. In order to Reference: URINE & UREA Therapy By Walter Last, www.health- science- spirit.com
173
find the most effective potency add one more step to each subsequent preparation of the remedy, that is dilute it a fourth, a fifth and a sixth time and so forth. Start with such higher dilutions; say sixth potency, especially if a remedy is made from fluid such as pus derived from a diseased part of the body. An alternative method is even simpler and recommended as an introduction to urine therapy and at times when cupfuls of urine are not tolerated. To 1 tablespoon of morning urine add 4 or 9 tablespoons of non- chlorinated water. Shake 50 times with a sharp downward stroke, and take a spoonful several times during the day; keep in the mouth for a minute before swallowing. Dilute 2 drops of urine with 1 tablespoon of non- chlorinated water. During an infection keep one drop of this under the tongue every 2 hours. Homeopathically energized remedies should not be exposed to strong magnetic or electromagnetic fields. Keep this urine remedy only lightly covered in a cool place but not in an electric refrigerator, and make up fresh daily. Social Considerations: The main problem when starting urine therapy is our social conditioning. You may overcome that by reading and contemplating about the expected health benefits. The taste of urine is not normally offensive, except if the body is rather polluted or when fasting or with strongly concentrated urine. Therefore, dilute strong urine, start with small and gradually increasing amounts or have a day on fruit before starting to ingest urine. Minimize salt and strong spices in the diet when on urine therapy. An easy way to drink urine or any other unpleasant fluid for beginners is by breathing only through the mouth and possibly pinching the nose until the mouth has been rinsed with water or juice or a piece of fruit may be eaten.
Reference: URINE & UREA Therapy By Walter Last, www.health- science- spirit.com
174
External Use: For skin problems such as burns, wounds, gangrene, psoriasis, eczema, dermatitis, fungus problems ageing skin as well as over inner tumors, inflammations and diseased organs a urine or urea pack or a combination of both is VERY EFFECTIVE: keep the affected area covered with a folded cloth well moistened with urine or concentrated urea solution, put another cloth or plastic sheet on top, renew several times daily. Urine becomes more alkaline when standing for a few hours and is then more effective than fresh urine for external applications. However it also smells much more and fresh urine seems to be adequate in my experience. With gangrene, dead flesh, skin infections and open cancer and ulcer sores it is even more effective to saturate the applied urine with urea that also removes offensive odors. With weeping or suppurating wounds, especially if associated with foul odor, it is also very beneficial to cover the area with dry urea crystals. Urine can be concentrated by leaving it for several hours in a flat dish in the sun or a warm place. This has been recommended by Armstrong for friction rubs to rejuvenate ageing skin. Armstrong also recommended urine packs over tumor sites or diseased organs in addition to rubbing the body daily for two hours with small amounts of urine. The main problem with urine packs is the offensive odor. You may try to prevent it by sealing the pack with a good tape, such as duct tape. You may completely seal it and keep the pack moist by injecting fresh urine several times a day with a syringe.
Reference: URINE & UREA Therapy By Walter Last, www.health- science- spirit.com
175
The medical establishment spent hundreds of millions of dollars to prosecute a cancer revolutionary.
(~ 1970 AD) Stanislav R. Burzynski, M.D. PhD. Nutshell: Inventor of Antineoplastons Books: The Burzynski Breakthrough Thomas Elias (2000)
Stanislav Rajmund Burzynski, M.D. PhD. (born January 23, 1943 in Lublin, Poland) He is the President and Chairman of Burzynski Research Institute Inc.
by
(The following information is excerpted from: Stanislaw R Burzynski, MD, PhD, Wellness Directory of Minnesota, www.mnwelldir.org/)
In 1970, Dr. Stanislaw Burzynski left the repressive communism of Poland for the freedom of America. Little did he suspect that twenty years later he’d wind up in a Texas courtroom facing trumped up charges and up to 270 years in prison—for curing CANCER? In 1967 Stanislaw Burzynski, at the age of 24, graduated with honors from the Lublin Medical Academy. Just a year later, he became one the youngest geniuses in Poland to earn a doctorate in biochemistry and hold two degrees. He went onto graduate school because of a passion he’d developed in medical school concerning amino acids, which are the basic building blocks of proteins. His early investigations were to determine if the levels of various amino acids in the blood stream Reference: Stanislaw R Burzynski, MD, PhD, Wellness Directory of Minnesota TM, All Right Reserved, www.mnwelldir.org
176
"ROBIN RESSEL (on camera interview): There were very few doctors that you would tell them that you were seeing Dr. Burzynski that would be kind of encouraging and positive with you. Most of them, they would hear the name "Burzynski" and they wouldn’t want to deal with you—because they were afraid. I am so relieved that we found Dr. Burzynski because literally it did save her life. Here she is now twenty- four, and she’s got a little boy who is almost five, and her second baby will be born in October—we just found out she’s having a little girl. (…) On- Screen Title Card: National Cancer Institute annual budget: $5,200,000,000."" - Interactive sourced transcript from Burzynski The Movie - Cancer Is Serious Business, directed by Eric Merola 2011, http://www.burzynskimovie.com/ 339 "Antineoplastens, which are peptides and amino acid derivatives destroy tumors, as discovered by Dr. Burzynski." - Interactive sourced transcript from Burzynski The Movie - Cancer Is Serious Business, directed by Eric Merola 2011, http://www.burzynskimovie.com/ 339
could be used to diagnose specific diseases. While doing this, he also learned that there were small proteins in the blood that were very similar to amino acids, but they’d never been identified. Burzynski identified them as PEPTIDES, complex molecules built from amino acids. He then discovered that a patient suffering from prostate cancer had very low levels of these peptides. He tested other cancer patients and discovered the same deficiency. This led Burzynski to develop his theory that it was these peptides that defended the body against cancer. Unable to continue any further in Poland, he left for America with twenty dollars in his pocket, a theory in his head, and an indefatigable attitude that shown in his smile. Burzynski found work at Baylor College of Medicine in Texas and quickly became a rising star in cancer research. Where modern science had seen these peptides in the blood as debris from the breakdown of proteins, Burzynski saw them as "information carriers" that the cancer cells just aren’t getting. With the correct information, the body would stop creating cancer and again create healthy cells. While focusing on blood, Burzynski realized that he constantly needed more and more blood to collect his peptides. Colleagues and friends began Reference: Stanislaw R Burzynski, MD, PhD, Wellness Directory of Minnesota TM, All Right Reserved, www.mnwelldir.org
177
ADRENAL GLAND. BLADDER. "Brain tumor, adult and childhood: Brain stem glioma, High- grade glioma, Mixed glioma, Visual pathway glioma, Oligodendroglioma, Glioblastoma multiforme, Anaplastic astrocytoma, Low- grade astrocytoma Choroid plexus neoplasm, Craniopharyngioma. Ependymoma, Germ cell tumor, Meningioma, Neurofibroma. PNET (medulloblastoma). Rhabdoid tumors of the central nervous system, Schwannoma Breast, Colon, Cancer of the head and neck Esophagus, Gastrointestinal tract, Hodgkin's Disease, Kidney, Leukemia in Adults: Chronic lymphocytic, Chronic myelogenous. Liver Lung: Adenocarcinoma, Bronchial alveolar carcinoma, Large cell, undifferentiated carcinoma, Non–small cell carcinoma, Squamous cell carcinom, Small cell carcinoma Lymphoma: NonHodgkin's lymphoma, Low, intermediate, and high grades Mantle zone lymphoma, Mycosis fungoides–Sezary syndrome, Primary central nervous system lymphoma, Macroglobulinema of Waldestrom, Malignant melanoma, Malignant fibrous histiocytoma, Mesothelioma, Multiple myeloma, Neuroblastoma, Neuroendocrine tumors, Osteosarcoma, Ovary, Pancreas, PNET outside the central nervous system, Prostate, Soft tissue sarcoma, Small intestine, Stomach, Unknown primary site Uterus, Cervix, and Vulva Wilms tumor" - Interactive sourced transcript from Burzynski The Movie - Cancer Is Serious Business, directed by Eric Merola 2011, http://www.burzynskimovie.com/ 339
avoiding him. They could only give him so much blood. Burzynski, like most creative geniuses, turned to another bodily fluid, URINE, to look for his peptides, and in doing so; he isolated 119 previously unknown peptides. Burzynski sent samples of his peptides to M D Anderson Cancer Center for testing. The results were unbelievable: some peptides selectively ATTACKED CANCER cells without harming normal cells. Cancer is called a neoplasm, or new formation. Burzynski decided to call his peptides, antineoplastons. Scientists then began grouping and labeling the various antineoplastons that Burzynski had discovered. One group was called antineoplastons A, one was antineoplastons L and another was antineoplastons O. Antineoplastons A was effective against a great variety of cancer cells; breast cancer, lymphoma, leukemia, bone, and brain cancers. Antineoplastons L had a more specific activity against leukemia while antineoplastons O was effective against osteosarcoma (bone cancer). Burzynski focused on antineoplastons A because of its activity against a wide variety of cancers. When animal studies showed that the substance had zero toxicity, his theory was completely formed and ready for publication. Reference: Stanislaw R Burzynski, MD, PhD, Wellness Directory of Minnesota TM, All Right Reserved, www.mnwelldir.org
178
"NARRATOR: Since Dr. Burzynski began treating cancer patients with Antineoplastons, he has successfully treated virtually every type of cancer relieving thousands of families from across the world of this dreaded disease. Yet, unlike other clinical trials which are supported by billion- dollar pharmaceutical companies, and are often assisted by large tax- funded research grants from the National Cancer Institute, the United States government currently prohibits any tax- payer money to be granted to Dr. Burzynski’s FDA- approved clinical trials. Dr. STANISLAW BURZYNSKI on camera interview: A single Phase 3 trial will cost about twenty- five million dollars. So how many can you run? You may run few at best. Nobody is giving me any money for that, we have to make money for that—and it’s twenty- five million dollars. Some other pharmaceutical companies, who come with an idea, they go to the National Cancer Institute and they receive a handsome grant—fifteen million dollars, whatever, and they do clinical trials. No one is giving me any money, okay? I am working like in a war- time condition, like working somewhere in the Gaza Strip or the West Bank—when the bombs are falling, we still have to treat patients, and we still have to do Phase 2 clinical trials." - Interactive sourced transcript from Burzynski The Movie - Cancer Is Serious Business, directed by Eric Merola 2011, http://www.burzynskimovie.com/ 339
He presented his theory in the spring of 1976 at the Annual Meeting of Federation of American Societies for Experimental Biology, the largest meeting in the US at that time. A year after this presentation, he found that he had lost his funding. Few options were open to him. He could work for almost any clinic or research institute as a researcher or teacher, or he could open a research institute. He’d already begun a growing private practice in association with a prominent Houston doctor that started up as an offshoot from his cancer research. He chose to go into private practice hoping to bring in funding for his research. He began treating patients with antineoplastons in 1976, but his research laboratory opened in 1977. In the years that followed, Dr Burzynski took a lot of shots from the medical community. They called him a "clever opportunist" who exploited people with cancer by offering them an expensive and ineffective, possibly dangerous cancer "cure" than came from urine. Since 1980, Dr. Burzynski began using synthetic antineoplastons that replaced those isolated from urine. In July of 1985, the FDA, along with members of Harris County Sheriff’s office, barged into Burzynski’s clinic seizing over 200,000 documents (research papers, patient records) and confiscating 11 Reference: Stanislaw R Burzynski, MD, PhD, Wellness Directory of Minnesota TM, All Right Reserved, www.mnwelldir.org
179
"NARRATOR: Given the existence of a treatment that is curing cancer at a rate that traditional medicine could only dream of, and doing so without any damaging side- effects, most would assume that every penny of our tax dollars allocated for cancer research would be thrown in Dr. Burzynski’s direction. Dr. JULIAN WHITAKER - on camera interview: The problem that we face however, is that a huge financial house has been built on the paradigm of purging the body of cancer cells. Burzynski’s discovery means that the foundation, the walls, and the roof of that house, need to be replaced. Think about it, we’ve got thousands of doctors in oncology, and in oncology residency programs, we’ve got the pharmaceutical industry pumping out chemotherapeutic agents every month. There are all kinds of machines that deliver radiation, we’ve got all this stuff in the war on cancer, and it’s trillions of dollars. I find it very interesting that we have all these walks for the cure of cancer. We’ve got all the wristbands, we’ve got all the donations—"we’re going to find a cure in this decade." All this money keeps pouring in—and it all goes to the same guys." - Interactive sourced transcript from Burzynski The Movie - Cancer Is Serious Business, directed by Eric Merola 2011, http://www.burzynskimovie.com/ 339
file cabinets. They loaded everything into a U- Haul and drove away. This was just the beginning of Dr Burzynski’s troubles. Over the next twelve years he would be driven to the point of bankruptcy battling the FDA, insurance companies, the Texas Board of Medical Examiners and Health Department, and the postal service for charges of mail fraud. Burzynski’s lowest point was sitting in a courtroom facing up to 270 years in prison for saving lives that no other person on earth could help (…). To summarize the outcome of Dr Burzynski’s plight, we can say that, after initial studies of his antineoplastons had shown great promise, the NCI and the Mayo Clinic pronounced them worthless, the American Cancer Society called them dangerous, and Burzynski was labeled a quack and a charlatan. The courts, after hearing the evidence, determined that antineoplastons are indeed "necessary to meet the patients' immediate needs for survival," and that his treatment was effective for some deadly brain cancers. The Texas Board of Medical Examiners continued to attack. The judged slapped them upside the head calling their decision:
Reference: Stanislaw R Burzynski, MD, PhD, Wellness Directory of Minnesota TM, All Right Reserved, www.mnwelldir.org
180
"NARRATOR (reading along with highlighted portions of a Boston Globe article): ... it’s time to take the Food and Drug Administration back from the drug companies. In 1992, Congress put the fox in the chicken coop. It passed the Prescription Drug User Fee Act, which authorizes drug companies to pay "user fees" to the FDA for each brand- name drug considered for approval. The user fee act put the FDA on the payroll of the industry it regulates... and it has drastically changed the way it operates. The part of the agency that reviews new drugs now gets more than half of its money from the pharmaceutical industry. (…) NARRATOR: The pharmaceutical industry is arguably the most profitable industry on our planet, with it’s profits being triple that of all of the Fortune 500 companies. [SOURCE: Fortune 4/30/07 Company Annual Reports] Rising profits result in rising stock prices, the only way this industry can sustain this profitable momentum is by continuing to introduce new patented drugs. And since the pharmaceutical industry relies on the FDA as it’s gatekeeper to introduce these new drugs, it’s in their best interest to insure the FDA remains as compliant as possible. And since the FDA is also an office of the United States government, it’s in the government’s best interest to preserve one of it’s most powerful industries. The former editor- in- chief of the New England Journal of Medicine, Dr. Marcia Angell, has been very outspoken with the idea that..." - Interactive sourced transcript from Burzynski The Movie Cancer Is Serious Business, directed by Eric Merola 2011 339
"In excess of the agency's statutory authority, not reasonably supported by substantial evidence, capricious or arbitrary, and characterized by abuse of discretion." All in all the facts stood for themselves. People came forward who testified that they would be dead today if not for Burzynski’s therapy. Others, outside the bastions of our repressive, money driven, pharmaceutical industry controlled medical system, have tested antineoplastons and have declared them to be not only successful in reversing a variety of cancers, but that they are wonderful preventatives. Dr. Burzynski too felt that they would make a pretty good preventative. He noticed that while patients underwent his therapy, that they just looked better. Their eyes were brighter, their hair color came back, wrinkles seemed to vanish and their immune systems were strengthened. So, while preparing for his FDA monitored Phase II trials, he invented supplements and creams and lotions based on his technology (…). The sale of his supplements supports the research at the Burzynski Clinic in Houston. Dr Burzynski told me, "If I were to die tomorrow, I would die a happy man." His therapy works. The results of his Phase II studies show conclusively that antineoplastons are Reference: Stanislaw R Burzynski, MD, PhD, Wellness Directory of Minnesota TM, All Right Reserved, www.mnwelldir.org
181
"NARRATOR (reading along with highlighted portions of a Boston Globe article): ... it’s time to take the Food and Drug Administration back from the drug companies. In 1992, Congress put the fox in the chicken coop. It passed the Prescription Drug User Fee Act, which authorizes drug companies to pay "user fees" to the FDA for each brandname drug considered for approval. The user fee act put the FDA on the payroll of the industry it regulates... and it has drastically changed the way it operates. The part of the agency that reviews new drugs now gets more than half of its money from the pharmaceutical industry. The FDA’s coziness with industry is underscored by the composition of it’s 18 advisory committees—outside experts who help evaluate drugs. Incredibly, many of these advisers work as consultants for drug companies. The FDA behaves as though the pharmaceutical industry is its user, not the public." - Interactive sourced transcript from Burzynski The Movie - Cancer Is Serious Business, directed by Eric Merola 2011 339 http://www.burzynskimovie.com/
effective against a wide range of malignancies (which now needs to be confirmed by the FDA). He now knows, as well, those cancers that antineoplastons cannot help. "Testicular cancer is one, "he told me, "and childhood leukemia." But we both knew that conventional medicine has already taken care of those things. Today, much of the research into genetic causes and cures for cancer are based upon his initial theories presented in 1976 presentation at the Annual Meeting of Federation of American Societies for Experimental Biology. "Times are changing," he smiled. "My therapy isn’t going away. I’ve saved hundreds of lives, antineoplastons will be here for years to come, medicine has to admit that we’ve accomplished something great here." Dr. Burzynski is in his sixties now. He looks younger than me. His hair is golden brown, not a hint of grey, and his smile is contagious. He drinks Polish mineral water, takes his own supplements, and saves lives. "If I were to die tomorrow, I would die as a happy man. I have saved hundreds of lives (some 3,000 advanced cancer patients were at my clinic in 1977), and therefore antineoplastons will be here for years to come. Medicine has to admit that we’ve accomplished something great here." - Dr.Burzynski Reference: Stanislaw R Burzynski, MD, PhD, Wellness Directory of Minnesota TM, All Right Reserved, www.mnwelldir.org
182
Photo: Jodi (Gold) Fenton "An MRI on June 1st of 2000, revealed the size of the enhancing portion of Jodi’s tumor, which was the part of her tumor that was the most aggressively growing. On June 6th, she started Antineoplaston treatment, and by July 3rd, only a month after starting treatment the enhancing portion of her tumor was gone. Her tumor remained non- existent up until October of the following year, when she stopped her antineoplaston therapy altogether. It’s one thing to be shown a single anecdotal case with this type of brain tumor, and it’s another to simply compare clinical trial data of inoperable anaplastic astrocytoma patients treated with toxic radiation and chemotherapy, versus, clinical trial data using only Dr. Burzynski’s non- toxic Antineoplaston therapy. A2005 clinical trial report using only radiation and chemotherapy, found that 5 of 54 patients, or 9%, were cancer- free at the end of treatment While a 2008 clinical trial report using only Antineoplastons, found that 5 of 20 patients, or 25%, were cancer- free at the end of treatment—with no toxic side- effects. Jodi Fenton is one of them." - Interactive sourced transcript from Burzynski The Movie - Cancer Is Serious Business, directed by Eric Merola 2011 339
Case Studies and Testimonials The following information is an Interactive sourced transcript from ‘Burzynski The Movie – Cancer Is Serious Business’ documentary, directed by Eric Merola 2011, ASIN: B003X3CF68 http://www.burzynskimovie.com/
Jodi (Gold) Fenton - Anaplastic Astrocytoma Grade III Jodie Foster Jodi Fenton on camera interview: On May 15th of 2000, I was diagnosed with an inoperable, stage three, anaplastic astrocytoma brain tumor. Following my diagnosis I was told that I had six to eighteen months to live. So I met with an oncologist here in Los Angeles and in San Francisco, and they were telling me at that time—the oncologist told me, that the protocol for me would be to do Temodar® (On screen- graphics: Temodar for Anaplastic Astrocytoma = 13.9 month median survival which is a chemotherapy, followed by a course of radiation. I asked them what that treatment would get me and they said maybe five years. "Maybe five years of life?" So of course I asked what would happen after five years, if I get to that five years and they said "well, we’ll see what’s available at that time" meaning I would perpetually be on a course of treatment. Didn’t sound good enough for me. Also at that time I had heard about Dr. Burzynski in Houston, and I found out about Dr. Burzynski through a friend of mine. But I met with a prominent neurosurgeon here—who wrote off Dr. Burzynski. He told me point blank that "antineoplastons don’t work". But Dr. Burzynski’s treatment really sounded right to me. So I started on his treatment on June 6, of 2000. In December of 2000, all that was left of the tumor was scar Reference: Burzynski The Movie - Cancer Is Serious Business, directed by Eric Merola 2011 burzynskimovie.com/
183
So the good news is that cancer can be cured. The worst type of cancer can be cured. For good. The people who are surviving, they live normal lives. No side- effects from the treatment, no symptoms, no sign of tumors—back to life. We started some of them as children, and now they have their own children. There is no impairment of fertility. They just live normals lives. The bad thing however is that we know that we cannot help everybody, but some of these patients. Well, if about 30% of patients can survive over five years, and a number of them live over ten years without any sign of cancer, that’s a good thing. But obviously this is just the beginning, we need to perfect this. We need to introduce the newer generation of Antineoplastons—which we call the "second and third generation of Antineoplastons" to make the treatment more effective, to cover a broader spectrum, and to be easier to administer. Dr. STANISLAW BURZYNSKI on camera interview: Interactive sourced transcript from Burzynski The Movie - Cancer Is Serious Business 2011
tissue—and again, this was confirmed through an MRI. On October of 2001, I stopped Antineoplastons therapy altogether. I’ve had annual MRIs since that time, so over the course of the last eight years, annual MRIs have confirmed, all that’s left of the tumor is scar tissue—and I’ve been off the treatment for that entire time. So, Dr. Burzynski cured me of a brain tumor (…). Four years after my diagnosis, I had run into one of the neuro- oncologists I had met with and told him that I had gone to Dr. Burzynski and I was cured, and he kind of wrote it off. I was very excited to tell him that I was cured, and he really burst my bubble about it. So it was somewhat depressing for me. Another doctor that I have, when I told him that I had anaplastic astrocytoma, he was very excited, he was like "bleep! bleep! bleep! I can’t believe this is you, because do you know what the prognosis for this is?", and I said yes. He said "I can’t believe you survived this", and he was very excited for me (…). Bristol- Myers Squibb's Tour Of Hope One of Jodi's biggest passions is road bicycling. After Jodi was cured and returned to riding regularly, in 2003 she applied to the Bristol- Myers Squibb Tour of Hope bicycle tour hosted by Lance Armstrong - and was one of 26 people chosen to participate in a cross country bicycle tour to promote awareness for participating in clinical trials and cancer research. When being interviewed for a spot on the team she was never asked where she was treated. Reference: Burzynski The Movie - Cancer Is Serious Business, directed by Eric Merola 2011 burzynskimovie.com/
184
"Now, if you are ever going to go into cancer treatment, you do not want to go into childhood brain tumors. Because childhood brain tumors, byin- large, are 100% fatal. This would be the worst class of cancer to treat, but he began getting enormous results. " Dr. JULIAN WHITAKER - on camera interview "Again, it’s one thing to observe a single anecdotal childhood brainstem glioma survivor, and it’s another see the results from FDA- supervised clinical trials treating Jessica’s type of cancer. Here is a table illustrating studies published in 2006, comparing the results of different childhood brainstem glioma treatments. There were three groups treated with radiation and chemotherapy, and two groups treated with Dr. Burzynski’s Antineoplastons. Out of all three groups treated with radiation and chemotherapy: only 1 of 107 patients, or 0.9% were cancer free after treatment. However, this patient did live beyond five years—presumably being devastated by the amount of chemotherapy and radiation. Out of both groups treated with Antineoplastons, 11 of the 40 patients, or 27.5% were cancer- free after treatment. And 11 of the 40 patients, or 27.5%, lived more than five years. Most of these brainstem glioma survivors who were not previously subjected to toxic chemotherapy and radiation before starting Antineoplaston treatment have gone on to enjoy full healthy lives." - Interactive sourced transcript from Burzynski The Movie - Cancer Is Serious Business, directed by Eric Merola 2011 339 http://www.burzynskimovie.com/
Considering how remarkable Jodi's story is, BristolMyers Squibb placed Jodi in full page ads in the New York Times, Wall Street Journal, and USA Today to promote the ride. She was interviewed alongside Lance Armstrong on CNN. Jodi was soon contacted by a nationwide publication to tell her story (who's name will not be revealed). During the initial phone interview with this publication, Jodi told the reporter she was treated with antineoplastons at the Burzynski Clinic. The reporter never called her back. Two weeks later Jodi called the reporter back to follow up; the reporter simply told her "we aren't going to run the story." Jodi has inferred that the reason they decided not to run her story is because she was treated at the Burzynski Clinic. Jodi was indeed cured in a clinical trial involving new cancer research. However, she was cured using antineoplastons—not a treatment that BristolMyers Squibb distributes or any treatment that is produced and distributed by any of the major pharmaceutical companies (…).
"Patient #1: The FDA has made a list, and decided who can live and who will die, I guess I didn’t make that list. Patient #2: I’ve had no chemotherapy, I’ve had no radiation, I choose Dr. Burzynski instead after a lot of research and a lot of searching. I’ve been in remission since 1989. Dr. Kessler, I’m not a statistic. Patient #3: We’re frustrated, there are rights—our constitutional rights have been violated, this has got to end, my children are asking me "daddy what does the future hold", my one daughter wrote a letter to the president of this country and said "please don’t pull the pug on my daddy". And that just broke my heart and broke my wife’s heart. Patient #3’s wife: My husband is a walking miracle, sixteen months ago our doctors told us there is nothing else they can do, and they told us to enjoy what little life he has left. Look at him, he biked 32 miles after being on Dr. Burzynski’s treatment for two months—and they’re saying we can’t have it?!" - Interactive sourced transcript from Burzynski The Movie - Cancer Is Serious Business, directed by Eric Merola 2011 339 http://www.burzynskimovie.com/
Reference: Burzynski The Movie - Cancer Is Serious Business, directed by Eric Merola 2011 burzynskimovie.com/
185
Jessica Reseel – Inoperable (Diffuse) Intrinsic Brainstem Glioma Dr. Stanislaw Burzynski - on camera interview: Arguably, the worst type of cancer is inoperable brainstem glioma. It usually occurs in the brain of a child. And, unfortunately, there is very little that can be done. Radiation is the only "treatment" available which can be used to slow down the progress. So that’s the type of tumor for which there is no curative treatment, no chemotherapy which has been approved, and numerous clinical trials were performed but failed in the past. So we selected this type of tumor, because we would like to prove the point beyond any doubt, that this type of cancer can be cured by the use of Antineoplastons— and we already have proof that it can be cured (…). Robin Ressel, father of - on camera interview: She was diagnosed in March of 1996, she was eleven—and she pretty much just started having really bad double vision is how we discovered it—and went to the eye doctor and that’s when they did the MRI and discovered it was a brainstem glioma. And they explained that hers was diffused, which means the healthy tissue and the cancerous tissue were swirled together—so of course surgery wasn’t an option. And with the radiation they suggested, her prognosis was probably going to be about eight to eighteen months (…). Jessica Ressel - on camera interview: The thing is, with the radiation, what it would do to you from what I understood is, they would shoot the beam through your ears, Reference: Burzynski The Movie - Cancer Is Serious Business, directed by Eric Merola 2011 burzynskimovie.com/
186
"Patient #4: I have a report from my family physician which tells how well I am doing, my tumors are leaving my body, and condition is improving every day. Now the FDA is saying to me "no, your doctor is a criminal, he should be put in jail, and he needs to be shut down" ... this, is criminal !! Patient #5: I want the FDA to get out of our lives and stay out of our doctorpatient relationship. Patient #6: What the classical conventional medicine had to do for me was there—nothing. For me, the next thing was the minister. I did not want to undergo chemotherapy, which I had a new name for, "kill ‘em therapy". Or any type of radiation, I was extremely lucky that I found Dr. Burzynski. And I don’t want the FDA to take this right from me. I came eighteen years ago from Communist Romania, and the tyrant dictator Ceauscescu, never stopped a doctor from treating anybody. How can we have something like this in the United States? - Interactive sourced transcript from Burzynski The Movie - Cancer Is Serious Business, directed by Eric Merola 2011 339 http://www.burzynskimovie.com/
and the beam would burn your healthy and your cancerous cells outside- in. So all your hair around your ears would be gone, never grow back, your ears would become deformed and burnt, you would become deaf, it would also destroy your pituitary gland which is the gland that helps you grow as you hit puberty... And it would make you stay in an eleven yearold body, and basically you’d go into a vegetative state, where you couldn’t take care of yourself, which wasn’t a very good quality of life (…). KY- 3 News Springfield, Nov. 19, 1996, Newscaster VO: Jessie Ressel is riding on the best news she’s had since March. She and her parents now believe they are on their way to a cure, for what doctors had said was an incurable brain tumor. Here at the Burzynski Clinic in Houston, Texas, the Ressel’s have found an experimental drug they could only dream of eight months ago. That’s when Jessie was still a fifth- grader, at a catholic elementary school in Springfield. It’s when one of her eyes started crossing in, she started seeing double, it’s when Jessie went to the doctor and learned that she had one of the most aggressive kinds of brain cancer—a malignant tumor doctors said would kill her within months, and that radiation would only give her a little more time. Today the medical pictures tell a different story, you can see the improvement immediately just looking at Jessie’s eyes now, compared to last May.
Reference: Burzynski The Movie - Cancer Is Serious Business, directed by Eric Merola 2011 burzynskimovie.com/
187
Photo: CT scan of tumors disappearing - Interactive sourced transcript from Burzynski The Movie - Cancer Is Serious Business, directed by Eric Merola 2011 339 http://www.burzynskimovie.com/
Narrator: An MRI on May 7th of 1996 revealed the size of the enhancing portion of Jessica’s tumor. One month into starting Antineoplastons treatment, her tumor disappeared. However, given the aggressive nature of this type of tumor, it quickly returned in August, and remained until November. In which time, Dr. Burzynski doubled her Antineoplastons dosage until her tumor went away in December. Only to return again in January of 1997, stayed around until April, and finally disappeared in May of 1997—one year after starting Antineoplastons treatment. Jessica’s tumor remained non- existent, up until October 2001, when her brainstem glioma was considered resolved (…). Kelsey Hill - Adrenocortical Carcinoma with metastasis to the lungs and liver. KELSEY, SARAH (mother), and STEVE HILL (father) - on camera interview. SARAH HILL: They came back, they said she has this large baseball- sized tumor in her abdomen, and not only that, but it’s in her kidney—it was everywhere, it was in her kidney and her liver and her lungs. So here we are thinking, basically, this child has literally a few months to live, is basically what they told us. At that point they said, "Well, we think we can get the original tumor out." So they had this surgeon, he was able to go in, he got the whole tumor—she did lose her left kidney and her left adrenal gland. And it was four drugs, and it was like eight pages of side- effects and very little hope that they would even work. The drugs were: Mitotane, Doxorubicin, Etoposide, Cisplatin. ... And they told us admittedly "this is the most toxic regimen that we have." We have a six- month old with one kidney, and the side effects were kidney failure, hearing failure, leukemia—other kinds of cancers coming from this... and I was just like "even if she’s going to pass away, I can’t do this to her, I can’t, why would I want her last few months of life to be miserable (…)?" NARRATOR: Upon the removal of Kelsey’s left kidney and left adrenal gland, her diagnosis was confirmed at the University of Texas Medical Branch, and again at M.D. Anderson cancer center. Where, a month later, M.D. Anderson also confirmed that Kelsey’s cancer had spread to her lungs. After desperately researching Kelsey’s situation, her family decided to decline Reference: Burzynski The Movie - Cancer Is Serious Business, directed by Eric Merola 2011 burzynskimovie.com/
188
all chemotherapy treatments offered my M.D. Anderson, and instead, enroll Kelsey into one of Dr. Burzynski’s clinical trials. By this time, Kelsey’s cancer had also spread into her liver. After starting her Antineoplastons treatment, the tumor in Kelsey’s liver was gone by August of 2007. CT scans of her chest revealed six tumors in her lungs at the start of treatment. One- by- one, the tumors in Kelsey’s lungs began to go away, leaving one small spot four years later which was deemed to be inactive and most likely scar tissue. Today, Kelsey Hill is considered to have had a complete response to her Antineoplastons treatment (…). Congressional Subcommittee hearing, Feb. 29, 1996. Sgt. Ric Schiff and daughter: My name is Sergeant Ric Schiff. I am an eleven- year veteran of the San Francisco police department. I hold the department’s highest metal of honor for bravery—that used to mean a lot more to me than it does now. What I’d like to talk to you about today is—my now 7 year old daughter. This is an identical twin, her sister is now dead. Her sister, when she was 4 years old, Crystin—developed a highly malignant brain tumor that had spread throughout her spine and her brain. The doctors told us that we had really two options—take her home and let her die, or bring her in for massive dosages of chemo and radiation simultaneously. In either event she was going to die, they were quite certain of that—and very quickly.Believing her only chance to be the standard route, we gave her the chemo and radiation. It burnt her skull so bad she had second degree burns and her hair never came back. To change her diapers we had to wear rubber gloves because her urine was so toxic and it burned her.At the end of 6 months, miraculously she survived the standard treatment, although there was a high expectation that she wouldn’t. She still had cancer. We were told "sorry, we’ve done everything we can, now she’s going to die, probably within a couple of months." My wife and I choosing not to except that, started reading—the first book I picked up, the third chapter, discussed Dr. Burzynski.As you may guess, I have some expertise in fraud, in fact I’m quite certain there are enough attorneys in the room that I could be ordered as an expert in fraud—and, I conducted my own investigation. I have no doubt the man is not a fraud. I have no doubt that he does what he does out of earnest belief that his medicine works. Now, you are in a position to judge for yourselves whether is works or not—but it’s well established by the FDA, that Reference: Burzynski The Movie - Cancer Is Serious Business, directed by Eric Merola 2011 burzynskimovie.com/
189
it’s non- toxic.Eighteen months later, we took my daughter off the Antineoplaston—she had not died. She had no signs of tumor, she remained free for eighteen months of cancer. Within a month, her cancer was wide- spread in her brain. We put her back on Burzynski’s—by the way at the objections of our doctors who for some reason felt that it had failed her. We put her back on— within nine weeks the tumor was completely gone. She died last July, of neurological necrosis—her brain fell apart from the radiation. The autopsy showed that she was completely cancer- free. Out of fifty- two cases of that disease ever, no one died cancer- free, just Cryssie. So she didn’t die of a terminal illness—she died of my inability to care for her properly and she died from bad advice. She died because there is a government institution, that disseminates false information, and is not looking out for the welfare of the people. You know, ladies and gentlemen I swore an oath eleven years ago and I think most of us in this room swore it at one time or another to uphold the constitution? It says "life" right in the beginning (...). Mariann Kunnari (with son Dustin): An MRI six weeks after we started Dr. Burzynski’s treatment revealed no tumor. We were very overjoyed. Dustin continued Antineoplastons therapy, and one year later a tumor one- inch by one- inch in size was found on the MRI that would be in April of 1995. Dr. Burzynski immediately raised Dustin’s dose of Antineoplastons. There were still no harsh side- effects at all. The next MRI in September of 1995 revealed that the tumor had almost disappeared again. To this day, it has not reappeared. If you look at Dustin right now, he’s a happy, healthy four- year- old, who has out- lived his prognosis. There is not a traditional treatment that would have kept him alive, with such good quality of life.
Reference: Burzynski The Movie - Cancer Is Serious Business, directed by Eric Merola 2011 burzynskimovie.com/
190
Review of Brain Tumor Cases Treated With Antineoplastons (The following information is excerpted from a Memorandum: Head, Quality Assurance and Compliance, Section, RA5, CTEP. Subject: Review of brain tumor cases Treated with Antineoplastons, Department of Health & Human Services, National Institutes of Health) 341
Patient #1 (E.L.) 46 year old white female who experience Jacksonian seizures and was diagnosed as having right parietal lobe glioblastoma multiforme in October 1987. Resected 11/10/87 at University of Maryland Hospital, and received radiation therapy following surgery. Tumor recurred in February 1988. Presented to Dr. Burzynski in March 1988. Treated initially with Antineoplastons A10 capsules, AS2- 1 injections and oral low dose methotrexate. Received only 8 days of MTX. Received intermittent steroids from 4/6/88 through 6/1/88. Considered a CR by 11/28/88 CT scan. Continued on full- dose treatment (0.5 to 1.0 gm A10 capsules daily, plus 2 gm AS2- 1 IV daily) until 4/3/89. At that time, she was placed on AS2- 1 capsules for maintenance therapy. In summer of 1989 patient discontinued treatment and in 8/89 recurrence was documented on MRI scan. Resection for recurrent glioblastoma multiforme at Johns Hopkins 11/28/89. Died 4/90. Pathology review: Slides from 11/10/87 resection confirm glioblastoma multiforme. Radiology review: Marked decrease in tumor size, possible complete response from 11/28/88 through 3/28/89 by CT. Recurrence possibly as early as 5/30/89 CT. Patient #2 (P.W.) 3 6 year old female who first presented in 1974 with Bell's palsy. It is not clear that this event was related to the later tumor which was first suspected in summer 1987. A stereotactic biopsy of the brain stem on 7/27/87 revealed anaplastic astrocytoma, stage IV, Grade 3. Received radiation therapy at UCSF (total 73Gy) until October 1987. Progression noted on scans of 2/88 and 4/88. Presented to Dr. Burzynski in May 1988 with paralysis of right side of face, diplopia, decreased strength in right upper extremity, right ear hearing loss, headaches and problems with balance and memory. Started on Antineoplastons A10 capsules, AS2- 1 IV and low dose oral
Reference: Memorandum: Review of brain tumor cases Treated with Antineoplastons, Department of Health & Human Services, National Institutes of Health
191
methotrexate from 5/25/88 until 7/12/88, when she was switched to IV A10 (30 gra/day) and IV AS2- 1 (15 gm/day) given overnight. This dose and schedule was continued until 8/10/89 when patient was switched to maintenance doses of oral A10 and AS2- 1. Received IV Decadron 2mg/day from 5/29/88 through 9/7/88. No steroids given since that date. Called CR at 1/23/89 MRI. All treatment discontinued on 1/21/90 and patient remains in CR (last MRI 1/29/91). Residual facial nerve palsy, no other symptoms. Patient #3 (J.K.) 47 year old white male who presented in April 1897 with deafness, progressive weakness and occasional seizures. Subtotal resection at UCSF April 24, 1987. Diagnosed as anaplastic astrocytoma close to the Foramen of Monroe. Patient treated at UCSF with radiation therapy + BUdR, which was stopped because of an exfoliative dermatitis. Patient next treated with combination of Procarbazine, CCNU, and vincristine which led to prolonged leukopenia and peripheral neuropathy. Progressed on treatment and switched to beta interferon (12/87 to spring 88). In June, 1988 started chemotherapy with DFMO and MGBG, but no response. Presented to Dr. Burzynski 7/13/88 and started daily IV A10 and AS2- 1 (overnight infusions). Showed slow progression initially, then stabilization by spring/summer 1989. On 5/22/89, antineoplastons dose was decreased and patient placed on AS2- 1 capsules. By spring 1990, CTs showed progression of former tumor and appearance of new lesions. Restarted 4/12/90 on daily IV A10 (1 gm/kg/day) and AS2- 1 (0.17 gm/kg/day) by continuous infusion pump. In June dose of AS2- 1 was increased to 0.23 gm/kg/day and decadron was added from 6/27/90 to 7/25/90. In September 1991, decreased A10 dose by 60% and AS2- 1 dose by 25%. Called PR in 10/91; approaching CR. Telephone follow up on the day of our visit; patient reported some memory deficit, but otherwise fine.
Reference: Memorandum: Review of brain tumor cases Treated with Antineoplastons, Department of Health & Human Services, National Institutes of Health
192
Pathology review: Slides from original subtotal resection showed infiltrating glioma (astrocytoma or mixed astrocytoma/oligodendroglioma), borderline anaplastic glioma. Radiology review: Very aggressive tumor. Original tumor showed "fleshy" component of 4.5 cm on 8/24/88. Latest CT on 9/6/91 shows cavity of 4.0 cm with "fleshy" component of 1.3 cm, which may be residual tumor or calcium deposit. Numerous new lesions appeared starting with 11/88 CT, but all had disappeared by 12/19/90 CT. Good PR, possible CR.
Patient #4 (P.M.) 7 year old white male who presented with diplopia, nausea and vomiting in 11/85. CT on 11/7/85 showed suprasellar mass and hydrocephalus. Shunt placed 11/8/85. On 11/11/85 underwent craniotomy and biopsy at Mayo Clinic. Diagnosed as Stage IV astrocytoma, histologic Grade 1, inoperable. Treated with vitamins and laetrile originally. At the beginning of 1988, the patient experienced headaches and tumor progression was noted. A second shunt was placed. Presented to Dr. Burzynski 4/18/88. Started on A10 capsules, AS2- 1 IV and low dose methotrexate. In June 1988, a slight increase in tumor size was noted. On 6/23/88 patient was switched to overnight IV A10 (1 gm/kg/day) and IV AS2- 1 (0.5 gm/kg/day). Progressive decrease in tumor size was noted; called a PR on basis of 4/17/90 MRI. Changed to continuous infusion A10 and AS2- 1 at same doses on 5/29/90. Latest MRI on 8/2/91 shows further decrease in tumor size. Pathology review: Slides from original biopsy. Well - differentiated astrocytoma, possibly juvenile pilocytic astrocytoma. Radiology review: Pre- treatment scans show a hypothalamic mass plus trilocular cyst. Main component of cyst + tumor in hypothalamus followed through serial scans. There was a substantial decrease in size of both solid and cystic components, with the decrease in the cystic part more dramatic. Decrease in solid component of approximately 40- 50%.
Reference: Memorandum: Review of brain tumor cases Treated with Antineoplastons, Department of Health & Human Services, National Institutes of Health
193
Chapter 4:
Extracts and Anti- Serums in Cancer Treatment
"Similia Similibus Curentur ("like cures like")" - Samuel Hahnemann
194
â&#x20AC;&#x17E;The anti- cancer servum was heavily suppressed. Some researchers won a Nobel prize, some died of poisoning. All remain forgotten. ." Thomas Joseph Glover, M.D. was a renowned physician and researcher originally from Toronto, Canada
Wendell Meredith Stanley (1904- 1971) American biochemist, virologist and Nobel laureate
(~ 1920 AD) Dr. T. J. Glover (~ 1950 AD) Wendell M. Stanley (~ 1940 AD) Dr. Reynals
Working Summary: Father of a Glover Therapy, based on an anti- cancer serum Books: The Treatment of Cancer in Man, based on 237 cancer cases, with 50 followups (1926), "The Cancer Blackout" by Nat Morris (1977), Glover, T.J. and White, J.E.: The Treatment Of Cancer In Man, Murdock Foundation, 1940, Loudon, J. and McCormack, J.: Preliminary report on the Glover micro- organism, (1925)., Loudon, J., and McCormack, J.: Notes on the isolation of the Glover micro- organism, IBID. 67, 5, Nov., 1926.l, Glover, T.J.: Progress in Cancer Research, IBID, (1926), Glover, T.J.: Bacteriology of Cancer, IBID, (1930), Glover, T.J.: and Engle, J.L.: STUDIES IN MALIGNANCY, New York: (1938)
(The following information is excerpted from: Alternative Cancer Remedies â&#x20AC;&#x201C; Facts for Historians and Medical Researchers by Vance Ferrell, Pilgrims Books, 1998 USA) 68
Dr. Glover, or Toronto Canada, was another physician who believed that cancer was caused by a VIRUS. With this in mind, and working with several associates, Glover studied viruses and developed a serum which was later lost. He began his research soon after entering medical practice in 1911; and, financed by a 195
"The story of the anti- cancer serum has been posted in its entirety from the book, "The Cancer Blackout" by Nat Morris (Publisher: Regent House 1977, pages 66 On June 11, the day following, the New York TIMES published an editorial stating that Doctor Glover had announced from San Francisco, where he was attending a medical congress, that claims made in his behalf for the curative powers of his serum were "premature" and that he himself would make no further statements until he had something to report to his colleagues. The editorial then continued: "While it is evident the medical profession is not ready to admit Doctor Glover's claims, his repudiation should mitigate the severity of any criticisms because he promptly repudiated claims made in his behalf... "There is nothing in the Glover or any other cancer cure to warrant delaying surgery for a single day." But that was an incorrect report; for Glover had not backed down an inch. Evidently Doctor Glover's repudiation either was not geniune or was falsely reported, for less than a month later he renewed his claims before the Philadelphia Clinical Society, in his paper, "The Etiology of Cancer- Treatment of Cancer with Antibacterial and Antitoxic Serum." He presented a complete description of the microorganisms he believed to be the cause of cancer, as well as proof of results obtained with his antiserum in a number of pathologically confirmed cases." Reference: Cancer Blood test....short history of Glover serum, THE GLOVER ANTICANCER SERUM, Copyright CureZone.org 342
wealthy industrialist, he developed a SERUM derived from the blood of horses. Several times, independently of one another, several researchers have used fluids from horses to eliminate cancer in humans. KREBIOZEN, developed in Brazil and then brought to Chicago, would later become the most famous example. Samples of the serum were sent free to hospitals so they could test it, in accordance with usual procedures. It WORKED SO WELL, that soon he was besieged by cancer patients from all over North America. The interesting fact about cancer remedies is that, although it has been firmly established that dietary and environmental factors are crucial factors; yet, upon studying medical history, we find that SO MANY different ways have been devised which produce remission from cancer! However, only those methods which reach down to the heart of the matter—and CHANGE THOSE THINGS IN THE LIFE WHICH CAUSED THE CANCER IN THE FIRST PLACE—are truly successful in the long run. A serum may eliminate the tumor, but it is very likely to return a few years later— UNLESS THE LIFESTYLE IS CORRECTED! This is why only a few of the methods described in this brief historical overview are to be preferred. Yes, there are substances which will destroy cancer sites, but the Reference: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell, Pilgrims Books, 1998 USA
196
"In spite of the furor, several leading Philadelphia hospitals began injecting Glover’s serum into cancer patients, with good results. At this point, we will conclude our report on Dr. Glover. The battle with the AMA continued for years. In 1940, Glover published his book, The Treatment of Cancer in Man, based on 237 cancer cases, with follow- ups on 50 originally reported in 1926. The malignancies were meticulously described by site, operability, length of treatment, survival periods, etc. Many cancer patients were alive and well 14 years after the treatment. This is all the more remarkable, since we are not told that Glover’s methods included any changes in lifestyle. Dr. Glover’s virus theory of cancer preceded his development of a serum derived from horses, just as Durovic’s virus theory would later lead to his development of a horse serum (Krebiozen). Note the June 5, 1924, Times comment, above, that a serum would be worthless if microorganisms do not cause cancer. Yet the serum was reported to have worked! In 1955, Dr. Stanley, of the University of California at Berkeley, was awarded the Nobel prize for identifying a cancer virus. The Swedish judges who awarded the prize were convinced, after careful examination, that Stanley had made a profound discovery which could benefit all of mankind. Yet no clinical testing or treatment of humans, based on his research, have ever been carried out. Not one. The matter was left to die a quiet death." - Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell, Pilgrims Books, 1998 USA 68
problem is not permanentlysolved unless important changes are made in one’s diet and way of life. In January 1921, the Toronto Academy of Medicine issued an official report that they had found "no evidence" that Glover’s serum had helped anyone. They also said that any so- called cures were due to "psychic suggestion" and nothing else. In spite of this setback, a number of physicians in Canada and America began using his serum. On June 4, 1924, a Philadelphian newspaper (the North American) published an article disclosing that Glover’s serum had produced favorable results. The next day, the New York Times published a statement by a leading physician, connected with Specific Systems of Treatment 52 Alternate Cancer Remedies the AMA, who flatly declared Glover’s serum to be utterly worthless. He added that as cancer was not a germborne disease, a serum treatment would accomplish nothing. "The cure of cancer otherwise than by surgery depends upon the discovery of its cause, and that remains as yet a mystery, through which only a few gleams of doubtful light have been cast." On June 11, the New York Times said that Glover, attending a medical convention in San Francisco, had announced that his serum was doubtful in value. The article concluded: "There is nothing in the Glover or any other cancer cure to warrant delaying surgery for a single day." But that was an incorrect report; for Glover had not backed down an inch. In spite of the furor, several leading Philadelphia hospitals began injecting Glover’s serum into cancer patients, with good results. At this point, we will conclude our report on Dr. Glover. The battle with the AMA continued for years. In 1940, Glover published his book, The Treatment of Cancer in Man, based on 237 cancer cases, with follow- ups on 50 originally reported in 1926. The malignancies were meticulously described by site, operability, length of treatment, survival periods, etc. Many cancer patients were alive and well 14 years after the treatment. This is all the more remarkable, since we are not told that Glover’s methods included any changes in lifestyle. Dr. Glover’s
Reference: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell, Pilgrims Books, 1998 USA
197
virus theory of cancer preceded his development of a serum derived from horses, just as Durovic’s virus theory would later lead to his development of a horse serum (Krebiozen). Note the June 5, 1924, Times comment, above, that a serum would be worthless if microorganisms do not cause cancer. Yet the serum was reported to HAVE WORKED! In 1955, Dr. Stanley, of the University of California at Berkeley, was awarded the Nobel prize for identifying a cancer virus. The Swedish judges who awarded the prize were convinced, after careful examination, that Stanley had made a profound discovery which could benefit all of mankind. Yet no clinical testing or treatment of humans, based on his research, has ever been carried out. Not one. The matter was left to die a quiet death. What the American Cancer Society knew in 1955 about Infections and Cancer (Excerpted from: McGrady & Morgan - Saturday Evening Post, 1964 / tobacco document, The American Cancer Society has suppressed research on infection and lung cancer for over 70 years. From: What the ACS Knew in 1955 About Infections and Cancer, http://www.smokershistory.com/) 343
In the 1940s and early 1950s in defense of the virus theory was the soft and cultivated voice of an emigré Spanish nobleman, Dr. Francisco Duran- Reynals, who had laboratory facilities (but not academic tenure) at Yale. One Yale colleague summed up the general reaction when he told students, 'If you are interested in viruses as a cause of cancer, go upstairs and listen to Hans Christian Andersen tell you a fairy story.' The little man upstairs reacted with politeness. 'In a field where all of us know so little,' he would say mildly, 'how can we afford to ignore any possibility, even the virus?' In private he admitted he was hurt by the contempt in which his ideas were held. Year after year DuranReynals continued to confront his apathetic or hostile peers with new evidence of cancer viruses in animals. In his big, old- fashioned laboratory at Yale he ran off a series of elegant experiments which proved that the Rous sarcoma - the cell- destroying virus of chicken cancer - was not confined to chickens but could leap the so- called species barrier Reference: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell, Pilgrims Books, 1998 USA
198
and incite cancers in ducks and turkeys. Indeed, the virus sometimes gained virulence as it passed from one species to another. He showed how a virus could lie dorman for many years before inciting cancer. He made many other basic contributions to the understanding of cancer viruses. Not until 1955 did the theories of Francisco Duran- Reynals come out of the shadow of disfavor. At the Third National Cancer Conference in Detroit that year one of the main speeches was delivered by Dr. Wendell Meredith Stanley, who had been awarded the Nobel Prize in 1946 for crystallizing the tobacco mosaic virus. Dr. Stanley bluntly told an audience composed of the world's most active cancer investigators that they should mend their ways, abandon the notion of an impenetrable species barrier, and seriously consider the possibility that VIRUSES ARE INVOLVED IN HUMAN CANCER. 'Basic biologic phenomena generally do not differ strikingly as one goes from one species to another,' Doctor Stanley reminded the cancer specialists. 'I regard the fact, now proved beyond contention, that viruses can cause cancer in animals to be directly pertinent to the human cancer problem.' A few months later Duran- Reynals, the gentle man of soft voice and iron determination, FELL PREY TO A STRANGE CANCER that first PARALYZED HIM, THEN KILLED HIM. Many of his colleagues, including his widow, suspect the cancer was incited by one of the viruses he had experimented with in his laboratory (â&#x20AC;Ś). Now at Albert Einstein Medical School, she has produced an awesome array of mouse cancers and has shown that these cancers can be prevented by immunizing the animals against the virus in advance. 'It is now clear,' Mrs. Duran- Reynals said recently, 'that Francisco was a prophet - not a dreamer or visionary, as his critics called him. Cancer control will be achieved by immunological methods. Cynics may delay the day - but sooner or later we shall prevent human cancers with vaccines and cure them with vaccines, antiserums or other measures which strengthen natural resistance." Reference: Alternative Cancer Remedies â&#x20AC;&#x201C; Facts for Historians and Medical Researchers by Vance Ferrell, Pilgrims Books, 1998 USA
199
â&#x20AC;&#x17E;Their life- saving work was ridiculed, suppressed and forgotten."
(~ 1930 AD) Dr. Walter B. Coffey (~1930 AD) John D. Humber (~ 1920 AD) Dr. Eaton (~ 1920 AD) Dr. Gye Working Summary: Pioneering of a unique adrenal extract anti- cancer serum.
(right) Dr Coffey, M.D. (1897- 1983) a chief surgeon and director of the Southern Pacific Railroad Hospital in San Francisco (left) John D. Humber, M.D., was a San Francisco surgeon
Articles: Autopsy Observations on One Hundred and Sixteen Cases of Malignant Disease, in Eighty- Nine of Which Experimental Injections of Suprarenal Cortex (Coffey- Humber) Were Given. By HOWARD A. BALL., M.D., (Am. Jr. Of Cancer, 1931 - 1360) (The following information is excerpted from: Alternative Cancer Remedies â&#x20AC;&#x201C; Facts for Historians and Medical Researchers by Vance Ferrell, Pilgrims Books, 1998 USA)68
Dr. Coffey was chief surgeon and director of the Southern Pacific Railroad Hospital in San Francisco from 1926 to 1938. Highly respected for his surgical skill, in the 1920s he devised an operation to relieve the intense pain of angina pectoris, and was invited to demonstrate his technique before several leading universities in Europe. As a rule, the men who developed new treatments for cancer were highly skilled and 200
"Dr. Coffey said that "injection of our extract Introduced subcutaneously will In twenty- four hours Indicate the location of the malignancy. He mentioned several recent cases, on 'one of which cancerous gowth on a patients tongue was teated by the new method, and in ten days the growth sloughed away completely. In another case of a type and stage considered incurable aMd fatal within six,months, two years after treatment, he said, the patient H well enough to do heavy manual labour daily. ''Radium delays sloughing," he said. "As a result of those injections patients who have been using opiates discontinue them voluntarily after the second or third injection, because the pain is re lieved." Dr. Coffey, In detailing some of the main points of the discovery, said: "We are almost scared to make these statements before you, but we feel we know something as a result of the remarkable success achieved in our experiments to date." - The Queenslander, To Help Humanity, March 27, 1930
respected medical doctors whom their peers recognized as BRILLIANT. Coffey was no exception. In the late 1920s, Coffey became interested in cancer therapy. It resulted from experimenting with an adrenal extract in treating high blood pressure in a patient who was also cancerous. Coffey was startled to find that the extract not only dramatically relieved the HIGH BLOOD PRESSURE — but the cancer as well. Very soon, John D. Humber, M.D., joined him in his research. Over the next several years, they experimented with various extracts from the adrenal cortex of cattle, and then decided that an extract from the adrenal cortex of sheep was the most effective. It is not commonly known, but Coffey is said to have originally obtained the cancer extract idea from a Dr. Eaton, a well- known San Francisco urologist. Eaton, himself, had been encouraged by a Dr. Gye, an English cancer specialist, to investigate the hormones of the adrenal cortex for possible anti- cancer factors. Learning of Eaton’s work, Coffey appropriated it as his own. This resulted in great enmity between the two men. As medical director of a large hospital, which treated many railroad workers, sent in from all over the western states, Coffey was in an excellent position to try out Eaton/Gye’s idea. Reference: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell, Pilgrims Books, 1998 USA
201
"Conclusion: In CALIFORNIA AND WESTERN MEDICINE (September, 1930, page 640) was printed the paper read by the authors, on August 23, 1930, before the Pacific Association of Railway Surgeons; that paper being partly based on the subject matter presented previously, on January 6, 1930, to the San Francisco Pathological Society. Since 1930, five years have elapsed (the time period set in the Geschickter criteria as being necessary before conclusions could be properly drawn as to value of therapeutic methods intended to alleviate cancer). In the two clinics maintained by the authors, at San Francisco and Los Angeles, a total of 8,061 patients with advanced cancer applied for registration and treatment; 548 of these not being registered, because they failed to comply with the requirements. The great majority of these patients were referred to the clinics by their attending physicians of California and other states, and in each instance an earnest endeavor was made to use all methods necessary for accurate diagnosis. Clinical histories, by both the attending physicians previously in charge and of the clinics, were carefully kept, and are in the files, in well tabulated and easily accessible form, for inspection by responsible parties.* In a total of 1,040 patients, each of whom received thirty or more injections with the authors' aqueous extract, there were 108 patients or 10.38 per cent, who are still living at the end of five years; and of this latter number, 52 patients, or 5 per cent, are clinically clear of cancer involvement at the end of five years(…)." B. Coffey and John D. Humber, Cancer Studies: In Relation to Results of Treatment with an Aqueous Extract Made from the Cortex of the Suprarenal Gland, A Five- Year Review on Treatment Results in Inoperable and Hopeless Malignancies 344
In January 1930, when he felt sufficient clinical evidence was available, Coffey demonstrated his technique before the San Francisco pathological Society. This brought him instant and widespread publicity! Reporters sent reports to newspapers all over America, describing the remarkable improvement of some of the patients. PAIN DECREASED, HEALTH SEEMED TO GENERALLY IMPROVE, AND CANCERS WERE DISAPPEARING. Records and comments by patients and staff were printed. There was a rising ovation for Dr. Coffey, from over 1,200 California physicians at their 1930 convention. Besieged by cancer victims, Coffey announced in the press that he would only accept those whose cases had been diagnosed, through approved laboratory procedures, as malignant by a physician, and then referred to himâ&#x20AC;&#x201D;along with a letter that the case could not be helped further by surgery or radiation. That was a wise move, since it provided documentation for the genuineness of each case, and did not conflict with the ongoing, brisk activity in surgery and radiation. He would only accept inoperable cases. In addition, those accepted for treatment had to agree in advance in writing to an autopsy report, if they died during treatment. Reference: Alternative Cancer Remedies â&#x20AC;&#x201C; Facts for Historians and Medical Researchers by Vance Ferrell, Pilgrims Books, 1998 USA
202
Dr. James Ewing, of the Cancer Memorial Hospital of New York, in his report to the International Congress of Cancer, held in Madrid, 1933, as quoted elsewhere, declared that "it is probably safe to state that not more than 5 per cent of the cancer cases live more than five years." In the light of Doctor Ewing's statement, it should be of interest to note that, in the analysis of the authors' total of 1,040 patients with inoperable cancer, and under observation for five years, a total of 108 patients, or 10.38 per cent, are living at the end of five years. (Since the above report was read at the St. Francis Hospital meeting of the American College of Surgeons session, in San Francisco, October 28 to November 1, 1935, two patients, still living, who are in this five- year group, have reported, making the total of living patients in this first five- year group 110, a percentage of 10.57 per cent of living patients, of which number 54, or 5.1 per cent are clear of symptoms.) As previously stated, the complete clinical records of all patients under observation in the last five years are open to inspection and study by responsible parties.t The authors submit that their studies, with the results obtained during the last five years, compare favorably with any in the literature; especially since they are based on observations of results in the massive amount of clinical material of advanced type that was under observation. It is needless to add that they are encouraged to go forward with their work. B. Coffey and John D. Humber, Cancer Studies: In Relation to Results of Treatment with an Aqueous Extract Made from the Cortex of the Suprarenal Gland, A Five- Year Review on Treatment Results in Inoperable and Hopeless Malignancies 344
Everything seemed to be doing well, but then Morris Fishbein, editor of the Journal of the AMA, heard about Coffey’s activities. He wrote: "Pathologists and surgeons who have investigated the method express nothing but profound disappointment with both the clinical and pathological results. These experts indicate that post- mortem examinations which have been made in at least 30 cases do not reveal any definite specific destruction of cancer tissue or evidence that the spread of cancer in the bodies of the afflicted patients has been retarded." In view of Coffey’s very thorough method of case documentation, it is remarkable that Fishbein would dare oppose him publicly in the pages of the Journal. At their next annual meeting, members of the California State Medical Society issued a public criticism of Fishbein for his "unethical and unscientific" remarks. As for Coffey, he had some remarks to make also: "It appears highly unjust and unethical if Dr. Fishbein has employed pathologists working in secret. Such investigations could have been carried on openly at any of our clinics with our utmost cooperation. Secret investigations such as he implies remind one of the secret tribunals of medieval days when the accused was tried and sentenced without opportunity to defend himself at open trial." The contenders were identified, and the battle was joined. Thoughtful students of medical history could recognize the final outcome. Patients by the thousands flocked to the Coffey- Humber Cancer Clinic in San Francisco, to receive the Coffey- Humber extract, as it came to be known. A branch was opened in Los Angeles; and, in 1931, a wealthy widow of a railroad magnate, living on Long Island, offered to give her mansion as a third clinic in the chain. This would open the entire East Coast to the new anti- cancer method. This resulted in a storm of opposition and protests. On one side were the common Reference: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell, Pilgrims Books, 1998 USA
203
masses, plus wealthy patrons and fabulously rich railroad executives who sided with "their boys." On the other was the New York City Welfare Board that, for some mysterious reason, saw fit to deny the people of New York the opportunity to obtain help. The application was denied. Later that same year (1931), Dr. Rowland H. Harris reported in the Journal of the AMA that he had investigated the extract and found it to be worthless, and even harmful. He said that, in some instances, it accelerated the growth of tumors. Fired with anger, Dr. R.W. Starr, director of the Los Angeles Coffey- Humber Cancer Clinic, declared that Harris was giving a false report. The anger and accusations continued. Dr. Balfour, a Mayo Clinic surgeon, was quoted by Time magazine as saying that "cancer is curable if [surgically] removed while it is a local disease. Cures by advertised serums, extracts, etc., are myths." Shortly afterward, Dr. Garland, a radiologist, stated that he was well- acquainted with the extract that it relieved no pain, and he had seen the patients "die like flies." In March 1936, Coffey and Humber published their results, to date: 7,513 presumably hopeless cancer patients. Of these, 3,872 died before they could receive 30 injections (the minimum needed for a fair test). Of the 3,641 which received the full treatments, 1,040 recovered from cancer, which is about one- fourth. Of these, about 10% lived four or more years. (It should again be noted here that the Coffey- Humber treatment neither included nor required any changes in diet or lifestyle. Without such changes, serums, extracts, etc., outstanding, long-term results could not be produced.) In his report, Coffey also noted a statement by a well- known pathologist, Ewing, who said that not 5% of cancer patients recovered after receiving surgery or radiation. In 1944, Dr. Coffey died. In later years, Dr. Humber decided to stop using the extract. Oddly enough, the method never received any kind of scientific investigation by its opponents. Yet the clinical trials in California were carefully, and openly, conducted in the presence of many physicians and thorough records were kept. Reference: Alternative Cancer Remedies â&#x20AC;&#x201C; Facts for Historians and Medical Researchers by Vance Ferrell, Pilgrims Books, 1998 USA
204
„Ridiculled and suppressed for helping the sick people."
(~ 1940 AD) Phillip Drosnes and Lillian Lazenby
Phillip Drosnes was a former tire dealer. and Lillian Lazenby was a hospital room supervisor. Two people who knew absolutely nothing about medicine, chemistry, physiology, or disease— decide to find a cancer remedy.
Working Summary: Creators of Mucorhicin, a mold based extract made out of wheat corn Recommended Literature: Silence That Is Golden — Can Be Murder (For the Doctor) (Of Cancer Victim) By Arthur J. Burks (The following information is excerpted from: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell, Pilgrims Books, 1998 USA) 68
Phil Drosnes was a former tire dealer. Mrs. Lillian Lazenby was a dietician. These two single people got together every so often to eat lunch and chat. One day as they talked, Phil commented that doctors didn’t know much. He said that he was bald and doctors couldn’t cure it; also a little deaf and they couldn’t solve that. And then there was cancer; they didn’t know how to cure it. Lazenby spoke up and said she sure wished she knew a cure, since her mother had died after great, lingering suffering. Drosnes seemed interested. Yes, he had a great uncle who had died of cancer. 205
"We spoke to the father of one patient, Karen G., who was given up as a hopeless brain tumor case, when she was eight. Intramedullary glioma of the brain stem and cerebellum— that was the diagnosis her physicians made. After a series of operations, she was taken home to die. She was in a coma, unconscious. paralyzed, with toes and hands twisted backward, when her parents came to the clinic. Karen was given Mucorhicin first through a tube in her nose. Her second dose was given orally. She began to improve at once and slowly, gradually she came back to life until about eight months later, she could sit in a wheel chair and the paralysis affected only one arm which continues to improve. "Today Karen is fifteen. She is blind, for the cancer had destroyed her sight before Mucorhicin therapy. But she is happy and well. Dr. Murray, in his written case history of Karen says: ‘Progress of this patient can only be described as amazing.’ "The same can be said for other patients who have been treated with Mucorhicin. While we were talking to Karen’s father, he mentioned two friends of his whose cancers had also disappeared when they got the Drosnes- Lazenby treatment. Can we prove that they had cancer? This becomes increasingly difficult. For instance, Karen’s hospital records have disappeared from the files at the hospital."—J.I. Rodale, The Health Finder, Vol. 2, 121 (1957) Source: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell, Pilgrims Books, 1998 USA 68
"So," he said banteringly, "I’ll help you find a cure." With the utter naivite of knowing nothing about the matter, they started in. There was not one item of medical equipment in their possession. No microscopes, nothing. If they had the equipment, they would not have known how to use it. The very fact that they accomplished as muchas they did reveals yet again that there are many avenues to success, when it comes to dealing with cancer. Casting about for an idea, the couple went to her (Lazenby’s) Pittsburgh home, took some pots and pans down into the basement. They found a sack of whole wheat and hauled it over to the tubs. Why whole wheat? Why not? What’s the difference? It’s as good as anything else to start with. Next, they needed to find some people with cancer. Since Mrs. Lazenby worked at a hospital, she slipped some of her formula into the orange juice she gave to three cancer patients who were bedridden and pronounced hopeless, According to Mr. Drosnes, all three seemed to improve somewhat in symptoms, appetite, and energy, but then they died. Later they were permitted to treat patients who had been discharged and sent home to die. The two drove to their homes twice a day to give them their extract, which they drank in fruit juice. Later, they had, administered Mucorhicin to patients at their homes, or wherever the patients were, twice daily. They stretched themselves so far, while still holding down their jobs to finance themselves, that they almost put slee out of their lives. They needed a clinic. The associate pastor of St. Joseph's church in Pittsburgh, Father F. X. Feldmeier, let them use the basement recreation rooms of the church. There their first medical supervisor, Dr. Paul A. Murray, administered or supervised the treatment of a rapidly growing roster of the otherwise doomed. There were some dramatic, if only temporary, remissions. Occasionally a recovery occurred. Then Dr. Paul A. Murray, a Pittsburg physician became interested in what they were doing, and offered to help them. Reference: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell, Pilgrims Books, 1998 USA
206
Later, Dr. Joseph Wilson joined the team. That same year, the two laypeople were arrested for practicing medicine without a license. But the case was set aside, since the clinic was under medical direction. The arrest brought publicity! Immediately, people all over greater Pittsburg sought the clinic for help, and medically affiliated organizations began opposing them. But the Drosnes- Lazenby Clinic had staunch friends among former patients and their relatives. The treatment had often been given free. At the urging of the Pittsburg City Council, an investigation was demanded. A medical doctor came from Washington, D.C.; he spoke with them for a little while and promised to return in six months to advise further, but never did. Then official reports were sent out, that he had examined their work to be fraudulent. No other "testing" occurred (…). Drosnes and Lazenby were trying to develop an "enzyme treatment." But what they actually produced was a raw wheat mixture, which, in addition to enzymes, contained a sizeable dose of B vitamins; vitamin C; vitamin E; and, in addition to a variety of other vitamins, a number of vitally needed minerals, including calcium and potassium. Such a vitamin- mineral supplement alone, administered twice a day, would probably have accomplished a great deal to help cancer patients— and probably was the source of help provided by the "Drosnes- Lazenby treatment." It is likely that a half pound of fresh, refrigerated wheat germ could be soaked for a few minutes, mashed through a sieve, fed immediately to an individual—and produce similar effects to the Drosnes- Lazenby formula. In each one, Drosnes and Lazenby were ridiculed, humiliated, and insulted. They were admittedly not "cancer experts" ! Worse still, they were, under the supervision of bona fide physicians, administering Mucorhicin to victims free. Such a thing was unheard of. You didn't treat a cancer patient free! (…)
Reference: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell, Pilgrims Books, 1998 USA
207
„The ultimate cancer cure is born."
(~ 1940 AD) Steven Durovic, M.D. Working Summary: The Father of Krebiozen, the ultimate immunostimulating drug against cancer. Also known as creatine treatment, Carcalon or Lipopolysacharide C, substance X, or drug X
Steven Durovic, M.D., professorship at the University of Belgrade and an independent researcher.
Recommended Literature: K- Krebiozen— Key to Cancer? By Herbert Bailey, A Matter of Life or Death by Herbert Bailey, The Incredible Story of Krebiozen, Krebiozen: The Great Cancer Mystery by George D. Stoddard, The Beacon Press, Inc. (1951), K. Krebiozen- Key to Cancer? by Herbert Bailey
(The following information is excerpted from: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell, Pilgrims Books, 1998 USA)
In 1933, Dr. Steven Durovic, left a professorship at the University of Belgrade, to do research work at the Pasteur Institute in Paris. He studied molds at a time when most physicians had not yet heard about Dr. Fleming’s 1929 discovery of penicillin. Durovic wondered if the unique, rapid growth of mold might somehow be applied to CANCER THERAPY. Durovic tried to reason as to the cause of cancer at the same time that another physician, halfway across the world, Andrew C. Ivy, was carrying out a 208
"...Whereas spontaneous cure (of cancer) remains a scientific curiosity with a rate of 0.00001%, the administration of Krebiozen has given a recovery rate of 12.5% or a 1,250,000 fold increase." - Steven Durovic, MD, post- graduate at U. of Vienna, and Pasteur Institute,; "Cancer and Krebiozen...", Today's Japan Orient/West, May 1961.
"..The Durovics (of Krebiozen:)...how costly (their) nine month trial was, and no government paid their legal fees as was done for the FDA." - Kitty Schumacher, Cancer Information Crusade, in letter to MDAC author, 1982.
similar pattern of thought: It seemed to both that all types of cancer share a common factor: UNREGULATED GROWTH. If something could be found that would cancel that factor, the cancer problem could be solved. The factor must already be in the human body and in animal bodies, because occasionally "spontaneous" recoveries occur. What could be this natural defense, this natural control? Unfortunately, neither physician gave much attention to nutrition, but the outcome of their work was still remarkable. When World War II burst upon Europe, Dr.Durovic joined the Yugoslav army, was captured by the Nazis, and imprisoned for 18 months in Italy. While there, he reasoned that there must be a substance which could induce rapid, uncontrolled growth in animals; which, in turn, should set up the body defenses against the unregulated growth. Meanwhile, Stevenâ&#x20AC;&#x2122;s older brother, Marco who had also been captured, was able to arrange help through wealthy friends in Rome. Freed, they all fled to Argentina. With the remnants of his fortune, Marco underwrote his brotherâ&#x20AC;&#x2122;s initial experiments. Steven was certain there was a growth- regulating factor in the body. It was well- known that any animal tissue grown artificially multiplied indefinitely, as long as there was nourishment for the cells. It is true that they grow slowly, but there was no growth regulation governing them. These same tissues, inside the body, maintained an orderly growth pattern. What caused the miracle of growth regulation? (Later researchers demonstrated a growth regulating factor. Tissues of an adult frog were placed within a tadpole, and the tadpole immediately stopped growing. The growth- stoppage factor, in the adult tissues, was stronger than the growth- stimulant factors in the tadpole. Similar effects have been observed in cockroaches and caterpillars.) But Durovic was searching, not for an antigrowth element, but an anti- abnormal growth substance. A related problem would be how to get the animal to produce this growth- regulating factor. Apparently not by injecting with cancer tissue. That had been
Reference: Alternative Cancer Remedies â&#x20AC;&#x201C; Facts for Historians and Medical Researchers by Vance Ferrell, Pilgrims Books, 1998 USA
209
tried repeatedly by many earlier researchers, in an attempt to produce antibodies against cancer. Such efforts generally met with failure. During his early years in Buenos Aires, Durovic worked with cattle, injecting various substances into them. Then he would draw blood, hoping to find a defense substance which had been produced. Eventually, he came across a substance, stimulated by the reticuloendothelial system (a body defense mechanism) which, although ineffective against cancer, tended to lower high blood pressure. Naming it Kositerin, he tried it on 150 patients at the Durand Hospital. Since his brother’s funds were nearly exhausted, they welcomed the help of a group of businessmen who wanted to sponsor the work, in order to reap profits from the forthcoming medicine. While still testing the substance, his thoughts turned back to the cancer research. The thought came to mind that perhaps he had not been giving a powerful enough jolt to the body defenses, in order to produce the growth factor in recoverable amounts. But what foreign bodies would produce the fastest growth? Bacteria? viruses? Perhaps it would be a fungus; he recalled his work back in Paris. Then one day as he was half dozing, he recalled the rich fields of his ancestral farmlands, and cows and horses grazing there. Then the thought flashed into mind: Among his father’s horses and cows, sometimes there had appeared a strange disease. It began as a tiny growth, usually on the side of the neck or jaw. Within a few weeks, the growth would burgeon into a huge tumor. The horse would become very sick and die, but some would recover and the tumor would totally disappear. This thought was the moment of BREAKTHROUGH. Surely, this was one of the fastest- growing living forms of animal tissue. When the horse recovered, something in the horse halted the rapid growth by killing the invading cells. —And all this was done in a matter of weeks! Checking into this, Durovic found that the growth was caused by a fungus, Actinomyces bovis, commonly known as "lumpy jaw." Immediately, he switched to horses and eventually had injected hundreds of horses Reference: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell, Pilgrims Books, 1998 USA
210
with extracts of Actinomyces. Their blood had yielded about a half- teaspoon of a whitish powder he believed was the growth- control regulator for which he was searching. The average yield from a horse was so small that it was almost invisible, yet it was so potent that it could protect the hundreds of pounds of a horse from a foreign growth within his body. Strangely enough, some horses yielded nothing while others were relatively rich producers of the substance. Trying out the substance on old dogs with natural cancers, Durovic found the cancers shrank noticeably; some even disappeared. Independent tests, done by friends at the School of Veterinary Medicine, University of Buenos Aires, confirmed his work. By this time he was ready to go to the United States, where he could have both his anticancer and his high blood pressure substances tested further. Sealing 500 ampules, each containing a tiny fraction of the mysterious substance, he said goodbye to his brother, boarded a plane and flew to Chicago, known to be an important medical center. Durovic had another reason for going to Chicago; he wanted to meet Dr. Andrew C. Ivy, one of the most prominent physicians in America. Durovic had recently discovered a paper by Ivy on a theory behind cancer formation, which agreed remarkably with his ownâ&#x20AC;Ś [story continues in the next chapter]
Reference: Alternative Cancer Remedies â&#x20AC;&#x201C; Facts for Historians and Medical Researchers by Vance Ferrell, Pilgrims Books, 1998 USA
211
â&#x20AC;&#x17E;A gigantic statue was discredited, suppressed, followed and threatened by the medical establishment.
(~ 1940 AD) Andrew C. Ivy, M.D.
(Dr. Andrew Ivy 18931978) was the AMA Section Chairman for Physiology and Pathology; Director- at- large of the American Cancer Society, Executive Director of the National Advisory Cancer Council, Scientific Director of the Naval Medical Research Institute, and President of the the American Physioloogical Society. Vice president at the University of Illinois, Executive Director of the National Advisory Cancer Council
Nutshell: Advocate of Krebiozen, the ultimate immunostimulating drug against cancer. Recommended Literature: Dr. Ivy wrote a 1499page book on ulcers and more than 1500 medical articles, K. Krebiozen- Key to Cancer? By Herbert Bailey, A Matter of Life or Death: The Incredible Story of Krebiozen by Herbert Bailey (Following information is excerpted from: The Incredible Story of Krebiozen by Herbert Bailey, 1958. Reprinted by The Arlin J. Brown Inf Centre, Inc. Source: whale.to) 345, 346
Steven Durovic came to the United States after several years of experimentation in South America, with a drug which he had discovered and which he believed to be a CURE FOR CANCER. Once in the United States he was brought to the attention of Dr. Andrew C. Ivy, a medical researcher of unassailable reputation and gigantic statue in his profession. Dr. Ivy was, at the time, vice president of the University of 212
Who was Dr. Ivy? Andrew Conway Ivy, was one of the most well- known and celebrated physicians around the globe. He was born and raised in Farmington, Missouri. After graduated from Southeast Missouri State Normal School he went on to the University of Chicago and in 1918 he have received a medical degree. After his graduation Dr. Ivy served as Chairman of the Division of Physiology and Pharmacology at Northwestern University from 1926 to 1945. That place later became a craddle of international reputation as a scholar, researcher, and writer. His 1400 page book on the treatment of ulcers was a standard text for nearly a century. More, he was the one, who come up with the process of mouth to mouth resuscitation of stricken individuals. Dr. Ivy was the author and\or coauthor of almost 1500 medical articles, the recipient of eleven major research awards and five honorary doctorates. One time Dr. Ivy served as AMA Section Chairman for Physiology and Pathology, Directorat- large of the American Cancer Society, Executive Director of the National Advisory Cancer Council, Scientific Director of the Naval Medical Research Institute, and President of the the American Physioloogical Society. As a medical researcher Dr. Ivy became a person of UNASSAILABLE REPUTATION. Because of his gigantic statue in his profession Dr Ivy became a vice president at the University of Illinois and a head of its huge Medical School.
Illinois, and head of its huge Medical School. His efforts in cancer research had led to his appointment as Executive Director of the National Advisory Cancer Council and he was also a director of the American Cancer Society. An important, a respected, an honored man. Early Results Show Promise: Dr. Ivy became interested in the theory and possibilities shown in Dr. Durovic's substance, Krebiozen, and he decided to test it in the scientific manner his experience had taught him was necessary for an accurate picture of the drug's potential. From the very beginning the results were astounding in their positiveness. Though Krebiozen was used only on persons who had been diagnosed as hopeless and close to death, its remarkable characteristics showed themselves almost at once. There was a lessening or COMPLETE DISAPPEARANCE OF PAIN, and in many cases TUMORS WERE DISSOLVED and replaced with healthy tissue. Physicians who were trying it all over the country reported like results. It began to look as though science had finally come up with a weapon against cancer that had a chance to win the fight. With such a product as a cancer cure, scientific and humanitarian considerations are joined by third Reference: The Incredible Story of Krebiozen by Herbert Bailey, 1958
213
"...All the TV stations in the NYPhiladelphia metropolitan area refused to sell time to Timex to permit public showing of a documentary it had produced on Krebiozen. ..Where the AMA previewed the documentary..." - American Jewish Ledger, 1964. "It is our understanding that the NIH with FDA approval, clinically test at least 100 products a year on cancer patients. We feel Krebiozen deserves a similar test. Why should either side be afraid of the truth? - US Senator Paul Douglas and ten other senators (in Chicago's American, 1966). "I have had some very interesting work with Dr. (Andrew C.) Ivy, and have had what I think, unusually good results with Krebiozen. Due to the controversy which was stimulated by adverse quarters, it was Army policy not to allow me to continue with this particular type of research project. I feel that Krebiozen, or perhaps a similar substance, is certainly on the threshold of finding an answer to some of our malignant (cancer) problems." Wallace H. Graham, Major General, US Air Force; physician to US President, letter in 1952." "During the course of Dr. Ivy’s trial, a letter was read into the court record written by a doctor from Indianapolis. The doctor stated in his letter that he was treating a patient who had multiple tumors, and that a biopsy of the tissue had shown these tumors to be cancerous. The doctor said that he had obtained Krebiozen from Dr.Ivy’s laboratories and had administered it, but that it had done absolutely no good (…)." - Herbert Bailey, K. Krebiozen- Key To Cancer? 347
consideration- commercialism. Without a doubt, a cancer cure is worth a lot of money. What victim would not offer all he owns, or all he can borrow for even a chance that he might be cured? Large drug companies have made millions on substances designed to treat diseases far less urgent and wide spread than cancer. This then is why two Chicago businessmen tried to get control of the distribution rights to Krebiozen. When they were refused, they threatened to ruin Krebiozen and everyone connected with it. One of the men who made this threat was the friend of J. J. Moore, then treasurer of the American Medical Association. The promise shown in the early tests of Krebiozen seemed to be emphasized with each new experiment. The excitement and relief provided by such apparent success left little room for worry over the threat that had been made. How could so proud and secure a venture as a scientifically proven cancer cure be scuttled by the influence of commercial interests? Dr. Ivy Pays the Price: The answer to that question came with devastating swiftness. In rapid succession Dr. Ivy was SUSPENDED from membership in the Chicago Medical Society, REMOVED from the vice presidency of the University of Illinois, and had his resignation Reference: The Incredible Story of Krebiozen by Herbert Bailey, 1958
214
"When called to the witness stand, however, the doctorâ&#x20AC;&#x2122;s answers were vague and evasive. Under the pressure of cross- examination, he finally broke down and admitted that he never had treated such a patient, never had ordered the biopsy in question, and never had used Krebiozen even once. The whole story had been a lie. Why did he give false testimony? His reply was that one of the FDA agents had written the letter and asked him to sign it. He did so because he wanted to help the agency put an end to quackery. In September of 1963, the FDA released a report to the effect that Krebiozen was, for all practical purposes, the same as creatine, a common substance that was found in every hamburger. To prove this point, they produced a photographic overlay supposedly showing the spectograms of Krebiozen and creatine superimposed over each other. These were published in Life magazine and other segments of the mass communications media as "unimpeachable proof" that Krebiozen was useless When Senator Paul Douglas saw the spectrograms, he was suspicious. So he asked Dr. Scott Anderson, one of the nationâ&#x20AC;&#x2122;s foremost authorities on spectograms, to make his own study. Using standard techniques of analysis, Dr. Anderson identified twenty- nine differences between the two substances. There were sixteen chemical and color differences. The version released to the press by the FDA had been carefully moved off center until there was a maximum appearance of similarity, but when restored to the true axis, the two were as different as night and day." - Herbert Bailey, K. Krebiozen- Key To Cancer? 347
accepted by both national cancer society's noted above. But worst of all, his work with Krebiozen was assailed as inaccurate and unscientific. His conclusions were dismissed or so interpreted as to discredit his research methods, methods which had been good enough to earn him a worldwide reputation, methods which till then had been regarded as the ultimate in scientific detachment and objectivity. Suddenly the approach was wrong, the conclusions untrue, the impression was fostered that Dr. Ivy was no longer capable of reliable scientific observation. It was even suggested that Dr. Ivy had become senile and was loyal to Krebiozen only because his mind was failing. How Krebiozen Fared: The fate of Krebiozen itself was similar. Within a few short months after Dr. Ivy made known some observations on 26 patients whose history showed Krebiozen to be of "promise," the Journal of the American Medical Association published a Status Report on Krebiozen. It dealt with 100 case histories, a project which top scientists would have difficulty in completing properly in two years, not six weeks, even working at top speed! The report was extremely damaging, and the temper of the average observer after reading it is reflected in a Chicago Tribune editorial which said, "Medically speaking, Reference: The Incredible Story of Krebiozen by Herbert Bailey, 1958
215
"Between 1919 and 1955 Ivy and his coworkers published more than 1500 papers, an average of more than 40 papers per year for more than 35 years. Science Citation Index shows that during the period from 1964 to 1971 Ivy's articles were cited more often than any other scientist in the world (â&#x20AC;Ś). Dr. Ivy is known to be a man of much determination and courage. Physiologists who worked with him closely have a warm friendship with him and know him as a man of high ideals and broad vision, with a wide knowledge of physiology and much wisdom and skill as an executive, Tn Chicago, he was particularly vigorous and effective in the defense of the use of animals for medical research. He attends meetings of the Society and has worked long and faithfully for the Society and its publications and for the advancement of physiology" Source: "History of the American Physiological Society - The Third Quarter Century 1937- 1962" by Wallace O. Fenn. Presentation by Morton I. Grossman 1970 348, 349 "Dr. Ivy (co- author of 1500 articles)...sent his article (on Krebiozen) to one medical journal after another. The journals accepted his article for publication, only to return it with apologies. ...Dr. Ivy was informed that the publi(shers) were told by the AMA Headquarters they would lose all their revenues from pharmaceutical advertising if they published Ivy's article. ...Finally, in desperation, Dr. Ivy turned to a small general publisher ("Henry Regnery, Chicago") and arranged for publication of his medical work." - Herbert Bailey. A Matter of Life or Death: The Incredible Story of Krebiozen 345
Krebiozen is dead. Let it be buried without ceremony." These people, among them thousands of doctors who rely on the Journal of the American Medical Association for all of their current medical information, never knew that the core of the report was faked. Mr. Bailey shows that the doctor who wrote the article made so many omissions of factual and favorable results and so altered the findings that were at his disposal that even the most naive researcher would have discredited his conclusions at once - as thoroughly antiscientific and worthless. These and other facts showing that the AMA acted in a biased and arbitrary fashion concerning Krebiozen were sworn to under oath at a subsequent investigation of the whole situation by the Illinois State Legislature. But still the smudges on the reputation of Krebiozen could not be erased. When anyone powerful enough to effect a change became interested, he would contact a doctor, perhaps a cancer specialist, who had seen and believed the A.M.A. report, and the doctor could only say he'd seen a report proving Krebiozen worthless. How could the doctor be aware that the article, not Krebiozen, was a fraud? How could he know that five patients examined by the author of the report (but deliberately omitted from it) were free from any detectable cancer after 5 years, due to treatment with Krebiozen? Reference: The Incredible Story of Krebiozen by Herbert Bailey, 1958
216
"The A.M.A. will not answer specific questions concerning Krebiozen." The reporter's s comment: ''. . . it sounds a bit like the A.M.A. is pleading the Fifth Amendment." Mr. Bailey's first book on the subject: K- Krebiozen- Key to Cancer? 350 "...My first book K - Krebiozen - Key to Cancer? (:)...An ad for the book placed in the Times ...the freest of the large circulation newspapers...The Times categorically refused a second ad...The Time's medical counselors had advised against accepting an ad..." "...I went to the Main Branch of the New York Public Library, the largest in the world. The librarian- in- charge advised me that...the author 'went against' the AMA (and) it was decided that this book (K- Krebiozen..) was to be 'taboo'." - Dr. Ivy. "Over the next three years, Krebiozin was destroyed. But to destroy Krebiozin you first had to destroy Andrew Ivy. How do you destroy the most influential, respected scientist in the United States? You get friends in the media. You get rid of his academic affiliations. You start a whisper campaign. And next thing you know, nobody wants to know the man. It took about five years, then they brought him up on a trial of fraud. It was at that point the longest medical trial in the United States' history. At the end of it, the jury found Ivy and the Durovic brothers innocent. Not only that, but they found the FDA irresponsible. And the jury actually made a statement, which is rare, about the contempt that the FDA had for honesty in what it did at trial." Fascism in Medicine by Gary Null, Ph.D 351
Bailey Names: The intrigue involved in this story is of melodramatic proportions. There are monitored phone calls, South American undercover agents, falsified medical reports, threats of deportation and suggestions of influence by the Vatican. The story is all written out, and every word is documented by Mr. Bailey. The villains are painted with certainty and positively identified. No innuendo or veiled references are employed to shield the author from possible libel or slander, yet in spite of Mr. Bailey's invitations, no single action of this kind has ever been instituted. To illustrate: a reporter on the staff of the New York Post, after reading the indictment contained in Mr. Bailey's first book on the subject: K- Krebiozen- Key to Cancer?, called the A.M.A. for specific answers to specific questions, such as, "Does J. J. Moore deny that he formed a conspiracy to gain control of Krebiwen?" or, "Does the A.M.A. deny that its official report against Krebiozen was falsified?" and was met with this stock answer: "The A.M.A. will not answer specific questions concerning Krebiozen." The reporter's s comment: '' . . . it sounds a bit like the A.M.A. is pleading the Fifth Amendment." A Book Is Buried: Tile negative attitude of the A.M.A. toward Krebiozen showed itself in the fate of Mr. Bailey's first book on the subject. The New York Times accepted one advertisement for the book, and then refused subsequent ads on the recommendations of its medical advisors. A favorable review of the book was written by the same paper's Reference: The Incredible Story of Krebiozen by Herbert Bailey, 1958
217
"No one seems to care. Certainly, no one in the million dollar fund- raising cancer clinics are excited over the almost miraculous ...record of...Krebiozen..." "Maybe the raising of millions of dollars of funds for charitable projects has become 'a racket', and the longer they remain in the test- tube stage of development, the longer patronage and job payrollers remain in their soft berths." "...this charity...They quibble too much over procedures...while we seek a cure. They complain too loudly against another who, seemingly, has perfected a work that the public expects its charity dollars to do. Maybe we should investigate the American Cancer Society's operations." "..Dr. Andrew C. Ivy, (is) the champion of the scientific doctrine of freedom of research, which has suffered in recent years through the falsity of certain politico- physician leaders of the AMA, who faked reports, suppressed honest information, brutally slugged the opposition, both physically and through pressures, used to prevent the truth about Krebiozen reaching the American people." - US Congressman Roland V. Libonati, Congressional Record, 1959.
science editor, but it never appeared in print. An unfortunate review followed. The New York Public Library, one of the world's largest, kept the book off its shelves until nearly a year after its publication, because of its "controversial" content. To underline the precariousness of being connected with such a book, the records will show that the publishers of K- Krebiozen- Key to Cancer were out of business within a year of publishing it. Dr. Ivy was having similar problems in publishing a monograph in which he reported on 687 patients over a six year period that had been treated with Krebiozen. The work showed observable benefits in 70% of the cases, and directly objectively beneficial results in 50% of the cases. Dr. Ivy sent an article based on this monograph to one medical journal after another- - - remember this was news on an effective treatment for cancer! - Only to have it returned with apologies and excuses for not being able to publish it. The monograph was finally published by a small general publisher, Henry Regnery, Chicago. Instead of headlines and excitement over the proven claim that Krebiozen had destroyed cancer cells in half of the patients treated with it, the monograph was greeted with apathy and indifference. The American Cancer Society officially announced that it would stand by the A.M.A. verdict of 1951 in the matter, as did others whose opinion could have helped foster interest or general acceptance. Misrepresentations Detailed: The stories of Krebiozen's fight for acceptance against organized medicine are catalogued in A Matter of Life or Death up to l957. They are too numerous for even a brief mention of all of them here, however the details of a correspondence between three Sloan- Kettering cancer specialists and a Mrs. Dorothea Seeber on behalf of a friend in the last stages of cancer are typical- - - Mrs. Seeber wrote a letter asking Sloan- Kettering doctors their opinion of Krebiozen and whether it would be advisable to use it on a "hopeless case." One doctor, whose signature is printed with his Reference: The Incredible Story of Krebiozen by Herbert Bailey, 1958
218
letter, as are the others, answers that "We tried it (Krebiozen) on 100 patients and I regret to say that we could not substantiate any of the claims ascribed to its use. Another answer said, "I have had only a few patients who have been tried on Krebiozen, and there was no improvement in their condition." A third wrote: "A considerable amount of work has been done on this drug and we found it is absolutely worthless." An affidavit by Dr Ivy is printed in the same chapter in which he swears that these three doctors NEVER ASKED FOR NOR RECEIVED any Krebiozen for use on cancer patients and could not, therefore, have come to any firsthand findings concerning it. Until 1956, the date of the affidavit, not a single ampule of Krebiozen had ever been sent to the SloanKettering Institute! As this book was written, Dr Ivy was making every worthwhile effort to get the A.M.A. to run a blind experiment on Krebiozen, the type in which neither the doctor nor the patient is aware of whether or not the injection he gives contains the substance being tested. The experiment would be set up by AMA experts; thev could choose the doctors and the patients, and the results would be published for the entire world to see if Krebiozen is a miracle or a fraud. As yet the AMA refuses to have any part of such an objective test. Why? The last chapter of the heroic Krebiozen story is yet to be written. When it is, it will be a humiliating admission to the American people that the most powerful medical authority in the world saw fit to deprive of a proper investigation a promising, now- proven, non- toxic cure for cancer, due to personal motives of one of its highest officials. It will also tell the GLORIOUS STORY of selfless men who sacrificed everything- money, security, position and reputation- in the attempt to get Krebiozen to those who need it. These and other heroes and villains will be brought to light. When this story is told openly, and to the world, the indignation and scorn that will be heaped upon those responsible for holding back Krebiozen defies the imagination.
Reference: The Incredible Story of Krebiozen by Herbert Bailey, 1958
219
Herber Bailey on Krebiozen: An Interview (The following information was excerpted from an interview by Mike Wallace. Mike Wallace interviewed Herbert Bailey, author of the book, A Matter of Life or Death (G.P. Putnam's Sons,1958), about the conspiracy to trash Krebiozen. The interview was published in "The New York Post" in 1958.)
Wallace: For years, you and a small group of scientists have been trying to gain recognition for Krebiozen, which you claim has apparently arrested and sometimes even cured cancer. Yet the medical profession as a whole has rejected Krebiozen. Why? Bailey: Because of the American Medical Assn. According to sworn testimony before an Illinois State Legislative Commission, the top echelons of the AMA have engaged in a deliberate conspiracy to prevent Krebiozen from getting a fair chance to prove itself. Wallace: The AMA is opposed to disease as much as any group in the country. Why should it try to ruin the chances of a possible cancer cure? Bailey: The reason is shocking beyond all imagination. The present treasurer of the AMA, Dr. J.J. Moore, tried several years ago to secure distribution rights to Krebiozen, because he knew how effective it was in experimental cancer cases. Moore and two businessmen offered $2,500,000 for the rights, but the discoverer of the drug, Dr. Steven Durovic turned down the offer. Ever since then Dr. Moore, through the AMA, has tried to discredit Krebiozen and everyone connected with it. Wallace: Has Dr. Moore or the AMA ever sued you for making such charges, or for publishing them in your book? Bailey: Of course not. What I say is true. And because it's true these men don't want any public airing of the issue in a court of law because it would blow the whole thing wide open. Their hope is to ignore the problem completely, making no comment, so that the issue will die of neglect. Wallace: But what about the thousands of dedicated physicians, the drug companies, the American Cancer Society, the science editors of newspapers? Why haven't they protested against this alleged conspiracy?[/i] Reference: An interview with Herbert Bailey, author of the book, A Matter of Life or Death about the conspiracy to trash Krebiozen.
220
Bailey: Once again, because of the enormous power of the AMA. Practically every doctor in the country belongs to it, and they're afraid of reprisal or expulsion if they defend Krebiozen. I know of 300 doctors who have treated patients with Krebiozen, but they tell me, "For God's sake; don't publicize my name, because I'll be kicked out of the AMA." And of course many doctors, through sheer ignorance, just don't know the facts. Wallace: What about the other groups? Bailey: The American Cancer Society has accepted the false cliams of the AMA, and most of the science editors of newspapers fear that if they tackle this issue head- on they'll be cutting off their main sources of medical information, which happen to be controlled by the AMA. Wallace: How can you be sure Krebiozen isn't just another quack cure? Bailey: Let's get this straight. We're not sure of anything. Mainly because we've been unable to get the cooperation of organized medicine to complete experiments. But we do know that starting in 1951, Krebiozen treatment was given to 320 patients with terminal or far- advanced cancer which had failed to respond to orthodox treatment. Fifty of those patients are alive today and cancer- free. Hundreds of other patients have also been helped. The chief sponsor of Krebiozen in this country is an internationally renowned scientist, Dr. Andrew C. Ivy, head of the Department of Clinical Science at the University of Illinois and a former director of the American Cancer Society. And that's good enough for me. Wallace: What do you think should be done about this controversy? Bailey: The only answer is a Congressional investigation of the whole problem, including the role played by the AMA and its Treasurer, Dr. J.J. Moore. I'm positive that such a probe would have the same kind of effect as the recent Congressional investigation of Dave Beck and the Teamsters Union.
Reference: An interview with Herbert Bailey, author of the book, A Matter of Life or Death about the conspiracy to trash Krebiozen.
221
„The work of Dr. Wachtel remains forgotten."
Henry K. Wachtel, M.D. was a New York City medical doctor and an independent researcher in cancer. He Discovered and patented a lipid substance from the pituitary under the name Antineol
(~ 1950 AD) Henry K. Wachtel, M.D. Working Summary: remarkable hormonal functions of the pituitary, it would indeed be possible for posterior pituitary extract to quicken body absorption of nutrients and accelerate waste elimination processes—for that is what that hormone normally does.
Books: The Role of the Pituitary in Cancer by Henry K. Wachtel, M.D., William- Frederick Press, 1954 (The following information is excerpted from: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell, Pilgrims Books, 1998 USA) 68
Dr. Wachtel, of New York City, was a vigorous opponent of the virus theory of cancer. Instead, he believed that cancer was caused by certain pathological changes in the metabolism, resulting from some normally harmless factors which, under certain circumstances, tend to induce the development of cancer. Frankly, that summary (derived from Wachtel’s 1954 book, The Role of the Pituitary in Cancer), could apply to about anything. A primary question here would be what were those circumstances? Part One of this present book clearly outlines a wide variety of circumstances, in diet and way of life, which have since been shown to greatly increase or lessen the likelihood of cancer. But, Reference: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell 1998
222
"The Endocrine System and Hormone Function Overview 1. The endocrine system is a major controlling system of the body. Through hormones, it stimulates such long- term processes as growth and development, metabolism, reproduction, and body defense. 2. Endocrine organs are small and widely separated in the body. Some are mixed glands (both endocrine and exocrine in function). Others are purely hormone producing. 3. All hormones are fat- souble (steroid)or water- soluble (amino acidbased) hormones. 4. Endocrine organs are activated to release their hormones into the blood by hormonal, humoral, or neural stimuli. Negative feedback is important in regulating hormone levels in the blood (…)." - Human Anatomy and Physiology, Endocrine System, http://www.lrn.org/
as the title of Wachtel’s book suggests, he thought that factors related to the pituitary were key causative agents in producing or preventing cancer. Noting that some species of animals are very cancer- resistant while others are quite susceptible, Wachtel felt that some humans were more resistant also. Interestingly enough, he cited certain factors which frequently appeared in cancersusceptible individuals, which are related to pituitary function: hyper alkalinity, hyperglycemia, changes in fatty sustenances, destruction of body proteins, breakdown of muscles, nitrogen levels which were imbalanced and too easily lost, and disorganized enzyme metabolism. But, rather than considering NUTRITIONAL AND LIFESTYLE factors, Wachtel maintained that such changes were due to pituitary disorders. So he prepared an acetone extract, drawn from the posterior lobe of the pituitary, and then prepared another extract from the anterior lobe. Injecting these into mice,—he found that the extract from the posterior lobe inhibited the growth of transplanted tumors; whereas extracts from the anterior lobe stimulated their growth! Also recall that, whereas Wachtel used pituitary extract to reduce cancerous growths, the Coffey- Humber extract was an adrenal extract. Wachtel was excited; he had made a great discovery.
Reference: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell 1998
223
"5. Blood- borne hormones alter the metabolic activities of their target organs. The ability of a target organ to respond to a hormone depends on the presence of receptors in or on its cells to which the hormone binds or attaches. 6. Fat- soluble (steroid) hormones directly influence the target cell's DNA by binding to receptor sites in the nucleus. Water- soluble (amino acid- based) hormones act through second messengers." - Human Anatomy and Physiology, Endocrine System, http://www.lrn.org/
Activity of the PITUITARY was thought to be the key to cancer growth or regression. At any rate, in 1950 Wachtel patented a lipid substance from the pituitary under the name Antineol. Using it, he found some improvement; and occasionally there was complete recovery. When Wachtel began to test his pituitary substance, he was removed from his post at Fordham University in New York City, and refused all future grants. In later years, Wachtel was outspoken in his claims, that the drug cartel had stopped his work. That concludes the available information on Dr. Wachtelâ&#x20AC;&#x2122;s treatment. At this point, it is of interest to turn to a physiology book and read up on the pituitary. Surely, there must be an answer to this mystery of extracts which enlarge or shrink tumors! But, doing so, you will find that the anterior lobe of the pituitary produces two types of growth hormones. Wachtel said that an anterior extract would increase tumor growth. No wonder; that extract contained normal growth hormones. Body growth is caused by hormones from the anterior pituitary. Lacking it, you would be a dwarf; too much produces gigantism. But what about the posterior lobes, which Wachtel said slowed malignant growth? That would be the important one to consider, since it was the one that shrank the tumors. Since the anterior produces growth hormones, does the posterior excrete or shrink hormones? (hypothetical theory) No, the posterior lobe operates in an entirely different manner: It is a special master gland which triggers the thyroid to increase metabolism all over the body! Carbohydrates and fats are digested more quickly; body heat is improved, along with a broad number of other factors. When Wachtel injected posterior pituitary extract, it would seem that he improved absorption of essential nutrients from the food, invigorated, and speeded body processes so the cancer cell could more easily be reduced.
Reference: Alternative Cancer Remedies â&#x20AC;&#x201C; Facts for Historians and Medical Researchers by Vance Ferrell 1998
224
„Dr. Beale was heavily ridiculed and forgotten."
Samuel Beale M.D. was a pioneering holistic physician from Massachusetts in the 1950s. He found out that insulin has an effect on other endocrine system and the influences which control it’s action and function. Serge A. Koroljow, M.D. was a New Jersey physician
(~ 1950 AD) S. Beale M.D., (~ 1960 AD) Serge Koroljow, M.D.
Working Summary: pioneer in cancer treatment with minute doses of insuline. And using its function for re- balancing the other parts of endocrine system. (The following information is excerpted from: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell, Pilgrims Books, 1998 USA)
Dr. Beale, of Sandwich, Massachusetts, was treating a near- gangrenous infection of the toe in a 63year- old patient, and found that the patient was slightly diabetic. When he began insulin injections, he found the toe improved dramatically, as well as the diabetes. When the patient’s diet was changed, the insulin was no longer needed, but the toe became worse. Beale began using small doses of insulin for healing ulcers and other serious skin breaks, with no dangerous side effects. Then he began treating cancer cases, ranging from minor skin cancer to cancers of the eye and breast. It is believed that the reaction caused by the insulin was increased oxidation. As the cell burned more oxygen, it had more energy. Since cancer cells lack oxygen, this Reference: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell 1998
225
"The molecular weight of Insulin is 39,000. It contains 10 of the essential Amino Acids. It is associated with anabolism and is in opposition to some of the catabolic glands. Perhaps because of its amino acid content, insulin appears to furnish the necessary material to repair defects in the nerve mechanism that transmits trophic impulses and thus aids in the restoring of a perverted cell to normal. Some of the indications of cancer susceptibiltiy are: 1. A defect in the metabolism of glucose. The sugar curve runs high in proportion to the degree of malignancy. 2. A disturbance of the calciumphosphorus balance. 3. Hyperalkalinity. (of the blood) (a tiny variation from normal) All the hormones are secreted in minute amounts and are tremendously potent. A teaspoonful of pure insulin would supply a diabetic, taking 40 units daily, for more than eight years. The balances of the body are delicate in the extreme. The variations from normal that constitute cancer susceptibility are so minute that the imagination fails to provide a tangible picture. The thyroid, secreting X mg. daily of thyroxin, would require 100 years to produce a dr achm. And the thyroid is a trifle over- active in cancer. (It is also the largest of the endocrine glands.) Having the delicacy of body balances in mind, it seems reasonable to expect to restore them with minute amounts of the right material. And insulin is that material (…)." - A paper written at the request of the British Associated Press and published in the News Review in London, England in 1947. By Samuel Beale.
burning may somehow have weakened those cells. Oddly enough, diabetics are no more likely than others to develop cancer, yet they have less insulin. Several years later, Serge A. Koroljow, M.D., a New Jersey physician, reported on his use of insulin in treating cancer (Psychiatric Quarterly, April, 1963). Koroljow reported that, in Germany, insulin is used routinely in the treatment of cancer. In Russia, the insulin treatment is used even more extensively. One Russian report described 16 cancer patients treated with insulin. Four recovered completely, 10 had temporary remission of 3- 6 months, and 2 showed no change.
Reference: Alternative Cancer Remedies â&#x20AC;&#x201C; Facts for Historians and Medical Researchers by Vance Ferrell 1998
226
"Insulin may be given once or twice each week in a dos'e of 3 to 5 units. Safe guides are the blood sugar and the blood pressure. In superficial growths, favorable results may follow injections directly under the growth. As a rule insulin should be used only as an adjunct to the accepted methods. A period of six weeks given to the use of insulin and the elimination of refined carbohydrates from the diet before the institution of surgery and radiation will be time well spent." A paper written at the request of the British Associated Press and published in the News Review in London, England in 1947. By Samuel Beale.
„The father of immune- augmentative therapy was ridiculed, suppressed and eventually Fraudulently accused of spreading AIDS contaminated serum."
(~ 1950 AD) Lawrence Burton, Ph.D. Working Summary: The pioneer of Immuno- Augmentative Therapy, four blood proteins to produce cancer remission. Dr Burton’s research that TNF (Tumor Necrosis Factor) was discovered. Lawrence Burton, 362 Ph.D. (1926- 1993 ) was a Zoologist who isolated fractions of blood serum, and developed, what he called, "immunoAugmentive Therapy," by injecting various blood products into cancer patients to stimulate the immune system.
Recommended Literature: Dr. Burton published sixty- five articles in peer review journals and was asked to be the keynote speaker at scientific conferences. (The following information is excerpted from: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell, Pilgrims Books, 1998 USA) 68
Born in the Bronx in 1926, Dr. Burton obtained a doctorate at New York University in 1955. (Frank Friedman, Ph.D.) Extracted a factor from the larvae of fruit flies which induced tumors in noncancerous insects. He then did research work at Cal Tech, New York University, and St. Vincent’s Hospital, where he was a senior investigator in the Hodgkin’s Disease Research Laboratory. In the late 1950s, he was back in New York with Friedman again, and they worked with others at St. Vincent’s in extracting a tumor- inhibiting factor from 227
"His studies led him to isolate certain naturally occurring factors—proteins in human serum—that cause tumors to grow and tumors to shrink. These factors are: 1. Tumor Antibody (Immunoglobulins: IgA, IgG, and IgM) 2. Tumor Complement Factor 3. Blocking Protein Factor 4. De- blocking Protein Factor It should also be noted that it was through Dr Burton’s research that TNF (Tumor Necrosis Factor) was discovered. Eventually, after a thorough study of how tumors grew and how they shrunk, Dr Burton was able to take these factors (some from healthy people and some from people with cancer) and create a serum that shrunk tumors. Here’s how the serum came about. Tumor antibodies are alerted to the presence of tumor cells by a protein produced by the tumor cells called TCF, or Tumor Complement Factor, which induces the tumor antibodies to destroy the tumor cells. Since this can be done in an unregulated manner, the body produces BPF, or Blocking Protein Factors, to shield the tumor cells and regulate the rate of tumor kill. This balance is further regulated by DPF, or de- blocking protein factor, an alpha 2 macroglobulin that neutralizes the blocking protein and permits antibodies to destroy tumor cells in a regulated matter (…)." - Lawrence Burton, PhD, Wellness Directory of Minnesota, Copyright © 2004, International Wellness Directory, www.mnwelldir.org 352
fruit flies. Oddly enough, the purpose of the research was not to find an anti- cancer agent, but to develop a method of speeding cancer experiments and thus save money. Then they extended these findings to mice. Using similar techniques, they extracted a factor from mouse blood which caused LONG- TERM REMISSION of cancer in mice. Burton reported on it in June 1959. The research team was utterly astonished! Within hours, the animals’ CANCERS would begin to disappear! According to Rottino’s later (1978) report, the research was new, original, and dramatic. In each case, the cancer would eventually return— but the fact that, for a time, it would diminish seemed astounding. They then used some of that factor from mouse blood and applied it, in vitro, to human cancer—and it shrunk down also. This factor consisted of four proteins which they had isolated in both mouse and human blood. These substances they called de- blocking protein (DP), tumor antibody 1 (TA1), tumor antibody 2 (TA2), and tumor complement (TC). Burton claimed that, when used in the right combination, these four substances could restore the normal immune function in cancer patients.
Reference: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell 1998
228
"However, this is a very balanced process and it can be upset by one or two or even all three factors getting out of hand, and when this occurs, the individual is said to be immunosuppressive or immunodeficient. It is in this state that cancer advances uncontrolled. One did not need to measure TNF levels to determine the condition of a patients immune system, though TNF is a factor in the serum Burton created to shrink tumors. Since controlling a tumor’s growth was a matter of balance, Burton designed a computer program that could take a patient’s current blood condition and measure immune system function. This, however, was done in the day prior to micro computers and a huge system was required to make these calculations. Today, one could design a simple machine (not unlike those used by diabetics to read their levels) that could get a thorough reading in a matter of seconds. Once knowing how the system was imbalanced, Burton could design a serum using the four factors, plus TNF that would shrink the patient’s tumor. Again, it is important to know that he got the factors for his sera (plural of serum) from human blood: TCF is obtained from the serum of persons with cancer; DPF and tumor antibodies are obtained from serum of persons without cancer; the rest can be gotten from either. Dr Lawrence Burton developed a system that could shrink tumors in the early sixties, long before President Nixon began funding the War on Cancer." - Lawrence Burton, PhD, Wellness Directory of Minnesota, Copyright © 2004, International Wellness Directory, //www.mnwelldir.org 352
Almost immediately, the Sloan- Kettering Institute sent men to see them. When the researchers at St. Vincent’s turned down their requests to sign contracts, all public and private research grant money to the hospital was suddenly terminated. The St. Vincent’s team switched from leukemic mice to animals with spontaneous breast cancers. Injecting their mouse- derived tumor- inhibiting factor into animals with rock- hard breast tumors, they watched in amazement as the growths become soft, spongy, and disappeared within a day or two (…).
(Reference: The following information is excerpted from: Lawrence Burton, PhD, Wellness Directory of Minnesota, http://www.mnwelldir.org) 352
(…) Invited by the American Cancer Society to a national seminar of oncologists, Burton brings along cages of mice all with visible tumors. In front of the esteemed oncologists he injects the mice and the next day, they have no visible tumors. "Fraud," some cried out. Burton offered them to bring in their own mice. He offered them the sera saying, "You inject them". No one took him up on his offer. In front of prominent scientists and reporters from across the nation, Burton picked up four mice with 229
Immune Augmentation Therapy Detailed Scientific Review "Summary: A review of the literature identified two articles on IAT. One was a best case report on 11 patients with pathologically confirmed peritoneal mesothelioma6. IAT was injected and survival was assessed. The patients reported a mean survival of 30 months, ranging from seven to 80 months. This was compared to a survival range of one to 60 months in the literature. In the second article, 79 patients with metastatic disease who had taken IAT were surveyed by phone to assess survival. Fifty were alive an average of 65 months after diagnosis; the 29 that died survived an average of 59 months. Some patients reported quality of life improvement7. No statistics were reported in this article." Source: The University of Texas MD Anderson Cancer Center 353- 360 Report of a survey of patients receiving immuno- augmentative therapy. Results: Of 23 patients tested for hepatitis B antibody, four tested positive. Of 24 patients tested for the HIV antibody, one reported a positive result. About a third reported being more ambulatory and another third reported improvement in appetite following first visit to the clinic. One half reported no change in their performance status. The patients in the study began IAT an average of 17 months after diagnosis and 50 of the 79 patients (63%) were alive an average of 65 months after diagnosis. The 29 deceased patients survived an average of 59 months. Source: The University of Texas MD Anderson Cancer Center 353- 360 Cassileth BR, Trock BJ, Lusk EJ, et al. 1987 360
large, bulging tumors and injected them with what he called a "de- blocking" agent. An hour later, the skeptical audience gathered around—and saw the TUMORS nearly gone. In a couple more hours, they were COMPLETELY GONE. Reporters suddenly rushed from the room and manned the phone banks. Banner headlines in Los Angeles read "15- Minute Cancer Cure for Mice: Humans Next?" (Burton later claimed that the American Cancer Society received an additional $4 million from the public for cancer research, following that announcement.) Six months later, in 1966, again under the auspices of the American Cancer Society, Dr Burton appeared before the New York Academy of Sciences and performed a demonstration in front of 70 scientists and 200 science writers. He injected cancerous mice with his serum and in just 45 minutes, the mice’s tumors shrunk 50%. An hour and a half later the tumors had practically disappeared. Newspapers around the world ran the story on their front pages while the prestigious peer journals got their story from an investigator for Sloan- Kettering and Dr Castle from the American Cancer Society (…).
Reference: Lawrence Burton, PhD, Wellness Directory of Minnesota, /www.mnwelldir.org
230
Study published by Quantum Medicine: A Journal of Comparative Therapeutics Purpose: Compared survival of (n=11) peritoneal mesotheliomas Type of Study: Case reports Methods: (Malignant mesothelioma) Subject population consisted of four females and seven males. Each of these cases were reviewed and analyzed. The patients had previous histological confirmation of diagnosis at laparotomy or subsequent confirmation at autopsy and a pattern of clinical responses compatible with malignant peritoneal mesothelioma. Upon assessment of the immuno- competence of the patients all 11 of them demonstrated a characteristic immunoprofile with elevated titers of prealbumin blocking protein factor and suppressed levels of an alpha 2 macroglobulin deblocking protein factor. All of the patients were given immuno- augmentative therapy by subcutaneous and intramuscular injection of human serum protein components derived from volunteer donors without neoplastic disease and of tumor complement factor derived from human serum of the persons with malignant mesothelioma. Results: All eleven subjects demonstrated a common response: weight gain and an increase of endurance for physical activity. Four males and one female were alive with survival times ranging from 22 to 80 months, with a mean of 43 months and median of 52 months. Of the other six cases mean survival was 23 months and median was 16 months, with a range of seven months to 50 months (…). Source: The University of Texas MD Anderson Cancer Center 353- 360 Clement, R.J., et al. Peritoneal mesotheliomas. 359
(Reference: The following information is excerpted from: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell, Pilgrims Books, 1998 USA) 68
(…) By the early 1970s, Burton and Friedman had developed a theory to explain what took place. Tumor antibodies (IgG gamma globulin, plus related IgA and IgM proteins) had interacted with de- blocking [unblocking] factors (such as alpha- 2- macroglobulin) and tumor complement. Burton gave it the name, Immuno- Augmentative Therapy (IAT). In 1975, Burton was offered an opportunity to test his method on humans. So he and Friedman left St. Vincent’s and founded the Immunology Research Foundation at Great Neck, New York. For a brief period, it appeared that the Burton- Friedman technique might be accepted (…).
(The following information is excerpted from: Lawrence Burton, PhD, Wellness Directory of Minnesota, http://www.mnwelldir.org) 352
(…) Then came the contract negotiations. The big wigs, NCI, Sloan- Kettering, and American Cancer Society wanted to buy it up from Burton. They’d give him grants and credit for it, but they wanted the rights. Burton turned them down.
231
The total subject population represents mean survival of 30 months with a range for all cases from seven months to 80 months. Authors compared these survival times to five reported series in the literature, ranging from one to 60 months. Source: The University of Texas MD Anderson Cancer Center 353- 360
Clement, R.J., et mesotheliomas. 359
al.
Peritoneal
"After my oncologist did all he could and finally gave up on me and sent me home to die, I turned to IAT ... not only did it save my life and led me into remission, but I feel great ... if only I had known about IAT in the beginning!" - Paraphrasing a few IAT patients using Dr. Burton’s clinic services http://yourlifeyourchoice.org/ 361 C.L.B. Delran, NJ, Malignant Melanoma "I was given 9 months to live with stage 4 Melanoma. Three months after my visit to ITL I was Cancer free. Miracles do happen in the Bahamas. I can not Thank you enough!" The following is the results from Carol’s CT Scan and PET/CT fusion imaging dated November 1, 2005: "There are no focal areas of hypermetabolism seen to suggest residual/recurrent disease. The previous areas identified on September 2, 2005 including right anterior abdominal wall, right forearm, and right shoulder are no longer appreciated… There is no evidence of residual/recurrent disease at this time. All areas of increased uptake on previous PET scans are no longer appreciated and have resolved." - An IAT patients using Dr. Burton’s clinic services http://yourlifeyourchoice.org/ 361
And overnight, Burton became the enemy. The funding stopped. Invitations to speak vanished. Publications refused to publish. The attacks began. Burton, nearly broke, had to stop his work. Instead he focused on opening a clinic to cure cancer. It took him a while, but in 1974 he opened a clinic in New York. Curing cancer in mice is one thing, but in humans it was much more difficult. Without his research funds, he was working in the dark. However, he was still able to realize a 50% success rate and received patients from physicians around the country. This was a remarkable rate considering that oncologists everywhere realized a success rate equal the success rate of patients with cancer who did nothing: 33%. Overall, within two years, because of harassment from the FDA (that sordid mistress to moneyed interests), Dr Burton was FORCED to close his clinic and he left the United States of America to find freedom. (Ironic, eh?) Burton opened a clinic in Freeport, Commonweal of the Bahamas in 1977. The Immunology Research Centre, Ltd was a nonprofit corporation, licensed to treat patients diagnosed with cancer (â&#x20AC;Ś).
Reference: Lawrence Burton, PhD, Wellness Directory of Minnesota, /www.mnwelldir.org
232
E.P. Malignant Pleural Mesothelioma Diagnosed June 2001 "After being blindsided by the diagnosis of Malignant Mesothelioma, a fatal cancer caused by asbestos exposure, I researched every traditional option. However all treatments pointed in the same direction. Traditional medicine offers no successful treatment for this type of cancer. I tried six months of chemotherapy however my body could not withstand the toxicity of the chemo drugs. Just as I was giving up hope I was introduced to a local gentleman who eight years prior received treatment through the IAT centre and is cancer free today. It has been two years since I began my treatment with IAT. I feel the combination of the treatment, my faith and the patient camaraderie is responsible for my survival of this almost always fatal disease. Today my life is good and my future is hopeful." - An IAT patients using Dr. Burtonâ&#x20AC;&#x2122;s clinic services http://yourlifeyourchoice.org/ 361
(The following information is excerpted from: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell, Pilgrims Books, 1998 USA) 68
(…) After setting up practice in the Bahamas, with a physician assistant, Burton claimed to be having good success. But his patients were all from overseas, and he did no follow- up studies, nor bothered to issue ongoing written reports of any kind. He was able to be a law to himself since the government loved the way he was bringing in so many tourist dollars. He did not have to report to anyone. But he did later claim that, of the 186 patients earlier treated in Great Neck between 1974 and 1977, 30 (16%) had what he termed "miracle remissions— they exhibited no sign of cancer." Some 79 80 others experienced tumor regression, and there was at least a partial stoppage of tumor growth in 60% of those treated. Only 8 of the 186 were not deemed "terminally ill," at the time of treatment with Burton’s method. Regarding his work in the Bahamas, John Beaty, M.D., of the Greenwich Hospital, Greenwich, Connecticut, who also taught medicine at Columbia University, sent 20 advanced patients to Burton. Beaty later told science writer Robert Houston that 10 of the 20 underwent tumor regression. "All ten owe their very survival to Dr. Burton’s treatment. . . They also showed tumor shrinkage, appetite improvement, weight gain, and loss of pain" (Robert Houston, "The Burton Syndrome," Our Town, April 22, 1979). When a prominent Israeli researcher sought to duplicate Burton’s methods in the late 1960s, Burton and Friedman refused to send him instructions for isolating the fractions of blood serum— the key step in the whole process, and the one most difficult to arrive at empirically. Burton’s response: "What if something went wrong? We’d be hung without a trial." In the summer of 1978, Burton asked Dr. Arthur Upton, the new National Cancer Institute director, to work with him. Wealthy sponsors would put up $1 million for Burton to treat 1,000 patients. These would be chosen by NCI as very advanced Reference: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell 1998
233
cases, sent to the Bahamas for treatment, and afterward returned to NCI for examination. NCI rejected the offer, declaring that Burton needed first to send them reports on all his cases, to date. Ignoring them, Burton went back to work. NCI was probably glad he did. But so much success was occurring that, in July 1985, NCI and several other U.S. health agencies, talked the Bahamian government into closing down Burton’s clinic. Government leaders were told that blood products everywhere were contaminated with AIDS, and therefore Burton’s work (which used four proteins from blood) must be stopped (…). As for Burton’s clinic, it was a short- lived victory for U.S. medical interests. In February 1986, the clinic reopened. (What NCI had not initially told the Bahamian government was that all the blood banks and hospital blood supplies in America were slightly tainted with HIV at the time, yet none of them were closed down.) Burton died in 1993, but his Immuno- Augmentative Therapy is still available at the clinic he founded in Freeport on Grand Bahama Island. Gustavo Andrade, M.D., of Tijuana, Mexico, is another physician who has had extensive clinical experience using the IAT method.
Reference: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell 1998
234
„Dr. Blumer was a strong advocate of chelation therapy."
Walter Blumer, M.D. was a prominent medical practicioner in Netstal, Switzerland. who became the advocate of chelation therapy. He showed that patients receiving a minimum of 30 oral treatments experienced an 85% reduction in cardiovascular events and a 90% reduction in new malignancies when compared to individuals in the same village who did not receive the treatments.
(~ 1960 AD) Walter Blumer, M.D. Working Summary: The Pioneer of Chelation therapy, a systematic removal of heavy metals (such as lead, mercury, nickel) from the body, thus reducing the likelihood that cancer will develop. Books: A textbook on EDTA Chelation Therapy by Walter Blumer M.D. (2001) (The following information is excerpted from: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell, Pilgrims Books, 1998 USA)
Beginning in 1958, a lengthy research study was conducted in Switzerland on 231 adults which lived in areas with a higher than average cancer mortality rate. (It is of interest that those areas were homes along heavily traveled highways. People living in traffic- free areas had a lower cancer rate!) These individuals also had a higher incidence of headaches, fatigue, nervous disorders, gastrointestinal problems, depression, and substance abuse. The researchers suspected that their higher exposure to lead from car exhausts might be the cause of the problems. In 1961, 59 of these people were given 10 or more EDTA Chelation treatments plus vitamins C and Reference: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell 1998
235
Ninety Percent Reduction in Cancer Mortality after Chelation Therapy by Walter Blumer, M.D., Elmer Cranton, M.D., ABSTRACT: Mortality from cancer was reduced 90% during an 18- year follow- up of 59 patients treated with Calcium- EDTA. Only one of 59 treated patients (1.7%) died of cancer while 30 of 172 non treated control subjects (17.6%) died of cancer (P=0.002). Death from atherosclerosis was also reduced. Treated patients had no evidence of cancer at the time of entry into this study. Observations relate only to long- term prevention of death from malignant disease, if chelation therapy is begun before clinical evidence of cancer occurs. Control and treated patients lived in the same neighborhood, adjacent to a heavily traveled highway in a small Swiss city. Both groups were exposed to the same amount of lead from automobile exhaust, industrial pollution and other carcinogens. Exposure to carcinogens was no greater for the studied population than exists in most other metropolitan areas throughout the world. Statistical analysis showed EDTA chelation therapy to be the only significant difference between controls and treated patients to explain the marked reduction in cancer mortality. Edta is well recognized as a therapy for lead toxicity. EDTA also removes other toxic heavy metals and nutritional elements such as iron which promote cancer by catalyzing free radical pathology (…). - Walter Blumer, M.D., Elmer Cranton, M.D., Journal of Advancement in Medicine 363 Reference List 364- 389
B1, while another 172 persons, untreated, served as a control group. Over the following 18 years, follow- up studies were conducted by Dr. Walter Blumer of Nestal, Switzerland, which revealed that only one of the 59 treated patients died of cancer (1.7%), comparedwith 30 deaths (17.6%) from cancer among the non-treated subjects. This is equivalent to a 90% reduction in cancer mortality. (In addition, Blumer found that death from atherosclerosis— hardening of the arteries—was also reduced.) (See Study Details) The Treatment: What is Chelation? It is a method of ridding the body of unnecessary and toxic metals. By removing toxic metal ions, it reduces internal inflammation caused by free radicals. This reduces the discomfort and disability from degenerative diseases such as arthritis, scleroderma. It helps reverse gangrene, alleviates intermittent claudication (cramps) of the legs, restores memory, and significantly reduces serum cholesterol (…). By 1948, the U.S. Navy began using EDTA to treat lead poisoning. Aspirin has been found to be 3½ times more toxic than EDTA. The Chelation method, primarily used by physicians, is EDTA (ethylenediaminetetraacetic acid) and is given by intravenous infusion. Over 500,000 patients have Reference: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell 1998
236
(…) Lead from automobile exhausts, petrochemicals form wear of automobile tires, cadmium, and other carcinogens are present in higher concentrations adjacent to heavily traveled automobile highways. These substances cause cancer and potentate other carcinogens. It was reported in an earlier paper that cancer mortality among 231 adults living along a heavily traveled highway was higher than among persons living in a traffic- free section of the same city1 Nervous disorders, headaches, fatigue, gastrointestinal disorders, depression, and substance abuse was also observed with higher frequency.2 It was postulated that lead exposure from automobile exhausts might be one cause of this difference. Beginning in 1961, a group of 59 patients with such symptoms was treated with parenteral doses of Calcium EDTA. Symptoms improved and urinary delta- amino levulinic acid diminished. Statistical Data: A group of 231 adults was studied beginning in late 1958. All resided along the main highway in a small Swiss city with a total population of approximately 3,000. Of these 231 people (105 men and 126 women), 31 persons, (17 men and 14 women) died of malignant tumors during the 18- year observation period (1959- 1976). Causes of death included 4 cases of bronchogenic carcinoma, 5 of colon carcinoma, 5 of gastric carcinoma, 2 of beast cancer, 3 of ovarian carcinoma, 1 of pancreatic carcinoma, 2 of pleural endothelioma, and 9 cases of other types of cancer. In all but one case, histopathological diagnosis was confirmed by a hospital pathologist (…). - Walter Blumer, M.D., Elmer Cranton, M.D., Journal of 363 Advancement in Medicine Reference List 364- 389
received it during the past 40 years. However, no drug firm will bother with it, since the patent on EDTA has expired. Therefore, it continues to be ignored by the American Medical Association Adverse Effects of Chelation Therapy (Excerpted from: EDTA Chelation Article, Vitamin Research Products Inc. 2001, http://intelegen.com 407 Reference List 390- 406)
The most serious potential adverse effect of EDTA Chelation is nephrotoxicity (kidney damage). This is dependent on the dose, the rate of infusion, the patient's kidney function, and the patient's body burden of toxic heavy metals. Kidney damage was not uncommon in the early days of Chelation therapy, when doses of EDTA in the range of 5- 10 grams per day were used, and treatments were administered as often as 5 days per week. Kidney damage can be easily prevented, however, by carefully adjusting the frequency, dose and rate in which the EDTA is administered. In addition, I have found that judicious administration of EDTA over prolonged periods (three to six months and longer) actually improves kidney function. Other potential adverse effects include hypocalcemia (excessively low blood levels of calcium) due to EDTA's binding excessively with calcium in the blood; hypoglycemia (low blood sugar), believed to be Reference: EDTA Chelation Article, Vitamin Research Products Inc. 2001
237
Twenty- eight of the deceased individuals had lived for 10 or more years directly adjacent to the highway and most were normally present in their homes for 24 hours of every day. Fifty- nine adult study patient received ten or more injections of 1.9 gm calcium EDTA plus vitamins C and B1 From 1959 through 1976, only one (1.7%) of patients treated with EDTA died from cancer. In comparison, of 172 untreated control subjects who had not received calcium EDTA, 30 (17.4%) died from cancer. This represents a ten- fold greater incidence of cancer mortality in untreated persons (P=0.002). The two groups were similar in all other respects. (â&#x20AC;Ś) Discussion: The fact that an identical group treated with EDTA experienced a 90% reduction in cancer mortality, as well as a reduction in death from all causes was also confirmed. The fact that the general mortality as well as cancer mortality was lower in treated than untreated individuals was also confirmed by Knutti and Schlatter.374 Their proposed explanation was that treated patients might possibly have been more health conscious or under better medical care, but this does not seem an adequate explanation of the recorded facts. Residents of less polluted areas experience a lower cancer mortality, despite the same level of medical care. Evidence presented in this paper indicated that (1) EDTA removes cancer causing or promoting substances, from the body, and (2) those substances are correlated with environmental pollution from vehicular traffic (â&#x20AC;Ś). - Walter Blumer, M.D., Elmer Cranton, M.D., Journal of Advancement in Medicine 363 Reference List 364- 389
due to accompanying hypocalcemia; and phlebitis (inflammation of the vein) usually due to improperly prepared solutions. Rarely reported side effects include chills and fever following infusion, exacerbation of congestive heart failure due to fluid overload, fatigue (usually due to hypoglycemia or hypocalcemia), seizures, arrythmias, or rash. Although these have been reported occasionally by others, I have never observed any of these rare side effects despite having administered thousands of IV EDTA treatments. The risk of incurring any of the above adverse effects has further been greatly reduced by the recent finding of Drs. Grant Born and Tammy Geurkink 390 that even greater benefit can be obtained by most patients who are treated with only 1.5 grams of EDTA per treatment, rather than with the standard dose of three grams. These physicians randomly divided 30 patients into two groups, each of which consisted of eight males and seven females. One group was treated with "high dose" EDTA (3 grams), and the other was treated with "low dose" (1.5 grams) (â&#x20AC;Ś). After 20 EDTA treatments, every patient in the high dose group improved significantly. Strikingly, every patient in the low dose group also improved, and this group had an even greater degree of overall improvement! Reference: EDTA Chelation Article, Vitamin Research Products Inc. 2001
238
"The overall reduction of death from all causes and increased longevity I the EDTA treated group shows that chelation therapy also reduces other common causes of mortality such as atherosclerosis and cardiovascular disease (â&#x20AC;Ś). Lead potentiates the carcinogenicity of aromatic hydrocarbons such as benzopyrene by five fold. 18 areas adjacent to heavily traveled highways are polluted with many other carcinogens, including polycyclic aromatic hydrocarbons, nitrosamines, epoxides, cadmium and asbestos, in addition to inorganic and tetraethyl lead. Since the data from this study were last reported, 5 new research has linked cancer to free radical pathology. 382- 384 EDTA removes transition elements, such as iron, which accelerate free radical pathology, including cancer. Iron is an essential nutritional element but it is also know to accumulate with age. Catalysis of lipid peroxidation by iron potentiates the cancer promoting substances. EDTA increases the urinary excretion of unbound and freely catalytic iron 10 times more then it does lead. There are many reasons why EDTA chelation therapy could act to prevent cancer. A recent publication by McDonagh, et al, 385 confirms improvement in a wide variety of symptoms, as first reported in this study population.385 Neurasthenic and nonspecific multi- organ symptoms improve significantly following EDTA chelation therapy, resulting in a marked improvement in the overall quality of life. Body stores of iron correlate with the risk of cancer.386- 388 and atherosclerosis. 389 EDTA removes unbound and potentially toxic iron from the body much more effectively than lead, 384 which may account for the findings in this study. - Walter Blumer, M.D., Elmer Cranton, M.D., Journal of Advancement in Medicine 363 Reference List 364- 407
„A biochemist successful in healing cancer dies on leukemia."
(~ 1960 AD) Mirko Beljanski, PhD Nuttshell: Inventor of a Formula Of RNA Fragments, practical application of these thories are completely new, powerful nontoxic drugs
Mirko Beljanski, PhD. (1923–1998) a FrenchSerbian molecular biologist, and the founder of the Beljanski Foundation; Charles Leopold Mayer prize in 1960 and has written 132 scientific articles pusblished in international journals.
Books: The Regulation of DNA Replication and Transcription, The Role of trigger Molecules in Normal and Malignant gene expression by Mirko Beljanski. Extraordinary Healing, How the discoveries of Mirko Beljanski, the world’s first green molecular biologist, can protect and restore your health by L. Stephen Coles, M.D., Ph.D., The Secret to Long Life in Your DNA, The Beljanski Approach to Cellular Health by Hervé Janecek, Ph.D. with Monique Beljanski.
(The following information is excerpted from: Biography: Mirko Beljanski, PhD. The Beljanski Foundation, Inc., The Beljanski Foundation | CIRIS http://beljanski.com) 408
Mirko Beljanski was born in 1923 in a small village in former Yugoslavia called Turija. His father Milan was a hard working mechanic who was very appreciated in the village while Dana, his mother, was a seamstress and very attentive to her children. Mirko was the only boy in the family and younger than his two
239
Testimonial: AIDS (Stage IV C2) and Hepatitis C "December 1984: I was at the hospital for an operation when I suffered a severe hemorage. Over 69 bags of blood were used to save my life. A month later, the first of a series of infections began, which ended up lasting four years. At the beginning of October 1988, my treating physician had me take an AIDS test. The results: positive, stage 4 C2. I had also acquired Hepatitis C from the blood transfusions. My doctor suggested letting the hospital take over from there. I categorically refused, ever conscious of the fact that even if my 1984 operation had saved my life, the transfusions had taken it away again. My doctor talked to me about a patient with the same illness who could no longer work because his condition had deteriorated so much, but who, following a new treatment, was doing much better and started working again: "I’ll try to find out the name of that product," he promised us. It was thus that we met Mirko Beljanski in his modest research laboratory in Ivry (...). Not long afterwards, I started to take his Pao Pereira, an antiviral product that he had developed himself. I took the latter regularly over the course of one month when, subtly and for the first time in years (since 1985 specifically), my urinary infections disappeared. Since the day I started taking the products, I have not gotten sick. My fatigue rapidly diminished, and I was able to starting working again. It is now 2010 and I’m still doing well." Reference: Beljanski Foundation, Testimonials Section, The Beljanski Foundation | CIRIS | All Rights Reserved. http://beljanski.com 409
sisters. He had a happy childhood; he loved school and was very studious. A serious student, Mirko obtained his Baccalaureate without difficulty. His dream was to go to France to continue his studies, but because of the civil war in Yugoslavia and the Second World War he was not able to leave the country until the age of 23. Then he immigrated to France to study biology at the Sorbonne. After receiving his PhD Mirko was hired as a research scientist with the CNRS (Centre National de la Recherche Scientifique- French equivalent to the NIH) to work at the Pasteur Institute. Mirko was very demanding of himself as well as others and was devoured by his passion for scientific research. When he was 26 years old Mirko met Monique Lucas, who was 19. He encouraged her to study biology and she came to work at the CNRS. After their marriage they began to work together under the direction of Professor Macheboeuf, who directed Mirko’s thesis. After Macheboeuf’s death in 1953 Jacques Monod became the director of the Pasteur Institute. This began a difficult phase for Mirko as Monod imposed his own ideas and methods on the Institute. Mirko Beljanski was one of the first molecular biologists to study RNA, which plays a dynamic role in cell regulation. In 1960 he received the Charles Reference: Biography: Mirko Beljanski, PhD. The Beljanski Foundation, Inc., The Beljanski Foundation | CIRIS http://beljanski.com
240
Testimonial: Leukemia Cancer Leukemia with a Bone Marrow Transplant "I express my profound gratitude to the work of Dr. Mirko Beljanski and his formulations. I strongly believe in the efficacy of their supplement products. I was diagnosed with lymphoblastic lymphoma (a serious form of leukemia) in 1987 and was hospitalized at the University Hospital Center receiving chemotherapy as my main treatment. Following that, I chose to have a bone marrow transplant rather than continuing chemotherapy whose duration no one could predict. Throughout the entire period, I used Beljanski’s formulations in addition to my treatment. My physicians were surprised to see how fast my white blood cells returned– on the 9th day after the transplant rather than on the 21st day as is commonly the case. And my departure from the hospital came more than a month before their earliest prediction. There was an enormous difference in my response to treatment versus those of other patients treated in the same way - but without the aid of the Beljanski approach. I continue to take these supplements two to three times per year as a maintenance treatment. For 15 years now, to the great astonishment of my friends who thought my situation was hopeless, I live a completely normal life in 2010." Reference: Beljanski Foundation, Testimonials Section, The Beljanski Foundation | CIRIS | All Rights Reserved. http://beljanski.com 410
Léopold Mayer prize for his work on the role of RNA IN PROTEIN SYNTHESIS. For 30 years he studied DNA and RNA function in depth and made numerous discoveries. For example, he discovered that reverse transcriptase exists not only in viruses but also in other organisms such as bacteria, fungus and fish. He developed the Oncotest, a biochemical test to evaluate the effect of environmental molecules on gene function and, above all, proposed a new vision of carcinogenesis, which was confirmed when he demonstrated that natural extracts had the ability to inhibit the synthesis of cancerous DNA without interfering with that of healthy DNA. Mirko Beljanski had to leave the Pasteur Institute in 1978 as his innovative ideas completely opposed those of its director. However, his ingenuity allowed him to pursue his research and to publish his findings in respected scientific journals. In total he published 133 original articles. Mirko continued his work at the ChatenayMalabry School of Pharmacy where he profited from his knowledge of cellular regulation to design supplements capable of helping sick people without harmful side effects. It was during this exceptionally fruitful period that he developed 4 extracts: Pao pereira, Rauwolfia Reference: Biography: Mirko Beljanski, PhD. The Beljanski Foundation, Inc., The Beljanski Foundation | CIRIS http://beljanski.com
241
Testimonial: Breast Cancer 4 Year in Remission December 9, 2005, I discovered a lump in the left breast. I got a diagnosis through an ultrasound and biopsy. The verdict was cancer, and my doctor suggested sessions of chemotherapy and radiation. After reflection, and because I didn’t feel comfortable with this treatment, in February 2006, I consulted another doctor who gave me more hope (...). On February 11, I started taking 18 gelcaps per day: 6 gelcaps 3 times a day, a half hour before each meal: 2 Pao pereira + 2 Rauwolfia vomitoria + 2 Ginkgo. February 14, I began a Breusee cure as I weighed 85 kg. It lasted 21 days and I lost 10 kg. This was quite a test, but I could overcome it. I went back on a normal diet and my new doctor prescribed a sensible crystallization which would confirm the arrest of the malignant process. I kept a chart of parameters that I find important and all is well. I reduced the dosage of Beljanski’s formulations in November 2006 to 9 per day (3 of each 3 times a day). In the case of biological decoding of my illness, I wrote 250 pages and that made me feel good. In 2010, morally and physically, all is well. The tumor is necrosed under the skin and it became very hard. I am thinking of leaving things in this state because it doesn’t really bother me, and I don’t envision undergoing surgery to have it removed because of the risk involved. After having taken control of my health, and as I like to give back to others, I am always speaking of Mirko Beljanski. It is my way of helping ill people and of recognizing this intelligent man. - Beljanski Foundation, Testimonials Section, The Beljanski Foundation, http://beljanski.com 411
vomitoria, Ginkgo biloba and a formula of RNA fragments. Mirko also showed that one of the extracts, Pao pereira, possessed anti- viral properties. So, he threw himself into the fight against HIV, the AIDS virus. In 1988 Mirko Beljanski settled in to the Centre de Recherche Biologique (CERBIOL) in Saint Prim, close to Lyon, where he perfected his extracts and their use. François Mitterrand, then president of France, turned to the Beljanski products during his battle with an advanced cancer of the prostate. Against all predictions his health improved and he was able to finish his second term as president. Dr. Claude Gubler revealed this secret in his book Le Grande Secret. After the passing of Mitterrand in 1996 the government came down on Mirko and put him under close scrutiny. The use of the Beljanski products in Europe caused the scientist to be the object of severe persecution, outlined in the book Mirko Beljanski or the Chronicle of a Scientific Fatwa Edition Trédaniel, Paris. As a result of these persecutions Mirko developed an aggressive leukemia. Without access to his own products, Mirko followed a TRADITIONAL TREATMENT and died in 1998. The bureaucrats never explained their arbitrary refusal to authorize Reference: Biography: Mirko Beljanski, PhD. The Beljanski Foundation, Inc., The Beljanski Foundation | CIRIS http://beljanski.com
242
Testimonial: Genevieve Tresse 5 years in remission It is time that I extend my thanks to CIRIS. Breast cancer was discovered in April 2005, and I had an operation in July 2005. The carcinome had spread, was grade 3, and my lymph nodes were very swollen. I refused treatment the first time, and then I agreed to radiation sessions. I stopped after 13 sessions. My body and my mind could no longer handle it. I met a young, attentive oncologist. I told her that I would do chemotherapy only if the cancer became metastatic. I saw when the metastases began. She called me in September 2005. OK. I did 3 of the 6 sessions. The diagnosis of the specialists were unanimous, and they estimated that I wouldn’t live beyond Spring 2006. I began to follow the Beljanski approach in September 2005 in conjunction with the anticipated program; it worked. Since then, all is well, and I continue to take Beljanski’s formulations. Very easy, very quick, a little costly but it was a choice. I sacrifice other things, but I follow the recommended treatment. As discussed, I didn’t think I’d live to see Spring 2006 (my oncologist didn’t think so either). I saw him that spring, I planted my garden, I lived in nature with the animals…I had a big family reunion in August 2006 and I will have another one, this year, in 2010. I lived accepting things, and I give thanks. I am 78 years old, and I believe that I will not die of cancer. Thank you Mirko Beljanski, I believe that that’s what worked. Thank you to all of the volunteers of CIRIS. - Beljanski Foundation, Testimonials Section, The Beljanski Foundation | CIRIS | http://beljanski.com 412
clinical trials on Pao pereira. Many sick people protested in the streets of Paris and Lyon to reclaim their access to the Beljanski products. The issue was brought before the European Court of Human Rights and, on February 7, 2002, the Court ruled unanimously in Beljanski’s favor in the case Beljanski vs. France. Mirko Beljanski devoted close to 50 years of his life to scientific research, always accompanied by his wife Monique who was his research assistant, as well as Doctors L. Le Goff, M. Plawecki et M. Y. Aaron- Da Cunha. When he made his discoveries concerning cancer dozens of doctors in France and Belgium associated with him to analyze how these extracts could compliment the classic protocols. Today Mirko Beljanski’s work continues in the United States, where his products are distributed by Natural Source International, Ltd. who makes a great effort to continue his research through clinical trials. Two such trials have just been concluded at Columbia University and the Cancer Treatment Centers of America with very promising results.
Reference: Biography: Mirko Beljanski, PhD. The Beljanski Foundation, Inc., The Beljanski Foundation | CIRIS http://beljanski.com
243
Testimonial: Bladder and Prostate Cancer And the doctor (not knowing I had taken the formulations created by Dr. Beljanski) concluded with a nod of his head "Yes, it’s a miracle!" I had my prostate removed in 1986 at age 64. Unfortunately in 1991 during a medical follow- up by the Department of Urology, Bordeaux University Hospital Center, tumors were discovered in my bladder and right prostate. Given this diagnosis, my doctors in both Bordeaux and Paris suggested a treatment by BCG drip. I thus underwent BCG drips at various frequencies for one year. However, my doctors didn’t know that in addition to these drips I was taking six capsules daily of Rauwolfia vomitoria. A generalist whom I had been advised to consult with prescribed this treatment to me. Thus, I am here today to attest to the efficacy of Beljanski’s formulations, and in particular Rauwolfia vomitoria in mastering prostate cancer. Medical statements made by my doctor at the Bordeaux University Hospital Center in 1995 reinforce my own comments. "It’s wonderful. I can confirm to you that there is no cancer left". Preventively to avoid any possible relapse, I still take three capsules daily of Rauwolfia extract and three capsules of Pao Pereira. As part of my medical follow- up, the doctors have observed that I even have a regrowth of normal prostate tissue. Thank you Dr. Mirko Beljanski for the tremendous opportunity you have given me. - Beljanski Foundation, Testimonials Section, The Beljanski Foundation | CIRIS | http://beljanski.com 413
„The work of Dr. Gold remains forgotten."
Joseph Gold, M.D., was a renowned NASA research scientist involved in space program. He dedicated his professional life researching the cachexia. He blocked a single liver enzyme from working—and that caused the cancer to die from starvation! Director of the Syracuse Cancer Research Institute
(~ 1970 AD) Joseph Gold, M.D. Working Summary: development of hydrazine sulfate as an anticancer drug.
(The following information is excerpted from: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell, Pilgrims Books, 1998 USA)
Dr Joseph Gold is an MD. He was also a research scientist for NASA, a US Air Force officer. When he left the military with a Presidential Citation from Eisenhower for his work in the space program, he had one goal, to answer the question: Is there a chemical way to stop cachexia? Gold had studied the work of Otto Warburg, and his theory of the nature of cancer cell metabolism. According to Warburg, all cancer cells live by fermenting sugar in what are essentially "airless" (anaerobic) reactions. Find a way of stopping this fermentation, and you will be able to stop the cancer. Later, in the 1950s, Dr. Dean Burk and associates at the National Cancer Institute had delved into Warburg’s contribution. Burk won a scientific prize for 244
What is Cachexia "First, cancer cells ferment glucose, a very inefficient mechanism. Second, as part of this fermentation, cancer cells create lactic acid. Third, this lactic acid goes to the liver. Fourth, this process also makes a cancer cell very acidic (which is why cancer cells do not like to be alkaline). Fifth, cancer cells are very inefficient at processing glucose, only about 5% as efficient, meaning they "waste" energy. Sixth, this wasted energy causes the cancer patient to become tired and malnurished. Seventh, this excessive use of glucose by a cancer cell is actually part of the process whereby cancer cells actually "steal" glucose from normal cells (cancer cells also steal nutrients from normal cells). Eighth, this means normal cells can literally starve to death, creating malnutrition and death. Note the vicious cycle in the above list. It is this cycle that causes the body to literally waste away. But there is another key part of the cycle: "Large tumours produce much lactic acid that is reconverted in the liver into glucose in a process that consumes much energy. It is of positive benefit to block this conversion by taking hydrazine sulphate or [cesium] chloride. The main benefits are weight gain and increased energy that are especially important in the last stage of cancer, called cachexia. In addition, tumour growth may be inhibited, in some instances tumours gradually disappeared." The Cachexia Treatment, www.cancertutor.com/ Copyright by Webster Kehr 416
demonstrating that Warburg was correct in his views about cancer ferments. (However, it was also discovered that, although rarely, cancer cells do use oxygen respiration; and, occasionally, some normal cells have fermenting mechanisms.) For a short time, oxalic acid (which blocked fermentation) was tried as a cancer remedy, but it failed. Like regular chemotherapy, it was so toxic that it injured regular cells as much as cancer cells. With all this information in hand, Joseph Gold went beyond either Warburg or Burk. He developed an enlarged theory: A primary cause of death from cancer is the weight loss and debilitation which occurs. The medical name for this is CACHEXIA. But why does it occur? If it could somehow to interrupted, the disease could be brought under control. But what causes cachexia? Why is the cancer patient reduced to skin and bones while his tumor grows vigorously? Orthodox medical theory had no answer to this. Here was Gold’s theory: Cachexia is the result of cancer’s ability to "RECYCLE ITS WASTES." But it does this by overloading the body with the task of trying to Reference: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell 1998
245
"Now we see another key part of the cycle, the liver converts the lactic acid back into glucose, and guess who eats much of this glucose? The cancer cells. But the conversion by the liver of the lactic acid back into glucose also takes large amounts of energy. Thus we can see a simplified picture of the entire cycle: 1) The cancer cells ferment massive amounts of glucose, which consumes energy, 2) They process the glucose with fermination, which is very inefficient, 3) A byproduct of this fermentation is lactic acid, 4) This lactic acid then goes into the liver, 5) The liver then converts this lactic acid back into glucose, consuming even more energy 6) Much of this glucose is consumed by the cancer cells and the cycle starts over. Here is another description: "Cachexia is the wasting away of the cancer patient's body. The person is reduced to skin and bones, while the cancer continues growing vigorously. What is happening is that the cancer incompletely metabolizes glucose, turning it into lactic acid ... This lactic acid (if it reaches the bloodstream) travels to the liver where it is converted back into glucose by a procedure that consumes an enormous amount of the body's energy. This happens over and over again as the cancer grows and the rest of the body wastes away. Hydrazine sulphate blocks a key enzyme in the liver that allows lactic acid to be converted into glucose."" - alkalizeforhealth.net/ 414, Article Source: The Cachexia Treatment, www.cancertutor.com/ Copyright by Webster Kehr 416
discharge those wastes. The resultant energy drain results in emaciation.(…) Gold attributed the problem solely to an excess of lactic acid: While regular cells use oxygen for energy, cancer uses glucose (sugar) as the fuel. But the result is fermentation. The sugar only partially metabolizes, or combusts. The waste product, which is lactic acid, is ejected by the cancer cells and carried by the blood to the liver and kidneys. But lactic acid is not simply expelled from the body. Instead, it is reconverted in the liver back into glucose. But the body must now expend a great amount of energy doing this. The glucose is then poured into the blood stream, and picked up by the cancer cells—and used as still more fuel! The vicious cycle broadens and deepens. "The net result is a loss of energy from normal body energy ‘pools.’ As the cancer grows, its production of lactic acid grows, imposing on the body a condition in which the normal body energy ‘pools’ become more and more depleted."— Joseph Gold, Cancer Research Institute, Informational Brochure, 1979. Eventually rapid weight loss and debility results— cachexia.
Reference: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell 1998
246
"Here is another way of looking at this cycle: "Cachexia: in a chronic infection/chronic disease, the patient's temperature rises, the CD4 count drops below the CD8 count, and the appetite wanes until the patient develops pathological anorexia. The body still needs nourishment, so it begins breaking down its fat stores, the process of glycogenesis, and also begins to break down proteins to deliver these sugar precursors, the ones produced by glycogenesis, to the body. The metabolism of tumor/cancer cells is much less efficient than those of normal cells: normal cells metabolize aerobically, using oxygen, which is 15 times more efficient than cancer cells that metabolize anaerobically, through a process of fermentation. Fermentation, being less efficient, requires much more sugar than aerobically metabolizing cells. Additionally, the metabolism rate of a tumor is much higher than that of normal cells, so the amount of sugar needed is still greater. Eventually the patient dies trying to feed the tumor. Starvation is the major cause of death in cancer and AIDS patients."" - Alternative Cancer Therapies, Wellness Directory of Minessota, http://www.mnwelldir.org Article Source: The Cachexia Treatment, www.cancertutor.com/ Copyright by Webster Kehr 416
"In short, when the person quits eating, the body starts to eat itself in order to feed the cancer cells. Here are more details:
"Cachexia is but the end result of an insidious process—unrecognizable at first, but slowly taking its toll of the body’s reserves until a ‘point of no return’ is reached. Cachexia begins with the very first cancer tissue. What we need is a way to stop the vicious cycle and thereby put a halt to the leading cause of death in cancer: cachexia."—Joseph Gold, "Proposed Treatment of Cancer by Inhibition of Gluconeogenesis," Oncology, 22:185- 207, 1968. So far, Gold’s research was fully approved by the powers that be, for it was in the realm of theory. But then he set to work in search of a substance which could block this interaction between the liver and the cancer cells. Trying one thing and then another (including the amino acid tryptophane), everything seemed to fail. Then, in the early 1970s, Gold read a research paper which stated that HYDRAZINE SULFATE had the ability to block a key enzyme in the liver— which allowed lactic acid to be converted into glucose. First, Gold tried hydrazine sulfate on four different transplantable tumor systems in animals. It seemed to work fairly well, and supported Gold’s theory. Cancer cells in the test tube were not injured, but in the body were destroyed. Therefore an indirect mechanism
Reference: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell 1998
247
"Lactic acid build- up induces an acid build- up within the cell, which now causes changes in the DNA of the cell to promote unlimited reproduction. In other words, the cancer feeds itself in an acid environment ... Another potential way to starve the cancer then is to interfere with the liver's ability to produce glucose from lactic acid (the enzyme is called phosphoenolpyruvate carboxykinase) through hydrazine sulfate. Again, the specific agent is not the emphasis but rather the conceptual approach to altering the tissue environment."" Mechanisms Of Cancer Development, Copyright by Jeremy E. Kaslow, M.D. all rights reserved, http://www.drkaslow.com 415
Article excerpted http://www.cancertutor.com/
from:
was involved. Further examination revealed that the cancer cells were not directly poisoned. Gold also found that hydrazine sulfate could be used to increase the effectiveness of regular cell poisoning drugs (chemotherapy) in animals. Perhaps best of all, if only small amounts were used, the chemical compound did its work without poisoning the normal cells. It is in no way a killer cell of any kindâ&#x20AC;&#x201D;including malignant ones. It only works by blocking a certain liver enzyme, needed to provide energy to the metabolism of the tumor. In 1973, Gold published his first report on his findings, and then gave a talk about it at the New York Academy of Sciences. Afterward, a physician came up and asked for further data on how to dispense it, since he had a woman cancer patient who, within three or four days, would be dead. Within a few weeks, the woman was DRAMATICALLY IMPROVED, and on her feet again. A number of other patients also experienced improvement. By August 1973, 20 or 30 patients were taking it in various parts of the country. By October, there were over a thousand. Gold began to experience difficulties in his requests for further funds from NCI for research. But Dr. Dean Burk was still at NCI. He it was who had Reference: Alternative Cancer Remedies â&#x20AC;&#x201C; Facts for Historians and Medical Researchers by Vance Ferrell 1998
248
Experience of the treatment with Sehydrin (Hydrazine Sulfate, HS) in the advanced cancer patients. The results of Sehydrin (Hydrazine Sulfate, HS) treatment of 740 patients with the advanced, recurrent or metastatic solid tumours of various localizations or malignant lymphomas, for whom all the methods of specific treatment (surgery, radiation, chemotherapy) had been exhausted are presented in this work. The objective response, symptomatic therapeutic effects and toxicity were estimated. Clinically significant objective responses were registered in patients with the soft tissue sarcomas, including neuroblastomas, and paradoxically- in such semimalignant tumours as desmoids. Although the objective response in patients with the lung cancer (90%- - non- small cell) was only 4%, stabilization of long duration was registered in 22% of cases connected with the impressive relief of heavy common symptoms in 38.5% of the treated patients. Such a subjective response was established in 46.6% of all the 740 cases. The drug given per os was well tolerated by patients in primary and subsequent courses and did not induce myelosuppression or other significant side effects. On the basis of observations available, Sehydrin may be assessed as an alternative drug for the treatment and symptomatic therapy of patients with some advanced solid tumours and malignant lymphomas at a disease stage when the other methods of treatment can not be used. A possible mechanism of antitumour and symptomatic action is being discussed. - Filov VA, Gershanovich ML, Danova LA, Ivin BA. Prof. N.N. Petrov Research Institute of Oncology, St. Petersburg, Russia 417
himself amplified somewhat on the work of Warburg. Gold’s findings vindicated both Warburg and Burk’s research into cancer cell metabolism. Burk was enthusiastic, and said so. He released this memorandum to the scientific community in mid- 1973: "Since April 1, 1973, upwards of 30 cachetic or ‘terminal’ cancer patients have been treated with gelatin capsules containing 60 mg of hydrazine sulfate three to four times a day (at intervals of about 6 hours). Usually within 24- 48 hours there is a marked return of appetite followed by continued increase in weight, remarkably restored physical activity, and eventually decrease in tumor size, decrease in pain, and related decrease in symptomatology."—Dean Burk, Memorandum, Department of Health, Education, and Welfare, National Institutes of Health, August 10, 1973. About six months later, Burk wrote: "[Hydrazine sulfate is] the most remarkable anti- cancer agent I have come across in my forty- five years of experience in cancer . . It would make little difference with hydrazine sulfate if the FDA wanted to balk, because this material is so cheap—and it is cheap because it is made by the trainload for industrial purposes."— Dean Burk, "New Approaches to Cancer Therapy," New England Natural Food Association Bulletin, Spring 1974. In a paper on the subject, presented before top officials at Sloan- Kettering Institute in New York, Burk said this: "Let me tell you this perfectly true story . . I could give you many. A woman with Hodgkin’s disease who had been flat on her back for seven weeks, who had no appetite and who had loss all her weight—a ‘paper- thin’ patient—took hydrazine sulfate. One week later she was shopping in the grocery store with her own bag; five day later she was spending most of the day in her garden. I don’t give that as any miraculous story—it is simply the plain truth."—Ibid. Reference: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell 1998
249
Hydrazine sulfate, because it was a chemical, was immediately put into clinical trials by the chemotherapy department at Sloan- Kettering. Since it had already been tried on humans, and since news of it was so widespread among physicians and somewhat among the general public, announcement was made in September that a joint SKISyracuse Cancer Research Institute study would begin. But, following that announcement, officials at SKI immediately drew back, and their participation was only deleterious. Patients who died before receiving even one dose were listed as "failures." Instead of receiving the optimal dosage (which was 60 milligrams of hydrazine sulfate for the first three days, 60 milligrams twice a day for the next three days, and 60 milligrams three times a day thereafter), SKI had them start with 1 milligram a day for the first day, 2 for the second, etc., until they reached 20 or 30 milligrams a day. When Gold appealed to them to abide by the original dosage agreement, SKI ordered a single massive dose of 120- 190 mg. to be given. This high dosage was toxic in the extreme, and eliminated all earlier improvements. According to Gold, the SKI chemotherapist told a relative of one of the patients that he had no "enthusiasm or interest in" hydrazine sulfate and that it was "worthless" in the treatment of cancer (ibid.). In the summer of 1974, Gold told a packed audience at a National Health Federation convention about the benefits of hydrazine sulfate. This caused the news about the compound to travel even farther. In response, the FDA issued a directive blocking access to the compound by physicians and making it illegal for chemical companies to sell hydrazine sulfate directly to the public. That announcement was immediately preceded by an official statement issued by the public affairs department of SKI: "(1) None of these patients responded positively to hydrazine sulfate, and (2) some of the patients developed neurotoxicity [nerve damage], apparently due to the administration of this drug. Reference: Alternative Cancer Remedies â&#x20AC;&#x201C; Facts for Historians and Medical Researchers by Vance Ferrell 1998
250
"Based on these findings, therefore, Sloan- Kettering Institute is no longer treating patients with hydrazine sulfate, nor are we conducting any further experiments with it at the present time."—SKI Statement, July 25, 1974. Calbiochem, Inc., a California drug company which had been interested in marketing it, immediately drew back, correctly declaring, that hydrazine sulfate was in the public domain and thus unpatentable. In other words, like goldenseal, chaparral, apricot kernels, pau d’arco tea, and vitamin C, there were no big profits to be made from it. "We saw absolutely no place to go with it," he said (David M. Rorvik, "Who Wrote the American Cancer Society’s Denunciation of Hydrazine Sulfate" Alicia Patterson Foundation Newsletter, New York, November 29, 1976). In March 1976, the American Cancer Society placed the substance on its list of unproved methods. In early 1979, NCI invited Dr. Michael L. Gershanovich, director of medical oncology, Petrov Research Institute of Oncology, Leningrad, to come to the United States and describe his four- year study of 225 patients on hydrazine sulfate. But, after arriving in America, Gershanovich was suddenly denied permission to speak at the May 1979 New Orleans meeting of the American Association for Cancer Research. However, the mistake had not been caught early enough, and abstracts (a summary) of Gershanovich’s planned talk were printed as abstract #969 in the Proceedings of the AACR. From 1984 to 1990 and beyond, Rowan T. Chlebowski, M.D., Ph.D., and his associates at UCLA in Los Angeles began publishing a series of reports documenting the ability of hydrazine sulfate to prevent weight loss in cancer. They found that critically ill patients showed only marginal response, but those in better condition when the treatment was started did better. After a year of treatment, 42% of those taking hydrazine sulfate were alive, compared to 18% of those who did not receive it. The use of this compound helps patients feel better within two or three weeks. But it occasionally can have mild side Reference: Alternative Cancer Remedies – Facts for Historians and Medical Researchers by Vance Ferrell 1998
251
effects, including mild numbness of the fingers and toes, nausea, vomiting, and slight drowsiness. Gold found that this could be reduced or eliminated by taking vitamin B6. The story of the development, and subsequent quashing, of hydrazine sulfate has all the drama and intrigue of an HBO movie. It is just one of the many drugs and formulas the National Cancer Institute buried for years. To cut long in short, Gold came, he developed a theory, tested the substance on animals with positive results. Gold had a highly publicized meeting with the NCI. They all shook hands and he turned over his papers, listing those things that should not be used during therapyâ&#x20AC;&#x201D;alcohol, sleeping pills, tranquilizers, etc.â&#x20AC;&#x201D;and the recommended dosages. The NCI tested it, did not follow his orders, purposely sabotaged the study, killed off all the patients, and successfully buried hydrazine sulfate for twenty years by issuing a paper stating that it was, according to their study, worthless. Yet the fact remains, that the subsequent patient studies show that Hydrazine Sulfate works (saves lives) greater than fifty percent of the time. Russia uses it freely today in many cancer programs.
Reference: Alternative Cancer Remedies â&#x20AC;&#x201C; Facts for Historians and Medical Researchers by Vance Ferrell 1998
252
Laboratory and clinical evidence (The following information is excerpted from: Unconventional therapies for cancer: 4. Hydrazine sulfate, Elizabeth Kaegi, MB, ChB, MSc, on behalf of the Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative. CMAJ â&#x20AC;˘ MAY 19, 1998; 158 (10), Copyright, 1998, Canadian Medical Association, All Rights Reserved) 418- 477
Several researchers have noted that hydrazine sulfate inhibits the enzyme PEPCK and that it may interfere with gluconeogenesis.425,448,449 Some animal studies have reported that these effects are potentiated when hydrazine sulfate is used in conjunction with other agents known to affect carbohydrate, lipid or protein metabolism positively. 450â&#x20AC;&#x201C;452 Hydrazine sulfate has been reported to have a cytotoxic effect on human glioblastoma cell lines.35 This finding has led some to suggest that the agent may be of value in the management of glioblastomas.454 A few animal studies have shown that hydrazine sulfate can stabilize or inhibit tumor growth. Most of these studies were by Gold,426,427 but some other researchers have reported similar results.451 Goldâ&#x20AC;&#x2122;s findings from animal studies suggesting that hydrazine sulfate enhances the effects of conventional chemotherapeutic agents 433, 455 serve as the basis for his recommendation that it be used in conjunction with any appropriate conventional therapy for cancer. With respect to clinical evidence, the scientific literature has fairly consistently reported that hydrazine sulfate is metabolically active and that it may normalize the carbohydrate metabolism of cancer patients with cachexia. 432, 434, 456, 457 However, the mechanisms of cachexia are now considered to be complex and to involve much more than anaerobic glucose metabolism. The prevailing theory is that cachexia results from a combination of metabolic abnormalities, including abnormal lipolysis caused by a combination of reduced energy intake and the effects of substances released by tumor tissue.458- 460 425,446,447
Reference: Unconventional therapies for cancer: 4. Hydrazine sulfate, Elizabeth Kaegi, MB, ChB, MSc
253
In terms of a direct effect of hydrazine sulfate on tumor growth, the clinical evidence has been much less consistent. A noticeable discrepancy was found between the results of clinical studies performed in the US and those conducted in Russia. Most of the US studies showed minimal, if any, beneficial effects,456, 461 – 465 whereas those conducted in Russia typically reported significant improvements in well- being, tumor stabilization and survival.434, 454, 466, 467 The exceptions to this generalization are the studies carried out by Gold 429, 430, 468 and by Chlebowski and colleagues 432, 434, 457 in the US that showed positive results. The Russian studies were mostly case series, and some included patients with many different types of cancer (…). 467, 469 The most recent US studies were randomized controlled trials that showed no benefit from the use of hydrazine sulfate in patients with advanced lung and colorectal cancer.463 – 465 However, Gold and other supporters of hydrazine sulfate were unconvinced by these findings. They argued that the treatment protocol used in these studies did not comply fully with the recommendation that patients receiving hydrazine sulfate strictly avoid the use of agents such as barbiturates, alcohol and benzodiazepines. (Gold believes that these substances interfere with hydrazine sulfate’s effectiveness.470 – 474) The expressed concerns of both Gold and the public 475 subsequently led to a review of the study by the US Government Accounting Office in 1997. This review found that the protocol used by the investigators was appropriate given the information available to them, but it did not formulate or express an opinion on the effectiveness or otherwise of ydrazine sulfate (…). 476 Conclusion: There is good evidence that hydrazine sulfate inhibits gluconeogenesis. Therefore, it may play a role in REDUCING the severity of cachexia and in IMPROVING the quality of life of cancer patients. Reference: Unconventional therapies for cancer: 4. Hydrazine sulfate, Elizabeth Kaegi, MB, ChB, MSc
254
Epilogue:
Reform Your Health
"Always question authority. The church says the earth is flat." - Anonymous 255
With this Volume I have given you the very BEST from the history of cancer healing. I strongly suggest you to continue studying this topic carefully and MAXIMIZE your KNOWLEDGE. Every step WILL EMPOWER you to "take charge" of your health and increase your resistance to doctors, drugs, hospitals. I say it is about time to BUILD UP a POWERFUL HEALTH today. Welcome to "THE EDUCATION OF CANCER HEALING" study collection. I see you in the next book!
"Youâ&#x20AC;&#x2122;re braver than you believe, and stronger than you seem, and smarter than you think." - A.A. Milne
256
Notes 1. 2. 3.
4. 5. 6. 7.
Article: Fermentation, www.angelfire.com, http://www.angelfire.com/al/aloysius/fermentation.html Article: http://en.wikipedia.org/wiki/Fermentation_%28food%29#cite_note- 7, Wikipedia.org Dubos J. (1951). "Louis Pasteur: Free Lance of Science, Gollancz. Quoted in Manchester K. L. (1995) Louis Pasteur (1822–1895)- - chance and the prepared mind.". Trends Biotechnol 13 (12): 511–515. doi:10.1016/S0167- 7799(00)89014- 9. PMID 8595136. © All Rights Reserved. Nobel Laureate Biography of Eduard Buchner at http://nobelprize.org © All Rights Reserved. "The Nobel Prize in Chemistry 1929". Retrieved 2007- 01- 28. © All Rights Reserved. Article: "Otto Warburg - Biography". Nobelprize.org.25 Feb 2013 http://www.nobelprize.org/nobel_prizes/medicine/laureates/1931/warburg.html. © All Rights Reserved. Article: "Otto Warburg". http://www.nndb.com, http://www.nndb.com/people/682/000127301/ © All Rights Reserved.
8. 9.
10.
11.
Article: http://www.ionways.com/water_ionization_potential.aspx © All Rights Reserved. Article: Reuben Chow, Ten Studies Showing the Link Between Sugar and Increased Cancer Risk, Monday, November 17, 2008, "NaturalNews Exclusive/NaturalNews Exclusive, All Rights Reserved", Learn more: http://www.naturalnews.com/024827_cancer_sugar_women.html#ixzz2LuZF3B3l Book: Nancy Appleton (Author), G. N. Jacobs (Author), Suicide By Sugar: A Startling Look at Our #1 National Addiction [Paperback], November 15, 2009, © All Rights Reserved. ISBN- 10: 0757003060, ISBN- 13: 978- 0757003066 More information about Dr. Jonathan Wright can be found at: http://www.tahomaclinic.com/ © All Rights Reserved.
12. 13. 14. 15. 16. 17. 18.
Article: Dr. Jonathan Wright, M.D., http://www.whale.to/a/wright_h.html © All Rights Reserved. More information about Dr. Robert Jay Rowen can be found at: http://www.doctorrowen.com/ © All Rights Reserved., Article: Dr. Robert Jay Rowen, M.D., http://www.whale.to/a/rowen_h.html © All Rights Reserved. Koch, William F., M.D.: The Survival in Neoplastic and Viral Diseases. Vanderkloot Press, Detroit, Michigan, 1955- 1958. Warburg, Dr. Otto, Director Max Tlanck- Institute for Cell Physiology, Berlin- Dahlem (Nobel Prize 1931); "On the origin of cancer cells," Science Magazine, Feb. 24, 1956, Volume 123, #3191. Warburg, Dr. Otto: "Revised lecture at the meeting of Nobel Laurets," June 30, 1966, Landau, Lake Constance, Germany. Burk, Dean, National Cancer Institute, Bethesda, Maryland: "The Prime cause and prevention of Cancer," Konrad Trietsch, Wurzburg, Germany, 1967; English edition by Dean Burk. 257
19. 20. 21. 22. 23. 24.
25. 26. 27.
Olney, Robert C., M.D. and contributors: "Treatment of Viral Hepatitis with Ultraviolet Blood Irradiation," Am. J. of Surg., Sept. 1955. Miley, George, M.D.: "The Ultraviolet Irradiation of Auto- transfused Blood: Studies in Oxygen Absorption Valves," Am. J.M.SC. 197:873, 1939. Olney, Robert C., M.D.: "Ultraviolet Blood Irradiation in Biliary Disease." American Journal of Surgery, August, 1946. Olney, Robert C., M.D.: "Ultraviolet Blood Irradiation Treatment of Pelvic Cellulitis." American Journal of Surgery, Oct. 1947. Olney, Robert C., M.D.: "Role of Ultraviolet Blood Irradiation Therapy, Not Technic, in Surgery." International College of Surgeons Journal, 1949. Study: Ultraviolet Blood Irradiation Therapy (Photo- Oxidation) The Cure That Time Forgot, Robert Jay Rowen, MD, Omni Medical Center, Anchorage, USA, Int. J. Biosocial Med Research, Vol. 14(2). 115132, 1996. 1044- 811 X/96/8/115/$ 1.50. 1996 Foundation For Biosocial Research. Robert Jay Rowen, MD, Omni Medical Center, Copyright (C) 1996 Foundation For Biosocial Research. All rights., reserved. Printed in the U.S.A. Omni Medical Center Correspondence address: 61- S East 82nd Ave, #300 Anchorage, AK 99518, http://www.whale.to/a/rowen.html, © All Rights Reserved. Laurens, Henry, The Physiologic Effects of Ultraviolet Irradiation, JAMA, Vol. 11, No. 26, December 24,1938, p. 2390. © All Rights Reserved. lbid, p. 2391. Douglas, W.C. MD, Into The Light, Second Opinion Publishing, Inc., 1993, pp. 18- 19. © All Rights Reserved.
28. 29. 30. 31. 32. 33. 34.
Ibid, P. 28. Knott, Emmett, Development of Ultraviolet Blood Irradiation, American Journal of Surgery, August, 1948, pp. 165- 171. Miley, George, Ultraviolet Blood Irradiation Therapy, Archives of Physical Therapy, September, 1942, pp. 537- 538. Miley, George, The Knott Technique of Ultraviolet Blood Irradiation in Acute Pyogenic Infections, The New York State Journal of Medicine, January 1, 1942, pp. 38- 46. Miley, George, Efficacy of Ultraviolet Blood Irradiation Therapy and Control of Staphylococcemias, American Journal of Surgery, Vol. 64, No. 3, pp. 313- 322. Rebbeck and Miley, Review of Gastroenterology, January- February, 43., P. 11. Miley and Christensen, Ultraviolet Blood Irradiation Therapy: Further Studies in Acute Infections, American Journal of Surgery, Vol. 73, No. 4, April, 1947, pp. 486- 493.
258
35. 36. 37. 38. 39. 40. 41. 42. 43. 44. 45. 46. 47. 48. 49. 50. 51. 52.
53.
Rebbeck, E.W., Ultraviolet Irradiation of Blood in the Treatment Of Escherichia coli Septicemia, Archives of Physical Therapy, 24:158- 167,1943. Barrett, Henry, The Irradiation of Autotransfused Blood by Ultraviolet Spectral Energy: Results of Therapy in 110 Cases, Medical Clinics of North America, May, 1940, pp. 723- 732. Douglas, W.C. MD, Into The Light, Second Opinion Publishing, Inc., 1993, pp. 97- 98. Miley, George, The Control of Acute Thrombophlebitis With Ultraviolet Blood Irradiation Therapy, American Journal of Surgery, June, 1943, pp. 354- 360. Miley, Seidel, and Christensen, Preliminary Report of Results Observed in Eight Cases of Intractable Bronchial Asthma, Archives of Physical Therapy, September, 1943, pp. 533- 542. Miley, Seidel, and Christensen, Ultraviolet Blood Irradiation Therapy of Apparently Intractable Bronchial Asthma, Archives of Physical Medicine, January, 1946, pp. 24- 29. Miley and Christensen, Archives of Physical Therapy, November, 1944, pp. 651- 656. Olney, R.C., American Journal of Surgery, Vol. 90, September 1955, pages 402 - 409. Rebbeck, E.W., Review of Gastroenterology, January- Februarv, 1943. Rebbeck, E.W., Preoperative Hemo- Irradiatiotts, American Journal of Surgery, August, 1943, pp.259265. Miley, George, The Ultraviolet Irradiation of Autotransfused Human Blood, Studies in Oxygen Absorption Values, Proceedings of the Physiological Society of Philadelphia, Session of April 17, 1939. Miley and Christensen, Ultraviolet Blood Irradiation Therapy in Acute Virus and Virus- Like Infections, The Review of Gastroenterology, Vol. 25, No. 4, April, 1948, pp. 271- 276. Miley, George, Recovery From Botulism Coma Following Ultraviolet Blood Irradiation, The Review of Gastroenterology, Vol. 13, No. 1, January- February, 1946. pp. 17- 18. Miley, George, Ultraviolet Blood Irradiation Therapy (Knott Technique) in Non- Healing Wounds, American Journal of Surgery, Vol. 65, No. 3, September, 1944, pp. 368- 372. Gurwitsch, A.: In Rahn, Otto, Invisible Radiations of Organisms, Protoplasma - Monographien, Berlin, Vorntraeger, 1936, Vol. 9. Douglas, W.C MD., Into The Light, Second Publishing, Inc., 1993, pp. 14- 15. Edelson, Richard, Scienlific American, August 1988, pages 1- 8. Gasparro, F.P., Mechanistic Events Underlying the Response oi CTCL Patients to Photophoresis. In: Extracorporeal Photochemotherapy: Clinical Aspects in the Molecular Basis for Efficacy, Austin, Texas, RG Landes Company, 1994; 101- 20. Pohlmann, et al, Wirksamkeit Von Pentoxifyllin und der Hamatogenen Oxydationstherapie, Natur- und GanzheitsMedizin, 1992; 5:80- 4.
259
54. 55. 56. 57. 58. 59. 60. 61. 62. 63. 64. 65.
Paulitschke, Turowski, and Lerche, Ergebnisse der Berliner HOT/UVB - Bergleichstudie bei Patienten mit peripheren arterielien Durchblutungsstorungen, Z. gesamte Inn. Med., No. 47, 1992, pp. 148- 153. Frick, G., A Linke: Die Ultraviolet bestrahlung des Blutes, ihre Entwicklung und derzeitiger Stand., Zschr- arztl., Forth. 80, 1986. Seng, G., Hematogenic Oxydationstherapie, Therapeuticon Six, June, 1988, pp. 370- 373. Krimmel, Hematogena Oxidationstherapie - Eine Mogliclikeit bei der konbinierten Tu?ttortiterapie, Arztezeitschr. f. Maturheilverf., November, 1989, 30., Jarhg. Miley, George, The Present Status of Ultraviolet Blood Irradiation (Knott Technique), Archives of Physical Therapy, Vol., 25., No. 6., June,1944,p.361. Bocci, Vielio, Studies on the Biological Effects of Ozone, 1. Induction of Interferon Gamma on Human Leukocytes, Haematologica, 1990,75:510- 5. Viral Diseases Bocci, Vielio, Ozonization of Blood for the Therapy Of and Immunodeficiencies: A Hypothesis, Medical Hypothesis, 1992, Vol., 39, pp. 30- 34. Douglas, William C. MD, Into the Light, p. 257. Mattman, Lida, Cell Wall Deficient Forms - Stealth Pathogens, CRC Press, 1993. Weg, Stuart, MD Private Communication, January, 1996. Book: Color Me Healthy by William Campbell Douglass II, MD, Publisher: Rhino Publishing, S.A.; 1 edition (June 25, 2003), ISBN- 10: 9962636108, ISBN- 13: 978- 9962636106, © All Rights Reserved. Article: Woodlands Healing Research Center, UltraViolet Light Therapy, www.woodmed.com, http://www.woodmed.com/index.php/services- a- therapies/ultraviolet- light- therapy, 2012) © All Rights Reserved.
66.
67. 68. 69.
Article: The Healing Power of Light, Photoluminescence: UV Lght Irradiation in the Laboratory by E.W: McDonagh, D.O., Light Party, Copyright © 1997. The Light Party. The Light Party, 20 Sunnyside Ave., Suite A- 156, Mill Valley, CA 94941. Tel: (415) 381- 4061 * Fax: (415) 381- 2645, Dedicated to "Health, Peace and Freedom for All" © All Rights Reserved. Book: Alternatives in cancer therapy: the complete guide to non- traditional treatments, Ross Pelton, Lee Charles Overholser, 1994, ISBN- 10: 0671796232 | ISBN- 13: 978- 0671796235 Book: Alternative Cancer Remedies, Facts for Historians and Medical Researchers by Vance Ferrell, Pilgrims Books 1998 © All Rights Reserved. Article: Dr. Louis Ignarro, American Entertainment International Speakers Bureau, American Entertainment International Speakers Bureau, 214 Lincoln St. Suite #113 Allston, MA 02134, Copyright 2012 American Entertainment International Speakers Bureau, Inc. Updated Monday February 25, 2013., http://www.aeispeakers.com/speakerbio.php?SpeakerID=1378 © All Rights Reserved.
260
70.
71.
Adams MR, McCredie R, Jessup W, Robinson J, Sullivan D, Celermajer DS. Oral L- arginine improves endothelium- dependent dilatation and reduces monocyte adhesion to endothelial cells in young men with coronary artery disease. Atherosclerosis 1997 Mar 21;129(2):261- 9. © All Rights Reserved. Slawinski M, Grodzinska L, Kostka- Trabka E, Bieron K, Goszcz A, Gryglewski RJ. L- Arginine substrate for NO synthesis - its beneficial effects in therapy of patients with peripheral arterial disease: comparison with placebo - preliminary results. Acta Physiol Hung 1996; 84(4):457- 8. © All Rights Reserved.
72. 73.
74.
75.
76.
77.
Tentolouris C, Tousoulis D, Goumas G, Stefanadis C, Davies G, Toutouzas P. L- Arginine in coronary atherosclerosis. Int J Cardiol 2000;75:123- 8. © All Rights Reserved. Article: "Arginine Helps Counter Atherosclerosis", Life Enhancement, © Copyright 2013 Life Enhancement Products, Inc. All Rights Reserved. http://www.life- enhancement.com/, http://www.lifeenhancement.com/magazine/article/518- arginine- helps- counter- atherosclerosis Article: Lind DS., Department of Surgery, University of Florida College of Medicine, Surgical Services, North Florida South Georgia VA Health Care System, Gainesville, FL 32608, USA. , J Nutr. 2004 Oct;134(10 Suppl):2837S- 2841S; discussion 2853S., PMID: 15465796 [PubMed - indexed for MEDLINE], http://www.ncbi.nlm.nih.gov/pubmed/15465796 © All Rights Reserved. Article: Mishra SI, Scherer RW, Geigle PM, Berlanstein DR, Topaloglu O, Gotay CC, Snyder C., Exercise interventions on health- related quality of life for cancer survivors., University of New Mexico, Albuquerque, NM, USA. , Cochrane Database Syst Rev. 2012 Aug 15;8:CD007566. doi: 10.1002/14651858.CD007566.pub2., PMID: 22895961 [PubMed indexed for MEDLINE], http://www.ncbi.nlm.nih.gov/pubmed/22895961 © All Rights Reserved. Article: Dietary supplementation with L- arginine in patients with breast cancer (> 4 cm) receiving multimodality treatment: report of a feasibility study., J. Brittenden, S. D. Heys, I. Miller, T. K. Sarkar, A. W. Hutcheon, G. Needham, F. Gilbert, M. McKean, A. K. Ah- See, and O. Eremin, Br J Cancer. 1994 May; 69(5): 918–921. PMCID: PMC1968918, PMC1968918, http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968918/ © All Rights Reserved. Anderson ED, Forrest AP, Hawkins RA, Anderson TJ, Leonard RC, Chetty U. Primary systemic therapy for operable breast cancer. Br J Cancer. 1991 Apr;63(4):561–566. [PMC free article] [PubMed] © All Rights Reserved.
78.
79.
Bonadonna G, Veronesi U, Brambilla C, Ferrari L, Luini A, Greco M, Bartoli C, Coopmans de Yoldi G, Zucali R, Rilke F, et al. Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more. J Natl Cancer Inst. 1990 Oct 3;82(19):1539–1545. [PubMed] Cheung CW, Johnson AE. Carcinoma of the breast: measurement and the management of treatment. I. The value of the data. Br J Radiol. 1991 Jan;64(757):29–36. [PubMed] 261
80.
81.
82. 83. 84. 85. 86. 87. 88.
89.
90. 91.
92.
De Lena M, Zucali R, Viganotti G, Valagussa P, Bonadonna G. Combined chemotherapy- radiotherapy approach in locally advanced (T3b- T4) breast cancer. Cancer Chemother Pharmacol. 1978;1(1):53–59. [PubMed] Feldman LD, Hortobagyi GN, Buzdar AU, Ames FC, Blumenschein GR. Pathological assessment of response to induction chemotherapy in breast cancer. Cancer Res. 1986 May;46(5):2578–2581. [PubMed] Fornage BD, Toubas O, Morel M. Clinical, mammographic, and sonographic determination of preoperative breast cancer size. Cancer. 1987 Aug 15;60(4):765–771. [PubMed] Gröhn P, Heinonen E, Klefström P, Tarkkanen J. Adjuvant postoperative radiotherapy, chemotherapy, and immunotherapy in stage III breast cancer. Cancer. 1984 Aug 15;54(4):670–674. [PubMed] Luboinski G, Nagadowska M, Pienkowski T. Preoperative chemotherapy in primarily inoperable cancer of the breast. Eur J Surg Oncol. 1991 Dec;17(6):603–607. [PubMed] Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer. 1981 Jan 1;47(1):207–214. [PubMed] Pain JA, Ebbs SR, Hern RP, Lowe S, Bradbeer JW. Assessment of breast cancer size: a comparison of methods. Eur J Surg Oncol. 1992 Feb;18(1):44–48. [PubMed] Park KG, Heys SD, Blessing K, Kelly P, McNurlan MA, Eremin O, Garlick PJ. Stimulation of human breast cancers by dietary L- arginine. Clin Sci (Lond) 1992 Apr;82(4):413–417. [PubMed] Remvikos Y, Beuzeboc P, Zajdela A, Voillemot N, Magdelénat H, Pouillart P. Correlation of pretreatment proliferative activity of breast cancer with the response to cytotoxic chemotherapy. J Natl Cancer Inst. 1989 Sep 20;81(18):1383–1387. [PubMed] Rodger A, Jack WJ, Hardman PD, Kerr GR, Chetty U, Leonard RC. Locally advanced breast cancer: report of phase II study and subsequent phase III trial. Br J Cancer. 1992 May;65(5):761–765. [PMC free article] [PubMed] Rubens RD. The management of locally advanced breast cancer. Br J Cancer. 1992 Feb;65(2):145– 147. [PMC free article] [PubMed] Sorace RA, Bagley CS, Lichter AS, Danforth DN, Jr, Wesley MW, Young RC, Lippman ME. The management of nonmetastatic locally advanced breast cancer using primary induction chemotherapy with hormonal synchronization followed by radiation therapy with or without debulking surgery. World J Surg. 1985 Oct;9(5):775–785. [PubMed] Swain SM, Sorace RA, Bagley CS, Danforth DN, Jr, Bader J, Wesley MN, Steinberg SM, Lippman ME. Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer. Cancer Res. 1987 Jul 15;47(14):3889–3894. [PubMed]
262
93.
94.
95.
96.
97.
98.
99.
Torosian MH, Mullen JL, Miller EE, Wagner KM, Stein TP, Buzby GP. Adjuvant, pulse total parenteral nutrition and tumor response to cycle- specific and cycle- nonspecific chemotherapy. Surgery. 1983 Aug;94(2):291–299. [PubMed] Torosian MH, Tsou KC, Daly JM, Mullen JL, Stein TP, Miller EE, Buzby GP. Alteration of tumor cell kinetics by pulse total parenteral nutrition. Potential therapeutic implications. Cancer. 1984 Mar 15;53(6):1409–1415. [PubMed] Study: Shukla J, Khan NM, Thakur VS, Poduval TB., L- arginine mitigates radiation- induced early changes in cardiac dysfunction: the role of inflammatory pathways., Radiat Res. 2011 Aug;176(2):15869. Epub 2011 Jun 10., PMID:21663395 [PubMed indexed for MEDLINE], http://www.ncbi.nlm.nih.gov/pubmed/21663395 Article: Katzmarzyk PT, Church TS, Craig CL, Bouchard C., Sitting time and mortality from all causes, cardiovascular disease, and cancer., Med Sci Sports Exerc. 2009 May;41(5):998- 1005. doi: 10.1249/MSS.0b013e3181930355., PMID: 19346988 [PubMed indexed for MEDLINE], http://www.ncbi.nlm.nih.gov/pubmed/19346988 Article: Bela Szende (1), Erno Tyihák(2) and Lajos Trézl(3), Role of arginine and its methylated derivatives in cancer biology and treatment, © 2001 Szende et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL. © All Rights Reserved. 1 Department of Pathology and Experimental Cancer Research, Semmelweis University and Molecular Pathology Research Group, Hungarian Academy of Sciences, Budapest, H- 1085 2 Plant Protection Institute, Hungarian Academy of Sciences, Budapest, H- 1022 3 Department of Organic Chemistry, Budapest University of Technology and Economics, Budapest, H- 1111, Hungary Cancer Cell International 2001, 1:3 doi:10.1186/1475- 2867- 1- 3, http://www.cancerci.com/content/1/1/3 © All Rights Reserved. Article: Bernstein L, Henderson BE, Hanisch R, Sullivan- Halley J, Ross RK., Physical exercise and reduced risk of breast cancer in young women., Department of Preventive Medicine, University of Southern California School of Medicine, Los Angeles 90033.,J Natl Cancer Inst. 1994 Sep 21;86(18):14038., PMID: 8072034 [PubMed indexed for MEDLINE] http://www.ncbi.nlm.nih.gov/pubmed/8072034 © All Rights Reserved. Article: The Russell Body - The Forgotten Clue to the Bacterial Cause of Cancer. By Cantwell AR Jr, JOIMR 2003;1(6):1 Published: 30 November 2003 (C) 2003, by Alan Cantwell, Jr. M.D.) http://rense.com/general44/russell.htm © All Rights Reserved. 263
100. Article: Royal Raymond Rife, By Jeff Rense, rense.com, http://rense.com/general31/rife.htm 101. Article: History Of The Development Of A Successful Treatment For Cancer And Other Virus, Bacteria And Fungi By Royal Raymond Rife. Copyright © Rifevideos.com. All rights reserved, http://www.rifevideos.com) 101 102. Article: Dr. Rife And The Death Of The Cancer Industry. By Max Planck. Taken from: DR. RIFE AND THE DEATH OF THE CANCER INDUSTRY. Rife Research Europe, Copyright, Peter Walker, http://www.rife.de/, http://www.rife.de/rife- and- cancer.html © All Rights Reserved. 103. Article: A PLACEBO STUDY OF AUDIO FREQUENCY THERAPY IN THE TREATMENT OF ARTHRITIS by Geoff Baker (B. App. Sci) Director of Research & Development BWBGELTECH PTY LTD / now: Electromed (Aust.) P/L, Copyright, Peter Walker, http://www.rife.de/) © All Rights Reserved. 104. Article: The Story of Antoine Priore, Rife Research Europe,, Copyright, Peter Walker, http://www.rife.de/, Rife Research Europe,, Copyright, Peter Walker, http://www.rife.de/, http://www.rife.de/priore,- thefrench- - rife- .html © All Rights Reserved. 105. http://www.cancerinform.org/ written by Gavin Phillips. According to the author, the information was derived from Daniel Haley's book, "Politics In Healing" 2000. The book’s reference is: Politics in Healing: The Suppression and Manipulation of American Medicine, Daniel Haley, 2000, BioMed Publishing Group, ISBN- 10: 0982513879, ISBN- 13: 978- 0982513873 © All Rights Reserved. 106. Article: The Amazing Wonders of Gaston Naessens, by Steven R. Elswick. Editor, Extraordinary Science, 1994, Nexus Magazine, http://www.nexusmagazine.com/, NEXUS Head Office, PO Box 30, Mapleton QLD 4560, Australia, Article source: http://www.whale.to, http://www.whale.to/v/naessens.html © All Rights Reserved.
107. Book: Politics in Healing: The Suppression and Manipulation of American Medicine, Daniel Haley, 2000, (p267), BioMed Publishing Group (December 1, 2000), ISBN- 10: 0982513879, ISBN- 13: 9780982513873 © All Rights Reserved. 108. Epstein MA, Achong BG, Barr YM (March 1964). "Virus Particles in Cultured Lymphoblasts from Burkitt's Lymphoma". Lancet 1 (7335): 702–3. doi:10.1016/S0140- 6736(64)91524- 7. PMID 14107961. 109. "Baruch S. Blumberg - Autobiography". Nobelprize.org. Retrieved 2010- 03- 17. 110. Beasley RP, Hwang LY, Lin CC, Chien CS (November 1981). "Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan". Lancet 2 (8256): 1129–33. doi:10.1016/S01406736(81)90585- 7. PMID 6118576 © All Rights Reserved.. 111. Yoshida, Mitsuaki; Jeang, Kuan- Teh (2005). "Preface to 25 years of HTLV- 1 and ATL research". Oncogene 24 (39): 5925. doi:10.1038/sj.onc.1208967. 112. Gallo RC (September 2005). "History of the discoveries of the first human retroviruses: HTLV- 1 and HTLV- 2". Oncogene 24 (39): 5926–30. doi:10.1038/sj.onc.1208980. PMID 16155599. 264
113. Seiki M, Hattori S, Yoshida M (November 1982). "Human adult T- cell leukemia virus: molecular cloning of the provirus DNA and the unique terminal structure". Proceedings of the National Academy of Sciences of the United States of America 79 (22): 6899–902. doi:10.1073/pnas.79.22.6899. PMC 347241. PMID 6294664. © All Rights Reserved. 114. "Harald zur Hausen - Autobiography". Nobelprize.org. Retrieved 2010- 03- 17. 115. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M (April 1989). "Isolation of a cDNA clone derived from a blood- borne non- A, non- B viral hepatitis genome". Science 244 (4902): 359–62. doi:10.1126/science.2523562. PMID 2523562. © All Rights Reserved. 116. Schmidt, C. (2008). "Yuan Chang and Patrick Moore: Teaming Up To Hunt Down Cancer- Causing Viruses". Journal of the National Cancer Institute 100 (8): 524–5, 529. doi:10.1093/jnci/djn122. PMID 18398088. © All Rights Reserved. 117. "Ethel Cesarman, M.D., Ph.D. | Weill Cornell Medical College". Med.cornell.edu. Retrieved 2010- 03- 17. 118. Beral V, Peterman TA, Berkelman RL, Jaffe HW (January 1990). "Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection?". Lancet 335 (8682): 123–8. doi:10.1016/0140- 6736(90)90001L. PMID 1967430. © All Rights Reserved. 119. Antman K, Chang Y (April 2000). "Kaposi's sarcoma". The New England Journal of Medicine 342 (14): 1027–38. doi:10.1056/NEJM200004063421407. PMID 10749966. © All Rights Reserved. 120. Feng H, Taylor JL, Benos PV, et al. (October 2007). "Human Transcriptome Subtraction by Using Short Sequence Tags To Search for Tumor Viruses in Conjunctival Carcinoma". Journal of Virology 81 (20): 11332–40. doi:10.1128/JVI.00875- 07. PMC 2045575. PMID 17686852. © All Rights Reserved. 121. Feng H, Shuda M, Chang Y, Moore PS (February 2008). "Clonal Integration of a Polyomavirus in Human Merkel Cell Carcinoma". Science 319 (5866): 1096–100. doi:10.1126/science.1152586. PMC 2740911. PMID 18202256. © All Rights Reserved. 122. Article: http://en.wikipedia.org/wiki/Oncovirus#cite_note- 8 123. Koike K (June 2007). "Hepatitis C virus contributes to hepatocarcinogenesis by modulating metabolic and intracellular signaling pathways". Journal of Gastroenterology and Hepatology 22 Suppl 1: S108–11. doi:10.1111/j.1440- 1746.2006.04669.x. PMID 17567457. © All Rights Reserved. 124. Hu J, Ludgate L (2007). "HIV- HBV and HIV- HCV coinfection and liver cancer development". Cancer Treatment and Research. Cancer Treatment and Research 133: 241–52. doi:10.1007/978- 0- 387- 468167_9. ISBN 978- 0- 387- 46804- 4. PMID 17672044. © All Rights Reserved. 125. Bellon M, Nicot C (2007). "Telomerase: a crucial player in HTLV- I- induced human T- cell leukemia". Cancer Genomics & Proteomics 4 (1): 21–5. PMID 17726237.
265
126. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S (September 2007). "Human papillomavirus and cervical cancer". Lancet 370 (9590): 890–907. doi:10.1016/S0140- 6736(07)61416- 0. PMID 17826171. © All Rights Reserved. 127. Parkin, Donald Maxwell (2006). "The global health burden of infection- associated cancers in the year 2002". International Journal of Cancer 118 (12): 3030–44. doi:10.1002/ijc.21731. PMID 16404738. 128. Klein E, Kis LL, Klein G (February 2007). "Epstein- Barr virus infection in humans: from harmless to life endangering virus- lymphocyte interactions". Oncogene 26 (9): 1297–305. doi:10.1038/sj.onc.1210240. PMID 17322915. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1479838/ © All Rights Reserved. 129. Livingston Foundation Medical Center 3232 Duke Street San Diego, CA 92110 USA Telephone: (619)224- 3515 Toll free information: (888)777- 7321 (U.S. and Canada only) FAX: (619)224- 6253 130. Book: Ministry of Healing by Ellen Gould Harmon White, Nabu Press (May 25, 2011), ISBN- 10: 1172812713, ISBN- 13: 978- 1172812714 © All Rights Reserved. 131. Book: The Cancer Industry by Ralph W. Moss, Ph.D., Equinox Press; New Updated Edition edition (October 8, 1996), ISBN- 10: 1881025098, ISBN- 13: 978- 1881025092 © All Rights Reserved. 132. Book: Cancer: A New Breakthrough, Virginia Livingston, Publisher: Cancer Book House (January 1972), Language: English, ISBN- 10: 0686297865, ISBN- 13: 978- 0686297864 133. Book: Food Alive: a Diet for Cancer and Chronic Diseases, Livingston- Wheeler, Livingston, Wheeler Medical Clinic Publications (1977), ASIN: B000M1OEI6 © All Rights Reserved. 134. Virginia Livingston, MD, Cancer Quack Or Medical Genius? By Alan Cantwell, MD, Los Angeles, CA © 2006 All Rights Reserved, 7- 16- 6, http://rense.com/general72/cancer.htm, [Dr. Alan Cantwell is a retired dermatologist and the author of THE CANCER MICROBE and FOUR WOMEN AGAINST CANCER, both available from Aries Rising Press, PO Box 29532, Los Angeles, CA 90029 (www.ariesrisingpress.com). Email: alancantwell@sbcglobal.net. Abstracts of 30 published papers can be found at the PubMed website ( type in Cantwell AR). Many of his personal writings can be found on www.google.com by using key words "alan cantwell" + articles. His books are also available on www.amazon.com and through Book Clearing House @ 1- 800- 431- 1579] © All Rights Reserved. 135. Further information pertaining to cancer microbe research (both pro and con) can be found by Googling: cancer microbe; bacterial pleomorphism; cell wall deficient bacteria; "alan cantwell"; "virginia livingston"; "Eleanor Alexander- Jackson"; as well as other names and key words mentioned in this communication. For a list of scientific publications pertaining to the microbiology of cancer, go to the PubMed website hosted by the National Institute of Health (www.ncbi.nlm.nih.gov) and type in "Cantwell AR", "Livingston VW", "Alexander- Jackson E", "Diller IC", "Seibert FB", etc. in the search box. This short communication is unlikely to convince many health professionals that bacteria cause cancer. However, after four decades of studying cancer microbes in cancerous tissue, I am personally convinced 266
that Dr. Virginia Livingston will one day be vindicated and recognized as one of the greatest medical geniuses of the twentieth century. Ralph W Moss, cancer advocate and author of The Cancer Industry, notes her passing was "a major loss to the cancer world." In the Cancer Chronicles #6, 1990, he writes, "Virginia Livingston was a great person and a great scientist. Sadly, she never received the recognition she deserved in her lifetime. The true scope of her achievements will only become known in years to come." This report honors the centennial of her birth which takes place on December 28, 2006. © All Rights Reserved.
136. Alexander- Jackson E. A specific type of microorganism isolated from animal and human cancer: bacteriology of the organism. Growth. 1954 Mar;18(1):37- 51. © All Rights Reserved. 137. Cantwell AR. Variably acid- fast cell wall- deficient bacteria as a possible cause of dermatologic disease. In, Domingue GJ (Ed). Cell Wall Deficient Bacteria. Reading: Addison- Wesley Publishing Co; 1982. Pp. 321- 360. © All Rights Reserved. 138. Cantwell A. The Cancer Microbe. Los Angeles: Aries Rising Press; 1990. © All Rights Reserved. 139. Cantwell A. Four Women Against Cancer. Los Angeles: Aries Rising Press; 2005. © All Rights Reserved. 140. Diller IC, Diller WF. Intracellular acid- fast organisms isolated from malignant tissues. Trans Amer Micr Soc. 1965; 84:138- 148. © All Rights Reserved. 141. Greenberg DE, Ding L, Zelazny AM, Stock F, Wong A, Anderson VL, Miller G, Kleiner DE, Tenorio AR, Brinster L, Dorward DW, Murray PR, Holland SM. A novel bacterium associated with lymphadenitis in a patient with chronic granulomatous disease. PLoS Pathog. 2006 Apr;2(4):e28. Epub 2006 Apr 14. © All Rights Reserved.
142. Hooper SJ, Crean SJ, Lewis MA, Spratt DA, Wade WG, Wilson MJ. Viable bacteria present within oral squamous cell carcinoma tissue. J Clin Microbiol. 2006 May;44(5):1719- 25. © All Rights Reserved. 143. Nuzum JW. The experimental production of metastasizing carcinoma of the breast of the dog and primary epithelioma in man by repeated inoculation of a micrococcus isolated from human breast cancer. Surg Gynecol Obstet. 1925; 11;343- 352. © All Rights Reserved. 144. Russell W. An address on a characteristic organism of cancer. Br Med J. 1890; 2:1356- 1360. © All Rights Reserved.
145. Russell W. The parasite of cancer. Lancet. 1899;1:1138- 1141. © All Rights Reserved. 146. Sauter C, Kurrer MO. Intracellular bacteria in Hodgkin's disease and sclerosing mediastinal B- cell lymphoma: sign of a bacterial etiology? Swiss Med Wkly. 2002 Jun 15;132(23- 24):312- 5. © All Rights Reserved.
147. Scott MJ. The parasitic origin of carcinoma. Northwest Med. 1925;24:162- 166. 148. Seibert FB, Feldmann FM, Davis RL, Richmond IS. Morphological, biological, and immunological studies on isolates from tumors and leukemic bloods. Ann N Y Acad Sci. 1970 Oct 30;174(2):690- 728.
267
149. Shannon BA, Garrett KL, Cohen RJ. Links between Propionibacterium acnes and prostate cancer. Future Oncol. 2006 Apr;2(2):225- 32. Review. © All Rights Reserved. 150. Wuerthele Caspe- Livingston V, Alexander- Jackson E, Anderson JA, et al. Cultural properties and pathogenicity of certain microorganisms obtained from various proliferative and neoplastic diseases. Amer J Med Sci. 1950; 220;628- 646. © All Rights Reserved. 151. Wuerthele- Caspe Livingston V, Livingston AM. Demonstration of Progenitor cryptocides in the blood of patients with collagen and neoplastic diseases. Trans NY Acad Sci. 1972; 174 (2):636- 654. 152. Young J. Description of an organism obtained from carcinomatous growths. Edinburgh Med J. 1921; 27:212- 221. © All Rights Reserved. 153. Book: The Cancer Microbe, Alan Cantwell, Publisher: Aries Rising Pr (July 1, 1990), Language: English, ISBN- 10: 0917211014, ISBN- 13: 978- 0917211010 © All Rights Reserved. 154. Book: Four Women Against Cancer, by Alan Cantwell, Publisher: Aries Rising Press (July 2005), Language: English, ISBN- 10: 0917211332, ISBN- 13: 978- 0917211331 © All Rights Reserved. 155. Book: Alternative Medicine Definitive Guide to Cancer by W. John Diamond, W. Lee Cowden, Burton Goldberg, Publisher: Alternativemedicine.com books; Re- issue edition (March 18, 1997), Language: English, ISBN- 10: 1887299017, ISBN- 13: 978- 1887299015 © All Rights Reserved. 156. Article: Cancer Research Institute Honors Dr. Laurie H. Glimcher, Dean of Weill Cornell Medical College Receives the 2012 William B. Coley Award for Distinguished Research in Basic Immunology, Powered by Big Medium™, © Weill Cornell Medical College. All rights reserved. http://weill.cornell.edu/news/releases/wcmc/wcmc_2012/10_18_12b.shtml © All Rights Reserved. 157. Article: [2010 Sept] Jordan baffled doctors when his leukaemia vanished, new evidence suggests a remarkable explanation... can a fever cure cancer?, http://www.whale.to/cancer/coleys.html © All Rights Reserved.
158. Article: http://www.cforyourself.com/Conditions/Cancer/cancer.html © All Rights Reserved. 159. Carolyn Freeman; Halperin, Edward C.; Brady, Luther W.; David E. Wazer (2008). Perez and Brady's Principles and Practice of Radiation Oncology. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. pp. 637–644. ISBN 0- 7817- 6369- X. © All Rights Reserved. 160. en.wikipedia.org/wiki/Hyperthermia_therapy#cite_note- PerezBrady08- 3. © All Rights Reserved. 161. More information on hyperthermia can be found from the National Cancer Institute’s fact sheet on hyperthermia treatments for cancer. You can read more about Coley’s story here or here. (http://www.damninteresting.com/?p=871) (http://en.wikipedia.org/wiki/William_Coley) © All Rights Reserved.
162. Article: http://correlatingcancer.com/cancer- anthropologyhistory/warming- up- to- an- ancient- concepthistory- of- fever- induced- cures/ © All Rights Reserved. 268
163. Review: Fever and cancer in perspective Uwe Hobohm, F. Hoffmann – La roche Ltd. Pharma Research, Basel, Switzerland, Cancer Immunol Immunother (2001) 50: 391- 396 DOI 10.1007, S002620I00216), Springer – Verlag 2001, http://bioinfo.mni.th- mh.de/cancer/hobohm- 2001- cii.pdf © All Rights Reserved. 164. Abel U, Becker N, Angerer R, Frentzel- Beyme R, Kaufmann M, Schlag P, Wysocki S, Wahrendorf J, Schulz G (1991) Common infections in the history of cancer patients and controls. J Cancer Res Clin Oncol 117: 339 © All Rights Reserved. 165. Albert ML, Sauter B, Bhardwaj N (1998) Dendritic cells acquire antigen from apoptotic cells and induce class © All Rights Reserved. 166. Axelrod RS, Havas HF, Murasko DM, Bushnell B, Guan CF (1988) Effect of the mixed bacterial vaccine on the immune response of patients with Non- small cell lung cancer and refractory malignancies. Cancer 6: 2219 © All Rights Reserved. 167. Botzler C, Issels R, Multhoff G (1996) 168. Boyd W (1966) The spontaneous regression of cancer. Thomas, Springfield, 111 © All Rights Reserved. 169. Bruns P (1888) Die Heilwirkung des Erysipelas auf Ges- chwulste. Beitr Klin Chir 3: 443 170. Busch W (1868) Aus der Sitzung der medicinischen Section vom 13 November 1867. Berl Klin Wochenschr 5: 137 © All Rights Reserved. 171. Challis GB, Slam HJ (1990) The spontaneous regression of cancer. A review of cases from 1900 to 1987. Acta Oncol 29: 545 © All Rights Reserved. 172. Chattergoon MA, Kim JJ, Yang J, Robinson TM, Lee DJ, Dentchev T, Wilson DM, Ayyav V, Weiner DB (2000) Targeted antigen delivery to antigen- presenting cells including dendritic cells engineered Fasmediated apoptosis. Nat Biotechnol 18: 974 © All Rights Reserved. 173. Coley- Nauts H, McLaren JR (1990) Coley toxins - the first century. Adv Exp Med Biol 267: 483 174. Coley WB (1893) A preliminary note on the treatment of inoperable sarcoma by the toxic product of erysipelas. Postgraduate 8: 278 © All Rights Reserved. 175. Deidier A (1725) Dissertation Medecinal et Chirurgical sur les Tumeurs, Paris © All Rights Reserved. 176. Engel P (1934) Ueber den Infektionsindex der Krebskranken. Wiener Klin Wochenschrift 37: 1118 177. Everson T, Cole W (1966) Spontaneous regression of cancer, Philadelphia © All Rights Reserved. 178. Falk MM, Issels RD (2001) Hyperthermia in oncology. Int J Hyperthermia 17: I © All Rights Reserved. 179. Fehleisen F (1882) Uber die Ziichtung der Erysipelkokken auf kunstlichem Nahrboden und die Ubertragbarkeit auf den Menschen. Dtsch Med Wochenschau 8: 553 © All Rights Reserved. 180. Gallucci S, Lolkema M, Matzinger P(I999) Natural adjuvants: endogenous activators of dendritic cells. Nat Med 5: 1249 © All Rights Reserved. 181. Hanson DF (1993) Fever and the immune response. J Immunol 151: 436 © All Rights Reserved.
269
182. Havas HF. Axe".rod RS. Burns M. Murasko D. Gonnewardene M (1993) Clinical results and immunologic effects of a mixed bacterial vaccine in cancer patients. Med Oncol Tumor Phar- macother 10: 145 © All Rights Reserved. 183. Johnston B (1962) Clinical effect of Coley's toxin. I. A controlled study. Cancer Chemother Reports 21: 19 © All Rights Reserved.
184. Johnston BJ, Novates ET (1962) Clinical effect of Coley's toxin. II. A seven- year study. Cancer Chem Rep 21: 43 © All Rights Reserved. 185. KOlmel K, Pfahlberg A, Mastrangelo G, Niin M. Botev I, Seebacher C, Schneider D, Lambert D, Shafir R, Kokoschka E, Kleeberg U, Henz B, Geffeller O (1999) Infections and melanoma risk: results of a multicentre EORTC case- study. © All Rights Reserved. 186. KSlmel K, Vehmeyer K, Gdhring E, Kuhn B, Wieding JU (1991) Treatment of advanced malignant melanoma by a pyr- ogenic bacterial lysate. A pilot study. Onkologie 14: 411 © All Rights Reserved. 187. Krummel MF, Allison JP (1996) CTLA- J engagement inhibits IL- 2 accumulation and cell cycle progression upon activation of resting T cells. J Exp Med 183: 2533 © All Rights Reserved. 188. Lassar O (1891) Zur Erysipelimpfung. Dtsch Med Wochenschr 17: 889 © All Rights Reserved. 189. Leach DR, Krummel MF, Allison JP (1996) Enhancement of antitumor immunity by CTLA- 4 blockade. Science 271 © All Rights Reserved. 190. Maurer S, Kttlmel KF (1998) Spontaneous regression of advanced malignant melanoma. Onkologie 21: 14 © All Rights Reserved. 191. Miller TR, Nicholson JT (1971) End results in reticulum sarcoma of bone treated by bacterial toxin therapy alone or combined with surgery and/or radiotherapy (47 cases) or with concurrent infection (5 cases). Cancer 27: 524 © All Rights Reserved. 192. MulthofT G, Botzler C, Wiesnet M, MUller E, Meier T, Wil- manns W, Issel RD (1995) A stress inducible 72- kDa heat- shock protein (HSP72) is expressed on the surface of human tumor cells, but not on normal cells. Int J Cancer 61: 272 © All Rights Reserved. 193. Nauts HC (1975) Beneficial effects of immunotherapy (bacterial toxins) on sarcoma of soft tissues, other than lymphosarcoma. Monograph of the Cancer Research Institute 194. Pardoll D (1998) Cancer vaccines. Nat Med 4: 525 © All Rights Reserved. 195. Reinhard EH, Good JT, Martin E (1950) Chemotherapy of malignant neoplastic diseases - abstract of discussion, with statement by MJ Shear, Bethesda. JAMA 142: 383 © All Rights Reserved. 196. Richardson MA, Ramirez T, Russell NC, Moye LA (1999) Coley toxins immunotherapy: a retrospective review. © All Rights Reserved. 197. Rubinfeld B, Robbins P, El- Gamil M, Albert I, Porfiri E, Polakis P (1997) Stabilization of beta- catenin by genetic defects in melanoma cell lines. Science 275: 1790 270
198. Sakamoto J, Teramukai S, Watanabe Y, Hayata Y, Okayasu T, Nakazoto H, Ohashi Y (2001) Metaanalysis of adjuvant immunotherapy using OK- 432 in patients with resected non- small- cell lung cancer. J Immunother 24: 250 199. Stames CO (1992) Coley's toxins in perspective. 200. Stephenson HE, Delmez JA, Renden DI, KimptonRS, Todd PC, Charron TL, Lindberg D (1971) Host immunity and spontaneous regression of cancer. Surg Gynecol Obstet 133: 649 201. Tang, Z.Y., Zhou, G., Chai, L.M., Zhou, M., Lu, J.Z., Liu, K.D., Havas F, Nauls H.C. (1991) Preliminary result of mixed bacterial vaccine as adjuvant treatment of hepatocellular carcinoma. Med Oncol Turn Pharmacother 8: 23 202. Trieb K, Sztankay A, Amberger A, Lechner H, Grubeck- Lobenstein B (1994) Hyperthermia inhibits proliferation and stimulates the expression of differentiation markers in cultured thyroid carcinoma cells. Cancer Lett 87: 65 203. Udono H, Srivastava PK (1993) Heat shock protein 70- asso- ciated peptides elicit specific cancer immunity. J Exp Med 178: 1391 204. Wiemann B, Stames CO (1994) Coley's toxins, tumor necrosis factor and cancer research: a historical perspective. Pharmacol Tber 64: 529 205. Article: Concern over deodorant chemicals, 2004, © BBC, http://news.bbc.co.uk/2/hi/health/3383393.stm 206. Study: Harvey PW, Everett DJ., Significance of the detection of esters of p- hydroxybenzoic acid (parabens) in human breast tumours., J Appl Toxicol. 2004 Jan- Feb;24(1):1- 4., Copyright 2004 John Wiley & Sons, Ltd., http://www.ncbi.nlm.nih.gov/pubmed/14745840 © All Rights Reserved. 207. Field SB, Franconi C, editors. Physics and Technology of Hyperthermia. Boston: Nijhoff, 1987. 208. Hahn GM. Hyperthermia and Cancer. New York: Plenum, 1982. © All Rights Reserved. 209. Paliwal BR, Hetzel FW, Dewhirst MW. Biological, Physical and Clinical Aspects of Hyperthermia. New York: American Institute of Physics, 1988. © All Rights Reserved. 210. Study details: Daniel S Kapp, PhD, MD, George M Hahn, PhD, and Robert W Carlson, MD., Chapter 35Principles of Hyperthermia, Bookshelf ID: NBK20842, © 2000, BC Decker Inc. © All Rights Reserved. 211. Coley W B. The treatment of malignant tumors by repeated inoculations of erysipelas, with a report of ten original cases. Am J Med Sci. 1893;105:488. [PubMed] © All Rights Reserved. 212. Field SB, Franconi C, editors. Physics and Technology of Hyperthermia. Boston: Nijhoff, 1987. 213. Hahn GM. Hyperthermia and Cancer. New York: Plenum, 1982. © All Rights Reserved. 214. Paliwal BR, Hetzel FW, Dewhirst MW. Biological, Physical and Clinical Aspects of Hyperthermia. New York: American Institute of Physics, 1988. © All Rights Reserved. 215. Read R A, Bedford J S. Thermal tolerance. Br J Radiol. 1980;53:920–921. [PubMed]
271
216. Armour E P, McEachern D, Wang Z, Corry P, Martinez A. Sensitivity of human cells to mild hyperthermia. Cancer Res. 1993;53:2740–2744. [PubMed] 217. Morimoto RI, Tissieres A, Georgopoulos C. Stress Proteins in Biology and Medicine. Cold Spring Harbor, New York. 1990. © All Rights Reserved. 218. Hahn GM, Adwankar MK, Basrur VS, Anderson RL. Survival of cells exposed to anticancer drugs after stress. In: Pardue ML, Feramisco JR, Lindquist S. Stress- Induced Proteins. New York, NY: Liss; 1989. p. 223–233. © All Rights Reserved. 219. Anderson R L, Tao T W, Betten D A, Hahn G M. Heat shock protein levels are not elevated in heatresistant B16 melanoma cells. Radiat Res. 1986;105:240–246. [PubMed] 220. Hahn G M, van Kersen I. Isolation and initial characterization of thermoresistant RIF tumor cell strains. Cancer Res. 1988;48:1803–1807. [PubMed] 221. Hiraoka M, Hahn G M. Changes in pH and blood flow induced by glucose and their effects on hyperthermia with or without BCNU in RIF- 1 tumours. Int J Hypertherm. 1990;6:97–103. [PubMed] 222. Millian A J. Whole- body hyperthermia induction techniques. Cancer Res. 1984;44(Suppl):4869S. [PubMed] 223. Pettigrew RT. Cancer therapy by whole- body heating. In Proceedings of the International Symposium on Cancer Therapy by Hyperthermia and Radiation. Edited by Wizenberg M, Robinson SF. Baltimore, MD: American College of Radiology; 1975;282–288. 224. Robins H I, Hugander A, Cohen J D. Whole body hyperthermia in the treatment of neoplastic disease. Radiol Clin North Am. 1989;27:603–610. [PubMed] 225. Storm F K. Clinical hyperthermia and chemotherapy. Radiol Clin North Am. 1989;27:621–627. [PubMed] 226. Anderson R L, Kapp D S. Hyperthermia in cancer therapy: current status. Med J Aust. 1990;152:310–315. [PubMed] 227. Samulski T V, Clegg S T, Das S, MacFall J, Prescott D M. Application of new technology in clinical hyperthermia. Int J Hyperthermia. 1994;10:389–394. [PubMed] 228. Cline H E, Hynynen K, Hardy C J, Watkins R D, Schenck J F, Jolesz F R. MR temperature mapping of focused ultrasound surgery. Magn Reson Med. 1994;31:628–366. [PubMed] 229. Sapareto S A, Dewey W C. Thermal dose determination in cancer therapy. Int J Radiat Oncol Biol Phys. 1984;10:787–800. [PubMed] 230. Oleson J R, Samulski T V, Leopold K A, Clegg S T, Dewhirst M W, Dodge R K, George S L. Sensitivity of hyperthermia trial outcomes to temperature and time: implications for thermal goals of treatment. Int J Radiat Oncol Biol Phys. 1993;25:289–297. [PubMed]
272
231. Kapp D S, Cox R. Thermal treatment parameters are most predictive of outcome in patients with single tumor nodules per treatment field in recurrent adenocarcinoma of the breast. Int J Radiat Oncol Biol Phys. 1995;33:887–899. [PubMed] 232. Meyer J L. The clinical efficacy of localized hyperthermia. Cancer Res. 1984;44 (Suppl):4745S–4751S. [PubMed] 233. Storm F K, Baker H W, Scanlon E F, Plenk H P, Meadows P M, Cohen S C, Olson C E, Thomson J W, Khandekar J D, Roe D, Nizze A, Morton D L. Magnetic- induction hyperthermia. Results of a 5- year multi- institutional national cooperative trial in advanced cancer patients. Cancer. 1985;55:2677–2687. [PubMed] 234. Petrovich Z, Langholz B, Gibbs F A, Sapozink M D, Kapp D S, Stewart R J, Emami B, Oleson J, Senzer N, Slater J, Astrahan M. Regional hyperthermia for advanced tumors: a clinical study of 353 patients. Int J Radiat Oncol Biol Phys. 1989;16:601–607. [PubMed] 235. Delepine N, Delepine G, Desbois JC, Sidi J, Jasmin C. Treatment of pelvic chondrosarcoma by an external deep heating device in 12 cases. Abstracts of Papers for the 5th European BSD- Users Conference: Hyperthermia in Clinical Oncology. Rotterdam, The Netherlands, May 19, 1990. 236. Barlogie B, Corry P M, Yip E, Lippman L, Johnston D A, Khalil K, Tenczynski T F, Reilly E, Lawson R, Dosik G, Rigor B, Hankenson R, Freireich E J. Total- body hyperthermia with and without chemotherapy for advanced human neoplasms. Cancer Res. 1979;39:1481–1489. [PubMed] 237. Bull J M, Lees D, Schuette W, Whang- Peng J, Smith R, Bynum G, Atkinson E R, Gottdiener J S, Gralnick H R, Shawker T H, DeVita V T Jr. Whole- body hyperthermia: a phase- I trial of a potential adjuvant to chemotherapy. Ann Intern Med. 1979;90:317–323. [PubMed] 238. Steindorfer P, Jakse R, Germann R, Schneider G, Berger A, Mischinger H J, Rehak P. Hyperthermia as an adjuvant to radiation and/or chemotherapy in far advanced recurrences of the head and neck region. Strahlenther Onkol. 1987;163:449–452. [PubMed] 239. van der Zee J, van Rhoon G C, Wike- Hooley J L, Faithfull N S, Reinhold H S. Whole- body hyperthermia in cancer therapy: a report of a phase I- II study. Eur J Cancer Clin Oncol. 1983;19:1189– 1200. [PubMed] 240. Stewart J R. Past clinical studies and future directions. Cancer Res. 1984;44(10 Suppl):4902–4904. [PubMed] Kapp D S. Site and disease selection for hyperthermia clinical trials. Int J Hyperthermia. 1986;2:139–156. [PubMed] 241. Serin M, Erkal H S, Cakmak A. Radiation therapy, cisplatin and hyperthermia in combination in management of patients with recurrent carcinomas of the head and neck with metastatic cervical lymph nodes. Int J Hyperthermia. 1999;15:371–381. [PubMed]
273
242. Perez C A, Gillespie B, Pajak T, Hornback N B, Emami B, Rubin P. Quality assurance problems in clinical hyperthermia and impact on therapeutic outcome: a report by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys. 1989;16:551–558. [PubMed] 243. Perez CA, Gillespie B, Pajak T, Hornback NB, Emami B, Rubin P. Quality assurance problems in clinical hyperthermia and impact on therapeutic outcome: a report by RTOG. In Radiation Oncology Center Scientific Report. St. Louis, MO: Mallinckrodt Institute of Radiology, 1987–1988, p 293. 244. Valdagni R, Amichetti M, Pani G. Radical radiation alone versus radical radiation plus microwave hyperthermia for N3 (TNM- UICC) neck nodes: a prospective randomized clinical trial. Int J Radiat Oncol Biol Phys. 1988;15:13–24. [PubMed] 245. Vernon C C, Hand J W, Field S R. et al. International Collaborative Hyperthermia Group. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. Int J Radiol Oncol Biol Phys. 1996;35:731–744. [PubMed] 246. Overgaard J, Gonzalez Gonzalez D, Hulshof M C C M, Arcangeli G, Dahl O, Molls O, Bentzen S M. Randomized trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. Lancet. 1995;345:540–543. [PubMed] 247. Valdagni R, Amichetti M. Report of long- term follow- up in a randomized trial comparing radiation therapy and radiation therapy plus hyperthermia to metastatic lymph- nodes in Stage IV head and neck patients. Int J Radiat Oncol Biol Phys. 1994;28:163–169. [PubMed] 248. Petersen I A, Kapp D S. Local hyperthermia and radiation therapy in the retreatment of superficially located recurrences in Hodgkin’s disease. Int J Radiat Oncol Biol Phys. 1990;18:603–611. [PubMed] 249. Knox S J, Kapp D S. Hyperthermia and radiation therapy in the treatment of recurrent Merkel cell tumors. Cancer. 1988;62:1479–1486. [PubMed] 250. Barnett T A, Kapp D S, Goffinet D R. Adenoid cystic carcinoma of the salivary gland: management of recurrent, advanced, or persistent disease with hyperthermia and radiation therapy. Cancer. 1990;65:2648– 2656. [PubMed] 251. Kapp D S, Cox R S, Fessenden P, Meyer J L, Prionas S D, Lee E R, Bagshaw M A. Parameters predictive for complications of treatment with combined hyperthermia and radiation therapy. Int J Radiat Oncol Biol Phys. 1992;22:999–1008. [PubMed] 252. Sugimachi K, Matsuda H, Ohno S, Fukuda A, Matsuoka H, Mori M, Kuwano H. Long term effects of hyperthermia combined with chemotherapy and irradiation for the treatment of patients with carcinoma of the esophagus. Surg Gynecol Obstet. 1988;167:319–323. [PubMed] 253. Sakamoto T, Katoh H, Shimizu T, Yamashita I, Takemori S, Tazawa K, Fujimaki M. Clinical results of treatment of advanced esophageal carcinoma with hyperthermia in combination with chemoradiotherapy. Chest. 1997;112:1487–1493. [PubMed] 274
254. Sharma S, Patel F D, Sandhu A P S, Gupta B D, Yadav N S. A prospective randomized study of local hyperthermia as a supplement and radiosensitizer in the treatment of carcinoma of the cervix with radiotherapy. Endocuriether/Hyperther Oncol. 1989;5:151. 255. Datta N R, Bose A K, Kapoor H K, Gupta S. Head and neck cancers: results of thermoradiotherapy versus radiotherapy. Int J Hyperthermia. 1990;6:479–486. [PubMed] 256. Kaplan I, Kapp D S, Bagshaw M A. Secondary external- beam radiotherapy and hyperthermia for local recurrence after 125- iodine implantation in adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys. 1991;20:551–554. [PubMed] 257. Berdov B A, Menteshashvili G Z. Thermoradiotherapy of patients with locally advanced carcinoma of the rectum. Int J Hyperthermia. 1990;6:881–890. [PubMed] 258. You Q - S, Wang R - Z, Suen G - Q, Yan F - C, Gao Y - J, Cui S - R, Zhao J - H, Zhao T - Z, Ding L. Combination preoperative radiation and endocavitary hyperthermia for rectal cancer: long- term results of 44 patients. Int J Hyperthermia. 1993;9:19–24. [PubMed] 259. Karasawa K, Muta N, Nakagawa K, Hasezawa K, Terahara A, Onogi Y, Sakata K - I, Aoki Y, Sasaki Y, Akanuma A. Thermoradiotherapy in the treatment of locally advanced nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys. 1994;30:1171–1177. [PubMed] 260. Prosnitz L R, Maguire P, Anderson J M, Scully S P, Harrelson J M, Jones E L, Dewhirst M, Samulski T V, Powers B E, Rosner G L, Dodge R K, Layfield L, Clough R, Brizel D M. The treatment of high- grade soft tissue sarcomas with preoperative thermoradiotherapy. Int J Radiat Oncol Biol Phys. 1999;45:941– 949. [PubMed] 261. van der Zee J, Gonzalez Gonzalez D, van Putten WLJ, Hart AAM, Koper PCM, Treurniet- Donker AD, Wignmaalen AJ, van Dijk JDP, van Rhoon GC. Hyperthermia combined with radiotherapy in deep seated tumors—a phase III trial. In Abstracts of the Hyperthermia in Clinical Oncology Meeting, Munich, Germany, 1993. 262. Kakehi M, Ueda K, Mukojima T, Hiraoka M, Seto O, Akanuma A, Nakatsugawa S. Multi- institutional clinical studies on hyperthermia combined with radiotherapy or chemotherapy in advanced cancer of deep- seated organs. Int J Hyperthermia. 1990;6:719–740. [PubMed] 263. Seegenschmiedt M H, Martus P, Fietkau R, Iro H, Brady L W, Sauer R. Multivariate analysis of prognostic parameters using interstitial thermoradiotherapy (IHT:IRT): tumor and treatment variables predict outcome. Int J Radiat Oncol Biol Phys. 1994;29:1049–1063. [PubMed] 264. Martinez A, Gersten D, Leslie J, Borrego C, Armour E, Corry P. Interstitial thermo- brachytherapy with continuous mild hyperthermia for the treatment of locally advanced or recurring pelvic malignancies. Abstracts of Papers for the Forty- First Annual Meeting of the Radiation Research Society and the
275
265.
266. 267.
268.
269. 270. 271. 272.
273. 274. 275.
276. 277.
Thirteenth Annual Meeting of the North American Hyperthermia Society, Dallas, Texas, March 20–25, 1993, p 122. Konings A W, Hettinga J V E, Lemstra W, Humphrey G B, Kampinga H H. Sensitizing for cisdiamminedichloroplatinum(II) action by hyperthermia in resistant cells. Int J Hyperthermia. 1993;9:553– 562. [PubMed] Wallner K E, Banda M, Li G C. Hyperthermic enhancement of cell kill by mitomycin C in mitomycin Cresistant Chinese hamster ovary cells. Cancer Res. 1987;47:1308–1312. [PubMed] Wallner K E, DeGregorio M W, Li G C. Hyperthermic potentiation of cis- diamminedichloroplatinum (II) cytotoxicity in Chinese hamster ovary cells resistant to the drug. Cancer Res. 1986;46:6242–6245. [PubMed] Rietbroek R C, Schilthuis M S, Bakker P J, van Dijk J D, Postma A J, Gonzalez Gonzalez D, Bakker A J, van der Velden J, Helmer horst T J, Veenhof C H. Phase II trial of weekly locoregional hyperthermia and cisplatin in patients with a previously irradiated recurrent carcinoma of the uterine cervix. Cancer. 1997;79:935–943. [PubMed] Bull J M. A review of systemic hyperthermia. Front Radiat Ther Oncol. 1984;18:171–176. [PubMed] Engelhardt R. Summary of recent clinical experience in whole- body hyperthermia combined with chemotherapy. Recent Results Cancer Res. 1988;107:200–204. [PubMed] Larkin J M. A clinical investigation of total- body hyperthermia as cancer therapy. Cancer Res. 1979;39:2252–2254. [PubMed] Maeta M, Koga S, Wada J, Yokoyama M, Kato N, Kawahara H, Sakai T, Hino M, Ono T, Yuasa K. Clinical evaluation of total- body hyperthermia combined with anticancer chemotherapy for far- advanced miscellaneous cancer in Japan. Cancer. 1987;59:1101–1106. [PubMed] Parks LC, Smith GV. Systemic hyperthermia by extracorporeal induction techniques and results. In Hyperthermia in Cancer Therapy. Edited by FK Storm. Boston: Hall, 1983;407–446. Ghussen F, Kruger I, Smalley R V, Groth W. Hyperthermic perfusion with chemotherapy for melanoma of the extremities. World J Surg. 1989;13:598–602. [PubMed] Krementz ET, Ryan RF, Carter RD, Sutherland CM, Reed RJ. Hyperthermic regional perfusion for melanoma of the limbs. In Cutaneous Melanoma. Clinical Management and Treatment Results Worldwide. Edited by Balch CM, Milton GW. Philadelphia, PA: Lippincott; 1985. p. 171. Rochlin D B, Smart C R. Treatment of malignant melanoma by regional perfusion. Cancer. 1965;18:1544–1550. [PubMed] Shiu M H, Knapper W H, Fortner J G, Yeh S, Horowitz G, Schnog J, Guerra J, Gould- Rossbach P, Ray C. Regional isolated limb perfusion of melanoma intransit metastases using mechlorethamine (nitrogen mustard). J Clin Oncol. 1986;4:1819–1826. [PubMed] 276
278. Stehlin J S Jr. Hyperthermic perfusion for melanoma of the extremities: experience with 165 patients, 1967 to 1979. Ann NY Acad Sci. 1980;335:352–355. [PubMed] 279. Hafström L, Rudenstam C - M, Blomquist E, Ingvar C, Jönsson P - E, Lagerlöf B, Lindholm C, Ringborg U, Westman G, Strup L. Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanomas of the extremities. J Clin Oncol. 1991;9:2091. [PubMed] 280. Cavaliere R, DiFilippo F, Giannarelli D, Caralini S, Anza M, Cavaliere F, Graziano F, Perri P. Hyperthermic antiblastic perfusion in the treatment of local recurrence or "in- transit" metastases of limb melanoma. Semin Surg Oncol. 1992;8:374–380. [PubMed] 281. Sutherland C M, Krementz E T, Carter R D, Muchmore J H. Randomized trials of heated perfusion of extremity melanoma. Cancer Treat Res. 1988;43:173–176. [PubMed] 282. Schraffordt Koops H, Eggermont A M, Lienard D, Kroon B B, Hoekstra H J, Van Geel A N, Niewe O E, Lejeune F J. Hyperthermic isolated limb perfusion for the treatment of soft tissue sarcomas. Semin Surg Oncol. 1998;14:210–214. [PubMed] 283. Olieman A F, Pras E, van Ginkel R J, Molenaar W M, Schraffordt Koops H, Hoekstra H J. Feasibility and efficacy of external beam radiotherapy after hyperthermic isolated limb perfusion with TNF- alpha and melphalan for limb- saving treatment in locally advanced extremity soft- tissue sarcoma. Int J Radiat Oncol Biol Phys. 1998;40:807–814. [PubMed] 284. Arcangeli G, Cividalli A, Mauro F, Nervi C, Pavin G. Enhanced effectiveness of adriamycin and bleomycin combined with local hyperthermia in neck node metastases from head and neck cancers. Tumori. 1979;65:481–446. [PubMed] 285. Moffat F L, Rotstein L E, Calhoun K, Langer J C, Makowka L, Ambus U, Palmer J A, Campbell A, Howard V, Mikkelsaar R, Venturi D, Laing D, Falk J A, Falk R E. Palliation of advanced head and neck cancer with radiofrequency hyperthermia and cytotoxic chemotherapy. Can J Surg. 1984;27:38–41. [PubMed] 286. Fujimura K, Kohno I, Sekiba K. Therapeutic effect of hyperthermia combined with chemotherapy on vulvar and vaginal carcinoma. Acta Med Okayama. 1987;41:55–62. [PubMed] 287. Koga S, Hamazoe R, Maeta M, Shimizu N, Murakami A, Wakatsuki T. Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C. Cancer. 1988;61:232–237. [PubMed] 288. Hamazoe R, Maeta M, Kaibara N. Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Cancer. 1994;73:2048–2052. [PubMed] 289. Fujimura T, Yonemura Y, Fushida S, Urade M, Takegawa S, Kamata T, Sugiyama K, Hasegawa H, Katayama K, Miwa K, Miyazaki T. Continuous hyperthermic peritoneal perfusion for the treatment of
277
290. 291.
292. 293. 294.
295.
296.
297.
298.
299.
peritoneal dissemination in gastric cancers and subsequent second- look operation. Cancer. 1990;65:65– 71. [PubMed] Harari P M, Shimm D S, Gerner E W, Alberts D S. Intraperitoneal chemotherapy plus regional/systemic hyperthermia in the treatment of advanced ovarian cancer. Reg Cancer Treat. 1989;2:54. Leopold K A, Oleson J R, Clarke- Pearson D, Soper J, Berchuck A, Samulski T V, Page R L, Blivin J, Tomberlin J K, Dewhirst M W. Intraperitoneal cisplatin and regional hyperthermia for ovarian carcinoma. Int J Radiat Oncol Biol Phys. 1993;27:1245–1251. [PubMed] What the ACS Knew in 1955 About Infections and Cancer, The American Cancer Society has suppressed research on infection and lung cancer for over 70 years. http://www.smokershistory.com/acs1955.htm Article: Dr Koch and Glyoxylide/ Malonide, cancerinform.org based on Daniel Haley's book, "Politics In Healing. © All Rights Reserved. Article: Cancer Prevention, by Marian Johnson, Clinical Coordinator with the Prevention Clinics at the Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center 1100 Fairview Ave. N., PO Box 19024, Seattle, WA 98109, © 2013 Fred Hutchinson Cancer Research Center, © All Rights Reserved.https://www.fhcrc.org/en/treatment/survivorship/survival- strategies/cancer- prevention.html Second Cancers, Surveillance Epidemiology and End Results, National cancer Institute, U.S. National Institutes of Health, www.cancer.gov, Surveillance Research Program, NCI, Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Suite 504, MSC 8316, 6116 Executive Boulevard, Bethesda, MD 20892- 8316, © All Rights Reserved. http://seer.cancer.gov/studies/endresults/study28.html Kleinerman RA, Boice JD Jr, Storm HH, Sparen P, Andersen A, Pukkala E, Lynch CF, Hankey BF, Flannery JT. Second primary cancer after treatment for cervical cancer. An international cancer registries study. Cancer 1995;76:442- 452. © All Rights Reserved. Travis LB, Curtis RE, Storm H, Hall P, Holowaty E, Van Leeuwen FE, Kohler BA, Pukkala E, Lynch CF, Andersson M, Bergfeldt K, Clarke EA, Wiklund T, Stoter G, Gospodarowicz M, Sturgeon J, Fraumeni JF Jr, Boice JD Jr. Risk of second malignant neoplasms among long- term survivors of testicular cancer. J Natl Cancer Inst 1997;89:1429- 1439. © All Rights Reserved. Travis LB, Holowaty EJ, Bergfeldt K, Lynch CF, Kohler BA, Wiklund T, Curtis RE, Hall P, Andersson M, Pukkala E, Sturgeon J, Stovall M. Risk of leukemia after platinum- based chemotherapy for ovarian cancer. N Engl J Med 1999; 340:351- 357. © All Rights Reserved. Travis LB, Gospodarowicz M, Curtis RE, Clarke EA, Andersson M, Glimelius B, Joensuu T, Lynch CF, van Leeuwen FE, Holowaty E, Storm H, Glimelius I, Pukkala E, Stovall M, Fraumeni JF Jr, Boice JD Jr, Gilbert E. Lung cancer following chemotherapy and radiotherapy for Hodgkin’s disease. J Natl Cancer Inst 2002;94:182- 192. © All Rights Reserved. 278
300. Travis LB, Hill DA, Dores GM, Gospodarowicz M, van Leewen FE, Holowaty E, Glimelius B, Andersson M, Wiklund T, Lynch CF, Van’t Veer MB, Glimelius I, Storm H, Pukkala E, Stovall M, Curtis R, Boice JD Jr, Gilbert E. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin’s disease. JAMA 2003; 290:465- 475. © All Rights Reserved. 301. Curtis RE, Freedman M, Sherman M, Fraumeni JF Jr. Uterine corpus cancer following tamoxifen therapy for breast cancer: difference in risk by histologic subtype. J Natl Cancer Inst 2003 (In Press). © All Rights Reserved. © All Rights Reserved.
302. Study: The Man Who Questions Chemotherapy, © Compass Internet Ltd 2011 All rights reserved, - Reg. in England 4516 221, by Mike Howell, http://www.positivehealth.com/article/cancer/researching- canceron- the- world- wide- web © All Rights Reserved. 303. Study: Sato T., Department of Maxillofacial Surgery, Life Science of Maxillofacial Systems, Faculty of Dentistry, Tokyo Medical and Dental University, [A study on effect of mechanical irritation in development and progression of tongue cancer] Kokubyo Gakkai Zasshi. 1995 Dec;62(4):532- 50., PMID:8583164 [PubMed - indexed for MEDLINE], http://www.ncbi.nlm.nih.gov/pubmed/8583164 304. Article: http://www.whale.to/a/ozone1.html © All Rights Reserved. 305. Article:The Healing of Cancer: The Cures the Cover- Ups and the Solution Now! by Barry Lynes, Publisher: Marcus Books (June 1990), Language: English, ISBN- 10: 0919951449, ISBN- 13: 9780919951440 © All Rights Reserved. 306. Official Research Website of Dr. Koch is: http://www.williamfkoch.com/ © All Rights Reserved. 307. Article: http://www.rexresearch.com/koch/kochindex.htm Copyright 1941 BY KOCH LABORATORIES, INC. 308. Recommended website: http://www.whale.to/cancer/koch.html © All Rights Reserved. http://www.williamfkoch.com/web/version2/default.php http://www.wellnesstimes.com/healthresources/articles/glyoxylide http://www.vitamincfoundation.org/goxy.htm http://www.rexresearch.com/koch/kochindex.htm http://www.cancerinform.org/kocha.html http://www.encognitive.com/node/2600 http://www.consumerhealth.org/articles/display.cfm?ID=20060216161340 309. Article: The article was found at Ralph Moss's CancerDecisions.com, "(Hyderabaad, May 28) http://www.truthquest2.com/glyoxylide.htm. Also the article was derived from Daniel Haley's book, "Politics In Healing." All quotes have a bracketed page number by them © All Rights Reserved. 310. 311. – 279
312. 313. Urine therapy: The simple use of ones own urine, Jos- hua Medicine man, www.hps- online.com, The Ultimate Resource for Cleansing, Prevention and Rejuvenation online. Copyright HPS- ONLINE.COM, Helping People Survive, 1996- 2010, All Rights Reserved. http://www.hps- online.com/hurine1.htm © All Rights Reserved.
314. Article: I drink my urine at you Herr Doktorei, by Tantra Bensko, http://www.unlikelystories.org/09/bensko1209.shtml © All Rights Reserved. 315. Article: URINE THERAPY A Natural Alternative That Works, When all other medicines and remedies failed, urine therapy successfully treated this woman's lifelong 'incurable' illness., Extracted from Nexus Magazine, Volume 3, #2 (February- March 1996). PO Box 30, Mapleton Qld 4560 Australia. Telephone: +61 (0)7 5442 9280; Fax: +61 (0)7 5442 9381, © 1994 by Martha M. Christy Extracted with permission from Chapters 1 and 2 of her book Your Own Perfect Medicine Published in 1994 by FutureMed, Inc., Scottsdale, Arizona, USA, Martha Christy is a nutritional and natural health- care consultant, medical research writer and editor, and author of the international bestseller, Learn to Control Stress with the Stress Test. Her other books include Reconstructing The Real You, Even Good Foods Can Be Bad For You (Personalizing Your Nutrition), Balancing Your Body's pH, Simple Diagnostic Tests You Can Do At Home, and Homeopathy and Your Own Perfect Medicine. © All Rights Reserved. 316. Book: Golden Fountain: The Complete Guide to Urine Therapy by Coen van der Kroon 317. Book: Your Own Perfect Medicine: The Incredible Proven Natural Miracle Cure that Medical Science Has Never Revealed! by Martha M. Christy © All Rights Reserved. 318. Book: The Water of Life: A Treatise on Urine Therapy by J.W. Armstrong 319. Book: Urine Therapy: Nature's Elixir for Good Health by Flora Peschek- Böhmer 320. Book: Urine The Holy Water by Harald Tietze 321. Book: Urine Therapy! Confessions Of A Mad Pee Drinker by P. P. Powers 322. Book: Urine Therapy by John F. Oquinn 323. Book: Uropathy: The Most Powerful Holistic Therapy by Martin J. Lara 324. Book: Miracles of Urine Therapy by C. P. Mithal 325. Book: Miracles of Urine Therapy by Beatrice Bartnett 326. Book: Urine- Therapy: It May Save Your Life by Beatrice Bartnett 327. Book: Second World Conference on Urine Therapy by Cohen Van Der Kroon 328. Book: Miracles of Urine Therapy: Nature's Natural Nectar to Cure Diseases by S. K. Sharma 329. Book: Urine Therapy: Self- Healing Through Intrinsic Medicine by C. P. Mithal 330. Book: Manav Mootra (Auto- Urine Therapy) by Raojibnai M. Patei 331. Book: Shivambu Gita Holy Water Therapy by Thakkar 280
332. Book: Chinese Health Care Secrets: A Natural Lifestyle Approach by Henry C. Lu 333. Book: Healing Joint Pain Naturally: Safe and Effective Ways to Treat Arthritis, Fibromyalgia, and Other Joint Diseases by Ellen Hodgson Brown 334. Book: Beyond Prozac: Antidotes for Modern Times by Michael J. Norden 335. Book: The Natural Way to Heal by Walter Last 336. Book: The Melatonin Miracle: Nature's Age- Reversing, Disease- Fighting, Sex- Enhancing Hormone by Walter Pierpaoli 337. Book: Waterworld DVD - Kevin Costner 338. Article: URINE & UREA Therapy By Walter Last, http://www.health- science- spirit.com/urine.html Walter Last is the author of 'The Natural Way to Heal', Publisher: Hampton Roads Publishing Company; 1 edition (February 2004), ISBN- 10: 1571743189, ISBN- 13: 978- 1571743183 © All Rights Reserved. 339. Documentary: Burzynski, the Movie (2010),Eric Merola (Director) | Rated: Unrated | Format: DVD, ASIN: B003X3CF68, © 2010 Burzynski Movie, All Rights Reserved, http://www.burzynskimovie.com/, http://www.burzynskimovie.com/index.php?option=com_content&view=article&id=100&Itemid=82 340. Article: Article: Stanislaw R Burzynski, MD, PhD, Wellness Direcotry f Minnessota TM, Copyright © 2004, 2005 International Wellness Directory, All Rights Reserved, http://www.mnwelldir.org/, http://www.mnwelldir.org/docs/history/biographies/burzynski.htm © All Rights Reserved. 341. Memorandum: From: Head, Quality Assurance and Compliance, Section, RA5, CTEP. Subject: Review of brain tumor cases Treated with Antineoplastons, Department of Health & Human Services, Department of Health & Human Services, National Institutes of Health National Cancer Institute, Date: 1991. http://www.clintonlibrary.gov/assets/storage/Research%20- %20Digital%20Library/jenningshsa/Box%20038/647904- correspondence- buryznski- stanislaw- 1.pdf © All Rights Reserved. 342. Article: Cancer Blood test....short history of Glover serum, THE GLOVER ANTI- CANCER SERUM, Copyright CureZone.org, Dallas, Texas, http://curezone.com/forums/am.asp?i=336485 343. Article: McGrady & Morgan - Saturday Evening Post, 1964 / tobacco document, The American Cancer Society has suppressed research on infection and lung cancer for over 70 years. From: What the ACS Knew in 1955 About Infections and Cancer, http://www.smokershistory.com/, http://www.smokershistory.com/acs1955.htm © All Rights Reserved. 344. Study: Walter B. Coffey and John D. Humber, Cancer Studies: In Relation to Results of Treatment with an Aqueous Extract Made from the Cortex of the Suprarenal Gland, A Five- Year Review on Treatment Results in Inoperable and Hopeless Malignancies: Report on 7,513 Cases, Read at the St. Francis Hospital meeting of the session of the American College of Surgeons, October 22- November 1, 1935, at San Francisco, California. Cal West Med. 1936 March; 44(3): 160–178. PMCID: PMC1760406, PMC1760406, National Center for Biotechnology Information, U.S. National Library of Medicine 8600 281
345.
346.
347. 348.
349. 350. 351. 352.
353.
354. 355. 356.
Rockville Pike, Bethesda MD, 20894 USA © All Rights Reserved.http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1760406/pdf/calwestmed00397- 0017.pdf Book: A Matter of Life or Death : The Incredible Story of Krebiozen by Herbert Bailey, Publisher: G. P. Putnam's Sons; 1st Edition / 2nd Printing edition (1958), ASIN: B001IOLXEO. Reprinted by The Arlin J. Brown Inf Centre, Inc, PO Box 251, Fort Belvoir, VA 22060. 703 451 8638, Herbert Bailey, known by his friends as The Brigadier, later wrote the first million- selling book on the subject of vitamins, Vitamin E: Your Key to a Healthy Heart ((Bantam, 1964). His crusade for vitamins succeeded after thirty years. © All Rights Reserved. Book: K Krebiozen Key To Cancer by Herbert Bailey, Publisher: Hermitage House; 1st edition (1955), ASIN: B000TZ3GXO © All Rights Reserved. Book: History of the American Physiological Society: The third quarter century, 1937- 1962, Wallace O Fenn, Publisher: Washington D.C.: The American Physiologcial Society (1963). 1st ed.; First Edition edition (1963), Language: English, ISBN- 10: 1199314218, ISBN- 13: 978- 1199314215, ASIN: B0006AYXZM © All Rights Reserved. Presentation of the Julius Friedenwald medal to Andrew Conway Ivy. by Grossman MI., Gastroenterology. 1970 Jun;58(6):747- 9., PMID:4912655 [PubMed - indexed for MEDLINE] Book: K Krebiozen Key To Cancer, Herbert Bailey, Publisher: Hermitage House; 1st edition (1955), Language: English, ASIN: B000TZ3GXO © All Rights Reserved. Speech: Fascism in Medicine, by Gary Null, Ph.D, Speech given May 15, 1994 at a forum on Democracy and Fascism Broadcast June 6, 1994 on Radio WBAI- FM, New York Article: Lawrence Burton, PhD, Wellness Directory of Minnesota, Copyright © 2004, International Wellness Directory, http://www.mnwelldir.org, © All Rights Reserved.http://www.mnwelldir.org/docs/history/biographies/burton.htm Article: Immune Augmentation Therapy Detailed Scientific Review, The University of Texas MD Anderson Cancer Center, http://www.mdanderson.org/educationandresearch/resourcesforprofessionals/clinical- tools- and- resources/cimer/therapies/nonplant- biologic- organic- pharmacologictherapies/immune- augmentation- scientific.html © All Rights Reserved. Moss R. IAT. Cancer Therapy: The Independent Consumer's Guide to Non- toxic Treatment and Prevention. Brooklyn, NY: Equinox press, 1992:476- 83. © All Rights Reserved. Null G. Cancer: Dr. Burzynski. Gary Null's complete guide to healing your body naturally.McGrawHill Book Company, 1988:95- 107. © All Rights Reserved. U. S. Congressional Office of Technology Assessment, Archived at Princeton University. Immunoaugmentative therapy chapter. [Web Page]. 1990. (Accessed 2007 May 17) © All Rights Reserved.
282
357.
358.
359. 360. 361. 362.
363.
364. 365. 366. 367. 368. 369. 370. 371. 372. 373.
U. S. Department of Health and Human Services PHSCfDC. Isolation of human T- lymphotrophic virus type II/Lymphadenopathy- associated virus from serum protein given to cancer patients. MMWR 1985;34:489- 91. © All Rights Reserved. Workshop on Alternative Medicine. Alternative Medicine: Expanding Medical Horizons. A Report to the National Institutes of Health on Alternative Medical Systems and Practices in the United States. Washington, DC: US Government Printing Office, 1992. © All Rights Reserved. Clement RJ, Burton L, Lampe GN. Peritoneal mesothelioma. Quantum Medicine: A Journal of Comparative Therapeutics 1988;1:68- 73. © All Rights Reserved. Cassileth BR, Trock BJ, Lusk EJ, et al. Report of a survey of patients receiving Immuno- augmentative therapy. Unpublished Study 1987 Sep. © All Rights Reserved. Quote: "Your Life, Your Choice", http://yourlifeyourchoice.org/testimonials- iat- cancer- clinic- bahamaspatients.htm, yourlifeyourchoice.org. All rights reserved. © All Rights Reserved. His work today is being carried on by the fine people who ran the Aidan Clinic. Today the Immunology Research Centre has a new name: Immuno- Technologies Cancer Clinic, and offers a wonderful combination of Burton’s therapies, those pioneered at the Aidan Clinic, and still others that are being tested at many clinics around the world (only you will NOT get a placebo at ITL (the nickname for Immuno- Technologies, Ltd)). © All Rights Reserved. Study: Walter Blumer, M.D. and Elmer Cranton, M.D., Ninety Percent Reduction in Cancer Mortality, Journal of Advancement in Medicine Volume 2, Numbers 1/2, Spring/Summer 1989. Source: http://www.gordonresearch.com/inner.cfm?itemCategory=46873&siteId=502&priorId=0 Blumer W. Jaumann R, Reich T: Morotsierungwichtigste ursung? Praxis 1972 © All Rights Reserved. Blumer W: Nervose Storungen durch autoabgase. Praxis 1970; 59: 1809- 1816. © All Rights Reserved. Blumer W, Reich T: Gesundheitsschadigung durch bleibenzin. Praxis 1975;64:261- 265. Blumer W, Riech T: Bleibenzin und krebsmortalitat. Schweit med Wschr 1976; 106:503- 506. Blumer W, Reich T: Leaded gasoline - a cause of cancer. Environmental International, 1980; 3: 465 71. Moeschlin S: Klinik und Therapie der Vergiftungen. Stuttgart, George Thieme Verlag, 1965. Blumer W: Bleidepots bei anwohnern einer autostrasse. Med Neuheiten June 1969; 75:3- 8. Roosels D: An atomic absorption determination of lead in urine after extraction with dither. Atom Abscam Newsweek 1968; 7:9- 10. Doss M, Schmidt A: Quantatative bestmtimmung vonrphobilinogen im urin mit ionenaustauchchromatographie- fertigsaulen. Z klin Chem klin Biochem 1971;9:99- 102. Blumer M, Blumer W, Reich T: Polycyclic aromatic hydrocarbons in soils of a mountain valley: Correlation with highway traffic and cancer incidence. Envir Sci Technol 1977;11: 1082- 1084. 283
374. Knutti R, Schlatter C: Motorisierung und Krebsgefahrdung. Schweiz med Wschr. 1977; 107:312 375. Balmus G, Nastac E, Sandulesco T: L'action d'un produit chelateur. Le calciethylaminediaminetetracetate disodique sur l'evolution du carcinome T8 Guerin chez le rat. Rev Path gen 1961;61: 423- 433. 376. Apffel CA, Walker JE, Issarescu S: Tumor rejection in experimental animals treated with radioprotective thiols. Cancer Res 1975; 35:429- 37. 377. Kallistratos G: Verhinderung der 3,4- Benzopyren- Kanzerogenese durch naturliche und synthetische Verbindungen. Munch med Wschr 1975;117:391- 394. 378. Leuchtenberger C, Leuchtenberger R, Zbinden I, Schleh E: SH reactivity of cigarette smoke and its correlation with carcinogenic effects on hamster lung cultures. Z Soz Prav med 1976;21:47- 50. 379. Mizrah IJ, Emmelot P: The effect of cysteine in the metabolic changes produced by two carcinogenic nnitrosodialkylamines in rat liver. Cancer Res 1962; 22:339- 351. 380. Furst A: Chelation and cancer - a speculative review, in Seven MJ, Johnson LA (eds): Metal Binding in Medicine. Philadelphia, J B Lipincott, 1960, pp 336 - 344. © All Rights Reserved. 381. Dehnen W, Monch W, Brockhaus A: Beeinflussung desAbbhaus von Benz(a)pyren in der Lunge durch Schwermetalle, in Girardet W 9ed) Lufthygiene und Silikoseforschung. Jahresbericht 1976, Band 9, W Girardet Ed., Essen 231. © All Rights Reserved. 382. Demopoulos HB, Peitronigro DD, Flamm ES, Seligman ML: The possible role of free radical reactions in carcinogenisis. Journal of Environmental Pathology and Toxicology. 1980;3:273 - 303. © All Rights Reserved.
383. Demopoulos HB, Peitronigro DD, Seligman ML: The development of secondary pathology with free radical reactions as a threshold mechanism. Journal of the American College of Toxicology. 1983; 2(3):173- 84. © All Rights Reserved. 384. Cranton EM, Frackelton JP: Free radical pathology in age- associated diseases: Treatment with EDTA chelation, nutrition and antioxidants. Journal of Holistic Medicine 1984; 6 (1) :6- 37. 385. McDonaugh EW, Rudolph CJ, Cheraskin E: The "clinical change" in patients treated with EDTA chelation plus multivitamin/trace mineral supplementation. Journal of Orthomolecular Psychiatry 1985; 14(1): 61- 65. © All Rights Reserved. 386. Stevens RG, Jones DY, Micozzi MS, et al: Body iron stores and the risk of cancer in Taiwan. JNCI 1988;319:1047- 1052.. © All Rights Reserved. 387. Stevens RG, Beasley RP, Blumberg BS: Iron binding proteins and risk of cancer in Taiwan. Jnci 1986;76:605- 610. © All Rights Reserved. 388. Selby JV, Friedman GD: Epidemiologic evidence of an association between body iron stores and risk of cancer. Int J Cancer 1988; 41 677- 682. © All Rights Reserved. 284
389. Sullivan JL: Iron and the sex difference in heart disease risk. Lancet 1981;1:1283- 1294. 390. Born, G.R., and Geurkink, T.L. Improved peripheral vascular function with low dose intravenous ethylene diamine tetraacetic acid (EDTA). Townsend Letter for Doctors. July, 1994, # 132, 722- 726. 391. Chappell, L.T., and Stahl, J.P. The correlation between EDTA Chelation therapy and improvement in cardiovascular function: A Meta- Analysis. J Adv Med, 1993, 6: 3, 139- 160. 392. Chappell, L.T., Stahl, J.P., and Evans, R. EDTA Chelation treatment for vascular disease: A MetaAnalysis using unpublished data. J Adv Med, 1994, 7: 3, 131- 142. 393. Hancke, C. and Flytlie, K., Benefits of EDTA Chelation Therapy in Arteriosclerosis: A retrospective study of 470 patients. J Advancement in Medicine, 1993., 6: 3, 161- 171. 394. Walker, Morton, and Gordon, Gary. The Chelation Answer. M. Evans and Company, New York, 1982. 395. Cranton, Elmer. Bypassing Bypass (2d Ed). Medex Publishers, Trout Dale, VA 24378- 0044, 1992. 396. Bjorksten, Johan. The crosslinkage theory of aging as a predictive indicator, in: A Textbook on EDTA Chelation Therapy, 1989, by Elmer M.Cranton (ed). Available from: American College for Advancement in Medicine, Laguna Niguel, CA, 1989. © All Rights Reserved. 397. Kindness, G., and Frackelton, J.P. Effect of EDTA on platelet aggregation in human blood. J Adv Med, 1989, 2: 4, 519- 530. © All Rights Reserved. 398. Harman, D. The biologic clock: The mitochondria? J Am Geriatr Soc, 1972, 20: 145- 147. 399. Miquel, J., Economos, A.C., Fleming, J., and Johnson, J.E. Mitochondrial role in cell aging. Exp Gerontol, 1980, 15: 575- 591. © All Rights Reserved. 400. Miquel, J. An update on the mitochondrial- DNA mutation hypothesis of cell aging. Mutation Research, 1992, 275: 209- 216. © All Rights Reserved. 401. Wallace, D.C. Mitochondrial genetics: a paradigm for aging and degenerative diseases? Science, 1992, 256:1063- 1064. © All Rights Reserved. 402. Shoffner, J.M. and Wallace, D.C. Oxidative phosphorylation diseases and mitochondrial DNA mutations: diagnosis and treatment, Ann Rev. Nutr, 1994, 14: 535- 568. 403. Flier, J.S. and Underhill, L.H. Mitochondria, DNA and disease, New England J of Medicine, 1995, 233:638- 644. © All Rights Reserved. 404. Gallagher, C.H. Aging of mitochondria. Nature, 1960, 187: 732, 566- 568. 405. Hunter, F.E., Malison, R., Bridgers, W.F., Schutz, B., and Atchison, A. J Biol Chem, 1959, 234: 693. 406. Born, G.R., and Geurkink, T.L. Improved peripheral vascular function with low dose intravenous ethylene diamine tetraacetic acid (EDTA). Townsend Letter for Doctors. July, 1994, # 132, 722- 726. 407. Article: EDTA Chelation: A Misunderstood Therapy for Atherosclerosis and other Chronic Diseases, © Vitamin Research Products Inc. 2001, http://intelegen.com/nutrients/chelation.htm, Copyright Intelegen Inc. 1995 - 2010 All rights reserved, © All Rights Reserved. 285
408. Article: Biography: Mirko Beljanski, PhD., http://beljanski.com, http://beljanski.com/engl/about/biographie- mirko- beljanski- phd/© copyright The Beljanski Foundation | CIRIS | All Rights Reserved. © All Rights Reserved. 409. Article: Testimonials, http://beljanski.com, http://beljanski.com/engl/2010/10/aids- stage- iv- c2- andhepatitis- c- mrs- francine- boquet/, © copyright The Beljanski Foundation | CIRIS | All Rights Reserved. 410. Article: Testimonials, http://beljanski.com, http://beljanski.com/engl/2010/10/aids- stage- iv- c2- andhepatitis- c- mrs- francine- boquet/, © copyright The Beljanski Foundation | CIRIS | All Rights Reserved. 411. Article: Testimonials, http://beljanski.com, http://beljanski.com/engl/2010/01/m- claude- frere/ , © copyright The Beljanski Foundation | CIRIS | All Rights Reserved. 412. Article: Testimonials, http://beljanski.com, http://beljanski.com/engl/2010/01/genevieve- tresse/ , © copyright The Beljanski Foundation | CIRIS | All Rights Reserved. 413. Article: Testimonials, http://beljanski.com, http://beljanski.com/engl/2010/01/bladder- and- prostatecancer- %E2%80%93- mr- georges- chaoui/ , © copyright The Beljanski Foundation | CIRIS | All Rights Reserved. 414. Quotation Source: Copyright © 2000 2013 AlkalizeForHealth, All rights reserved. http://www.alkalizeforhealth.net/cancerpain.htm 415. Quotation Source: MECHANISMS OF CANCER DEVELOPMENT, Copyright 2012 - Jeremy E. Kaslow, M.D. - all rights reserved, http://www.drkaslow.com/html/cancer.htm © All Rights Reserved. 416. Article: The Cachexia Treatment Hydrazine Sulphate (i.e. Hydrazine Sulfate) by R. Webster Kehr, Copyright by R. Webster Kehr, All Right Reserved, http://www.cancertutor.com/, http://www.cancertutor.com/Cancer/Hydrazine.html 417. Study: Filov VA, Gershanovich ML, Danova LA, Ivin BA., Experience of the treatment with Sehydrin (Hydrazine Sulfate, HS) in the advanced cancer patients., Prof. N.N. Petrov Research Institute of Oncology, St. Petersburg, Russia., Invest New Drugs. 1995;13(1):89- 97., PMID:7499115, [PubMed indexed for MEDLINE], http://www.ncbi.nlm.nih.gov/pubmed/7499115 © All Rights Reserved. 418. Study: Unconventional therapies for cancer: 4. Hydrazine sulfate, Elizabeth Kaegi, MB, ChB, MSc, on behalf of the Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative, This article, on hydrazine sulfate, is fourth in the series that reviews the safety and effectiveness of 6 unconventional therapies commonly used by Canadian cancer patients. The purpose and methodology of the review appear in part 1 (CMAJ 1998;158[7]:897- 902). CMAJ 1998;158:1327- 30. CMAJ • MAY 19, 1998; 158 (10), Copyright, 1998, Canadian Medical Association, Annotated bibliographies providing more detailed references are available in print from the Canadian Breast Cancer Research Initiative (CBCRI; address appears at end of article). The reference lists and the lay summaries of the findings (published in 1997) can be found on the CBCRI’s Web site (www.breast.cancer.ca). The following article 286
419. 420. 421.
422. 423.
424. 425. 426.
adapts the lay summary on hydrazine sulfate for clinicians and provides references for the key findings. [Copies of this and other articles in the series can be found on CMAJ’s Web site (www.cma.ca/cmaj/series/therapy.htm) © All Rights Reserved.http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1229327/pdf/cmaj_158_10_1327.pdf] Warburg O. On the origin of cancer cells. Science 1956;123:309- 14. Macbeth RAL, Bekesi JG. Oxygen consumption and anaerobic glycolysis of human malignant and normal tissue. Cancer Res 1962;22:244- 8. © All Rights Reserved. Gold J. Metabolic profiles in human solid tumors: I. A new technic for the utilization of human solid tumors in cancer research and its application to the anaerobic glycolysis of isologous benign and malignant colon tissues. Cancer Res 1966;26:695- 705. © All Rights Reserved. Gold J. Proposed treatment of cancer by inhibition of gluconeogenesis. Oncology 1968;22:185- 207. Ray PD, Foster DO, Lardy HA. Paths of carbon in gluconeogenesis and lipogenesis: IV. Inhibition by Ltryptophan of hepatic gluconeogenesis at the level of phosphoenolpyruvate formation. J Biol Chem 1966;241(17):3904- 8. © All Rights Reserved. Gold J. Inhibition of Walker 256 intramuscular carcinoma in rats by administration of L- tryptophan. Oncology 1970;24(4):291- 303. © All Rights Reserved. Ray PD, Hanson RL, Lardy HA. Inhibition by hydrazine of gluconeogenesis in the rat. J Biol Chem 1970;245(4):690- 6. © All Rights Reserved. Gold J. Inhibition of gluconeogenesis at the phosphoenolpyruvate carboxykinase and pyruvate carboxylase reactions, as a means of cancer chemotherapy. Oncology 1974;29:74- 89. © All Rights Reserved.
427. Gold J. Inhibition of Walker 256 intramuscular carcinoma in rats by administration of L- tryptophan and hydrazine sulfate [abstract 116]. Proc Am Assoc Cancer Res 1970;11:30. © All Rights Reserved. 428. Gold J. Inhibition of Walker 256 intramuscular carcinoma in rats by administration of hydrazine sulfate. Oncology 1971;25:66- 71. © All Rights Reserved. 429. Gold J. Use of hydrazine sulfate in terminal and preterminal cancer patients: results of investigational new drug (IND) study in 84 evaluable patients. Oncology 1975;32:1- 10. © All Rights Reserved. 430. Gold J. Anabolic profiles in late- stage cancer patients responsive to hydrazine sulfate. Nutr Cancer 1981;3(1):13- 9. © All Rights Reserved. 431. Ontario Breast Cancer Information Exchange Project. A guide to unconventional cancer therapies. Aurora (ON): R&R Bookbar; 1994. p. 278- 80. © All Rights Reserved. 432. Chlebowski RT, Bulcavage L, Grosvenor M, Oktay E, Block JB, Chlebowski JS, et al. Hydrazine sulfate influence in nutritional status and survival in nonsmall- cell lung cancer. J Clin Oncol 1990;8(1):9- 15.
287
433. Gold J. Enhancement by hydrazine sulfate of antitumor effectiveness of cytoxan, mitomycin C, methotrexate and bleomycin, in Walker 256 carcinosarcoma in rats. Oncology 1975;31:44- 53. 434. Chlebowski RT, Heber D, Richardson B, Block JB. Influence of hydrazine sulfate on abnormal carbohydrate metabolism in cancer patients with weight loss. J Cancer Res 1984;44:857- 61. 435. Tweedie DJ, Erikson JM, Prough RA. Metabolism of hydrazine anti- cancer agents. Pharmacol Ther 1987;34:111- 27. 436. Noda A, Sendo T, Ohno K, Noda H, Goto S. Metabolism and cytotoxicity of hydrazine in isolated rat hepatocytes. Chem Pharma Bull (Tokyo) 1987;35 (6):2538- 44. © All Rights Reserved. 437. Gold J. Incompatibility of hydrazine sulfate and pentobarbital in the treat- Unconventional therapies for cancer: hydrazine sulfate CMAJ • MAY 19, 1998; 158 (10) 1329 Vitamins A, C and E will be the topic of the next article in the series, to appear in the June 2 issue. ment of tumor bearing animals [abstract 999]. Proc Am Assoc Cancer Res 1977; 18:250. © All Rights Reserved. 438. Suzuki H, Tominaga T, Mizuno H, et al. Ethanol and hydrazine sulfate induced chronic hepatic injury in rats: the curative effect of administration of glucogenic amino acids. Alcohol Alcohol Suppl 1993;1A:1117. © All Rights Reserved. 439. Zimmerman HJ, Ishak KG. The hepatic injury of monoamine oxidase inhibitors. J Clin Psychopharmacol 1987;7(4):211- 3. © All Rights Reserved. 440. Berkow R, editor. The Merck manual of diagnosis and therapy. 16th ed. Toronto: WB Saunders Publishers; 1992. © All Rights Reserved. 441. Toth B. Hydrazine, methylhydrazine and methylhydrazine sulfate carcinogenesis in Swiss mice: failure of ammonium hydroxide to interfere in the development of tumors. Int J Cancer 1972;9:109- 18. 442. Menon MM, Bhide SV. Perinatal carcinogenicity of isoniazid (INH) in Swiss mice. J Cancer Res Clin Oncol 1983;105:258- 61. © All Rights Reserved. 443. Baló J. Role of hydrazine in carcinogenesis. Adv Cancer Res 1979;30:151- 64. 444. Bosan WS, Shrank RC, MacEwan JD, Gaworski CL, Newberne PM. Methylation of DNA guanine during the course of induction of liver cancer in hamsters by hydrazine or dimethylnitrosamine. Carcinogenesis 1987;8:439- 44. © All Rights Reserved. 445. Toth B. Teratogenic hydrazines: a review. In Vivo 1993;7(1):101- 10. © All Rights Reserved. 446. Silverstein R, Christoffersen CA, Morrison DC. Modulation of endotoxin lethality in mice by hydrazine sulfate. Infect Immun 1989;57(7):2072- 8. © All Rights Reserved. 447. Chlebowski RT, Heber D. Metabolic abnormalities in cancer patients: carbohydrate metabolism. Surg Clin North Am 1986;66(5):957- 68. © All Rights Reserved. 448. Filov VA, Burova TM. [Gluconeogenesis during therapy of experimental tumors with hydrazine sulfate] (Russian). Biull Eksp Biol Med 1984;97(1):73- 4. © All Rights Reserved. 288
449. Grubbs B, Rogers W, Cameron I. Total parenteral nutrition and inhibition of gluconeogenesis on tumorhost responses. Oncology 1979;36:216- 23. Š All Rights Reserved. 450. Gold J. Potentiation by clofibrate of in vivo tumor inhibition by hydrazine sulfate and cytotoxic agents, in Walker 256 intramuscular carcinoma. Cancer Biochem Biophys 1978;3(1):41- 5. 451. Nelson JAS, Falk RE. The efficacy of phloridzin and phloretin on tumor cell growth. Anticancer Res 1993;13:2287- 92. 452. Ottery FD. Supportive nutrition to prevent cachexia and improve quality of life. Semin Oncol 1995;22(2 Suppl 3):98- 111. 453. Chlebowski RT, Dietrich M, Tsunokai R, Block JB. Hydrazine sulfate: clinical pharmacokinetics and influence on in vitro growth of human glioblastoma cell lines [abstract 1002]. Proc Am Assoc Cancer Res 1985;26:254. 454. Filov VA, Gershanovich ML, Ivin BA, Danova LA, Gurchin FA, Naryshkin AG, et al. [Therapy of primary brain tumors with Sehydrin] (Russian). Vopr Onkol 1994;40(7- 12):332- 6. 455. Gold J. Inhibition by hydrazine sulfate and various hydrazides, of in vivo growth of Walker 256 intramuscular carcinoma, B- 16 melanoma, Murphy- Sturm lymphosarcoma and L- 1210 solid leukemia. Oncology 1973;27:69- 80. 456. Ochoa M Jr, Wittes RE, Krakoff IH. Trial of hydrazine sulfate (NSC- 150014) in patients with cancer. Cancer Chemother Rep 1975;59(6):1151- 4. 457. Tayek JA, Heber D, Chlebowski RT. Effect of hydrazine sulfate on wholebody protein breakdown measured by 14C- lysine metabolism in lung cancer patients. Lancet 1987;2:241- 3. 458. Bruera E. Current management of anorexia and cachexia in patients with advanced cancer. Oncology 1992;49(Suppl 2):35- 42. 459. Parnes HL, Aisner J. Protein calorie malnutrition and cancer therapy. Drug Saf 1992;7(6):404- 16. 460. Pisters PWT, Pearlstone DB. Protein and amino acid metabolism in cancer cachexia: investigative techniques and therapeutic interventions. Crit Rev Clin Lab Sci 1993;30(3):223- 72. 461. Strum SB, Bierman HR, Thompson R. Hydrazine sulfate in patients with neoplasia [abstract 1090]. Proc Am Assoc Cancer Res 1975;16:243. 462. Lerner HJ, Regelson W. Clinical trial of hydrazine sulfate in solid tumors. Cancer Treat Rep 1976;60(7):959- 60. 463. Kosty MP, Fleishman SB, Herndon JE, Coughlin K, Kornblith AB, Scalzo A, et al. Cisplatin, vinblastine, and hydrazine sulfate in advanced, non- small- cell lung cancer: a randomized placebo- controlled, double blind phase III study of the cancer and leukemia group B. J Clin Oncol 1994;12(6):1113- 20.
289
464. Loprinzi CL, Kuross SA, O’Fallon JR, Gesme DH, Gerstner JB, Rospond RM, et al. Randomized placebocontrolled evaluation of hydrazine sulfate in patients with advanced colorectal cancer. J Clin Oncol 1994;12(6):1121- 5. 465. Loprinzi CL, Goldberg RM, Su JQ, Mailliard JA, Kuross SA, Maksymiuk AW, et al. Placebo- controlled trial of hydrazine sulfate in patients with newly diagnosed non- small- cell lung cancer. J Clin Oncol 1994;12(6):1126- 9. 466. Gershanovich ML, Danova LA, Kondratyev VB, Malyugina LL, Stukov AN, Seitz JF, et al. Clinical data on the antitumor activity of hydrazine sulfate. Cancer Treat Rep 1976;60(7):933- 5. 467. Gershanovich ML, Danova LA, Ivin BA, Filov VA. Results of clinical study of antitumor action of hydrazine sulfate. Nutr Cancer 1981;3(1):7- 12. © All Rights Reserved. 468. Gold J. Hydrazine sulfate: a current perspective [review]. Nutr Cancer 1987;9(2- 3):59- 66. 469. Filov VA, Danova LA, Gershanovich ML, Ivin BA, Dementyeva NP, Beyvis PV, et al. Results of clinical evaluation of hydrazine sulfate. Vopr Onkol 1990 ;36(6):721- 6. © All Rights Reserved. 470. Gold J. Hydrazine sulfate in the treatment of cancer. Cancer Treat Rep 1976;60(7):964- 5. 471. Piantadosi S. Hazards of small clinical trials. J Clin Oncol 1990;8(1):1- 3. © All Rights Reserved. 472. Gold J. Hydrazine sulfate in nonsmall- cell lung cancer. J Clin Oncol 1990;8:1117- 8. 473. Herbert V. Three stakes in hydrazine sulfate’s heart, but questionable cancer remedies, like vampires, always rise again. J Clin Oncol 1994;12(6):1107- 8. © All Rights Reserved. 474. Kosty MP, Herndon JE, Green MR, McIntyre OR. Placebo- controlled randomized study of hydrazine sulfate in lung cancer. J Clin Oncol 1995;13(6): 1529- 30. © All Rights Reserved. 475. Kamen J. The cancer empire strikes back. Penthouse 1994;Nov:104- 5. © All Rights Reserved. 476. Steinhardt B, director, Health Services Quality and Public Issues, US General Accounting Office, Washington. Letter to Leonard Weiss, PhD, Minority Staff Director, Senate Committee on Governmental Affairs; 1998 Jan 8. [Letter in public domain; on file with the Canadian Breast Cancer Research Initiative.] © All Rights Reserved. 477. General reference books and journals Alternative medicine: expanding medical horizons: a report to the National Institute of Health on Alternative Medical Systems and Practices in the United States. Washington:National Institutes of Health; 1994. Publ no NIH 94- 066. Lerner M. Choices in healing: integrating the best of conventional and complementary approaches to cancer. Cambridge (MA): MIT Press; 1994. Ontario Breast Cancer Information Exchange Project. A guide to unconventional cancer therapies. Aurora (ON): R&R Bookbar; 1994. Fugh- Berman A. Alternative medicine, what works. Tucson: Odonian Press; 1996. 290
-
Peer- reviewed journals dealing with unconventional therapies: Alternative Therapies in Health and Medicine The Journal of Alternative and Complementary Medicine 478. Article: The Story of Ozone by Dr. Saul Pressman, DCh, LTOH, http://www.o3center.org/, PLASMAFIRE INTL, 7186- 205th Street, Langley, BC, Canada V2Y 1T1, 604- 532- 9596, http://www.o3center.org/Articles/TheStoryofOzone.html) All rights reserved 479. Article: Judah Folkman, M.D. Foundations for Cancer Therapy, American Academy of Achievement, www.achievement.org, ©1996 - 2013 American Academy of Achievement. All Rights Reserved, 479 480. Quote: Zetter BR., Harvard Medical School, Boston, Massachusetts 02115, USA, Annu Rev Med. 1998;49:407- 24. Angiogenesis and tumor metastasis., http://www.ncbi.nlm.nih.gov/pubmed/9509272. 481. Article: Dr. Judah Folkman: A true scientific giant has died, Respectful Insolence, Posted by Orac on January 15, 2008, http://scienceblogs.com/insolence/2008/01/15/judah- folkman- a- true- scientific- giant- ha/ 482. Article: Anticancer foods by Giselle Brand, http://conceptnutrition.com.au/ 2008), http://conceptnutrition.com.au/anti- cancer- foods/ 483. Y. Cao, R. Cao,’Angiogenesis inhibited by drinking tea’ Nature, 398 (6726), 1999; 381. 484. J. Fidler, ‘Angiogenic heterogeneity:regulation of neoplastic angiogenesis by the organ microenvironment’ Journal of the National Cancer Institute, 93(14), 2001; 1040- 41. 485. S. Paget, ‘The distribution of secondary growths in cancer of the breast’ Lancet 1889; 1:571- 3. 486. Y. J. Surh, ‘Cancer chemoprevention with dietary phytochemicals’ Nature Reviews Cancer, 3(10), 2003: 768- 80. 487. J. Jankun, S. H. Selman, R. Swierz, E. Skrzypczak- Jankun, ‘Why drinking green tea could prevent cancer’ Nature, 387(6633), 1997: 561. 488. M. Demeule, B. Annabi, J. Michaud- Levesque, S. Lamy, R. Beliveau, ‘Dietary prevention of cancer: Anticancer and antiangiogenic properties of green tea polyphenols’ Medicinal Chemistry Reviews – Online 2, 2005: 49- 58. 489. J. R. Zhou, L. Yu, Z. Mai, G. L. Blackburn, ‘Combined inhibition of estrogen- dependent human breast carcinoma by soy and tea bioactive components in mice’ International Journal of Cancer, 108(1), 2004; 8- 14. 490. J. R. Zhou, L. Yu, Y. Zhong, G. L. Blackburn, ’Soy phytochemicals and tea bioactive components in mice’ Journal of Nutrition, 133(2), 2003: 516- 21. 491. H. Wu, M. C. Pike, D, O. Stram, ‘Meta- analysis: Dietary fat intake, Serum Estrogen levels and the Risk of Breast Cancer’ Journal of the National Cancer Institute, 1999: 529- 34. 492. K. Mehta, P. Pantazis, T. McQueen, B.B. Aggarwal, ‘Antiproliferative effect of curcumin (diferuloylmethane) against human breast tumour cell lines’ Anticancer Drugs, 8(5), 1977: 470- 81. 493. S. Shishodia, B.B. Aggarwal, ‘Nuclear factor- kappa B activation: a question of life or death’ Journal of Biochemistry and Molecular Biology, 35(1), 2002: 28- 40. 494. B. B. Aggarwal, S. Shishodia, Y. Takada, et al. ‘Curcumin suppresses the paclitaxel- induced nuclear factor kappa B pathway in breast cancer cells and inhibits lung metestasis of human breast cancer in nude mice’ Clinical Cancer Research, 11(20), 2005: 7490- 98.
291
495. P. M. Kidd, ‘The Use of Mushroom Glucans and Proteoglycans in Cancer Treatment’ Alternative Medicine Review, 5(1), 2000: 4- 27. 496. H. Nakazato, A. Koike, S. Saji, N. Ogawa, J. Sakamoto, ‘Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer’ Lancet, 343, 1994: 1122- 6. 497. M. Hara, T. Hanaoka, M. kobayashi, et al. ‘Cruciferous vegetables, mushrooms and gastrointestinal cancer risks in a multicentre, hospital- based case- control study in Japan’ Nutrition Cancer, 46(2), 2003: 138- 47. 498. L. Labrecque, S. Lamy, A. Chapus, et al. ‘Combined inhibition of PDGF and VEGF receptors by ellagic acid, a dietary- derived phenolic compound’ Carcinogenesis, 26(4), 2005: 821- 6. 499. N. Seeram, L. Adams, Y. Zhang, et al. ‘Blackberry, black raspberry, blueberry, cranberry, red raspberry and strawberry extracts inhibit growth and stimulate apoptosis of human cancer cells in vitro’ Journal of Agricultural Food Chemicals, 54, 2006L 9329- 39. 500. R. Smith ‘Let food be thy medicine…’ British Medical Journal, 2004: 328. 501. H. Kikuzaki, N. Nakatani, ‘Antioxidant effects of some ginger constituents’ Journal of Food Science. 58(6), 1993, 1407- 10. 502. C. M. Cover, S. J. Hsieh, E. J.Cram. et al. ‘Indole- 3- carbinol and tamoxifen cooperate to arrest the cell cycle of MCF – 7 human breast cancer cells’ Cancer Research, 59(6), 1999: 1244- 51. 503. L. Gamet- Payraste, P. Li, S. Lumeau, et al. ‘Sulforaphane, a Naturally Occuring Isothiocyanate, Induces cell Cycle Arrest and Apoptosis in HT29 Human Colon Cancer Cells’ Cancer Research, 60(5), 2000: 1426- 33. 504. P. Terry, A. Wolk, H. Vainio, E. Weiderpass, ‘Fatty fish consumption lowers the risk of endometrial cancerL a nationwide case- control study in Sweden’ Cancer Epidemiology, Biomarkers & Prevention, 11(1), 2002; 143- 5. 505. P. Terry, P. Lichtenstein, M. Feychting, A. Ahlbom, A. Wolk, ‘Fatty fish consumption and the risk of prostate cancer’ Lancet, 357(9270), 2001: 1765- 6. 506. C. H. MacLean, S. J. Newberry, W. A. Mojica, et al. ‘Effects of omega- 3 fatty acids on cancer risk: a systematic review’ JAMA, 295(4), 2006: 403- 15. 507. M. P. Rayman, ‘The importance of selenium to human health’ Lancet, 356(9225), 2000: 233- 41. 508. J. M. Lappe, K. Travers- Gustafson, K. M. Davies, R. R. Recker, R. P. Heaney, ‘Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial’ American Journal of Clinical Nutrition, 85, 2007: 1586- 91. 509. R. Beliveau, D. Gingras, ‘Green tea: prevention and treatment of cancer by nutraceuticals’ Lancet, 354(9439), 2004:1021- 2. 510. D. P. Rose, J. M. Connolly, ‘Regulation of tumour angiogenesis by dietary fatty acids and eicosanoids’ Nutr Cancer, 37(2), 2000:119- 27. 511. T. Norat, S. Bingham, P. Ferrari, et al. ‘Meat, fish and colorectal cancer risk: the European Prospective Investigation into cancer and nutrition’ Journal of National Cancer Institute, 97(12), 2005:906- 16. 512. P. Terry, P. Lishtenstein, M. Feychting, A. Ahlbom, A. Wolk, ‘Fatty fish consumption and risk of prostate cancer’ Lancet, 357(9270), 2001: 1764- 6. 513. L. T. Hooper, R. Thompson, R. Harrison, et al. ‘Risks and benefits of omega- 3 fatty acidson cancer risk: a systematic review’ JAMA, 295(4), 2006: 403- 15.
292
514. M. P. Rayman, ‘The importance of selenium to human health’ Lancet, 356(9225), 2000:233- 41. 515. L. Kiremidjian- schumacher, M. Roy, H. I. Wishe, M. W. Cohen, G. Stotzky ‘Supplementation with selenium and human immune cell functios. II. Effect on cytotoxic lymphocytes and natural killer cells’ Biological Trace Element Research, 41(1- 2), 1994: 115- 27. 516. J. M. Lappe, k. Travers- Gustafson, K. M. davies, R. R. Recker, R. P. Heaney, ‘Vitamin D and calcium supplementation reduces cancer risk: results of a randomised trial’ American Journal Clinical Nutrition, 85, 2007: 1586- 91. 517. Article: Diet, Lifestyle & Angiogenesis, Understanding Angiogenesis, The Angiogenesis Foundation, http://www.angio.org/understanding/diet.php 518. Study: Robey IF, Baggett BK, Kirkpatrick ND, Roe DJ, Dosescu J, Sloane BF, Hashim AI, Morse DL, Raghunand N, Gatenby RA, Gillies RJ., Bicarbonate increases tumor pH and inhibits spontaneous metastases., Arizona Cancer Center, University of Arizona, Tucson, Arizona, USA. Cancer Res. 2009 Mar 15;69(6):2260-8. doi: 10.1158/00085472.CAN-07-5575. Epub 2009 Mar 10., http://www.ncbi.nlm.nih.gov/pubmed/19276390 519. Study: Bodey G, Bueltmann B, Duguid W, Gibbs D, Hanak H, Hotchi M, Mall G, Martino P, Meunier F, Milliken S, et al., Fungal infections in cancer patients: an international autopsy survey., M.D. Anderson Cancer Center, Houston, Texas 77030., Eur J Clin Microbiol Infect Dis. 1992 Feb;11(2):99-109., PMID:1396746 [PubMed - indexed for MEDLINE], http://www.ncbi.nlm.nih.gov/pubmed/1396746
293
Peter Havasi:
Biography
"Only freedom from prejudice and tireless zeal avail for the most holy of the endeavours of mankind, the practice of the true art of healing." - Samuel Hahnemann, Founder of Homeopathy (1755- 1843) 294
Peter Havasi (Nutr.Th, Herb.Th, Irid, Acu, Natur, Hom, Aura, Itec, Bsy) is an independent cancer researcher, historian, speaker, health educator, life-strategist and martial artist. Thomas A. Edison said, "The doctor of the future will give no medicine, but will interest his or her patients in the care of the human frame, in a proper diet, and in the cause and prevention of disease." In the early years of life he witnessed how his close family members suffered from cancer epidemics. Watching them die slowly in agony, this experience left deep marks in both his heart and soul. Peter Havasi: "There is nothing more important in the world today than to be openminded, reading between the lines, questioning facts, cultivating the big picture perspective and always looking outside of the box. My concept of freedom, wealth and happiness is based on searching for ways how to build physical, emotional and spiritual strengths as well as cultivate an independent mindset. This is what I truly believe in!" Without hesitation, he dropped the world of finance and swapped it for professional sports career and travelling. As a professional mountain- bike guide, he passionately tamed many mountain tracks in various places of the Mediterranean. A fast-paced modern lifestyle didnâ&#x20AC;&#x2122;t last for long. After few years the health destructive lifestyle began to reflect itself in forms of various health problems. Finding out that his condition falls into the same category as CANCER, he soon realized that his own health faces the same journey downhill towards the same
295
slaughterhouse his close relatives experienced. Throughout his sports career, Peter’s frame of mind changed into a warrior attitude challenging everything beyond its reach. Peter got the message loud and clear, and he saw gaining his health back another SPORTS CHALLENGE. In a split of a second he threw his career and immediately swapped it for a long and intense healing crusade, exploring ways how to heal diseases, BUILD POWERFUL HEALTH and WIN HIS LIFE BACK. Peter Havasi: "I have always wanted to make something big out of my life. Riding bikes day and night, testing your own boundaries sounds like fun, but there is more than that! At some stage I came to a point, that… it is finding the STRENGTH to face the deepest fears, what makes a man’s life truly BIG!" Peter obtained the knowledge and skills in many healing arts specializing in cancer and other modern epidemics. Among others, Peter got certified in Herbal Healing Arts, Nutritional Healing Arts, Naturopathy, Iridology, Acupressure and Massage, Homeopathy, and Yoga and Pilates. Peter is also a certified Fitness Coach specializing in High- Intensity Excercise. On top of natural healing, Peter also became a student of several martial arts, practicing them daily. His work is based on cancer research, selfpublishing and public education. Peter Havasi: "I see the art of natural healing as the most self-oriented form of martial arts. Even on different levels, both develop strength, power, integrity, toughness, coordination, speed, and balance – amongst others. Both cultivate a powerful character based on discipline, prediction, responsibility, respect, honor… you name it. From my perspective, arts of healing and arts of fighting are ONE and the same." 296
Peter believes that if you learn how to prevent cancer, you will learn how to heal and prevent many other problems which became our modern epidemics. Throughout the healing crusade, Peter explored all possible methods of supporting the body, mind and spirit by natural NOURISHING, CLEANSING, REBALANCING, and STRENGTHENING. Beside strong health followed by endless discipline and passion, Peter also strongly believes in FREEDOM, TRUTH and JUSTICE. With his book series, he shows that the world does possess adequate information resources to PREVENT and HEAL CANCER efficiently with the help of safe natural alternatives. Peter is not afraid to challenge and reveal thousands of studies, bring dead cancer healers back to life, and share their healing stories with YOU. He has led a rebellious, crusading, sacrificing and colorful life to bring the truth into the light. Not many professionals would dare put their professional, financial and social reputations on the line as many times as this courageous maverick has. Peter reveals medical truths and deceptions, often at risk of being labeled heretical. He is driven by passion for living a long and powerful life and wants his readers to share that passion. Their health and well- being comes first. Peter is antidogmatic and unwavering in his dedication to improve the quality of life of his readers. He has repeatedly gone far beyond the call of duty in his work to spread the truth about the history of cancer healing. For several years, he endured economic and physical and social hardship to research independently the history of alternative cancer healing. This learning experience, not to mention his dynamic story telling ability and wit, makes 297
his books uniquely interesting and easy to read. He shares his open-minded opinion to health care, often amazing his readers by telling them how to jumpstart the powers of natural healing and make them work for them. With his work, Peter brings a natural ALTERNATIVE to hospitals, medical doctors, butchery, chemical drugs, and personal physical, emotional and financial bankruptcy caused by our system of disease management. The authorâ&#x20AC;&#x2122;s personal commitment is to integrate an alternative among standardized dysfunction of chronic diseases with medical doctors, drugs and agonizing surgical operations. Peter dedicated his professional life to building and integrating his practice of health enhancement amongst those who are interested. Itâ&#x20AC;&#x2122;s called "Building POWERFUL HEALTH", also known as HAVASI LIFE BUILDING. In comparison to the standard treatment, HAVASI Life Building is more fun, far less costly, and it allows you to live your life to the fullest potential!
298
For more information, please visit Peter Havasiâ&#x20AC;&#x2122;s web site at www.PETERHAVASI.com.
299
"The greatest pleasure in life is doing what people say you cannot do." - Walter Bagehot
Photo: Peter Havasi, Turkey (2005)
300
MAXIMIZE your KNOWLEDGE with the next Volume! You may have finished reading this book, but there is more on the way! Peter’s Life Building crusade brings to life a whole fleet of books to bring YOU a step closer towards powerful health! In the next book, "The Education of Cancer Healing Volume VIII: Martyrs" you will be revealed as follows:
Facts about more than 20 successful Cancer Researchers
Vitamins in Cancer Treatment
Minerals in Cancer Treatment
Other Substances in Cancer Treatment
Debunking years of suppression … and much more!
More info at: www.PETERHAVASI.com
301
The HAVASI LIFE BUILDING Store
Peter Havasi - The Education of Cancer Healing Volume I: Wake- up Call
Peter Havasi - The Education of Cancer Healing Volume II: Specialists
Peter Havasi - The Education of Cancer Healing Volume III: Ancients
Peter Havasi - The Education of Cancer Healing Volume IV: Pioneers
Peter Havasi - The Education of Cancer Healing Volume V: Explorers
Peter Havasi - The Education of Cancer Healing Volume VI Mavericks
More info at: www.PETERHAVASI.com
302
Peter Havasi - The Education of Cancer Healing Volume VII: Heretics
Peter Havasi - The Education of Cancer Healing Volume VIII: Martyrs
Peter Havasi - The Education of Cancer Healing Volume IX: All- In- One
Peter Havasi - The Education of Cancer Healing Volume X: Warriors
More info at: www.PETERHAVASI.com
303
304